Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:stilbenol
go back to main search page
Accession:CHEBI:36027 term browser browse the term
Definition:Any stilbenoid with at least one phenolic group.


show annotations for term's descendants           Sort by:
dihydroresveratrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor increases activity
multiple interactions 		ISO dihydroresveratrol results in increased activity of AHR protein
dihydroresveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] 		CTD PMID:28279696 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Fabp4 fatty acid binding protein 4 decreases expression ISO dihydroresveratrol results in decreased expression of FABP4 CTD PMID:21852083 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
isorhapontigenin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Agt angiotensinogen multiple interactions EXP isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Hydrogen Peroxide]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Malondialdehyde]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] CTD PMID:15607907 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO isorhapontigenin results in decreased expression of CCND1 protein CTD PMID:37619952 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in increased expression of CDH1 protein CTD PMID:37619952 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased localization of CTNNB1 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased phosphorylation of CTNNB1 protein CTD PMID:37619952 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT1 protein CTD PMID:37619952 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein CTD PMID:37619952 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein CTD PMID:37619952 NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit affects expression EXP isorhapontigenin affects the expression of FOS protein CTD PMID:15607907 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in increased phosphorylation of GSK3B protein CTD PMID:37619952 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta affects activity EXP isorhapontigenin affects the activity of IKBKB protein CTD PMID:15607907 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit affects expression EXP isorhapontigenin affects the expression of JUN protein CTD PMID:15607907 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] CTD PMID:15607907 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] CTD PMID:15607907 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions EXP isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] CTD PMID:15607907 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Meg3 maternally expressed 3 multiple interactions ISO isorhapontigenin inhibits the reaction [sodium bichromate results in decreased expression of MEG3] CTD PMID:37619952 NCBI chr 6:134,274,056...134,306,249 JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO isorhapontigenin results in decreased expression of MKI67 protein CTD PMID:37619952 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated 9 multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA CTD PMID:37619952 NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions EXP isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein CTD PMID:15607907 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Snai2 snail family transcriptional repressor 2 multiple interactions ISO [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of SNAI2 protein CTD PMID:37619952 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349 		JBrowse link
pinosylvin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb10 ATP binding cassette subfamily B member 10 decreases expression ISO pinosylvin results in decreased expression of ABCB10 mRNA CTD PMID:23333577 NCBI chr19:68,850,108...68,881,689
Ensembl chr19:68,850,134...68,880,203 		JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 decreases expression ISO pinosylvin results in decreased expression of ABCE1 mRNA CTD PMID:23333577 NCBI chr19:45,109,880...45,134,819
Ensembl chr19:45,109,906...45,134,819 		JBrowse link
G Arhgap29 Rho GTPase activating protein 29 decreases expression ISO pinosylvin results in decreased expression of ARHGAP29 mRNA CTD PMID:23333577 NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729 		JBrowse link
G Art1 ADP-ribosyltransferase 1 increases expression ISO pinosylvin results in increased expression of ART1 mRNA CTD PMID:23333577 NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146 		JBrowse link
G Bag2 BAG cochaperone 2 decreases expression ISO pinosylvin results in decreased expression of BAG2 mRNA CTD PMID:23333577 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bcap29 B-cell receptor-associated protein 29 decreases expression ISO pinosylvin results in decreased expression of BCAP29 mRNA CTD PMID:23333577 NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA CTD PMID:23333577 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA CTD PMID:23333577 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Cbx3 chromobox 3 decreases expression ISO pinosylvin results in decreased expression of CBX3 mRNA CTD PMID:23333577 NCBI chr 4:81,876,155...81,889,912
Ensembl chr 4:81,876,649...81,889,911 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO pinosylvin results in decreased expression of CCNA2 protein CTD PMID:23333577 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions 		ISO pinosylvin results in decreased expression of CCND1 protein
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA 		CTD PMID:23333577 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccne1 cyclin E1 decreases expression ISO pinosylvin results in decreased expression of CCNE1 protein CTD PMID:23333577 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Cdca2 cell division cycle associated 2 decreases expression ISO pinosylvin results in decreased expression of CDCA2 mRNA CTD PMID:23333577 NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639 		JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression ISO pinosylvin results in decreased expression of CDK2 protein CTD PMID:23333577 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk2ap1 cyclin-dependent kinase 2 associated protein 1 decreases expression ISO pinosylvin results in decreased expression of CDK2AP1 mRNA CTD PMID:23333577 NCBI chr12:37,910,718...37,919,446
Ensembl chr12:37,910,718...37,919,446 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression ISO pinosylvin results in decreased expression of CDK4 protein CTD PMID:23333577 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk8 cyclin-dependent kinase 8 decreases expression ISO pinosylvin results in decreased expression of CDK8 mRNA CTD PMID:23333577 NCBI chr12:13,851,024...13,919,017
Ensembl chr12:13,851,024...13,917,992 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO pinosylvin results in increased expression of CDKN1A mRNA CTD PMID:23333577 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cenpf centromere protein F decreases expression ISO pinosylvin results in decreased expression of CENPF mRNA CTD PMID:23333577 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cep290 centrosomal protein 290 increases expression ISO pinosylvin results in increased expression of CEP290 mRNA CTD PMID:23333577 NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B decreases expression ISO pinosylvin results in decreased expression of CHAF1B mRNA CTD PMID:23333577 NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733 		JBrowse link
G Chd1 chromodomain helicase DNA binding protein 1 increases expression ISO pinosylvin results in increased expression of CHD1 mRNA CTD PMID:23333577 NCBI chr 1:65,334,905...65,402,270
Ensembl chr 1:65,335,218...65,401,280 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression ISO pinosylvin results in decreased expression of CKS2 mRNA CTD PMID:23333577 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression ISO pinosylvin results in decreased expression of COX5A mRNA CTD PMID:23333577 NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279 		JBrowse link
G Cox7c cytochrome c oxidase subunit 7C decreases expression ISO pinosylvin results in decreased expression of COX7C mRNA CTD PMID:23333577 NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA; pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein CTD PMID:23333577 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Dchs2 dachsous cadherin-related 2 increases expression ISO pinosylvin results in increased expression of DCHS2 mRNA CTD PMID:23333577 NCBI chr 2:170,775,818...170,983,844
Ensembl chr 2:170,776,682...170,981,770 		JBrowse link
G Dhx15 DEAH-box helicase 15 decreases expression ISO pinosylvin results in decreased expression of DHX15 mRNA CTD PMID:23333577 NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828 		JBrowse link
G Dsg1 desmoglein 1 decreases expression ISO pinosylvin results in decreased expression of DSG1 mRNA CTD PMID:23333577 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Eno1 enolase 1 decreases expression ISO pinosylvin results in decreased expression of ENO1 mRNA CTD PMID:23333577 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit increases expression ISO pinosylvin results in increased expression of ERCC1 mRNA CTD PMID:23333577 NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120 		JBrowse link
G Etfb electron transfer flavoprotein subunit beta increases expression ISO pinosylvin results in increased expression of ETFB mRNA CTD PMID:23333577 NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659 		JBrowse link
G Fbxo8 F-box protein 8 increases expression ISO pinosylvin results in increased expression of FBXO8 mRNA CTD PMID:23333577 NCBI chr16:38,676,011...38,721,849
Ensembl chr16:38,676,014...38,721,906 		JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO pinosylvin results in decreased expression of FDPS mRNA CTD PMID:23333577 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fh fumarate hydratase decreases expression ISO pinosylvin results in decreased expression of FH mRNA CTD PMID:23333577 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627 		JBrowse link
G Fth1 ferritin heavy chain 1 increases expression ISO pinosylvin results in increased expression of FTH1 mRNA CTD PMID:23333577 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO pinosylvin results in increased expression of GADD45A mRNA CTD PMID:23333577 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO pinosylvin results in increased expression of GDF15 mRNA; pinosylvin results in increased expression of GDF15 protein CTD PMID:23333577 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gnai1 G protein subunit alpha i1 decreases expression ISO pinosylvin results in decreased expression of GNAI1 mRNA CTD PMID:23333577 NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198 		JBrowse link
G Gtf2h5 general transcription factor IIH subunit 5 decreases expression ISO pinosylvin results in decreased expression of GTF2H5 mRNA CTD PMID:23333577 NCBI chr 1:49,061,904...49,068,612
Ensembl chr 1:49,061,959...49,070,039 		JBrowse link
G H3f3b H3.3 histone B decreases expression ISO pinosylvin results in decreased expression of H3-3B mRNA CTD PMID:23333577 NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636 		JBrowse link
G Hal histidine ammonia lyase increases expression ISO pinosylvin results in increased expression of HAL mRNA CTD PMID:23333577 NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744 		JBrowse link
G Hmox2 heme oxygenase 2 increases expression ISO pinosylvin results in increased expression of HMOX2 mRNA CTD PMID:23333577 NCBI chr10:11,303,512...11,337,640
Ensembl chr10:11,303,512...11,318,800 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 decreases expression ISO pinosylvin results in decreased expression of HSP90AB1 mRNA CTD PMID:23333577 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Id2 inhibitor of DNA binding 2 multiple interactions
decreases expression 		ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA
pinosylvin results in decreased expression of ID2 mRNA 		CTD PMID:23333577 NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO pinosylvin results in decreased expression of IDI1 mRNA CTD PMID:23333577 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Il1rap interleukin 1 receptor accessory protein decreases expression ISO pinosylvin results in decreased expression of IL1RAP mRNA CTD PMID:23333577 NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342 		JBrowse link
G Irf2bp1 interferon regulatory factor 2 binding protein 1 increases expression ISO pinosylvin results in increased expression of IRF2BP1 mRNA CTD PMID:23333577 NCBI chr 1:87,780,782...87,783,483
Ensembl chr 1:87,779,406...87,785,661 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 increases expression ISO pinosylvin results in increased expression of JAG1 mRNA CTD PMID:23333577 NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872 		JBrowse link
G Kbtbd6 kelch repeat and BTB domain containing 6 decreases expression ISO pinosylvin results in decreased expression of KBTBD6 mRNA CTD PMID:23333577 NCBI chr15:61,257,360...61,259,117 JBrowse link
G Lrrc25 leucine rich repeat containing 25 increases expression ISO pinosylvin results in increased expression of LRRC25 mRNA CTD PMID:23333577 NCBI chr16:18,840,867...18,847,722
Ensembl chr16:18,840,867...18,846,464 		JBrowse link
G Lsm6 LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated decreases expression ISO pinosylvin results in decreased expression of LSM6 mRNA CTD PMID:23333577 NCBI chr19:46,002,592...46,017,152 JBrowse link
G Mcm5 minichromosome maintenance complex component 5 decreases expression ISO pinosylvin results in decreased expression of MCM5 mRNA CTD PMID:23333577 NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758 		JBrowse link
G Metap2 methionyl aminopeptidase 2 decreases expression ISO pinosylvin results in decreased expression of METAP2 mRNA CTD PMID:23333577 NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521 		JBrowse link
G Mex3d mex-3 RNA binding family member D decreases expression ISO pinosylvin results in decreased expression of MEX3D mRNA CTD PMID:23333577 NCBI chr 7:9,976,253...9,983,383
Ensembl chr 7:9,976,253...9,983,383 		JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA CTD PMID:23333577 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mrpl14 mitochondrial ribosomal protein L14 decreases expression ISO pinosylvin results in decreased expression of MRPL14 mRNA CTD PMID:23333577 NCBI chr 9:22,800,286...22,812,711
Ensembl chr 9:22,795,744...22,812,855 		JBrowse link
G Mrpl41 mitochondrial ribosomal protein L41 decreases expression ISO pinosylvin results in decreased expression of MRPL41 mRNA CTD PMID:23333577 NCBI chr 3:28,178,837...28,179,755
Ensembl chr 3:28,162,197...28,181,250 		JBrowse link
G Mt4 metallothionein 4 increases expression ISO pinosylvin results in increased expression of MT4 mRNA CTD PMID:23333577 NCBI chr19:10,869,735...10,871,831
Ensembl chr19:10,869,735...10,871,831 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
decreases expression 		ISO [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA
pinosylvin results in decreased expression of MYC protein 		CTD PMID:23333577 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Nup35 nucleoporin 35 decreases expression ISO pinosylvin results in decreased expression of NUP35 mRNA CTD PMID:23333577 NCBI chr 3:85,965,907...85,991,659
Ensembl chr 3:85,945,080...85,992,027 		JBrowse link
G Oaz1 ornithine decarboxylase antizyme 1 decreases expression ISO pinosylvin results in decreased expression of OAZ1 mRNA CTD PMID:23333577 NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO pinosylvin results in decreased expression of PCNA mRNA CTD PMID:23333577 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Polr2j RNA polymerase II subunit J increases expression ISO pinosylvin results in increased expression of POLR2J mRNA CTD PMID:23333577 NCBI chr12:26,179,649...26,185,201
Ensembl chr12:26,179,649...26,185,201 		JBrowse link
G Ppat phosphoribosyl pyrophosphate amidotransferase decreases expression ISO pinosylvin results in decreased expression of PPAT mRNA CTD PMID:23333577 NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405 		JBrowse link
G Ptges2 prostaglandin E synthase 2 decreases expression ISO pinosylvin results in decreased expression of PTGES2 mRNA CTD PMID:23333577 NCBI chr 3:36,088,246...36,095,430
Ensembl chr 3:36,088,246...36,097,694 		JBrowse link
G Ptk2 protein tyrosine kinase 2 decreases expression ISO pinosylvin results in decreased expression of PTK2 protein modified form CTD PMID:23333577 NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091 		JBrowse link
G Pxmp4 peroxisomal membrane protein 4 increases expression ISO pinosylvin results in increased expression of PXMP4 mRNA CTD PMID:23333577 NCBI chr 3:163,553,582...163,570,829
Ensembl chr 3:163,553,599...163,570,829 		JBrowse link
G Rad23b RAD23 homolog B, nucleotide excision repair protein decreases expression ISO pinosylvin results in decreased expression of RAD23B mRNA CTD PMID:23333577 NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426 		JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression ISO pinosylvin results in decreased expression of RB1 protein CTD PMID:23333577 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbbp8 RB binding protein 8, endonuclease decreases expression ISO pinosylvin results in decreased expression of RBBP8 mRNA CTD PMID:23333577 NCBI chr18:3,198,188...3,263,643
Ensembl chr18:3,197,310...3,263,985 		JBrowse link
G Rbx1 ring-box 1 decreases expression ISO pinosylvin results in decreased expression of RBX1 mRNA CTD PMID:23333577 NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO pinosylvin results in decreased expression of RRM2 mRNA CTD PMID:23333577 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Sec22b SEC22 homolog B, vesicle trafficking protein increases expression ISO pinosylvin results in increased expression of SEC22B mRNA CTD PMID:23333577 NCBI chr 2:188,188,783...188,209,565
Ensembl chr 2:188,188,751...188,211,600 		JBrowse link
G Serbp1 Serpine1 mRNA binding protein 1 decreases expression ISO pinosylvin results in decreased expression of SERBP1 mRNA CTD PMID:23333577 NCBI chr 4:97,731,200...97,748,438
Ensembl chr 4:97,731,277...97,751,518 		JBrowse link
G Sgta small glutamine rich tetratricopeptide repeat co-chaperone alpha increases expression ISO pinosylvin results in increased expression of SGTA mRNA CTD PMID:23333577 NCBI chr 7:9,304,381...9,321,157
Ensembl chr 7:9,304,197...9,321,669 		JBrowse link
G Slc38a2 solute carrier family 38, member 2 increases expression ISO pinosylvin results in increased expression of SLC38A2 mRNA CTD PMID:23333577 NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619 		JBrowse link
G Snrpb2 small nuclear ribonucleoprotein polypeptide B2 decreases expression ISO pinosylvin results in decreased expression of SNRPB2 mRNA CTD PMID:23333577 NCBI chr 3:150,852,814...150,862,364
Ensembl chr 3:150,852,790...150,863,428 		JBrowse link
G Snrpg small nuclear ribonucleoprotein polypeptide G decreases expression ISO pinosylvin results in decreased expression of SNRPG mRNA CTD PMID:23333577 NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:120,369,685...120,377,261
Ensembl chr  X:120,369,685...120,377,261 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase decreases expression ISO pinosylvin results in decreased expression of SRC protein modified form CTD PMID:23333577 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462 		JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 decreases expression ISO pinosylvin results in decreased expression of SRSF10 mRNA CTD PMID:23333577 NCBI chr 5:153,372,307...153,386,520
Ensembl chr 5:153,372,316...153,386,513 		JBrowse link
G Srsf11 serine and arginine rich splicing factor 11 decreases expression ISO pinosylvin results in decreased expression of SRSF11 mRNA CTD PMID:23333577 NCBI chr 2:249,733,464...249,760,296
Ensembl chr 2:249,733,464...249,760,499 		JBrowse link
G Srsf3 serine and arginine rich splicing factor 3 decreases expression ISO pinosylvin results in decreased expression of SFRS3 mRNA CTD PMID:23333577 NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,093,565...7,103,516 		JBrowse link
G Ssbp1 single stranded DNA binding protein 1 decreases expression ISO pinosylvin results in decreased expression of SSBP1 mRNA CTD PMID:23333577 NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:70,232,794...70,243,700 		JBrowse link
G Stx6 syntaxin 6 increases expression ISO pinosylvin results in increased expression of STX6 mRNA CTD PMID:23333577 NCBI chr13:69,882,647...69,928,895
Ensembl chr13:69,882,620...69,931,036 		JBrowse link
G Tbc1d25 TBC1 domain family, member 25 increases expression ISO pinosylvin results in increased expression of TBC1D25 mRNA CTD PMID:23333577 NCBI chr  X:16,986,629...17,010,228
Ensembl chr  X:16,986,269...17,010,230 		JBrowse link
G Timm13 translocase of inner mitochondrial membrane 13 decreases expression ISO pinosylvin results in decreased expression of TIMM13 mRNA CTD PMID:23333577 NCBI chr 7:9,459,490...9,460,849
Ensembl chr 7:9,459,582...9,460,862 		JBrowse link
G Tmed2 transmembrane p24 trafficking protein 2 increases expression ISO pinosylvin results in increased expression of TMED2 mRNA CTD PMID:23333577 NCBI chr12:37,713,522...37,722,606
Ensembl chr12:37,713,529...37,722,606 		JBrowse link
G Tmprss3 transmembrane serine protease 3 decreases expression ISO pinosylvin results in decreased expression of TMPRSS3 mRNA CTD PMID:23333577 NCBI chr20:9,253,497...9,275,167
Ensembl chr20:9,255,467...9,275,720 		JBrowse link
G Tnrc6c trinucleotide repeat containing adaptor 6C decreases expression ISO pinosylvin results in decreased expression of TNRC6C mRNA CTD PMID:23333577 NCBI chr10:103,367,498...103,478,246
Ensembl chr10:103,367,647...103,478,246 		JBrowse link
G Tp53 tumor protein p53 increases expression ISO pinosylvin results in increased expression of TP53 protein CTD PMID:23333577 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 increases expression ISO pinosylvin results in increased expression of TSC22D1 mRNA CTD PMID:23333577 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tuba1b tubulin, alpha 1B decreases expression ISO pinosylvin results in decreased expression of TUBA1B mRNA CTD PMID:23333577 NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tubb5 tubulin, beta 5 class I decreases expression ISO pinosylvin results in decreased expression of TUBB mRNA CTD PMID:23333577 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Ube2d1 ubiquitin-conjugating enzyme E2D 1 decreases expression ISO pinosylvin results in decreased expression of UBE2D1 mRNA CTD PMID:23333577 NCBI chr20:17,308,459...17,341,427
Ensembl chr20:17,331,646...17,341,427 		JBrowse link
G Ubxn2a UBX domain protein 2A decreases expression ISO pinosylvin results in decreased expression of UBXN2A mRNA CTD PMID:23333577 NCBI chr 6:33,603,804...33,645,958
Ensembl chr 6:33,603,804...33,632,202
Ensembl chr20:33,603,804...33,632,202 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO pinosylvin results in increased expression of UCHL1 mRNA CTD PMID:23333577 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Usp22 ubiquitin specific peptidase 22 decreases expression ISO pinosylvin results in decreased expression of USP22 mRNA CTD PMID:23333577 NCBI chr10:46,328,092...46,354,939
Ensembl chr10:46,328,092...46,371,723 		JBrowse link
G Usp7 ubiquitin specific peptidase 7 increases expression ISO pinosylvin results in increased expression of USP7 mRNA CTD PMID:23333577 NCBI chr10:7,335,508...7,432,018
Ensembl chr10:7,367,604...7,432,013 		JBrowse link
G Zbtb44 zinc finger and BTB domain containing 44 decreases expression ISO pinosylvin results in decreased expression of ZBTB44 mRNA CTD PMID:23333577 NCBI chr 8:37,724,237...37,782,220
Ensembl chr 8:37,724,250...37,776,691 		JBrowse link
G Zfp207 zinc finger protein 207 decreases expression ISO pinosylvin results in decreased expression of ZNF207 mRNA CTD PMID:23333577 NCBI chr10:65,883,630...65,895,895
Ensembl chr10:65,883,599...65,895,895 		JBrowse link
G Zfp330 zinc finger protein 330 decreases expression ISO pinosylvin results in decreased expression of ZNF330 mRNA CTD PMID:23333577 NCBI chr19:42,218,213...42,229,516
Ensembl chr19:42,205,549...42,229,516 		JBrowse link
pterostilbene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions ISO pterostilbene inhibits the reaction [potassium oxonate results in increased expression of ABCG2 protein] CTD PMID:22865646 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain increases expression ISO pterostilbene results in increased expression of ACADM mRNA CTD PMID:26443543 NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions EXP [Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of ACOX1 protein CTD PMID:25083823 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases activity 		ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased activity of AHR protein]; pterostilbene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] CTD PMID:28279696 PMID:31004704 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions ISO pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 protein] CTD PMID:21355597 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases expression
multiple interactions
increases phosphorylation 		ISO pterostilbene results in decreased expression of AKT1 mRNA
pterostilbene results in decreased phosphorylation of and results in decreased activity of AKT1 protein
pterostilbene results in increased phosphorylation of AKT1 protein 		CTD PMID:20152895 PMID:24154491 PMID:31139082 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO pterostilbene results in decreased expression of AMACR mRNA CTD PMID:20152895 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Atf2 activating transcription factor 2 multiple interactions ISO pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form] CTD PMID:19549798 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745 		JBrowse link
G Atg5 autophagy related 5 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] CTD PMID:34405320 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]] CTD PMID:34405320 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression 		ISO pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAD protein]
pterostilbene results in increased expression of BAD protein 		CTD PMID:20681671 PMID:31139082 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression ISO pterostilbene results in increased expression of BAK1 protein CTD PMID:23313376 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
affects response to substance
increases expression 		ISO pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAX protein]
BAX protein affects the susceptibility to pterostilbene
pterostilbene results in increased expression of BAX mRNA; pterostilbene results in increased expression of BAX protein 		CTD PMID:20152895 PMID:20681671 PMID:22572619 PMID:23313376 PMID:24936659 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
increases expression 		ISO [pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein; pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein]
pterostilbene results in decreased expression of BCL2 mRNA; pterostilbene results in decreased expression of BCL2 protein
pterostilbene results in increased expression of BCL2 protein 		CTD PMID:18852136 PMID:20152895 PMID:20681671 PMID:24936659 PMID:31139082 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 increases expression
multiple interactions
decreases expression 		ISO pterostilbene results in increased expression of BCL2L1 protein
pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein]
pterostilbene results in decreased expression of BCL2L1 protein 		CTD PMID:20681671 PMID:23313376 PMID:31139082 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Becn1 beclin 1 multiple interactions ISO BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]] CTD PMID:34405320 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bid BH3 interacting domain death agonist increases expression ISO pterostilbene results in increased expression of BID protein modified form CTD PMID:20681671 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Camp cathelicidin antimicrobial peptide multiple interactions
increases expression 		ISO calcipotriene promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP protein]; paricalcitol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP protein]
pterostilbene results in increased expression of CAMP mRNA; pterostilbene results in increased expression of CAMP protein 		CTD PMID:24039193 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]] CTD PMID:34474091 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp3 caspase 3 increases cleavage
increases expression
increases activity
multiple interactions 		ISO pterostilbene results in increased cleavage of CASP3 protein
pterostilbene results in increased expression of CASP3 mRNA
pterostilbene results in increased activity of CASP3 protein
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein]; pterostilbene inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP3 protein] 		CTD PMID:20152895 PMID:20681671 PMID:23313376 PMID:24936659 PMID:25341683 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 multiple interactions
increases activity 		ISO 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP4 protein] CTD PMID:25341683 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp7 caspase 7 multiple interactions ISO pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein] CTD PMID:33930484 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 multiple interactions ISO pterostilbene results in increased cleavage of and results in increased activity of CASP8 protein CTD PMID:20681671 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 increases activity
multiple interactions
increases expression
increases cleavage 		ISO pterostilbene results in increased activity of CASP9 protein
pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP9 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein]
pterostilbene results in increased expression of CASP9 protein
pterostilbene results in increased cleavage of CASP9 protein 		CTD PMID:20152895 PMID:20681671 PMID:25341683 PMID:33930484 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase multiple interactions
increases expression 		ISO CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]]
pterostilbene inhibits the reaction [Streptozocin results in decreased expression of CAT]
pterostilbene results in increased expression of CAT mRNA 		CTD PMID:25341683 PMID:26700463 PMID:34474091 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions ISO CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]
3-methyladenine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; Ammonium Chloride inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; Chloroquine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein] 		CTD PMID:34405320 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions 		ISO
EXP 		pterostilbene results in decreased expression of CCND1 protein
pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 protein] 		CTD PMID:19549798 PMID:20398797 PMID:20681671 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccne1 cyclin E1 decreases expression EXP pterostilbene results in decreased expression of CCNE1 protein CTD PMID:20398797 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
increases expression 		ISO pterostilbene inhibits the reaction [Azoxymethane results in decreased expression of CDH1 protein]
pterostilbene results in increased expression of CDH1 protein 		CTD PMID:20681671 PMID:23921149 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression EXP pterostilbene results in decreased expression of CDK2 protein CTD PMID:20398797 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression EXP pterostilbene results in decreased expression of CDK4 protein CTD PMID:20398797 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions 		ISO pterostilbene results in increased expression of CDKN1A protein
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]] 		CTD PMID:23313376 PMID:34405320 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO pterostilbene results in increased expression of CDKN1B protein CTD PMID:23313376 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions ISO CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]] CTD PMID:34405320 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions EXP [Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of CPT1A protein CTD PMID:25083823 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein CTD PMID:24319627 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cycs cytochrome c, somatic affects localization
increases expression 		ISO pterostilbene affects the localization of CYCS protein
pterostilbene results in increased expression of CYCS mRNA; pterostilbene results in increased expression of CYCS protein 		CTD PMID:22450950 PMID:22572619 PMID:26443543 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases expression 		ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased expression of CYP1A1 protein]
pterostilbene results in decreased expression of CYP1A1 mRNA 		CTD PMID:22450950 PMID:31004704 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity ISO pterostilbene results in decreased activity of CYP1A2 protein CTD PMID:16684708 PMID:30394306 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO pterostilbene results in increased expression of CYP2B6 mRNA CTD PMID:30394306 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 decreases activity ISO pterostilbene results in decreased activity of CYP2C19 protein CTD PMID:30394306 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression 		ISO 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of DDIT3 protein]
pterostilbene results in increased expression of DDIT3 mRNA; pterostilbene results in increased expression of DDIT3 protein 		CTD PMID:22450950 PMID:25341683 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha increases cleavage ISO pterostilbene results in increased cleavage of DFFA protein CTD PMID:20681671 NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728 		JBrowse link
G Dhrs2 dehydrogenase/reductase 2 increases expression ISO pterostilbene results in increased expression of DHRS2 mRNA; pterostilbene results in increased expression of DHRS2 protein CTD PMID:24936659 NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein increases expression
affects localization 		ISO pterostilbene results in increased expression of DIABLO protein
pterostilbene affects the localization of DIABLO protein 		CTD PMID:22450950 PMID:22572619 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions ISO [resveratrol co-treated with pterostilbene] results in decreased expression of DNMT1 mRNA CTD PMID:26459286 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions ISO [resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA CTD PMID:26459286 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta multiple interactions ISO pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA] CTD PMID:26459286 NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGF protein] CTD PMID:19447859 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR protein] CTD PMID:19447859 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A increases phosphorylation ISO pterostilbene results in increased phosphorylation of EIF2A protein CTD PMID:25341683 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation 		ISO 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein] CTD PMID:25341683 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Elk1 ETS transcription factor ELK1 multiple interactions ISO pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form] CTD PMID:19549798 NCBI chr  X:3,692,367...3,709,252
Ensembl chr  X:3,693,293...3,709,249 		JBrowse link
G Esr1 estrogen receptor 1 increases expression
multiple interactions 		ISO pterostilbene results in increased expression of ESR1 protein
[resveratrol co-treated with pterostilbene] results in increased expression of ESR1 mRNA; [resveratrol co-treated with pterostilbene] results in increased expression of ESR1 protein 		CTD PMID:27159275 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein] CTD PMID:24361291 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO pterostilbene results in increased expression of FAS protein CTD PMID:20681671 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand increases expression ISO pterostilbene results in increased expression of FASL protein CTD PMID:20681671 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase multiple interactions EXP [Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of FASN protein CTD PMID:25083823 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of FOS protein] CTD PMID:18551458 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fut1 fucosyltransferase 1 increases expression ISO pterostilbene results in increased expression of FUT1 mRNA CTD PMID:22450950 NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO pterostilbene results in increased expression of GDF15 mRNA CTD PMID:22450950 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions ISO pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] CTD PMID:33930484 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA] CTD PMID:25341683 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] CTD PMID:20681671 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases expression 		ISO NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]
pterostilbene results in decreased expression of GSR mRNA 		CTD PMID:21355597 PMID:25341683 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G H2ax H2A.X variant histone multiple interactions ISO [Resveratrol co-treated with pterostilbene] results in decreased expression of H2AX protein modified form; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]] CTD PMID:26459286 PMID:34405320 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hdac5 histone deacetylase 5 multiple interactions
increases phosphorylation 		ISO HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter] CTD PMID:26443543 NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244 		JBrowse link
G Hmga1 high mobility group AT-hook 1 multiple interactions ISO CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of HMGA1 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]]
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]] 		CTD PMID:34405320 PMID:34474091 NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]] CTD PMID:34474091 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions 		ISO pterostilbene results in increased expression of HMOX1 mRNA; pterostilbene results in increased expression of HMOX1 protein
[pterostilbene co-treated with kaempferol] results in increased expression of HMOX1 mRNA; pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 mRNA]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]]
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 protein] 		CTD PMID:21355597 PMID:22450950 PMID:25111660 PMID:31139082 PMID:33930484 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M increases expression ISO pterostilbene results in increased expression of HNRNPM mRNA CTD PMID:22450950 NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression 		ISO 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of HSPA5 protein]
pterostilbene results in increased expression of HSPA5 mRNA; pterostilbene results in increased expression of HSPA5 protein 		CTD PMID:25341683 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression ISO pterostilbene results in increased expression of HSPA9 mRNA CTD PMID:22450950 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 decreases expression ISO pterostilbene results in decreased expression of HSPE1 protein CTD PMID:24936659 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Ifng interferon gamma multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]]
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IFNG protein] 		CTD PMID:19549798 PMID:22698256 PMID:34405320 PMID:34474091 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il18 interleukin 18 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]] CTD PMID:34474091 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of IL1A protein]
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA] 		CTD PMID:34405320 PMID:34474091 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]]
pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] 		CTD PMID:19549798 PMID:22698256 PMID:34474091 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL6 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] 		CTD PMID:22698256 PMID:34405320 PMID:34474091 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO pterostilbene inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein] CTD PMID:26700463 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Itgb8 integrin subunit beta 8 decreases expression
increases expression 		ISO pterostilbene results in decreased expression of ITGB8 mRNA
pterostilbene results in increased expression of ITGB8 mRNA 		CTD PMID:22450950 NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245 		JBrowse link
G Jak2 Janus kinase 2 decreases phosphorylation ISO pterostilbene results in decreased phosphorylation of JAK2 protein CTD PMID:23313376 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] CTD PMID:18551458 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 multiple interactions ISO pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] CTD PMID:26700463 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Klf2 KLF transcription factor 2 multiple interactions
increases expression 		ISO MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter]
pterostilbene results in increased expression of KLF2 mRNA; pterostilbene results in increased expression of KLF2 protein 		CTD PMID:26443543 NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in decreased expression of LAMP1 protein] CTD PMID:34405320 NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159 		JBrowse link
G Ldlr low density lipoprotein receptor decreases expression ISO pterostilbene results in decreased expression of LDLR mRNA CTD PMID:22153697 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] CTD PMID:34405320 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases phosphorylation 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK1 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK1 protein
pterostilbene results in decreased phosphorylation of MAPK1 protein 		CTD PMID:19447859 PMID:24154491 PMID:26138072 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions ISO MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]] CTD PMID:19549798 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
decreases phosphorylation 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK3 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK3 protein
pterostilbene results in decreased phosphorylation of MAPK3 protein 		CTD PMID:19447859 PMID:24154491 PMID:26138072 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk7 mitogen-activated protein kinase 7 multiple interactions
increases phosphorylation 		ISO MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein] CTD PMID:26443543 NCBI chr10:46,669,721...46,675,768
Ensembl chr10:46,669,721...46,675,806 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK8 protein CTD PMID:19447859 PMID:24154491 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions ISO pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK9 protein CTD PMID:19447859 PMID:24154491 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member decreases expression ISO pterostilbene results in decreased expression of MCL1 protein CTD PMID:23313376 NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782 		JBrowse link
G Mlkl mixed lineage kinase domain like pseudokinase multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased phosphorylation of MLKL protein] CTD PMID:34474091 NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein] CTD PMID:20681671 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp28 matrix metallopeptidase 28 multiple interactions ISO pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP26 protein] CTD PMID:20681671 NCBI chr10:68,738,651...68,762,377
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions ISO pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP7 protein]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of MMP7 mRNA]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] CTD PMID:20681671 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mmp9 matrix metallopeptidase 9 decreases expression
decreases activity
multiple interactions 		ISO pterostilbene results in decreased expression of MMP9 mRNA
pterostilbene results in decreased activity of MMP9 protein
pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein]
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] 		CTD PMID:19447859 PMID:19617202 PMID:20152895 PMID:20681671 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression ISO pterostilbene results in decreased expression of MYC protein CTD PMID:19549798 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Nfatc4 nuclear factor of activated T-cells 4 multiple interactions ISO NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] CTD PMID:34474091 NCBI chr15:33,256,912...33,284,522
Ensembl chr15:33,274,153...33,285,582 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
affects localization
increases expression
increases phosphorylation 		ISO 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde affects the localization of NFE2L2 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]]
pterostilbene affects the localization of NFE2L2 protein
pterostilbene results in increased expression of NFE2L2 protein
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein]; pterostilbene results in increased expression of and results in increased localization of NFE2L2 protein; pterostilbene results in increased phosphorylation of and affects the localization of NFE2L2 protein 		CTD PMID:21355597 PMID:25341683 PMID:26700463 PMID:31139082 PMID:33930484 More... NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein] CTD PMID:18852136 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [pterostilbene co-treated with Quercetin] results in decreased degradation of NFKBIA protein; [pterostilbene co-treated with Quercetin] results in decreased phosphorylation of NFKBIA protein
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKBIA protein] 		CTD PMID:18551458 PMID:18852136 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]] CTD PMID:34474091 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]
pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein] 		CTD PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22698256 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions 		ISO pterostilbene results in increased expression of NQO1 mRNA; pterostilbene results in increased expression of NQO1 protein
[pterostilbene co-treated with kaempferol] results in increased expression of NQO1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of NQO1 protein; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]] 		CTD PMID:25111660 PMID:25341683 PMID:31139082 PMID:34474091 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nqo2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 increases expression ISO pterostilbene results in increased expression of NQO2 mRNA; pterostilbene results in increased expression of NQO2 protein CTD PMID:24936659 NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions
affects binding 		ISO pterostilbene binds to and results in increased activity of NR1I2 protein
pterostilbene binds to NR1I2 protein 		CTD PMID:20869355 PMID:30394306 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO pterostilbene binds to and results in increased activity of NR1I3 protein alternative form CTD PMID:20869355 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases expression
multiple interactions 		ISO pterostilbene results in increased expression of PARP1 protein modified form
pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of PARP1 protein] 		CTD PMID:19549798 PMID:33930484 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression EXP pterostilbene results in decreased expression of PCNA protein CTD PMID:20398797 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 increases expression ISO pterostilbene results in increased expression of PDK4 mRNA CTD PMID:26443543 NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381 		JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression ISO pterostilbene results in decreased expression of PGAM1 protein CTD PMID:24936659 NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO [resveratrol co-treated with pterostilbene] promotes the reaction [afimoxifene results in decreased expression of PGR mRNA]; [resveratrol co-treated with pterostilbene] promotes the reaction [Estradiol results in increased expression of PGR mRNA] CTD PMID:27159275 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions EXP
ISO 		pterostilbene binds to and results in increased activity of PPARA protein
pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]] 		CTD PMID:15853379 PMID:34474091 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression ISO pterostilbene results in increased expression of PPARGC1A mRNA CTD PMID:26443543 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions
increases phosphorylation 		ISO PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein]
pterostilbene results in increased phosphorylation of PRKAA1 protein 		CTD PMID:26443543 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450 		JBrowse link
G Prkcb protein kinase C, beta multiple interactions ISO pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] CTD PMID:21355597 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Psme3 proteasome activator subunit 3 decreases expression ISO pterostilbene results in decreased expression of PSME3 protein CTD PMID:24936659 NCBI chr10:86,757,933...86,765,719
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]
pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] 		CTD PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22842666 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]] CTD PMID:34474091 NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419 		JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression EXP pterostilbene results in decreased expression of RB1 protein CTD PMID:20398797 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [pterostilbene co-treated with Quercetin] affects the localization of RELA protein; [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein]
pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of RELA protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] 		CTD PMID:18551458 PMID:18852136 PMID:21355597 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ripk1 receptor interacting serine/threonine kinase 1 multiple interactions ISO NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein] CTD PMID:34474091 NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167 		JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 multiple interactions ISO NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]] CTD PMID:34474091 NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025 		JBrowse link
G Sars1 seryl-tRNA synthetase 1 increases expression ISO pterostilbene results in increased expression of SARS1 mRNA CTD PMID:22450950 NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365 		JBrowse link
G Sesn2 sestrin 2 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] CTD PMID:34405320 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO [resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 mRNA; [resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 protein CTD PMID:26459286 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Sirt2 sirtuin 2 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in decreased expression of SIRT2 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] CTD PMID:34474091 NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:93,181,224...93,204,499 		JBrowse link
G Slc22a12 solute carrier family 22 member 12 multiple interactions ISO pterostilbene inhibits the reaction [potassium oxonate results in increased expression of SLC22A12 protein] CTD PMID:22865646 NCBI chr 1:213,274,266...213,282,793
Ensembl chr 1:213,274,275...213,281,380 		JBrowse link
G Snai1 snail family transcriptional repressor 1 decreases expression ISO pterostilbene results in decreased expression of SNAI1 protein CTD PMID:23921149 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases expression 		ISO [pterostilbene co-treated with kaempferol] results in increased expression of SOD1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of SOD1 protein; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of SOD1 mRNA]
pterostilbene results in increased expression of SOD1 protein 		CTD PMID:25111660 PMID:33930484 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
increases expression
increases activity 		ISO [pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein; HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter]; pterostilbene results in increased expression of and results in increased activity of SOD2 protein; SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein]
pterostilbene results in increased expression of SOD2 protein
ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein]; fulvestrant inhibits the reaction [pterostilbene results in increased expression of SOD2 protein]
pterostilbene results in increased activity of SOD2 protein 		CTD PMID:18852136 PMID:22450950 PMID:22572619 PMID:24361291 PMID:26443543 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sp1 Sp1 transcription factor multiple interactions ISO SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] CTD PMID:18852136 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO bafilomycin A1 inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; Cycloheximide promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]] CTD PMID:34405320 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 decreases expression
decreases phosphorylation
decreases activity 		ISO pterostilbene results in decreased expression of STAT3 protein modified form
pterostilbene results in decreased phosphorylation of STAT3 protein
pterostilbene results in decreased activity of STAT3 protein 		CTD PMID:22450950 PMID:23313376 PMID:26138072 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stk11 serine/threonine kinase 11 increases phosphorylation ISO pterostilbene results in increased phosphorylation of STK11 protein CTD PMID:26443543 NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965 		JBrowse link
G Terf1 telomeric repeat binding factor 1 multiple interactions ISO pterostilbene inhibits the reaction [Ethanol results in increased expression of TERF1 protein] CTD PMID:34405320 NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:8,226,345...8,255,753 		JBrowse link
G Tert telomerase reverse transcriptase decreases expression
multiple interactions 		ISO pterostilbene results in decreased expression of TERT mRNA; pterostilbene results in decreased expression of TERT protein
pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT protein]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT mRNA]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT protein] 		CTD PMID:26459286 PMID:34405320 NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]]
pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] 		CTD PMID:19549798 PMID:22698256 PMID:23731018 PMID:34405320 PMID:34474091 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 increases expression ISO pterostilbene results in increased expression of TP53 mRNA CTD PMID:20152895 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tpt1 tumor protein, translationally-controlled 1 decreases expression ISO pterostilbene results in decreased expression of TPT1 protein CTD PMID:24936659 NCBI chr15:57,562,217...57,568,968
Ensembl chr15:57,566,067...57,569,554 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases glucuronidation
decreases activity
multiple interactions 		ISO UGT1A1 protein results in increased glucuronidation of pterostilbene
pterostilbene results in decreased activity of UGT1A1 protein
pterostilbene inhibits the reaction [[UGT1A1 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] 		CTD PMID:23965644 PMID:31812603 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases glucuronidation
multiple interactions
decreases activity 		ISO UGT1A3 protein results in increased glucuronidation of pterostilbene
pterostilbene inhibits the reaction [[UGT1A3 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide]
pterostilbene results in decreased activity of UGT1A3 protein 		CTD PMID:23965644 PMID:31812603 NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a6a UDP glucuronosyltransferase family 1 member A6a multiple interactions
decreases activity 		ISO pterostilbene inhibits the reaction [[UGT1A6 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide]
pterostilbene results in decreased activity of UGT1A6 protein 		CTD PMID:31812603 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 affects glucuronidation
decreases activity
multiple interactions 		ISO UGT1A9 protein affects the glucuronidation of pterostilbene
pterostilbene results in decreased activity of UGT1A9 protein
pterostilbene inhibits the reaction [[UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] 		CTD PMID:23965644 PMID:31812603 NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 decreases activity
multiple interactions 		ISO pterostilbene results in decreased activity of UGT2B7 protein
pterostilbene inhibits the reaction [[UGT2B7 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] 		CTD PMID:31812603 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451 		JBrowse link
G Umod uromodulin multiple interactions ISO pterostilbene inhibits the reaction [potassium oxonate results in increased expression of UMOD protein] CTD PMID:22865646 NCBI chr 1:183,247,676...183,261,665
Ensembl chr 1:183,247,674...183,261,030 		JBrowse link
G Zfp488 zinc finger protein 488 decreases expression ISO pterostilbene results in decreased expression of ZNF488 mRNA CTD PMID:22450950 NCBI chr16:9,289,286...9,299,928
Ensembl chr16:9,280,322...9,300,400 		JBrowse link
resveratrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 4933427D14Rikl RIKEN cDNA 4933427D14 gene like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of KIAA0753 mRNA CTD PMID:23557933 NCBI chr10:57,282,433...57,331,259
Ensembl chr10:57,281,439...57,331,259 		JBrowse link
G A3galt2 alpha 1,3-galactosyltransferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of A3GALT2 mRNA CTD PMID:23557933 NCBI chr 5:146,385,725...146,398,156
Ensembl chr 5:146,385,746...146,400,043 		JBrowse link
G A4galt alpha 1,4-galactosyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of A4GALT mRNA CTD PMID:23557933 NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171 		JBrowse link
G Aacs acetoacetyl-CoA synthetase increases expression ISO resveratrol results in increased expression of AACS protein CTD PMID:25505154 NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543 		JBrowse link
G Aagab alpha- and gamma-adaptin binding protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AAGAB mRNA CTD PMID:23557933 NCBI chr 8:72,978,719...73,017,275
Ensembl chr 8:72,978,741...73,017,278 		JBrowse link
G Aamdc adipogenesis associated, Mth938 domain containing multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AAMDC mRNA CTD PMID:23557933 NCBI chr 1:161,273,205...161,303,253
Ensembl chr 1:161,262,347...161,299,340 		JBrowse link
G Aamp angio-associated, migratory cell protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AAMP mRNA CTD PMID:23557933 NCBI chr 9:83,312,519...83,318,325
Ensembl chr 9:83,312,519...83,318,325 		JBrowse link
G Aatf apoptosis antagonizing transcription factor increases phosphorylation ISO resveratrol results in increased phosphorylation of AATF protein CTD PMID:25311616 NCBI chr10:69,796,502...69,889,671
Ensembl chr10:69,794,007...69,889,634 		JBrowse link
G Aatk apoptosis-associated tyrosine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AATK mRNA CTD PMID:23557933 NCBI chr10:105,789,171...105,825,634
Ensembl chr10:105,785,469...105,825,618 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression
decreases expression
multiple interactions 		ISO resveratrol results in increased expression of ABCA1 mRNA; resveratrol results in increased expression of ABCA1 protein
resveratrol results in decreased expression of ABCA1 protein
2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of ABCA1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of ABCA1 protein]; [resveratrol results in increased expression of ABCA1 protein] which results in increased secretion of Cholesterol; ADORA2A protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein]; PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 mRNA]; PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein]; ZM 241385 inhibits the reaction [resveratrol results in increased expression of ABCA1 protein] 		CTD PMID:16901463 PMID:20372816 PMID:23041272 PMID:24165878 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abca6 ATP binding cassette subfamily A member 6 increases expression ISO resveratrol results in increased expression of ABCA6 protein CTD PMID:25505154 NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
decreases expression
multiple interactions 		ISO
EXP 		Resveratrol results in increased expression of ABCB1 mRNA; Resveratrol results in increased expression of ABCB1 protein
Resveratrol results in decreased expression of ABCB1 mRNA; Resveratrol results in decreased expression of ABCB1 protein
resveratrol results in decreased expression of ABCB1; resveratrol results in decreased expression of ABCB1 mRNA; resveratrol results in decreased expression of ABCB1 protein
[[Resveratrol co-treated with Doxorubicin] results in decreased expression of ABCB1 mRNA] which results in increased uptake of Doxorubicin; [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ABCB1 mRNA; [methoxy poly(ethylene glycol-co-epsilon-caprolactone) co-treated with tocophersolan co-treated with Resveratrol] results in decreased expression of ABCB1 protein; [Resveratrol co-treated with Doxorubicin] results in decreased expression of ABCB1 mRNA; [Resveratrol results in increased susceptibility to Doxorubicin] which results in decreased expression of ABCB1 mRNA; [Resveratrol results in increased susceptibility to Doxorubicin] which results in decreased expression of ABCB1 protein; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [Rifampin results in increased expression of ABCB1 protein] 		CTD PMID:18634814 PMID:19047049 PMID:19484992 PMID:19828106 PMID:24161697 More... NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression ISO resveratrol results in increased expression of ABCB1B protein CTD PMID:25505154 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcb5 ATP binding cassette subfamily B member 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABCB5 mRNA CTD PMID:23557933 NCBI chr 6:145,978,860...146,075,776
Ensembl chr 6:145,978,906...146,077,039 		JBrowse link
G Abcb7 ATP binding cassette subfamily B member 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABCB7 mRNA CTD PMID:23557933 NCBI chr  X:73,361,296...73,502,464
Ensembl chr  X:73,361,310...73,502,547 		JBrowse link
G Abcb9 ATP binding cassette subfamily B member 9 increases expression ISO resveratrol results in increased expression of ABCB9 mRNA CTD PMID:25436977 NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 decreases expression
decreases response to substance
multiple interactions 		ISO resveratrol results in decreased expression of ABCC1
ABCC1 protein results in decreased susceptibility to resveratrol
[[resveratrol co-treated with Doxorubicin] results in decreased expression of ABCC1 mRNA] which results in increased uptake of Doxorubicin; [resveratrol co-treated with Doxorubicin] results in decreased expression of ABCC1 mRNA; [resveratrol results in decreased expression of ABCC1] which results in increased uptake of Doxorubicin; resveratrol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; resveratrol inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione]; resveratrol promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] 		CTD PMID:16156793 PMID:19828106 PMID:20350534 PMID:24161697 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 affects export
decreases expression
multiple interactions 		ISO
EXP 		ABCC2 protein affects the export of resveratrol
Resveratrol results in decreased expression of ABCC2 mRNA; Resveratrol results in decreased expression of ABCC2 protein
resveratrol results in decreased expression of ABCC2 mRNA; resveratrol results in decreased expression of ABCC2 protein
[Probenecid results in decreased activity of ABCC2 protein] which results in decreased secretion of resveratrol metabolite; [verlukast results in decreased activity of ABCC2 protein] which results in decreased secretion of resveratrol metabolite; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]
resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; resveratrol inhibits the reaction [Genistein promotes the reaction [RXRA protein binds to ABCC2 promoter]]; resveratrol inhibits the reaction [Genistein results in increased expression of ABCC2 mRNA]; resveratrol inhibits the reaction [Genistein results in increased expression of ABCC2 protein] 		CTD PMID:15686436 PMID:15955639 PMID:20089784 PMID:21689630 PMID:25418378 More... NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression
multiple interactions 		ISO
EXP 		Resveratrol results in increased expression of ABCC3 mRNA; Resveratrol results in increased expression of ABCC3 protein
[resveratrol co-treated with Streptozocin] results in increased expression of ABCC3 mRNA; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein]
resveratrol metabolite promotes the reaction [ABCC3 protein results in increased transport of estradiol-17 beta-glucuronide] 		CTD PMID:18634814 PMID:19114588 PMID:25418378 PMID:25905778 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases response to substance
multiple interactions 		ISO ABCC4 protein results in decreased susceptibility to resveratrol
resveratrol inhibits the reaction [ABCC4 protein results in increased export of Cyclic GMP]; resveratrol promotes the reaction [ABCC4 protein results in increased hydrolysis of Adenosine Triphosphate] 		CTD PMID:16156793 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 decreases response to substance
multiple interactions 		ISO ABCC5 protein results in decreased susceptibility to resveratrol
[resveratrol co-treated with HMGB1 protein] results in increased expression of ABCC5 mRNA
resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] 		CTD PMID:16156793 PMID:25979658 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abcc8 ATP binding cassette subfamily C member 8 affects binding
multiple interactions
increases response to substance 		EXP
ISO 		resveratrol binds to ABCC8 protein
resveratrol inhibits the reaction [Glyburide binds to ABCC8 protein]
ABCC8 protein results in increased susceptibility to resveratrol
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ABCC8 mRNA 		CTD PMID:17138562 PMID:19095654 PMID:23557933 NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982 		JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 affects binding
multiple interactions 		ISO resveratrol binds to ABCC9 protein
resveratrol inhibits the reaction [Glyburide binds to ABCC9 protein] 		CTD PMID:17138562 NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ABCD2 mRNA] CTD PMID:31298478 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABCD3 mRNA CTD PMID:23557933 NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504 		JBrowse link
G Abcf1 ATP binding cassette subfamily F member 1 decreases expression ISO resveratrol results in decreased expression of ABCF1 protein CTD PMID:25505154 NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240 		JBrowse link
G Abcf2 ATP binding cassette subfamily F member 2 increases expression ISO resveratrol results in increased expression of ABCF2 protein CTD PMID:25505154 NCBI chr 4:11,485,865...11,500,067
Ensembl chr 4:11,487,395...11,500,053 		JBrowse link
G Abcf3 ATP binding cassette subfamily F member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABCF3 mRNA CTD PMID:23557933 NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 increases expression
increases activity
multiple interactions 		ISO resveratrol results in increased expression of ABCG1 mRNA; resveratrol results in increased expression of ABCG1 protein
resveratrol results in increased activity of ABCG1 protein
[Coumestrol co-treated with Resveratrol] results in decreased expression of ABCG1 mRNA; [Resveratrol results in increased expression of ABCG1 protein] which results in increased secretion of Cholesterol; PPARG protein promotes the reaction [Resveratrol results in increased expression of ABCG1 mRNA]; ZM 241385 inhibits the reaction [Resveratrol results in increased expression of ABCG1 protein] 		CTD PMID:16901463 PMID:19167446 PMID:20372816 PMID:23041272 PMID:23770099 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases transport
multiple interactions
affects transport
increases expression
decreases expression 		ISO ABCG2 protein results in increased transport of resveratrol metabolite
resveratrol inhibits the reaction [potassium oxonate results in increased expression of ABCG2 protein]
AHR protein promotes the reaction [resveratrol results in increased expression of ABCG2 protein]; Elacridar inhibits the reaction [ABCG2 protein affects the transport of resveratrol]; Elacridar inhibits the reaction [Protons promotes the reaction [ABCG2 protein results in increased export of resveratrol]]; Protons promotes the reaction [ABCG2 protein results in increased export of resveratrol]; resveratrol analog inhibits the reaction [ABCG2 protein results in increased transport of Methotrexate]
resveratrol results in increased expression of ABCG2 mRNA; resveratrol results in increased expression of ABCG2 protein
resveratrol results in decreased expression of ABCG2 mRNA; resveratrol results in decreased expression of ABCG2 mRNA alternative form 		CTD PMID:17032904 PMID:17077187 PMID:19114588 PMID:20804740 PMID:21304978 More... NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABCG8 mRNA CTD PMID:23557933 NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730 		JBrowse link
G Abhd1 abhydrolase domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABHD1 mRNA CTD PMID:23557933 NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464 		JBrowse link
G Abhd11 abhydrolase domain containing 11 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA CTD PMID:19167446 NCBI chr12:27,318,739...27,322,016
Ensembl chr12:27,318,749...27,321,970 		JBrowse link
G Abhd14a abhydrolase domain containing 14A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABHD14A mRNA CTD PMID:23557933 NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697 		JBrowse link
G Abhd14b abhydrolase domain containing 14b multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABHD14B mRNA CTD PMID:23557933 NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833 		JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression ISO resveratrol results in increased expression of ABHD15 mRNA CTD PMID:19371625 NCBI chr10:62,861,335...62,866,726
Ensembl chr10:62,861,317...62,868,540 		JBrowse link
G Abhd17a abhydrolase domain containing 17A, depalmitoylase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABHD17A mRNA CTD PMID:23557933 NCBI chr 7:9,775,016...9,781,447 JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABHD3 mRNA CTD PMID:23557933 NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492 		JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO resveratrol results in increased expression of ABHD6 protein CTD PMID:25505154 NCBI chr15:19,289,967...19,337,500
Ensembl chr15:19,289,969...19,337,193 		JBrowse link
G Abi1 abl-interactor 1 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of ABI1 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of ABI1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr17:90,006,917...90,088,002
Ensembl chr17:90,006,925...90,087,827 		JBrowse link
G Abi3bp ABI family member 3 binding protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABI3BP mRNA CTD PMID:23557933 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Abitram actin binding transcription modulator increases expression ISO Resveratrol results in increased expression of ABITRAM protein CTD PMID:25505154 NCBI chr 5:76,301,054...76,308,140
Ensembl chr 5:76,301,054...76,308,140 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions ISO purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]]; resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] CTD PMID:22397755 NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846 		JBrowse link
G Ablim1 actin-binding LIM protein 1 increases expression ISO resveratrol results in increased expression of ABLIM1 mRNA CTD PMID:12569576 NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Abracl ABRA C-terminal like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABRACL mRNA CTD PMID:23557933 NCBI chr 1:14,474,802...14,484,992
Ensembl chr 1:14,474,803...14,485,055 		JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ABRAXAS2 mRNA CTD PMID:23557933 NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:197,077,158...197,102,757 		JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ABTB2 mRNA] CTD PMID:31298478 NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A increases expression ISO resveratrol results in increased expression of ACAA1A protein CTD PMID:25505154 NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 increases expression ISO resveratrol results in increased expression of ACAA2 protein CTD PMID:25505154 NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases phosphorylation
decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased phosphorylation of ACACA protein
resveratrol analog results in decreased expression of ACACA protein; resveratrol results in decreased expression of ACACA mRNA
[Resveratrol co-treated with Dietary Fats] results in decreased expression of ACACA mRNA; [T0901317 co-treated with Resveratrol] results in increased phosphorylation of ACACA protein; Resveratrol inhibits the reaction [Ethanol results in increased expression of ACACA mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of ACACA protein]; STK11 protein promotes the reaction [Resveratrol results in increased phosphorylation of ACACA protein]
[Plant Extracts co-treated with Resveratrol] results in increased expression of ACACA mRNA; [splitomicin results in decreased activity of SIRT1 protein] inhibits the reaction [Resveratrol results in increased phosphorylation of ACACA protein]; dorsomorphin inhibits the reaction [Resveratrol results in increased phosphorylation of ACACA protein]; Resveratrol inhibits the reaction [T0901317 results in increased expression of ACACA mRNA]; SIRT1 protein promotes the reaction [Resveratrol results in increased phosphorylation of ACACA protein] 		CTD PMID:17438283 PMID:17464184 PMID:18482975 PMID:18755807 PMID:19071085 More... NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta decreases phosphorylation ISO resveratrol results in decreased phosphorylation of ACACB protein CTD PMID:22898769 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acad10 acyl-CoA dehydrogenase family, member 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACAD10 mRNA CTD PMID:23557933 NCBI chr12:40,561,900...40,604,378
Ensembl chr12:40,566,701...40,604,378 		JBrowse link
G Acad11 acyl-CoA dehydrogenase family, member 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACAD11 mRNA CTD PMID:23557933 NCBI chr 8:113,560,142...113,625,346
Ensembl chr 8:113,560,196...113,625,352 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACAD9 mRNA CTD PMID:23557933 NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain multiple interactions
increases expression 		EXP
ISO 		Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA]
resveratrol results in increased expression of ACADL protein 		CTD PMID:25505154 PMID:36989710 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain multiple interactions
increases expression 		ISO [resveratrol co-treated with Dietary Fats] results in increased expression of ACADM mRNA; SIRT1 protein promotes the reaction [resveratrol results in increased expression of ACADM mRNA]
[Plant Extracts co-treated with Resveratrol] results in increased expression of ACADM mRNA 		CTD PMID:18755807 PMID:19934007 PMID:23557933 PMID:26423427 PMID:26443543 NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864 		JBrowse link
G Acads acyl-CoA dehydrogenase short chain increases expression ISO resveratrol results in increased expression of ACADS mRNA; resveratrol results in increased expression of ACADS protein CTD PMID:22610192 PMID:25505154 NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain increases expression ISO resveratrol results in increased expression of ACADSB protein CTD PMID:25505154 NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561 		JBrowse link
G Acan aggrecan multiple interactions ISO [Hyaluronic Acid co-treated with resveratrol] results in increased expression of ACAN mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ACAN mRNA; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ACAN mRNA]] 		CTD PMID:23557933 PMID:23595953 PMID:26526931 NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779 		JBrowse link
G Acap2 ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACAP2 mRNA CTD PMID:23557933 NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 multiple interactions ISO Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of ACAT1 protein] CTD PMID:26027833 NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042 		JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACBD3 mRNA CTD PMID:23557933 NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355 		JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACBD5 mRNA CTD PMID:23557933 NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286 		JBrowse link
G Acbd6 acyl-CoA binding domain containing 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACBD6 mRNA CTD PMID:23557933 NCBI chr13:70,277,036...70,412,598
Ensembl chr13:70,277,057...70,412,597 		JBrowse link
G Accsl 1-aminocyclopropane-1-carboxylate synthase-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACCSL mRNA CTD PMID:23557933 NCBI chr 3:100,281,817...100,296,514
Ensembl chr 3:100,261,941...100,296,514 		JBrowse link
G Acd ACD, shelterin complex subunit and telomerase recruitment factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACD mRNA CTD PMID:23557933 NCBI chr19:50,496,634...50,499,397
Ensembl chr19:50,496,635...50,499,326 		JBrowse link
G Ace angiotensin I converting enzyme multiple interactions
decreases expression 		ISO
EXP 		resveratrol affects the reaction [Dietary Fats affects the activity of ACE protein]; resveratrol affects the reaction [Dietary Fats affects the expression of ACE mRNA]
resveratrol decreases expression of mRNA in kidney of male offspring from pregnant dams treated with 2,3,7,8-tetrachlorodibenzodioxine and dexamethasone
resveratrol results in decreased expression of ACE protein
Resveratrol inhibits the reaction [Colchicine results in decreased activity of ACE protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of ACE mRNA] 		CTD
RGD		 PMID:17135773 PMID:21962734 PMID:22191573 PMID:27260466 PMID:30127255 RGD:401793709 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Acer2 alkaline ceramidase 2 multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of ACER2 mRNA
resveratrol results in increased expression of ACER2 mRNA 		CTD PMID:25905778 NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583 		JBrowse link
G Ache acetylcholinesterase multiple interactions ISO
EXP 		[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ACHE mRNA
Resveratrol inhibits the reaction [Diazinon results in decreased activity of ACHE protein]; Resveratrol inhibits the reaction [Ethanol results in increased activity of ACHE protein] 		CTD PMID:20663516 PMID:23422878 PMID:23557933 PMID:35403302 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression ISO resveratrol results in decreased expression of ACIN1 protein CTD PMID:25505154 NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166 		JBrowse link
G Ackr1 atypical chemokine receptor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACKR1 mRNA CTD PMID:23557933 NCBI chr13:88,314,735...88,316,354
Ensembl chr13:88,293,188...88,317,807 		JBrowse link
G Acly ATP citrate lyase increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of ACLY mRNA
[Dietary Fats co-treated with resveratrol] affects the expression of ACLY mRNA; resveratrol inhibits the reaction [Dietary Fats results in increased expression of ACLY protein] 		CTD PMID:20706672 PMID:26055348 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Acmsd aminocarboxymuconate semialdehyde decarboxylase increases expression EXP resveratrol results in increased expression of ACMSD mRNA CTD PMID:25905778 NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427 		JBrowse link
G Acot13 acyl-CoA thioesterase 13 increases expression ISO resveratrol results in increased expression of ACOT13 protein CTD PMID:25505154 NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876 		JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions
decreases expression 		EXP [resveratrol co-treated with Streptozocin] results in decreased expression of ACOT2 mRNA
resveratrol results in decreased expression of ACOT2 mRNA 		CTD PMID:25905778 NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502 		JBrowse link
G Acot4 acyl-CoA thioesterase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ACOT4 mRNA CTD PMID:19167446 NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138 		JBrowse link
G Acot7 acyl-CoA thioesterase 7 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ACOT7 mRNA CTD PMID:19167446 NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033 		JBrowse link
G Acot8 acyl-CoA thioesterase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACOT8 mRNA CTD PMID:23557933 NCBI chr 3:173,950,530...173,962,188
Ensembl chr 3:173,950,531...173,962,570 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACOT9 mRNA
resveratrol results in increased expression of ACOT9 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr  X:43,922,943...43,973,311
Ensembl chr  X:43,914,923...43,973,205 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions EXP
ISO 		resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]
[Plant Extracts co-treated with Resveratrol] results in increased expression of ACOX1 mRNA 		CTD PMID:17134953 PMID:23557933 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox3 acyl-CoA oxidase 3, pristanoyl multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACOX3 mRNA CTD PMID:23557933 NCBI chr14:79,358,604...79,405,160
Ensembl chr14:79,302,042...79,400,881 		JBrowse link
G Acp1 acid phosphatase 1 increases expression ISO resveratrol results in increased expression of ACP1 protein CTD PMID:25505154 NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959 		JBrowse link
G Acp3 acid phosphatase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACP3 mRNA CTD PMID:23557933 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant multiple interactions ISO resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] CTD PMID:16267019 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Acp6 acid phosphatase 6, lysophosphatidic multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of ACP6 mRNA CTD PMID:26667767 NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:187,349,186...187,422,743 		JBrowse link
G Acr acrosin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACR mRNA CTD PMID:23557933 NCBI chr 7:122,517,910...122,524,110
Ensembl chr 7:122,517,934...122,524,087 		JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ACSL3 mRNA CTD PMID:26667767 NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACSL4 mRNA
Resveratrol inhibits the reaction [Acrolein results in increased expression of ACSL4 protein]
Resveratrol results in increased expression of ACSL4 mRNA 		CTD PMID:23557933 PMID:34813903 PMID:37419272 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 increases expression ISO resveratrol results in increased expression of ACSL5 mRNA CTD PMID:22610192 NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of ACSM2A mRNA
resveratrol results in increased expression of ACSM2A mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of ACSM3 mRNA CTD PMID:26667767 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle decreases expression
increases expression 		ISO
EXP 		resveratrol results in decreased expression of ACTA1 mRNA
resveratrol results in increased expression of ACTA1 mRNA 		CTD PMID:25394648 PMID:25905778 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Acta2 actin alpha 2, smooth muscle decreases expression
increases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of ACTA2 mRNA; resveratrol results in decreased expression of ACTA2 protein
Resveratrol results in increased expression of ACTA2 mRNA
resveratrol inhibits the reaction [Carbon Tetrachloride affects the expression of ACTA2 mRNA]; resveratrol inhibits the reaction [Carbon Tetrachloride affects the expression of ACTA2 protein]; resveratrol inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein]
3-deazaneplanocin inhibits the reaction [resveratrol results in decreased expression of ACTA2 mRNA]; EZH2 mRNA promotes the reaction [resveratrol results in decreased expression of ACTA2 mRNA]; resveratrol inhibits the reaction [TGFB2 protein results in increased expression of ACTA2 mRNA]; resveratrol inhibits the reaction [TGFB2 protein results in increased expression of ACTA2 protein]
resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of ACTA2 mRNA]; resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ACTA2 protein]
Resveratrol results in decreased expression of ACTA2 mRNA; Resveratrol results in decreased expression of ACTA2 protein 		CTD PMID:9581680 PMID:20797428 PMID:23262250 PMID:23297412 PMID:23815229 More... NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta affects expression EXP resveratrol affects the expression of ACTB mRNA CTD PMID:15748624 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actbl2 actin, beta-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACTBL2 mRNA CTD PMID:23557933 NCBI chr 2:44,591,391...44,594,138
Ensembl chr 2:44,591,391...44,594,138 		JBrowse link
G Actl10 actin-like 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACTL10 mRNA CTD PMID:23557933 NCBI chr 3:163,517,265...163,518,765
Ensembl chr 3:163,516,855...163,520,048 		JBrowse link
G Actl6b actin-like 6B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACTL6B mRNA CTD PMID:23557933 NCBI chr12:24,761,660...24,778,193
Ensembl chr12:24,761,693...24,778,151 		JBrowse link
G Actl9 actin-like 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACTL9 mRNA CTD PMID:23557933 NCBI chr 7:14,936,690...14,938,067
Ensembl chr 7:14,935,601...15,006,102 		JBrowse link
G Actmap actin maturation protease multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACTMAP mRNA CTD PMID:23557933 NCBI chr 1:91,618,012...91,627,490
Ensembl chr 1:91,617,859...91,627,489 		JBrowse link
G Actn1 actinin, alpha 1 decreases expression ISO resveratrol results in decreased expression of ACTN1 protein CTD PMID:25505154 NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Actn2 actinin alpha 2 decreases expression ISO resveratrol results in decreased expression of ACTN2 mRNA CTD PMID:22610192 NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552 		JBrowse link
G Actn4 actinin alpha 4 decreases expression ISO resveratrol results in decreased expression of ACTN4 protein CTD PMID:25505154 NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320 		JBrowse link
G Actr10 actin related protein 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR10 mRNA CTD PMID:23557933 NCBI chr 6:95,182,082...95,208,325
Ensembl chr 6:95,182,111...95,209,021 		JBrowse link
G Actr2 actin related protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR2 mRNA CTD PMID:23557933 NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998 		JBrowse link
G Actr3 actin related protein 3 decreases expression ISO resveratrol results in decreased expression of ACTR3 protein CTD PMID:25505154 NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711 		JBrowse link
G Actr6 actin related protein 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR6 mRNA CTD PMID:23557933 NCBI chr 7:26,037,574...26,058,362
Ensembl chr 7:26,037,574...26,060,604 		JBrowse link
G Acy3 aminoacylase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACY3 mRNA CTD PMID:23557933 NCBI chr 1:210,709,238...210,715,258
Ensembl chr 1:210,709,294...210,715,633 		JBrowse link
G Acyp1 acylphosphatase 1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of ACYP1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ACYP1 mRNA
resveratrol results in increased expression of ACYP1 mRNA 		CTD PMID:19167446 PMID:23557933 NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:110,650,213...110,663,612 		JBrowse link
G Ada adenosine deaminase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADA mRNA CTD PMID:23557933 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 increases expression ISO resveratrol results in increased expression of ADAM10 protein CTD PMID:23129026 NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600 		JBrowse link
G Adam11 ADAM metallopeptidase domain 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAM11 mRNA CTD PMID:23557933 NCBI chr10:88,224,185...88,242,865
Ensembl chr10:88,224,347...88,242,864 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADAM17 mRNA
resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of ADAM17 mRNA] 		CTD PMID:23557933 PMID:24548422 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam33 ADAM metallopeptidase domain 33 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAM33 mRNA CTD PMID:23557933 NCBI chr 3:138,715,428...138,736,392
Ensembl chr 3:138,724,046...138,736,347 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADAM9 mRNA
resveratrol results in increased expression of ADAM9 protein 		CTD PMID:18089832 PMID:23557933 NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646 		JBrowse link
G Adamts12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS12 mRNA CTD PMID:23557933 NCBI chr 2:61,759,975...62,054,716
Ensembl chr 2:61,759,987...62,054,716 		JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif, 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS14 mRNA CTD PMID:23557933 NCBI chr20:29,685,876...29,762,685
Ensembl chr20:29,685,876...29,762,682 		JBrowse link
G Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS16 mRNA CTD PMID:23557933 NCBI chr 1:34,258,899...34,388,952
Ensembl chr 1:34,258,899...34,388,952 		JBrowse link
G Adamts18 ADAM metallopeptidase with thrombospondin type 1 motif, 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS18 mRNA CTD PMID:23557933 NCBI chr19:58,596,095...58,749,239
Ensembl chr19:58,597,761...58,749,138 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS2 mRNA CTD PMID:23557933 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS4 mRNA CTD PMID:23557933 NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514 		JBrowse link
G Adamts7 ADAM metallopeptidase with thrombospondin type 1 motif, 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTS7 mRNA CTD PMID:23557933 NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132 		JBrowse link
G Adamtsl1 ADAMTS-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTSL1 mRNA CTD PMID:23557933 NCBI chr 5:105,010,471...105,965,792
Ensembl chr 5:105,010,464...105,964,394 		JBrowse link
G Adat1 adenosine deaminase, tRNA-specific 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADAT1 mRNA CTD PMID:23557933 NCBI chr19:56,825,153...56,866,136
Ensembl chr19:56,826,849...56,866,117 		JBrowse link
G Adat2 adenosine deaminase, tRNA-specific 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADAT2 mRNA CTD PMID:23557933 NCBI chr 1:9,774,680...9,795,376
Ensembl chr 1:9,774,680...9,795,376 		JBrowse link
G Adat3 adenosine deaminase, tRNA-specific 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAT3 mRNA CTD PMID:23557933 NCBI chr 7:9,759,758...9,761,127
Ensembl chr 7:9,758,671...9,764,582 		JBrowse link
G Adcy4 adenylate cyclase 4 increases expression EXP resveratrol results in increased expression of ADCY4 mRNA CTD PMID:25905778 NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026 		JBrowse link
G Adcy9 adenylate cyclase 9 decreases expression ISO resveratrol results in decreased expression of ADCY9 mRNA CTD PMID:22610192 NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792 		JBrowse link
G Add3 adducin 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA CTD PMID:19167446 NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504 		JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRA1 mRNA CTD PMID:23557933 NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869 		JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 decreases expression
increases expression 		ISO
EXP 		resveratrol results in decreased expression of ADGRE5 mRNA
resveratrol results in increased expression of ADGRE5 mRNA 		CTD PMID:21738342 PMID:25905778 NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641 		JBrowse link
G Adgrf2 adhesion G protein-coupled receptor F2 multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ADGRF2P mRNA CTD PMID:26667767 NCBI chr 9:25,735,607...25,745,962
Ensembl chr 9:25,735,686...25,763,899 		JBrowse link
G Adgrf3 adhesion G protein-coupled receptor F3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRF3 mRNA CTD PMID:23557933 NCBI chr 6:31,853,018...31,864,441
Ensembl chr 6:31,830,832...31,864,441 		JBrowse link
G Adgrg2 adhesion G protein-coupled receptor G2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRG2 mRNA CTD PMID:23557933 NCBI chr  X:38,106,067...38,231,286
Ensembl chr  X:38,106,067...38,231,331 		JBrowse link
G Adgrl2 adhesion G protein-coupled receptor L2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRL2 mRNA CTD PMID:23557933 NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933 		JBrowse link
G Adi1 acireductone dioxygenase 1 increases expression ISO resveratrol results in increased expression of ADI1 protein CTD PMID:22349766 NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855 		JBrowse link
G Adig adipogenin decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ADIG mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADIG mRNA 		CTD PMID:23557933 PMID:25338179 NCBI chr 3:167,574,963...167,580,296
Ensembl chr 3:167,574,925...167,580,297 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
decreases secretion
increases expression
affects secretion
increases secretion 		ISO
EXP 		[Ethanol co-treated with Resveratrol] results in increased expression of ADIPOQ protein; dorsomorphin inhibits the reaction [Resveratrol results in increased expression of ADIPOQ protein]; ERO1A protein inhibits the reaction [Resveratrol results in decreased secretion of ADIPOQ protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of ADIPOQ protein]; GSTK1 protein affects the reaction [Resveratrol promotes the reaction [ADIPOQ protein binds to ADIPOQ protein]]; GSTK1 protein affects the reaction [Resveratrol results in increased expression of ADIPOQ protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [Ethanol results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [TNF protein results in decreased secretion of ADIPOQ protein]; Resveratrol promotes the reaction [ADIPOQ protein binds to ADIPOQ protein]
Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein]; Resveratrol inhibits the reaction [bisphenol A results in decreased expression of ADIPOQ protein]; Resveratrol inhibits the reaction [Fructose results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [Fructose results in decreased expression of ADIPOQ protein]; Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADIPOQ mRNA; Resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA]
resveratrol results in decreased secretion of ADIPOQ protein
resveratrol metabolite results in increased expression of ADIPOQ mRNA; resveratrol results in increased expression of ADIPOQ mRNA; resveratrol results in increased expression of ADIPOQ protein
resveratrol affects the secretion of ADIPOQ protein
resveratrol results in increased secretion of ADIPOQ protein 		CTD PMID:17374693 PMID:17452443 PMID:17967414 PMID:18755807 PMID:19356108 More... NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions
increases expression 		EXP
ISO 		FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; resveratrol inhibits the reaction [Streptozocin results in decreased expression of ADIPOR1 protein]
resveratrol results in increased expression of ADIPOR1 mRNA
Ethanol promotes the reaction [resveratrol results in increased expression of ADIPOR1 mRNA] 		CTD PMID:18755807 PMID:24413998 NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255 		JBrowse link
G Adipor2 adiponectin receptor 2 increases expression
increases expression 		ISO resveratrol results in increased expression of ADIPOR2 mRNA
resveratrol increases expression of Adipor2 mRNA in liver 		CTD
RGD		 PMID:18755807 PMID:18755807 RGD:25824943 NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adm adrenomedullin decreases secretion ISO resveratrol results in decreased secretion of ADM protein CTD PMID:22178239 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adm2 adrenomedullin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADM2 mRNA CTD PMID:23557933 NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:122,272,808...122,274,594 		JBrowse link
G Adnp activity-dependent neuroprotector homeobox multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADNP mRNA CTD PMID:23557933 NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188 		JBrowse link
G Adora1 adenosine A1 receptor multiple interactions EXP
ISO 		[8-cyclopentyl-1,3-dimethylxanthine results in decreased activity of ADORA1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein]; [8-cyclopentyl-1,3-dimethylxanthine results in decreased activity of ADORA1 protein] which results in decreased susceptibility to resveratrol
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADORA1 mRNA 		CTD PMID:15345477 PMID:23557933 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Adora2a adenosine A2a receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADORA2A mRNA; ADORA2A protein promotes the reaction [Resveratrol results in increased expression of ABCA1 protein]; ADORA2A protein promotes the reaction [Resveratrol results in increased expression of CYP27A1 protein]; ADORA2A protein promotes the reaction [Resveratrol results in increased expression of NR1H3 protein] CTD PMID:23041272 PMID:23557933 NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802 		JBrowse link
G Adora3 adenosine A3 receptor multiple interactions EXP [MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein]; [MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BCL2 protein]; [MRS 1191 results in decreased activity of ADORA3 protein] which results in decreased susceptibility to resveratrol CTD PMID:15345477 NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686 		JBrowse link
G Adpgk ADP-dependent glucokinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADPGK mRNA CTD PMID:23557933 NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:68,595,248...68,623,178 		JBrowse link
G Adra2b adrenoceptor alpha 2B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADRA2B mRNA CTD PMID:23557933 NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525 		JBrowse link
G Adrb1 adrenoceptor beta 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ADRB1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADRB1 mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237 		JBrowse link
G Adsl adenylosuccinate lyase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ADSL mRNA CTD PMID:23557933 NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872 		JBrowse link
G Afap1 actin filament associated protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AFAP1 mRNA CTD PMID:23557933 NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939 		JBrowse link
G Aff4 ALF transcription elongation factor 4 increases phosphorylation
decreases expression 		ISO
EXP 		resveratrol results in increased phosphorylation of AFF4 protein
resveratrol results in decreased expression of AFF4 mRNA 		CTD PMID:25311616 PMID:25905778 NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580 		JBrowse link
G Afg2a AFG2 AAA ATPase homolog A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AFG2A mRNA CTD PMID:23557933 NCBI chr 2:122,234,619...122,425,808
Ensembl chr 2:122,234,738...122,425,808 		JBrowse link
G Afg3l2 AFG3 like matrix AAA peptidase subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AFG3L2 mRNA CTD PMID:23557933 NCBI chr18:63,224,163...63,269,000
Ensembl chr18:63,224,163...63,269,000 		JBrowse link
G Afp alpha-fetoprotein multiple interactions ISO Resveratrol affects the reaction [sodium arsenate affects the expression of AFP protein] CTD PMID:37797956 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Aftph aftiphilin decreases expression ISO resveratrol results in decreased expression of AFTPH mRNA CTD PMID:25888808 NCBI chr14:99,072,761...99,127,006
Ensembl chr14:99,072,761...99,126,727 		JBrowse link
G Agbl4 AGBL carboxypeptidase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AGBL4 mRNA CTD PMID:23557933 NCBI chr 5:130,483,551...131,762,906 JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
decreases expression 		ISO [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein]; [resveratrol results in increased activity of PPARG protein] which results in decreased expression of AGER protein; resveratrol inhibits the reaction [ALB protein modified form results in increased expression of AGER protein]
resveratrol results in decreased expression of AGER protein 		CTD PMID:20372816 PMID:23936610 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AGFG1 mRNA CTD PMID:23557933 NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910 		JBrowse link
G Agfg2 ArfGAP with FG repeats 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AGFG2 mRNA CTD PMID:23557933 NCBI chr12:24,649,008...24,692,069
Ensembl chr12:24,649,038...24,685,197 		JBrowse link
G Aggf1 angiogenic factor with G patch and FHA domains 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AGGF1 mRNA CTD PMID:23557933 NCBI chr 2:28,354,073...28,380,794
Ensembl chr 2:28,354,073...28,380,759 		JBrowse link
G Agk acylglycerol kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AGK mRNA CTD PMID:23557933 NCBI chr 4:70,081,550...70,160,642
Ensembl chr 4:70,081,035...70,160,709 		JBrowse link
G Ago4 argonaute RISC component 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AGO4 mRNA CTD PMID:23557933 NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402 		JBrowse link
G Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AGPAT1 mRNA CTD PMID:23557933 NCBI chr20:4,140,565...4,149,531
Ensembl chr20:4,140,565...4,150,445 		JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AGPAT3 mRNA CTD PMID:23557933 NCBI chr20:10,330,650...10,415,026
Ensembl chr20:10,394,465...10,410,632 		JBrowse link
G Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 increases expression ISO resveratrol results in increased expression of AGPAT4 protein CTD PMID:25505154 NCBI chr 1:51,075,081...51,181,548
Ensembl chr 1:51,075,081...51,180,976 		JBrowse link
G Agps alkylglycerone phosphate synthase increases expression
multiple interactions 		ISO resveratrol results in increased expression of AGPS protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of AGPS mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277 		JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA CTD PMID:19167446 NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677 		JBrowse link
G Agr3 anterior gradient 3, protein disulphide isomerase family member multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AGR3 mRNA CTD PMID:19167446 NCBI chr 6:58,370,701...58,393,944
Ensembl chr 6:58,370,701...58,399,859 		JBrowse link
G Agrn agrin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AGRN mRNA CTD PMID:23557933 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agt angiotensinogen multiple interactions
decreases response to substance
increases phosphorylation 		EXP
ISO 		resveratrol inhibits the reaction [AGT protein modified form results in increased expression of RCAN1 mRNA]; resveratrol inhibits the reaction [AGT protein modified form results in increased expression of RPS6KB1 protein modified form]; resveratrol inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK3 protein]; resveratrol inhibits the reaction [AGT protein modified form results in increased phosphorylation of RPS6KB1 protein]; resveratrol inhibits the reaction [AGT protein promotes the reaction [SIRT1 protein binds to FOXO1 protein]]; resveratrol inhibits the reaction [AGT protein results in decreased expression of SOD2 protein]; resveratrol inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; resveratrol inhibits the reaction [AGT protein results in increased acetylation of FOXO1 protein]; resveratrol inhibits the reaction [AGT protein results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]; resveratrol inhibits the reaction [AGT protein results in increased expression of NPPA protein]; resveratrol inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]; resveratrol inhibits the reaction [AGT protein results in increased expression of NPPB protein]; resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein]; resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased localization of GAB1 protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of AGT mRNA; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein]]; Resveratrol inhibits the reaction [AGT protein results in increased activity of RHOA protein]; Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein]; Resveratrol inhibits the reaction [Uric Acid results in increased expression of AGT mRNA]; Resveratrol inhibits the reaction [Uric Acid results in increased expression of AGT protein]
[Resveratrol co-treated with Dietary Fats] results in decreased expression of AGT mRNA; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [AGT protein results in increased activity of RHOA protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein]]; Resveratrol inhibits the reaction [AGT protein modified form results in increased expression of NPPA mRNA]; Resveratrol inhibits the reaction [AGT protein modified form results in increased expression of RCAN1 mRNA]; Resveratrol inhibits the reaction [AGT protein modified form results in increased expression of RPS6KB1 protein modified form]; Resveratrol inhibits the reaction [AGT protein results in increased activity of RHOA protein]; Resveratrol inhibits the reaction [AGT protein results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein]
resveratrol results in decreased susceptibility to AGT protein modified form
resveratrol results in increased phosphorylation of AGT protein 		CTD PMID:12237323 PMID:15849355 PMID:15878161 PMID:16257180 PMID:18543488 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions
decreases expression 		ISO
EXP 		resveratrol affects the reaction [Dietary Fats affects the expression of AGTR1A mRNA]
resveratrol decreases expression of mRNA in kidney of male offspring from pregnant dams treated with 2,3,7,8-tetrachlorodibenzodioxine and dexamethasone
resveratrol results in decreased expression of AGTR1 protein
resveratrol results in decreased expression of AGTR1 mRNA; resveratrol results in decreased expression of AGTR1 protein
[Niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in decreased expression of AGTR1 mRNA] 		CTD
RGD		 PMID:18420994 PMID:27260466 PMID:30127255 RGD:401793709 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtrap angiotensin II receptor-associated protein decreases activity ISO resveratrol results in decreased activity of AGTRAP protein CTD PMID:24454499 NCBI chr 5:163,790,565...163,802,174
Ensembl chr 5:163,791,887...163,802,174 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of AHCTF1 mRNA
resveratrol results in decreased expression of AHCTF1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr13:94,013,894...94,068,348
Ensembl chr13:94,014,469...94,068,058 		JBrowse link
G Ahcy adenosylhomocysteinase affects expression ISO resveratrol affects the expression of AHCY protein CTD PMID:22234583 NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AHCYL1 mRNA CTD PMID:23557933 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AHCYL2 mRNA CTD PMID:23557933 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahdc1 AT hook, DNA binding motif, containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AHDC1 mRNA CTD PMID:23557933 NCBI chr 5:150,512,182...150,578,804
Ensembl chr 5:150,512,037...150,583,144 		JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression ISO resveratrol results in decreased expression of AHNAK protein CTD PMID:25505154 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ahr aryl hydrocarbon receptor increases activity
increases expression
increases localization
affects activity
affects localization
multiple interactions 		ISO
EXP 		resveratrol results in increased activity of AHR protein
resveratrol results in increased expression of AHR mRNA
resveratrol results in increased localization of AHR protein
resveratrol results in increased expression of AHR mRNA; resveratrol results in increased expression of AHR protein
resveratrol affects the activity of AHR protein
resveratrol affects the localization of AHR protein
[Resveratrol binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Sunitinib; Resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of AHR protein]
[Curcumin co-treated with resveratrol] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; resveratrol binds to and results in decreased activity of AHR protein; resveratrol inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]; resveratrol results in increased expression of and results in increased activity of AHR protein
6-formylindolo(3,2-b)carbazole inhibits the reaction [Resveratrol results in increased expression of AHR mRNA]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Resveratrol affects the localization of AHR protein]; [Estradiol co-treated with Resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of AHR mRNA; [Resveratrol results in decreased activity of AHR protein] inhibits the reaction [Sunitinib results in increased expression of CYP1A1 mRNA]; AHR mutant form inhibits the reaction [6-formylindolo(3,2-b)carbazole promotes the reaction [Resveratrol results in increased expression of CXCL8 mRNA]]; AHR mutant form inhibits the reaction [6-formylindolo(3,2-b)carbazole promotes the reaction [Resveratrol results in increased expression of CXCL8 protein]]; AHR mutant form inhibits the reaction [Resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]; AHR mutant form inhibits the reaction [Resveratrol results in increased expression of CXCL8 mRNA]; AHR mutant form inhibits the reaction [Resveratrol results in increased expression of CXCL8 protein]; AHR mutant form inhibits the reaction [Resveratrol results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Resveratrol results in increased expression of ABCG2 protein]; AHR protein promotes the reaction [Resveratrol results in increased expression of PON1 mRNA]; Resveratrol analog binds to and results in increased activity of AHR protein; Resveratrol binds to and affects the localization of AHR protein; Resveratrol binds to and results in decreased activity of AHR protein; Resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]]; Resveratrol inhibits the reaction [[Benzo(a)pyrene results in increased activity of AHR protein] promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Resveratrol inhibits the reaction [[copper(II) nitrate binds to 1,10-phenanthroline binds to Quinolones] which results in increased activity of AHR protein]; Resveratrol inhibits the reaction [[copper(II) nitrate binds to 5-methyl-1,10-phenanthroline binds to Quinolones] which results in increased activity of AHR protein]; Resveratrol inhibits the reaction [[oltipraz promotes the reaction [AHR protein binds to CYP1A1 promoter]] which results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [AHR protein binds to CYP1A1 promoter]; Resveratrol inhibits the reaction [AHR protein results in decreased expression of BRCA1]; Resveratrol inhibits the reaction [Benzo(a)pyrene affects the localization of AHR protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene binds to AHR protein]; Resveratrol inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of and results in increased localization of AHR protein]; Resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased localization of AHR protein]; Resveratrol promotes the reaction [AHR protein binds to PTGS2 promoter] 		CTD PMID:9865727 PMID:10496959 PMID:10496962 PMID:11597580 PMID:11959854 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor decreases expression
increases expression
multiple interactions 		EXP resveratrol decreases expression of mRNA in kidney of male offspring from pregnant dams treated with 2,3,7,8-tetrachlorodibenzodioxine and dexamethasone
resveratrol results in increased expression of AHRR protein
[Resveratrol co-treated with Tetrachlorodibenzodioxin] results in increased expression of AHRR protein 		CTD
RGD		 PMID:24136580 PMID:29935225 PMID:30127255 RGD:401793709 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Ahsa2 activator of HSP90 ATPase homolog 2 increases expression ISO resveratrol results in increased expression of AHSA2 protein CTD PMID:25505154 NCBI chr14:101,677,447...101,688,706
Ensembl chr14:101,677,447...101,686,923 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein decreases phosphorylation ISO resveratrol results in decreased phosphorylation of AHSG protein CTD PMID:25311616 NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039 		JBrowse link
G Aif1 allograft inflammatory factor 1 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of AIF1 protein
Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of AIF1 protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of AIF1 protein] 		CTD PMID:27093858 PMID:34391968 PMID:34614429 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aif1l allograft inflammatory factor 1-like decreases expression ISO resveratrol results in decreased expression of AIF1L protein CTD PMID:25505154 NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 multiple interactions
increases secretion
affects localization 		EXP
ISO 		resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium affects the localization of AIFM1 protein]
resveratrol results in increased secretion of AIFM1 protein
resveratrol affects the localization of AIFM1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of AIFM1 mRNA; BAK1 protein promotes the reaction [Resveratrol results in increased secretion of AIFM1 protein]; PD 150606 inhibits the reaction [Resveratrol affects the localization of AIFM1 protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased expression of AIFM1 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein] 		CTD PMID:16617056 PMID:16759640 PMID:17636462 PMID:18276737 PMID:19466539 More... NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Aimp2 aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 increases expression ISO resveratrol results in increased expression of AIMP2 protein CTD PMID:25505154 NCBI chr12:15,814,854...15,824,432
Ensembl chr12:15,814,878...15,824,431 		JBrowse link
G Aire autoimmune regulator multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AIRE mRNA CTD PMID:23557933 NCBI chr20:10,635,775...10,650,709
Ensembl chr20:10,635,775...10,650,709 		JBrowse link
G Ajap1 adherens junctions associated protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AJAP1 mRNA CTD PMID:23557933 NCBI chr 5:169,190,477...169,302,938
Ensembl chr 5:169,190,477...169,304,515 		JBrowse link
G Ak2 adenylate kinase 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of AK2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of AK2 mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610 		JBrowse link
G Ak6 adenylate kinase 6 increases expression ISO resveratrol results in increased expression of AK6 protein CTD PMID:25505154 NCBI chr 2:33,528,388...33,540,445
Ensembl chr 2:33,528,035...33,540,441
Ensembl chr20:33,528,035...33,540,441 		JBrowse link
G Ak9 adenylate kinase 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AK9 mRNA CTD PMID:23557933 NCBI chr20:46,307,100...46,523,537
Ensembl chr20:46,307,119...46,523,536 		JBrowse link
G Akap10 A-kinase anchoring protein 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AKAP10 mRNA CTD PMID:23557933 NCBI chr10:47,044,819...47,108,153
Ensembl chr10:47,044,819...47,108,203 		JBrowse link
G Akap11 A-kinase anchoring protein 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AKAP11 mRNA CTD PMID:23557933 NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335 		JBrowse link
G Akap8 A-kinase anchoring protein 8 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of AKAP8 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of AKAP8 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900 		JBrowse link
G Akap9 A-kinase anchoring protein 9 multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of AKAP9 mRNA
resveratrol results in increased expression of AKAP9 mRNA 		CTD PMID:19228061 PMID:23557933 NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338 		JBrowse link
G Akna AT-hook transcription factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AKNA mRNA CTD PMID:23557933 NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:81,792,929...81,831,528 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of AKR1B1 mRNA
Resveratrol inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 mRNA]; Resveratrol inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 protein] 		CTD PMID:21355597 PMID:25905778 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 multiple interactions ISO [resveratrol co-treated with HMGB1 protein] results in increased expression of AKR1B10 mRNA CTD PMID:25979658 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of AKR1C3 mRNA CTD PMID:25905778 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation
increases phosphorylation
decreases expression
affects binding
affects phosphorylation
decreases activity 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; [Resveratrol binds to NQO2 protein] inhibits the reaction [NQO2 protein binds to AKT1 protein]; CBX7 protein inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; MIR21 mRNA inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; MRK 003 affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; NQO2 protein inhibits the reaction [Resveratrol results in decreased expression of AKT1 protein]; PTEN protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [AKT1 protein binds to NQO2 protein]; Resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein
resveratrol results in decreased phosphorylation of AKT1 protein
resveratrol results in increased phosphorylation of AKT1 protein
resveratrol results in decreased expression of AKT1 mRNA; resveratrol results in decreased expression of AKT1 protein; resveratrol results in decreased expression of AKT1 protein modified form
resveratrol binds to AKT1 protein
resveratrol affects the phosphorylation of AKT1 protein
resveratrol results in decreased activity of AKT1 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]]; [Resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of AKT1 protein; [Sirolimus co-treated with Resveratrol] promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1 protein]; PRKAA2 protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; PTPN11 protein affects the reaction [Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of AKT1 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein]; Resveratrol promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1 protein]; Resveratrol promotes the reaction [Wortmannin results in decreased phosphorylation of AKT1 protein]; Sirolimus inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]]; Wortmannin promotes the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of AKT1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; [Resveratrol co-treated with Pravastatin] results in increased phosphorylation of AKT1 protein; [Resveratrol co-treated with Streptozocin] results in decreased phosphorylation of AKT1 protein; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of AKT1 mRNA]; Resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Resveratrol results in increased phosphorylation of and results in increased activity of AKT1 protein; Wortmannin inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein] 		CTD PMID:15829497 PMID:15849355 PMID:15882976 PMID:15925284 PMID:16343977 More... NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt1s1 AKT1 substrate 1 decreases phosphorylation
multiple interactions 		ISO
EXP 		resveratrol results in decreased phosphorylation of AKT1S1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of AKT1S1 mRNA
[resveratrol co-treated with Sirolimus] results in decreased phosphorylation of AKT1S1 protein
[Sirolimus co-treated with resveratrol] results in decreased phosphorylation of AKT1S1 protein; resveratrol inhibits the reaction [Sirolimus inhibits the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1S1 protein]]; resveratrol promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1S1 protein] 		CTD PMID:23557933 PMID:24304514 PMID:25311616 NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:104,469,803...104,476,167 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 multiple interactions
decreases expression 		ISO [Doxorubicin co-treated with resveratrol] affects the expression of AKT2 mRNA; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]
resveratrol results in decreased expression of AKT2 mRNA 		CTD PMID:23452621 PMID:26969377 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 decreases expression ISO resveratrol results in decreased expression of AKT3 mRNA CTD PMID:25667456 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020 		JBrowse link
G Alb albumin multiple interactions
affects expression
decreases abundance
decreases secretion 		ISO
EXP 		resveratrol binds to and affects the folding of ALB protein; resveratrol binds to and affects the folding of and results in increased stability of ALB protein; resveratrol inhibits the reaction [ALB protein modified form results in increased activity of NFKB1 protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased activity of RELA protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased expression of AGER protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased expression of IL1B protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased expression of TNF protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [ALB protein modified form results in increased phosphorylation of MAPK3 protein]
Resveratrol affects the expression of ALB protein
resveratrol results in decreased abundance of ALB protein
resveratrol inhibits the reaction [Ethanol results in decreased expression of ALB protein]
resveratrol results in decreased secretion of ALB protein 		CTD PMID:17054386 PMID:17597382 PMID:20332614 PMID:21086752 PMID:21270273 More... NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALCAM mRNA CTD PMID:23557933 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 increases expression ISO resveratrol results in increased expression of ALDH18A1 protein CTD PMID:25505154 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases activity ISO resveratrol results in decreased activity of ALDH1A1 protein CTD PMID:22692956 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 increases expression ISO Resveratrol results in increased expression of ALDH1A2 mRNA CTD PMID:29990529 NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO resveratrol results in decreased expression of ALDH1A3 mRNA CTD PMID:18586690 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 decreases expression ISO resveratrol results in decreased expression of ALDH1B1 mRNA CTD PMID:18930334 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases expression ISO resveratrol results in increased expression of ALDH1L2 protein CTD PMID:25505154 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of ALDH2 mRNA
Resveratrol increases expression and activity of Aldh2 protein in rat liver
resveratrol results in increased expression of ALDH2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ALDH2 mRNA; Resveratrol promotes the reaction [Ethanol results in increased expression of ALDH2 mRNA] 		CTD
RGD		 PMID:22056336 PMID:23557933 PMID:25505154 PMID:28688179 RGD:14981582 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ALDH3A1 mRNA CTD PMID:23557933 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of ALDH3A2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ALDH3A2 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648 		JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH3B2 mRNA CTD PMID:19167446 NCBI chr 1:210,679,749...210,694,187
Ensembl chr 1:210,675,302...210,694,155 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of ALDH3B2 mRNA CTD PMID:19167446 NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879 		JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH4A1 mRNA
resveratrol results in increased expression of ALDH4A1 mRNA; resveratrol results in increased expression of ALDH4A1 protein 		CTD PMID:19167446 PMID:22610192 PMID:25505154 NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673 		JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of ALDH9A1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ALDH9A1 mRNA CTD PMID:23557933 PMID:26667767 NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481 		JBrowse link
G Aldob aldolase, fructose-bisphosphate B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ALDOB mRNA CTD PMID:23557933 NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C increases expression ISO resveratrol results in increased expression of ALDOC mRNA CTD PMID:15582268 NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133 		JBrowse link
G Alg14 ALG14, UDP-N-acetylglucosaminyltransferase subunit increases expression ISO resveratrol results in increased expression of ALG14 protein CTD PMID:25505154 NCBI chr 2:212,053,008...212,130,136
Ensembl chr 2:212,044,969...212,130,140 		JBrowse link
G Alg2 ALG2, alpha-1,3/1,6-mannosyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALG2 mRNA CTD PMID:23557933 NCBI chr 5:66,564,328...66,568,887
Ensembl chr 5:66,564,330...66,568,887 		JBrowse link
G Alg3 ALG3, alpha-1,3- mannosyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ALG3 mRNA CTD PMID:23557933 NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060 		JBrowse link
G Alg6 ALG6, alpha-1,3-glucosyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALG6 mRNA CTD PMID:23557933 NCBI chr 5:119,520,415...119,606,365
Ensembl chr 5:119,520,430...119,606,659 		JBrowse link
G Alg8 ALG8, alpha-1,3-glucosyltransferase increases expression ISO resveratrol results in increased expression of ALG8 protein CTD PMID:25505154 NCBI chr 1:161,095,570...161,115,533
Ensembl chr 1:161,095,412...161,115,527 		JBrowse link
G Alg9 ALG9, alpha-1,2-mannosyltransferase decreases expression ISO resveratrol results in decreased expression of ALG9 mRNA CTD PMID:19371625 NCBI chr 8:60,013,429...60,085,159
Ensembl chr 8:60,009,618...60,085,054 		JBrowse link
G Alkbh1 alkB homolog 1, histone H2A dioxygenase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALKBH1 mRNA CTD PMID:23557933 NCBI chr 6:112,799,234...112,819,708
Ensembl chr 6:112,799,234...112,819,708 		JBrowse link
G Alkbh2 alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase increases expression EXP resveratrol results in increased expression of ALKBH2 mRNA CTD PMID:25905778 NCBI chr12:48,156,825...48,161,489
Ensembl chr12:48,156,827...48,161,483 		JBrowse link
G Alkbh3 alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALKBH3 mRNA CTD PMID:23557933 NCBI chr 3:100,394,942...100,429,466
Ensembl chr 3:100,380,273...100,427,294 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type decreases activity
decreases expression
multiple interactions 		ISO resveratrol results in decreased activity of ALOX12 protein
resveratrol results in decreased expression of ALOX12 protein
resveratrol inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] 		CTD PMID:17027136 PMID:25116358 NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions ISO resveratrol binds to and results in decreased activity of ALOX15 protein CTD PMID:10491155 NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723 		JBrowse link
G Alox15b arachidonate 15-lipoxygenase, type B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ALOX15B mRNA CTD PMID:23557933 NCBI chr10:54,391,331...54,400,648
Ensembl chr10:54,391,302...54,400,648 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase decreases expression
multiple interactions 		ISO Resveratrol results in decreased expression of ALOX5 protein
resveratrol binds to and results in decreased activity of ALOX5 protein; resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4] 		CTD PMID:10491155 PMID:23751068 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein increases expression EXP resveratrol results in increased expression of ALOX5AP mRNA CTD PMID:25905778 NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038 		JBrowse link
G Alpk1 alpha-kinase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALPK1 mRNA CTD PMID:23557933 NCBI chr 2:218,801,425...218,924,013
Ensembl chr 2:218,780,189...218,921,646 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions EXP resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] CTD PMID:11018766 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Alpp alkaline phosphatase, placental multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ALPP mRNA CTD PMID:23557933 NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ALS2 mRNA CTD PMID:23557933 NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660 		JBrowse link
G Alyref Aly/REF export factor decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ALYREF protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of THOC4 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395 		JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 decreases activity
multiple interactions 		ISO resveratrol results in decreased activity of AMD1 protein
[Coumestrol co-treated with resveratrol] results in increased expression of AMD1 mRNA 		CTD PMID:12663506 PMID:19167446 NCBI chr20:45,250,289...45,324,939
Ensembl chr20:45,250,289...45,265,982 		JBrowse link
G Amfr autocrine motility factor receptor multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of AMFR mRNA
resveratrol results in increased expression of AMFR protein 		CTD PMID:19167446 PMID:25505154 NCBI chr19:11,002,451...11,038,182
Ensembl chr19:11,002,101...11,038,364 		JBrowse link
G Amh anti-Mullerian hormone multiple interactions EXP resveratrol inhibits the reaction [Dihydrotestosterone results in increased secretion of AMH protein] CTD PMID:25667201 NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867 		JBrowse link
G Amhr2 anti-Mullerian hormone receptor type 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AMHR2 mRNA CTD PMID:23557933 NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104 		JBrowse link
G Amigo1 adhesion molecule with Ig like domain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AMIGO1 mRNA CTD PMID:23557933 NCBI chr 2:198,511,285...198,516,744
Ensembl chr 2:198,511,039...198,521,146 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AMIGO2 mRNA CTD PMID:23557933 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AMMECR1 mRNA CTD PMID:19167446 NCBI chr  X:111,262,792...111,368,099
Ensembl chr  X:111,262,792...111,368,099 		JBrowse link
G Ammecr1l AMMECR1 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AMMECR1L mRNA CTD PMID:23557933 NCBI chr18:23,661,649...23,685,391
Ensembl chr18:23,661,341...23,685,649 		JBrowse link
G Amotl1 angiomotin-like 1 increases expression ISO resveratrol results in increased expression of AMOTL1 mRNA CTD PMID:23750556 NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:19,634,510...19,748,869 		JBrowse link
G Amy1 amylase alpha 1 multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of AMY2B mRNA
Resveratrol inhibits the reaction [bisphenol A results in increased expression of AMY1 protein] 		CTD PMID:23557933 PMID:37570835 NCBI chr 2:204,071,101...204,085,910
Ensembl chr 2:204,071,098...204,086,239 		JBrowse link
G Anapc1 anaphase promoting complex subunit 1 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of ANAPC1 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of ANAPC1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464 		JBrowse link
G Anapc16 anaphase promoting complex subunit 16 decreases expression ISO resveratrol results in decreased expression of ANAPC16 protein CTD PMID:25505154 NCBI chr20:28,470,282...28,484,601
Ensembl chr20:28,470,282...28,484,987 		JBrowse link
G Andpro androgen regulated protein increases expression ISO Resveratrol results in increased expression of CST4 mRNA CTD PMID:17257620 NCBI chr 3:157,171,739...157,178,262
Ensembl chr 3:157,171,740...157,178,104 		JBrowse link
G Angptl2 angiopoietin-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANGPTL2 mRNA CTD PMID:23557933 NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of ANGPTL4
[resveratrol co-treated with Streptozocin] results in decreased expression of ANGPTL4 mRNA 		CTD PMID:24722352 PMID:25905778 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Angptl6 angiopoietin-like 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANGPTL6 mRNA CTD PMID:23557933 NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111 		JBrowse link
G Ankfy1 ankyrin repeat and FYVE domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKFY1 mRNA CTD PMID:23557933 NCBI chr10:57,810,781...57,882,495
Ensembl chr10:57,810,781...57,882,495 		JBrowse link
G Ankmy2 ankyrin repeat and MYND domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKMY2 mRNA CTD PMID:23557933 NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:58,615,243...58,657,685 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ANKRD1 mRNA CTD PMID:26667767 NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751 		JBrowse link
G Ankrd10 ankyrin repeat domain 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD10 mRNA CTD PMID:23557933 NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD11 mRNA CTD PMID:23557933 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd13c ankyrin repeat domain 13C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD13C mRNA CTD PMID:23557933 NCBI chr 2:249,679,752...249,729,272
Ensembl chr 2:249,681,872...249,729,272 		JBrowse link
G Ankrd26 ankyrin repeat domain containing 26 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD26 mRNA CTD PMID:23557933 NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256 		JBrowse link
G Ankrd33 ankyrin repeat domain 33 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD33 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD33 mRNA CTD PMID:23557933 NCBI chr 7:134,102,906...134,106,860
Ensembl chr 7:134,103,811...134,106,566 		JBrowse link
G Ankrd34c ankyrin repeat domain 34C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD34C mRNA CTD PMID:23557933 NCBI chr 8:99,151,112...99,161,607
Ensembl chr 8:99,146,556...99,162,260 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD44 mRNA CTD PMID:23557933 NCBI chr 9:63,621,193...63,921,999
Ensembl chr 9:63,555,869...63,921,940 		JBrowse link
G Ankrd46 ankyrin repeat domain 46 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD46 mRNA CTD PMID:23557933 NCBI chr 7:69,532,303...69,553,311
Ensembl chr 7:69,532,304...69,545,421 		JBrowse link
G Ankrd50 ankyrin repeat domain containing 50 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD50 mRNA CTD PMID:23557933 NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340 		JBrowse link
G Ankrd53 ankyrin repeat domain 53 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD53 mRNA CTD PMID:23557933 NCBI chr 4:117,804,702...117,810,650
Ensembl chr 4:117,804,548...117,810,645 		JBrowse link
G Ankrd60 ankyrin repeat domain 60 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD60 mRNA CTD PMID:23557933 NCBI chr 3:182,784,062...182,793,852
Ensembl chr 3:182,783,172...182,794,070 		JBrowse link
G Anks4b ankyrin repeat and sterile alpha motif domain containing 4B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKS4B mRNA CTD PMID:23557933 NCBI chr 1:183,934,528...183,989,127
Ensembl chr 1:183,978,769...183,989,122 		JBrowse link
G Anln anillin, actin binding protein decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of ANLN mRNA
resveratrol results in increased expression of ANLN mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513 		JBrowse link
G Ano1 anoctamin 1 increases expression ISO resveratrol results in increased expression of ANO1 mRNA CTD PMID:19371625 NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550 		JBrowse link
G Ano4 anoctamin 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANO4 mRNA CTD PMID:23557933 NCBI chr 7:25,216,389...25,625,811
Ensembl chr 7:25,216,389...25,625,746 		JBrowse link
G Ano7 anoctamin 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANO7 mRNA CTD PMID:23557933 NCBI chr 9:101,364,915...101,392,711
Ensembl chr 9:101,364,842...101,394,173 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANP32A mRNA CTD PMID:23557933 NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922 		JBrowse link
G Anp32e acidic nuclear phosphoprotein 32 family member E multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of ANP32E mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ANP32E mRNA
resveratrol results in increased expression of ANP32E protein 		CTD PMID:19167446 PMID:23557933 PMID:25505154 NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986 		JBrowse link
G Anxa1 annexin A1 decreases expression ISO resveratrol results in decreased expression of ANXA1 protein CTD PMID:25505154 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa11 annexin A11 decreases expression ISO resveratrol results in decreased expression of ANXA11 protein CTD PMID:18089832 NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839 		JBrowse link
G Anxa2 annexin A2 increases expression ISO resveratrol results in increased expression of ANXA2 mRNA; resveratrol results in increased expression of ANXA2 protein CTD PMID:18089832 PMID:23750556 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa3 annexin A3 increases cleavage
increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased cleavage of ANXA3 protein
resveratrol results in increased expression of ANXA3 mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of ANXA3 mRNA 		CTD PMID:23088850 PMID:25905778 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa4 annexin A4 multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ANXA4 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ANXA4 mRNA CTD PMID:23557933 PMID:26667767 NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513 		JBrowse link
G Anxa5 annexin A5 increases expression ISO resveratrol results in increased expression of ANXA5 protein CTD PMID:12060119 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Anxa6 annexin A6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ANXA6 mRNA CTD PMID:23557933 NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359 		JBrowse link
G Aoah acyloxyacyl hydrolase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AOAH mRNA CTD PMID:23557933 NCBI chr17:48,503,812...48,745,161
Ensembl chr17:48,503,812...48,745,146 		JBrowse link
G Aopep aminopeptidase O multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AOPEP mRNA CTD PMID:23557933 NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104 		JBrowse link
G Aox1 aldehyde oxidase 1 affects expression
multiple interactions 		ISO
EXP 		resveratrol affects the expression of AOX1 mRNA
Resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1 mRNA]; Resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1] 		CTD PMID:23525482 PMID:24894866 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap1g1 adaptor related protein complex 1 subunit gamma 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AP1G1 mRNA CTD PMID:23557933 NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586 		JBrowse link
G Ap2a1 adaptor related protein complex 2 subunit alpha 1 decreases expression ISO resveratrol results in decreased expression of AP2A1 protein CTD PMID:25505154 NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655 		JBrowse link
G Ap2a2 adaptor related protein complex 2 subunit alpha 2 decreases expression ISO resveratrol results in decreased expression of AP2A2 protein CTD PMID:25505154 NCBI chr 1:206,081,856...206,155,146
Ensembl chr 1:206,081,878...206,155,150 		JBrowse link
G Ap2b1 adaptor related protein complex 2 subunit beta 1 decreases expression ISO resveratrol results in decreased expression of AP2B1 protein CTD PMID:25505154 NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539 		JBrowse link
G Ap3d1 adaptor related protein complex 3 subunit delta 1 decreases expression ISO resveratrol results in decreased expression of AP3D1 protein CTD PMID:18089832 NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342 		JBrowse link
G Ap3m1 adaptor related protein complex 3 subunit mu 1 increases expression ISO resveratrol results in increased expression of AP3M1 protein CTD PMID:25505154 NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104 		JBrowse link
G Ap4b1 adaptor related protein complex 4 subunit beta 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AP4B1 mRNA CTD PMID:23557933 NCBI chr 2:194,006,926...194,018,971
Ensembl chr 2:194,006,919...194,018,968 		JBrowse link
G Ap4e1 adaptor related protein complex 4 subunit epsilon 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AP4E1 mRNA CTD PMID:23557933 NCBI chr 3:134,726,338...134,792,820
Ensembl chr 3:134,726,287...134,792,818 		JBrowse link
G Ap4s1 adaptor related protein complex 4 subunit sigma 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AP4S1 mRNA CTD PMID:23557933 NCBI chr 6:74,863,742...74,916,907
Ensembl chr 6:74,868,558...74,912,406 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 decreases expression
increases expression 		ISO resveratrol results in decreased expression of APAF1 mRNA; resveratrol results in decreased expression of APAF1 protein
resveratrol results in increased expression of APAF1 mRNA 		CTD PMID:12002526 PMID:12569576 PMID:14749477 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of APBA1 mRNA CTD PMID:23557933 NCBI chr 1:230,790,297...230,995,986
Ensembl chr 1:230,790,297...230,995,986 		JBrowse link
G Apbb1 amyloid beta precursor protein binding family B member 1 increases expression ISO resveratrol results in increased expression of APBB1 mRNA CTD PMID:22610192 NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552 		JBrowse link
G Apc APC regulator of WNT signaling pathway multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of APC mRNA CTD PMID:23557933 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apc2 APC regulator of WNT signaling pathway 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of APC2 mRNA CTD PMID:23557933 NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210 		JBrowse link
G Apcdd1l APC down-regulated 1 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of APCDD1L mRNA CTD PMID:23557933 NCBI chr 3:183,000,504...183,076,628
Ensembl chr 3:183,000,521...183,076,339 		JBrowse link
G Apcs amyloid P component, serum multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of APCS mRNA] CTD PMID:31298478 NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 decreases expression
decreases activity 		EXP
ISO 		Resveratrol results in decreased expression of APEX1 mRNA
resveratrol results in decreased activity of APEX1 protein 		CTD PMID:16373707 PMID:33775663 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Api5 apoptosis inhibitor 5 decreases expression ISO resveratrol results in decreased expression of API5 protein CTD PMID:25505154 NCBI chr 3:100,833,417...100,858,580
Ensembl chr 3:100,833,417...100,858,580 		JBrowse link
G Apln apelin increases expression
multiple interactions 		ISO resveratrol metabolite results in increased expression of APLN mRNA; resveratrol results in increased expression of APLN mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of APLN mRNA 		CTD PMID:23557933 PMID:23717508 NCBI chr  X:132,058,739...132,091,518
Ensembl chr  X:132,081,759...132,091,246 		JBrowse link
G Aplp2 amyloid beta precursor like protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of APLP2 mRNA CTD PMID:23557933 NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031 		JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions ISO resveratrol inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]; resveratrol inhibits the reaction [APOA1 protein results in increased export of Cholesterol] CTD PMID:19717637 PMID:23041272 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa2 apolipoprotein A2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of APOA2 mRNA CTD PMID:23557933 NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410 		JBrowse link
G Apoa4 apolipoprotein A4 multiple interactions
decreases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in decreased expression of APOA4 mRNA
Resveratrol inhibits the reaction [Dietary Fats affects the expression of APOA4 mRNA]; Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of APOA4 mRNA]
resveratrol results in decreased expression of APOA4 mRNA 		CTD PMID:17086191 PMID:18930334 PMID:25905778 PMID:31298478 NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164 		JBrowse link
G Apob apolipoprotein B decreases expression
decreases secretion 		ISO resveratrol results in decreased expression of APOB protein
resveratrol results in decreased secretion of APOB protein 		CTD PMID:12612140 PMID:25505154 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Apoc1 apolipoprotein C1 increases expression ISO resveratrol results in increased expression of APOC1 mRNA CTD PMID:25888808 NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155 		JBrowse link
G Apoc4 apolipoprotein C4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of APOC4 mRNA CTD PMID:23557933 NCBI chr 1:88,463,713...88,467,909
Ensembl chr 1:88,463,713...88,468,044 		JBrowse link
G Apoe apolipoprotein E increases expression
decreases expression
affects secretion 		ISO
EXP 		resveratrol results in increased expression of APOE mRNA
resveratrol results in decreased expression of APOE mRNA
resveratrol affects the secretion of APOE protein 		CTD PMID:19228061 PMID:19371625 PMID:22610192 PMID:24802182 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apol2 apolipoprotein L2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of APOL2 mRNA CTD PMID:23557933 NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223 		JBrowse link
G Apom apolipoprotein M decreases expression ISO resveratrol results in decreased expression of APOM protein CTD PMID:25505154 NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218 		JBrowse link
G Apoo apolipoprotein O multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of APOO mRNA CTD PMID:23557933 NCBI chr  X:63,151,736...63,256,696
Ensembl chr  X:63,151,814...63,256,690 		JBrowse link
G App amyloid beta precursor protein multiple interactions
decreases response to substance
decreases secretion
increases degradation
decreases expression
affects binding
affects folding 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of APP mRNA; [Resveratrol results in increased phosphorylation of PRKAA1 protein] which results in decreased expression of APP protein modified form; dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of APP protein modified form]; lactacystin inhibits the reaction [Resveratrol results in decreased secretion of APP protein]; PSMB5 protein affects the reaction [Resveratrol results in decreased secretion of APP protein]; Resveratrol inhibits the reaction [APP protein results in increased abundance of Superoxides]; Resveratrol results in decreased secretion of and results in increased degradation of APP protein; YU101 inhibits the reaction [Resveratrol results in decreased secretion of APP protein]
resveratrol results in decreased susceptibility to APP protein
resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Ascorbic Acid]; resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Glutathione]; resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Tocopherols]; resveratrol inhibits the reaction [APP protein modified form results in decreased activity of CAT protein]; resveratrol inhibits the reaction [APP protein modified form results in decreased activity of GSR protein]; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of ARC protein]; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of DLG4 protein]; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of GSK3B protein modified form]; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of IDE protein]; resveratrol inhibits the reaction [APP protein modified form results in increased abundance of Lipid Peroxides]; resveratrol inhibits the reaction [APP protein modified form results in increased expression of MAPT protein modified form]; resveratrol inhibits the reaction [APP protein modified form results in increased expression of MAPT protein]; resveratrol inhibits the reaction [APP protein results in increased acetylation of RELA protein]; resveratrol inhibits the reaction [APP protein results in increased expression of and results in increased activity of NOS2 protein]; resveratrol inhibits the reaction [APP protein results in increased expression of PTGS2 protein]; resveratrol inhibits the reaction [APP protein results in increased secretion of Dinoprostone]; resveratrol promotes the reaction [Catechin results in decreased susceptibility to APP protein]
resveratrol results in decreased secretion of APP protein mutant form
resveratrol results in increased degradation of APP protein modified form
resveratrol results in decreased expression of APP protein modified form
resveratrol binds to [APP protein binds to APP protein]
resveratrol affects the folding of APP protein modified form
resveratrol results in decreased expression of APP protein; resveratrol results in decreased expression of APP protein modified form
resveratrol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]; resveratrol inhibits the reaction [APP protein results in increased phosphorylation of NFKBIA protein]; resveratrol inhibits the reaction [APP protein results in increased phosphorylation of STAT1 protein]; resveratrol inhibits the reaction [APP protein results in increased phosphorylation of STAT3 protein]; resveratrol inhibits the reaction [APP protein results in increased secretion of IL6 protein]; resveratrol inhibits the reaction [APP protein results in increased secretion of TNF protein] 		CTD PMID:15134381 PMID:16162502 PMID:16183991 PMID:16212921 PMID:16685418 More... NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Appbp2 amyloid beta precursor protein binding protein 2 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of APPBP2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of APPBP2 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr10:70,555,212...70,597,267
Ensembl chr10:70,555,212...70,597,193 		JBrowse link
G Aprt adenine phosphoribosyl transferase increases expression ISO resveratrol results in increased expression of APRT protein CTD PMID:25505154 NCBI chr19:67,534,737...67,537,027 JBrowse link
G Aptx aprataxin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of APTX mRNA CTD PMID:23557933 NCBI chr 5:60,593,338...60,618,946
Ensembl chr 5:60,597,648...60,618,790 		JBrowse link
G Aqp1 aquaporin 1 increases expression ISO resveratrol results in increased expression of AQP1 mRNA CTD PMID:20706672 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp11 aquaporin 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP11 mRNA CTD PMID:23557933 NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:161,457,754...161,467,945 		JBrowse link
G Aqp12a aquaporin 12A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP12A mRNA CTD PMID:23557933 NCBI chr 9:101,001,939...101,007,425
Ensembl chr 9:101,001,939...101,007,425 		JBrowse link
G Aqp2 aquaporin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP2 mRNA CTD PMID:23557933 NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression 		ISO resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AQP3 mRNA]
resveratrol results in increased expression of AQP3 mRNA 		CTD PMID:20706672 PMID:26454884 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp6 aquaporin 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP6 mRNA CTD PMID:23557933 NCBI chr 7:132,611,069...132,614,004
Ensembl chr 7:132,611,065...132,614,049 		JBrowse link
G Aqp7 aquaporin 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP7 mRNA CTD PMID:23557933 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AQP8 mRNA CTD PMID:23557933 NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242 		JBrowse link
G Aqr aquarius intron-binding spliceosomal factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AQR mRNA CTD PMID:23557933 NCBI chr 3:121,329,287...121,399,375
Ensembl chr 3:121,329,289...121,399,321 		JBrowse link
G Ar androgen receptor increases expression
decreases expression
decreases activity
multiple interactions 		ISO resveratrol results in increased expression of AR protein
resveratrol results in decreased expression of AR mRNA; resveratrol results in decreased expression of AR protein
Resveratrol results in decreased activity of AR protein
[resveratrol results in decreased activity of AR protein] which results in increased expression of PTEN mRNA; AR protein affects the reaction [[resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein]; resveratrol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; resveratrol inhibits the reaction [HIF1A protein results in increased activity of AR protein]; resveratrol inhibits the reaction [Oxygen deficiency promotes the reaction [Dihydrotestosterone results in increased activity of AR protein]]; resveratrol inhibits the reaction [Oxygen deficiency results in increased activity of AR protein]; resveratrol promotes the reaction [bicalutamide results in decreased activity of AR protein] 		CTD PMID:10606230 PMID:15767336 PMID:17486135 PMID:17675339 PMID:20706672 More... NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Araf A-Raf proto-oncogene, serine/threonine kinase increases expression
multiple interactions 		ISO resveratrol results in increased expression of ARAF protein
ARAF protein affects the reaction [resveratrol results in increased expression of and results in increased activity of EGR1 protein] 		CTD PMID:18089832 PMID:25645941 NCBI chr  X:3,780,932...3,845,919
Ensembl chr  X:3,780,932...3,792,611 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of ARC mRNA
resveratrol inhibits the reaction [APP protein modified form results in decreased expression of ARC protein] 		CTD PMID:23557933 PMID:25654502 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Areg amphiregulin multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of AREG mRNA CTD PMID:26667767 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arf1 ARF GTPase 1 increases expression ISO resveratrol results in increased expression of ARF1 protein CTD PMID:25505154 NCBI chr10:44,497,543...44,513,994 JBrowse link
G Arf4 ARF GTPase 4 increases expression ISO resveratrol results in increased expression of ARF4 protein CTD PMID:25505154 NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011 		JBrowse link
G Arf5 ARF GTPase 5 increases expression ISO resveratrol results in increased expression of ARF5 protein CTD PMID:25505154 NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835 		JBrowse link
G Arfgap2 ARF GTPase activating protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARFGAP2 mRNA CTD PMID:23557933 NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247 		JBrowse link
G Arfgef1 ARF guanine nucleotide exchange factor 1 increases expression ISO resveratrol results in increased expression of ARFGEF1 protein CTD PMID:25505154 NCBI chr 5:13,764,507...13,859,237
Ensembl chr 5:13,764,975...13,859,237 		JBrowse link
G Arfgef2 ARF guanine nucleotide exchange factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARFGEF2 mRNA CTD PMID:23557933 NCBI chr 3:175,966,575...176,052,715
Ensembl chr 3:175,966,579...176,052,713 		JBrowse link
G Arfgef3 ARFGEF family member 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ARFGEF3 mRNA CTD PMID:19167446 NCBI chr 1:15,058,574...15,223,742
Ensembl chr 1:15,058,579...15,223,742 		JBrowse link
G Arg1 arginase 1 increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of ARG1 mRNA
resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA]
[resveratrol co-treated with enterotoxin B, staphylococcal] results in increased expression of ARG1 protein 		CTD PMID:22646800 PMID:23832548 PMID:25108154 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Arg2 arginase 2 multiple interactions ISO resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ARG2 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ARG2 protein] CTD PMID:24951775 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap25 Rho GTPase activating protein 25 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARHGAP25 mRNA CTD PMID:23557933 NCBI chr 4:121,454,151...121,532,293
Ensembl chr 4:121,454,151...121,552,913 		JBrowse link
G Arhgap27 Rho GTPase activating protein 27 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGAP27 mRNA CTD PMID:23557933 NCBI chr10:88,780,527...88,813,275
Ensembl chr10:88,780,527...88,814,616 		JBrowse link
G Arhgap33 Rho GTPase activating protein 33 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGAP33 mRNA CTD PMID:23557933 NCBI chr 1:94,903,566...94,917,074
Ensembl chr 1:94,902,922...94,917,684 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 decreases expression ISO resveratrol results in decreased expression of ARHGAP5 mRNA; resveratrol results in decreased expression of ARHGAP5 protein CTD PMID:18089832 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgap9 Rho GTPase activating protein 9 multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of ARHGAP9 mRNA
resveratrol results in increased expression of ARHGAP9 mRNA 		CTD PMID:25905778 NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336 		JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha decreases expression ISO resveratrol results in decreased expression of ARHGDIA mRNA CTD PMID:25667456 NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347 		JBrowse link
G Arhgdig Rho GDP dissociation inhibitor gamma multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGDIG mRNA CTD PMID:23557933 NCBI chr10:15,723,525...15,725,719
Ensembl chr10:15,723,525...15,725,688 		JBrowse link
G Arhgef16 Rho guanine nucleotide exchange factor 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGEF16 mRNA CTD PMID:23557933 NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:170,126,575...170,148,624 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 increases expression ISO resveratrol results in increased expression of ARHGEF2 protein CTD PMID:25505154 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646 		JBrowse link
G Arhgef25 Rho guanine nucleotide exchange factor 25 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGEF25 mRNA CTD PMID:23557933 NCBI chr 7:64,891,260...64,898,382
Ensembl chr 7:64,890,879...64,898,697 		JBrowse link
G Arhgef3 Rho guanine nucleotide exchange factor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARHGEF3 mRNA CTD PMID:23557933 NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819 		JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor 39 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARHGEF39 mRNA CTD PMID:23557933 NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870 		JBrowse link
G Arid1a AT-rich interaction domain 1A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARID1A mRNA CTD PMID:23557933 NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386 		JBrowse link
G Arid1b AT-rich interaction domain 1B decreases expression EXP resveratrol results in decreased expression of ARID1B mRNA CTD PMID:25905778 NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793 		JBrowse link
G Arid3b AT-rich interaction domain 3B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARID3B mRNA CTD PMID:23557933 NCBI chr 8:67,089,141...67,136,764
Ensembl chr 8:67,083,802...67,152,245 		JBrowse link
G Arid4a AT-rich interaction domain 4A decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of ARID4A mRNA
resveratrol results in increased expression of ARID4A mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of ARID4A mRNA 		CTD PMID:12569576 PMID:15280659 PMID:23557933 NCBI chr 6:95,258,429...95,335,987
Ensembl chr 6:95,258,429...95,329,840 		JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARIH2 mRNA CTD PMID:23557933 NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284 		JBrowse link
G Arl1 ARF like GTPase 1 increases expression ISO resveratrol results in increased expression of ARL1 protein CTD PMID:25505154 NCBI chr 7:25,007,401...25,018,572
Ensembl chr 7:25,006,981...25,019,319 		JBrowse link
G Arl14ep ARF like GTPase 14 effector protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARL14EP mRNA CTD PMID:23557933 NCBI chr 3:113,896,731...113,908,994
Ensembl chr 3:113,898,076...113,908,833 		JBrowse link
G Arl2 ARF like GTPase 2 increases expression ISO resveratrol results in increased expression of ARL2 protein CTD PMID:25505154 NCBI chr 1:212,863,422...212,875,425
Ensembl chr 1:212,863,423...212,875,373 		JBrowse link
G Arl3 ARF like GTPase 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ARL3 mRNA CTD PMID:19167446 NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279 		JBrowse link
G Arl6 ARF like GTPase 6 increases expression ISO resveratrol results in increased expression of ARL6 protein CTD PMID:25505154 NCBI chr11:54,180,271...54,207,136
Ensembl chr11:54,181,241...54,210,813 		JBrowse link
G Arl8b ARF like GTPase 8B increases expression ISO resveratrol results in increased expression of ARL8B protein CTD PMID:25505154 NCBI chr 4:143,304,597...143,348,580
Ensembl chr 4:143,304,621...143,349,068 		JBrowse link
G Armc1 armadillo repeat containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARMC1 mRNA CTD PMID:23557933 NCBI chr 2:103,524,333...103,568,355
Ensembl chr 2:103,524,333...103,568,355 		JBrowse link
G Armc10 armadillo repeat containing 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARMC10 mRNA CTD PMID:23557933 NCBI chr 4:14,291,211...14,306,799
Ensembl chr 4:14,291,211...14,306,817 		JBrowse link
G Armc5 armadillo repeat containing 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARMC5 mRNA CTD PMID:23557933 NCBI chr 1:192,250,580...192,257,347
Ensembl chr 1:192,249,939...192,257,348 		JBrowse link
G Armc7 armadillo repeat containing 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARMC7 mRNA CTD PMID:23557933 NCBI chr10:101,222,056...101,238,598
Ensembl chr10:101,222,067...101,238,597 		JBrowse link
G Armcx3 armadillo repeat containing, X-linked 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARMCX3 mRNA CTD PMID:23557933 NCBI chr  X:102,230,464...102,234,017
Ensembl chr  X:102,219,848...102,263,297 		JBrowse link
G Armh3 armadillo-like helical domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARMH3 mRNA CTD PMID:23557933 NCBI chr 1:254,615,274...254,797,673
Ensembl chr 1:254,615,274...254,781,315 		JBrowse link
G Armt1 acidic residue methyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DCPH1 mRNA CTD PMID:23557933 NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases localization 		EXP
ISO 		Resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]]; Resveratrol inhibits the reaction [[bisphenol A co-treated with Dietary Fats] results in increased expression of ARNT mRNA]
resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 enhancer]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 promoter]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 enhancer]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 promoter]]
resveratrol results in increased localization of ARNT protein 		CTD PMID:18708364 PMID:19376845 PMID:20846786 PMID:21756928 PMID:31489946 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARPC1B mRNA
resveratrol results in decreased expression of ARPC1B protein 		CTD PMID:23557933 PMID:25505154 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504 		JBrowse link
G Arpc4 actin related protein 2/3 complex, subunit 4 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ARPC4 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ARPC4 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 4:148,077,799...148,088,427
Ensembl chr 4:148,077,240...148,088,428 		JBrowse link
G Arpc5 actin related protein 2/3 complex, subunit 5 decreases expression ISO resveratrol results in decreased expression of ARPC5 protein CTD PMID:25505154 NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283 		JBrowse link
G Arpc5l actin related protein 2/3 complex, subunit 5-like decreases expression ISO resveratrol results in decreased expression of ARPC5L protein CTD PMID:25505154 NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240
Ensembl chr 9:43,169,462...43,177,240 		JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARPP19 mRNA CTD PMID:23557933 NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385
Ensembl chr 8:119,691,942...119,692,385 		JBrowse link
G Arrb2 arrestin, beta 2 multiple interactions
affects response to substance 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARRB2 mRNA; ARRB2 protein affects the reaction [Resveratrol results in decreased expression of GSK3B protein modified form]
ARRB2 protein affects the susceptibility to resveratrol 		CTD PMID:20457218 PMID:23557933 NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487 		JBrowse link
G Arsb arylsulfatase B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ARSB mRNA CTD PMID:23557933 NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611 		JBrowse link
G Arsi arylsulfatase family, member I multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARSI mRNA CTD PMID:23557933 NCBI chr18:56,634,556...56,642,168
Ensembl chr18:56,625,487...56,642,168 		JBrowse link
G Artn artemin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARTN mRNA CTD PMID:23557933 NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457 		JBrowse link
G Arx aristaless related homeobox multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ARX mRNA CTD PMID:23557933 NCBI chr  X:62,010,097...62,022,009
Ensembl chr  X:62,010,097...62,022,002 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 decreases expression ISO resveratrol results in decreased expression of ASAH1 mRNA CTD PMID:19371625 NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305 		JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ASAP1 mRNA CTD PMID:19167446 NCBI chr 7:97,675,354...97,982,523
Ensembl chr 7:97,675,354...97,982,024 		JBrowse link
G Asb1 ankyrin repeat and SOCS box-containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASB1 mRNA CTD PMID:23557933 NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:99,567,867...99,583,907 		JBrowse link
G Asb13 ankyrin repeat and SOCS box-containing 13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASB13 mRNA CTD PMID:23557933 NCBI chr17:71,474,531...71,493,238
Ensembl chr17:71,474,531...71,505,633 		JBrowse link
G Asb15 ankyrin repeat and SOCS box containing 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASB15 mRNA CTD PMID:23557933 NCBI chr 4:53,987,217...54,014,128
Ensembl chr 4:53,971,712...54,016,369 		JBrowse link
G Asb18 ankyrin repeat and SOCS box-containing 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASB18 mRNA CTD PMID:23557933 NCBI chr 9:97,979,018...98,043,609
Ensembl chr 9:97,979,264...98,043,540 		JBrowse link
G Asb3 ankyrin repeat and SOCS box-containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASB3 mRNA CTD PMID:23557933 NCBI chr14:108,860,318...108,988,939
Ensembl chr14:108,811,930...108,988,942 		JBrowse link
G Asb4 ankyrin repeat and SOCS box-containing 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASB4 mRNA CTD PMID:23557933 NCBI chr 4:34,473,527...34,511,163
Ensembl chr 4:34,473,408...34,512,888 		JBrowse link
G Asb7 ankyrin repeat and SOCS box-containing 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASB7 mRNA CTD PMID:23557933 NCBI chr 1:129,621,462...129,677,788
Ensembl chr 1:129,635,330...129,677,505 		JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASCC3 mRNA CTD PMID:23557933 NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 decreases expression
increases expression 		ISO resveratrol results in decreased expression of ASCL1 mRNA; resveratrol results in decreased expression of ASCL1 protein
resveratrol results in increased expression of ASCL1 mRNA 		CTD PMID:12002526 PMID:21184191 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Ascl5 achaete-scute family bHLH transcription factor 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASCL5 mRNA CTD PMID:23557933 NCBI chr13:50,043,520...50,044,988
Ensembl chr13:50,033,178...50,044,936 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA CTD PMID:19167446 NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352 		JBrowse link
G Ash1l ASH1 like histone lysine methyltransferase decreases expression EXP resveratrol results in decreased expression of ASH1L mRNA CTD PMID:25905778 NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:176,644,924...176,780,847 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASIC1 mRNA CTD PMID:23557933 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) multiple interactions
increases expression
decreases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of ASNS mRNA
resveratrol results in increased expression of ASNS mRNA
resveratrol results in decreased expression of ASNS mRNA 		CTD PMID:12002526 PMID:12569576 PMID:25905778 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspdh aspartate dehydrogenase domain containing multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASPDH mRNA CTD PMID:23557933 NCBI chr 1:104,094,983...104,097,244
Ensembl chr 1:104,094,954...104,097,244 		JBrowse link
G Aspg asparaginase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASPG mRNA CTD PMID:23557933 NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417 		JBrowse link
G Asph aspartate-beta-hydroxylase decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of ASPH mRNA
resveratrol results in increased expression of ASPH protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ASPH mRNA 		CTD PMID:23557933 PMID:25505154 PMID:25888808 NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215 		JBrowse link
G Asphd1 aspartate beta-hydroxylase domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASPHD1 mRNA CTD PMID:23557933 NCBI chr 1:190,983,506...190,987,440
Ensembl chr 1:190,983,506...190,987,440 		JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ASPM mRNA CTD PMID:19167446 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Asrgl1 asparaginase and isoaspartyl peptidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASRGL1 mRNA CTD PMID:23557933 NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198 		JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression ISO resveratrol results in increased expression of ASS1 mRNA; resveratrol results in increased expression of ASS1 protein CTD PMID:18089832 PMID:25505154 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Aste1 asteroid homolog 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ASTE1 mRNA CTD PMID:23557933 NCBI chr 8:114,905,349...114,923,775
Ensembl chr 8:114,905,266...114,923,105 		JBrowse link
G Astl astacin like metalloendopeptidase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASTL mRNA CTD PMID:23557933 NCBI chr 3:135,016,444...135,032,177
Ensembl chr 3:135,016,444...135,032,177 		JBrowse link
G Astn2 astrotactin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ASTN2 mRNA CTD PMID:23557933 NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD1 mRNA CTD PMID:23557933 NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of ATAD2 mRNA
[Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD2 mRNA 		CTD PMID:19167446 PMID:23557933 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atad5 ATPase family, AAA domain containing 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD5 mRNA CTD PMID:23557933 NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376 		JBrowse link
G Atcay ATCAY kinesin light chain interacting caytaxin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATCAY mRNA CTD PMID:23557933 NCBI chr 7:9,138,485...9,162,249
Ensembl chr 7:9,138,587...9,163,370 		JBrowse link
G Ate1 arginyltransferase 1 decreases expression EXP resveratrol results in decreased expression of ATE1 mRNA CTD PMID:25905778 NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:194,391,843...194,511,348 		JBrowse link
G Atf1 activating transcription factor 1 increases phosphorylation
multiple interactions 		ISO resveratrol results in increased phosphorylation of ATF1 protein
resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA] 		CTD PMID:20080969 PMID:23452621 NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485 		JBrowse link
G Atf2 activating transcription factor 2 increases phosphorylation
multiple interactions
increases activity 		ISO
EXP 		resveratrol results in increased phosphorylation of ATF2 protein
resveratrol inhibits the reaction [Streptozocin results in increased expression of ATF2 protein]
resveratrol results in increased activity of ATF2 protein 		CTD PMID:18222423 PMID:26446263 PMID:26499206 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
increases expression
decreases expression
affects response to substance 		ISO
EXP 		ATF3 protein affects the reaction [resveratrol results in increased expression of KL mRNA]; ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP3 protein]; ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP7 protein]; resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; resveratrol promotes the reaction [[KLF4 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]
resveratrol results in increased expression of ATF3 mRNA; resveratrol results in increased expression of ATF3 protein
resveratrol results in decreased expression of ATF3 mRNA
ATF3 protein affects the susceptibility to resveratrol
ATF3 protein affects the reaction [resveratrol results in increased expression of KL mRNA]; resveratrol affects the localization of and results in increased expression of ATF3 protein; resveratrol promotes the reaction [ATF3 protein binds to JUN protein]; resveratrol promotes the reaction [ATF3 protein binds to KL promoter] 		CTD PMID:12002526 PMID:15280659 PMID:15897233 PMID:19167446 PMID:21205742 More... NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO
EXP 		resveratrol inhibits the reaction [Ethanol results in increased expression of ATF4 protein]
Resveratrol inhibits the reaction [Dietary Fats results in increased expression of ATF4 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of ATF4 protein]
Resveratrol inhibits the reaction [Acrolein results in increased expression of ATF4 protein] 		CTD PMID:24224909 PMID:26055348 PMID:34302886 PMID:34813903 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf5 activating transcription factor 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATF5 mRNA CTD PMID:23557933 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions
increases expression 		ISO
EXP 		resveratrol inhibits the reaction [arsenic trioxide results in increased expression of ATF6 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]
Resveratrol inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]
resveratrol results in increased expression of ATF6 protein 		CTD PMID:24264887 PMID:25107562 PMID:31298478 PMID:31433112 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atf7 activating transcription factor 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATF7 mRNA CTD PMID:23557933 NCBI chr 7:135,537,351...135,649,188
Ensembl chr 7:135,542,111...135,599,899 		JBrowse link
G Atg101 autophagy related 101 increases expression ISO resveratrol results in increased expression of ATG101 protein CTD PMID:25505154 NCBI chr 7:134,277,223...134,286,387
Ensembl chr 7:134,272,847...134,286,379 		JBrowse link
G Atg12 autophagy related 12 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATG12 mRNA CTD PMID:23557933 NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261 		JBrowse link
G Atg2b autophagy related 2B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATG2B mRNA CTD PMID:23557933 NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109 		JBrowse link
G Atg3 autophagy related 3 decreases expression
increases expression 		ISO resveratrol results in decreased expression of ATG3 mRNA
resveratrol results in increased expression of ATG3 mRNA 		CTD PMID:23750556 NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
affects response to substance 		ISO resveratrol promotes the reaction [Ethanol results in increased expression of ATG5 mRNA]
resveratrol results in increased expression of ATG5 mRNA
ATG5 protein affects the susceptibility to resveratrol
ATG5 protein affects the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form]; ATG5 protein affects the reaction [Resveratrol affects the metabolism of MAP1LC3B protein]; ATG5 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; ATG5 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; ATG5 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]; ATG5 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Resveratrol inhibits the reaction [Particulate Matter results in increased expression of ATG5 mRNA]; Resveratrol inhibits the reaction [Particulate Matter results in increased expression of ATG5 protein]; Sirolimus inhibits the reaction [Resveratrol inhibits the reaction [Particulate Matter results in increased expression of ATG5 protein]] 		CTD PMID:12002526 PMID:12569576 PMID:23680031 PMID:24095927 PMID:24145604 More... NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg9b autophagy related 9B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATG9B mRNA CTD PMID:23557933 NCBI chr 4:11,678,548...11,686,097
Ensembl chr 4:11,678,299...11,686,079 		JBrowse link
G Atl2 atlastin GTPase 2 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATL2 mRNA
resveratrol results in increased expression of ATL2 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320 		JBrowse link
G Atl3 atlastin GTPase 3 increases expression
multiple interactions 		ISO resveratrol results in increased expression of ATL3 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ATL3 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
decreases expression
increases acetylation
increases phosphorylation
increases activity 		ISO
EXP 		2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin promotes the reaction [Resveratrol results in increased phosphorylation of ATM protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Hydrogen Peroxide promotes the reaction [Resveratrol results in increased phosphorylation of ATM protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of ATM protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Resveratrol promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of ATM protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of ATM protein]; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AX protein; [Temozolomide co-treated with Resveratrol] results in increased phosphorylation of ATM protein; ATM mutant form inhibits the reaction [Resveratrol results in increased expression of MICA protein]; ATM mutant form inhibits the reaction [Resveratrol results in increased expression of ULBP2 protein]; Bleomycin promotes the reaction [Resveratrol results in increased phosphorylation of ATM protein]; Caffeine inhibits the reaction [[Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]; Hydrogen Peroxide promotes the reaction [Resveratrol results in increased phosphorylation of ATM protein]; Resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of ATM protein]; Resveratrol promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of ATM protein]; Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]
Resveratrol results in decreased expression of ATM mRNA
resveratrol results in increased acetylation of ATM protein
resveratrol results in increased phosphorylation of ATM protein
resveratrol results in increased activity of ATM protein 		CTD PMID:15975956 PMID:22029423 PMID:23445485 PMID:23522185 PMID:24933654 More... NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atosa atos homolog A multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of ATOSA mRNA CTD PMID:19167446 NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression
decreases expression 		ISO resveratrol results in increased expression of ATOX1 mRNA
resveratrol results in decreased expression of ATOX1 protein 		CTD PMID:22610192 PMID:25505154 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp13a1 ATPase 13A1 increases expression ISO resveratrol results in increased expression of ATP13A1 protein CTD PMID:25505154 NCBI chr16:19,649,065...19,665,126
Ensembl chr16:19,649,066...19,665,120 		JBrowse link
G Atp13a3 ATPase 13A3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP13A3 mRNA CTD PMID:23557933 NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 decreases expression ISO resveratrol results in decreased expression of ATP1A1 mRNA CTD PMID:22610192 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ATP1B1 mRNA
resveratrol affects the reaction [Dietary Fats affects the expression of ATP1B1 mRNA] 		CTD PMID:22610192 PMID:27260466 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP1B2 mRNA CTD PMID:23557933 NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression ISO resveratrol results in decreased expression of ATP1B3 mRNA CTD PMID:22610192 NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of ATP2A2 mRNA
resveratrol results in decreased expression of ATP2A2 mRNA
resveratrol results in increased expression of ATP2A2 protein
Resveratrol inhibits the reaction [DMD gene mutant form results in decreased expression of ATP2A2 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 protein]; Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ATP2A2 mRNA]; Resveratrol promotes the reaction [Dietary Fats results in decreased expression of ATP2A2 mRNA] 		CTD PMID:22610192 PMID:23297412 PMID:23557933 PMID:23695218 PMID:25425099 More... NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp2a3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP2A3 mRNA
resveratrol results in increased expression of ATP2A3 mRNA 		CTD PMID:19167446 PMID:22610192 NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278 		JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP2B1 mRNA CTD PMID:23557933 NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904 		JBrowse link
G Atp4b ATPase H+/K+ transporting subunit beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP4B mRNA CTD PMID:23557933 NCBI chr16:82,846,329...82,855,242
Ensembl chr16:82,846,329...82,855,242 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP5F1A mRNA
Resveratrol results in increased expression of ATP5F1A mRNA; Resveratrol results in increased expression of ATP5F1A protein
SIRT1 protein affects the reaction [Resveratrol results in increased expression of ATP5F1A mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of ATP5F1A mRNA] 		CTD PMID:23557933 PMID:25394648 PMID:34216621 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1c ATP synthase F1 subunit gamma multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP5F1C mRNA
Resveratrol results in increased expression of ATP5F1C protein 		CTD PMID:23557933 PMID:25505154 NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073 		JBrowse link
G Atp5f1e ATP synthase F1 subunit epsilon increases expression ISO Resveratrol results in increased expression of ATP5F1E mRNA CTD PMID:22610192 NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214 		JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 decreases expression ISO Resveratrol results in decreased expression of ATP5IF1 protein CTD PMID:25505154 NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 increases expression
multiple interactions 		ISO Resveratrol results in increased expression of ATP5MC1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of ATP5MC1 mRNA 		CTD PMID:19167446 PMID:22610192 NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363 		JBrowse link
G Atp5mc2 ATP synthase membrane subunit c locus 2 increases expression ISO Resveratrol results in increased expression of ATP5MC2 mRNA CTD PMID:22610192 NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:135,669,848...135,678,231 		JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 increases expression ISO Resveratrol results in increased expression of ATP5MC3 mRNA CTD PMID:17112576 NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:79,218,014...79,220,664 		JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO Resveratrol results in increased expression of ATP5ME mRNA CTD PMID:22610192 NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988 		JBrowse link
G Atp5mg ATP synthase membrane subunit G multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP5MG mRNA
Resveratrol results in increased expression of ATP5MG mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831 		JBrowse link
G Atp5pb ATP synthase peripheral stalk-membrane subunit b increases expression ISO Resveratrol results in increased expression of ATP5PB mRNA CTD PMID:22610192 NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387 		JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP increases expression ISO Resveratrol results in increased expression of ATP5PO mRNA CTD PMID:22610192 NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520 		JBrowse link
G Atp6v0a4 ATPase H+ transporting V0 subunit a4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V0A4 mRNA CTD PMID:23557933 NCBI chr 4:67,727,145...67,809,092
Ensembl chr 4:67,727,145...67,809,092 		JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V0E2 mRNA CTD PMID:23557933 NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680 		JBrowse link
G Atp6v1a ATPase H+ transporting V1 subunit A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1A mRNA CTD PMID:23557933 NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603 		JBrowse link
G Atp6v1b1 ATPase H+ transporting V1 subunit B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V1B1 mRNA CTD PMID:23557933 NCBI chr 4:117,781,444...117,800,103
Ensembl chr 4:117,781,444...117,800,103 		JBrowse link
G Atp6v1b2 ATPase H+ transporting V1 subunit B2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1B2 mRNA CTD PMID:23557933 NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839 		JBrowse link
G Atp6v1c1 ATPase H+ transporting V1 subunit C1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1C1 mRNA CTD PMID:23557933 NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1D mRNA CTD PMID:23557933 NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346 		JBrowse link
G Atp6v1f ATPase H+ transporting V1 subunit F increases expression ISO resveratrol results in increased expression of ATP6V1F mRNA CTD PMID:22610192 NCBI chr 4:59,033,020...59,035,980 JBrowse link
G Atp6v1h ATPase H+ transporting V1 subunit H multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1H mRNA CTD PMID:23557933 NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516 		JBrowse link
G Atp7a ATPase copper transporting alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP7A mRNA CTD PMID:23557933 NCBI chr  X:75,159,635...75,267,094
Ensembl chr  X:75,159,782...75,267,093 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP8B1 mRNA CTD PMID:23557933 NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027 		JBrowse link
G Atp8b2 ATPase phospholipid transporting 8B2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP8B2 mRNA CTD PMID:19167446 NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575 		JBrowse link
G Atp9b ATPase phospholipid transporting 9B (putative) increases expression ISO resveratrol results in increased expression of ATP9B mRNA CTD PMID:25888808 NCBI chr18:76,451,821...76,643,931
Ensembl chr18:76,451,821...76,643,893 		JBrowse link
G Atpaf2 ATP synthase mitochondrial F1 complex assembly factor 2 increases expression ISO resveratrol results in increased expression of ATPAF2 protein CTD PMID:25505154 NCBI chr10:45,705,157...45,721,282
Ensembl chr10:45,697,027...45,721,383 		JBrowse link
G Atr ATR serine/threonine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATR mRNA; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AX protein; Caffeine inhibits the reaction [[Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]; Resveratrol results in increased activity of [ATM protein co-treated with ATR protein] CTD PMID:15975956 PMID:23557933 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Atrx ATRX, chromatin remodeler decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of ATRX mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of ATRX mRNA
Resveratrol results in decreased expression of ATRX mRNA 		CTD PMID:23557933 PMID:25888808 PMID:25905778 PMID:33775663 NCBI chr  X:74,916,548...75,062,880
Ensembl chr  X:74,916,548...75,062,880 		JBrowse link
G Atxn2l ataxin 2-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATXN2L mRNA CTD PMID:23557933 NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579 		JBrowse link
G Atxn3 ataxin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATXN3 mRNA; [Resveratrol binds to and results in increased activity of SIRT1 protein] which results in decreased activity of ATXN3 protein mutant form CTD PMID:17885668 PMID:23557933 NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:126,839,327...126,872,781 		JBrowse link
G Atxn7l2 ataxin 7-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ATXN7L2 mRNA CTD PMID:23557933 NCBI chr 2:198,527,066...198,535,899
Ensembl chr 2:198,527,066...198,534,062 		JBrowse link
G Atxn7l3 ataxin 7-like 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ATXN7L3 mRNA CTD PMID:23557933 NCBI chr10:87,742,993...87,750,247
Ensembl chr10:87,744,369...87,750,245 		JBrowse link
G Auh AU RNA binding methylglutaconyl-CoA hydratase increases expression ISO resveratrol results in increased expression of AUH mRNA CTD PMID:22610192 NCBI chr17:12,481,396...12,576,748
Ensembl chr17:12,481,416...12,602,587 		JBrowse link
G Aurka aurora kinase A multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of AURKA mRNA
resveratrol results in increased expression of AURKA mRNA 		CTD PMID:19167446 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkb aurora kinase B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA CTD PMID:19167446 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Aurkc aurora kinase C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AURKC mRNA CTD PMID:23557933 NCBI chr 1:75,876,773...75,882,893
Ensembl chr 1:75,876,773...75,897,426 		JBrowse link
G Auts2 activator of transcription and developmental regulator AUTS2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of AUTS2 mRNA CTD PMID:19167446 NCBI chr12:29,739,138...30,830,386
Ensembl chr12:29,740,523...30,830,386 		JBrowse link
G Avl9 AVL9 cell migration associated multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AVL9 mRNA CTD PMID:23557933 NCBI chr 4:87,291,062...87,338,537
Ensembl chr 4:87,291,798...87,331,916 		JBrowse link
G Avpr2 arginine vasopressin receptor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of AVPR2 mRNA CTD PMID:23557933 NCBI chr  X:156,785,009...156,787,477
Ensembl chr  X:156,785,139...156,787,477 		JBrowse link
G Axin2 axin 2 increases expression
decreases expression 		EXP
ISO 		resveratrol results in increased expression of AXIN2 mRNA
resveratrol results in decreased expression of AXIN2 mRNA; resveratrol results in decreased expression of AXIN2 protein
Resveratrol results in decreased expression of AXIN2 mRNA; Resveratrol results in decreased expression of AXIN2 protein 		CTD PMID:21188121 PMID:21291235 PMID:22935447 PMID:23848300 NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575 		JBrowse link
G Azin1 antizyme inhibitor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of AZIN1 mRNA CTD PMID:23557933 NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515 		JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO resveratrol inhibits the reaction [Metribolone results in increased expression of B2M mRNA] CTD PMID:18586690 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3galnt1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of B3GALNT1 mRNA CTD PMID:25905778 NCBI chr 2:156,157,234...156,187,037
Ensembl chr 2:156,156,265...156,188,404 		JBrowse link
G B3galnt2 beta-1,3-N-acetylgalactosaminyltransferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of B3GALNT2 mRNA CTD PMID:23557933 NCBI chr17:56,030,409...56,072,952
Ensembl chr17:56,030,409...56,072,952 		JBrowse link
G B3gnt3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT3 mRNA CTD PMID:23557933 NCBI chr16:18,434,114...18,444,851
Ensembl chr16:18,435,378...18,444,738 		JBrowse link
G B3gnt4 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT4 mRNA CTD PMID:23557933 NCBI chr12:38,729,653...38,734,911
Ensembl chr12:38,728,889...38,734,744 		JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of B3GNT5 mRNA CTD PMID:19167446 NCBI chr11:94,645,480...94,657,584
Ensembl chr11:94,645,480...94,660,514 		JBrowse link
G B3gnt8 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT8 mRNA CTD PMID:23557933 NCBI chr 1:90,263,387...90,266,292
Ensembl chr 1:90,263,827...90,270,287 		JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B4GALNT4 mRNA CTD PMID:23557933 NCBI chr 1:205,600,989...205,611,889
Ensembl chr 1:205,600,989...205,611,889 		JBrowse link
G B4galt2 beta-1,4-galactosyltransferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B4GALT2 mRNA CTD PMID:23557933 NCBI chr 5:136,697,981...136,707,783
Ensembl chr 5:136,697,981...136,710,422 		JBrowse link
G B4galt7 beta-1,4-galactosyltransferase 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of B4GALT7 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of B4GALT7 mRNA CTD PMID:23557933 NCBI chr17:9,023,667...9,032,742
Ensembl chr17:9,023,618...9,032,745 		JBrowse link
G Bace2 beta-secretase 2 increases expression ISO resveratrol results in increased expression of BACE2 mRNA CTD PMID:22610192 NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression
decreases expression
increases phosphorylation 		ISO
EXP 		[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]
[nano-diamino-tetrac co-treated with Resveratrol] inhibits the reaction [Thyroxine results in decreased expression of BAD mRNA]; [Plant Extracts co-treated with Resveratrol] results in decreased expression of BAD mRNA; Resveratrol inhibits the reaction [Thyroxine results in decreased expression of BAD mRNA]; Thyroxine inhibits the reaction [Resveratrol results in increased expression of BAD mRNA]
Resveratrol results in increased expression of BAD mRNA; Resveratrol results in increased expression of BAD protein
resveratrol results in increased expression of BAD protein
resveratrol results in increased expression of BAD mRNA
resveratrol results in decreased expression of BAD protein
resveratrol results in increased phosphorylation of BAD protein
[8-cyclopentyl-1,3-dimethylxanthine results in decreased activity of ADORA1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein]; [MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein] 		CTD PMID:15345477 PMID:16731767 PMID:17872969 PMID:20370652 PMID:22610192 More... NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag2 BAG cochaperone 2 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of BAG2 mRNA
resveratrol results in increased expression of BAG2 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bag3 BAG cochaperone 3 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of BAG3 mRNA] CTD PMID:31298478 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bag5 BAG cochaperone 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BAG5 mRNA CTD PMID:23557933 NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492 		JBrowse link
G Bag6 BAG cochaperone 6 increases expression ISO resveratrol results in increased expression of BAG6 protein CTD PMID:25505154 NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases activity
multiple interactions
increases response to substance
increases expression
affects folding 		ISO resveratrol results in increased activity of BAK1 protein
Resveratrol results in increased expression of and results in increased localization of BAK1 protein
[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK1 protein]; BAK1 protein promotes the reaction [resveratrol results in increased secretion of AIFM1 protein]; BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein]; CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein]; resveratrol results in increased expression of and results in increased localization of BAK1 protein
BAK1 protein results in increased susceptibility to resveratrol
resveratrol results in increased expression of BAK1 mRNA; resveratrol results in increased expression of BAK1 protein 		CTD PMID:12002526 PMID:12569576 PMID:12902349 PMID:16550006 PMID:16617056 More... NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Banf2 BANF family member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BANF2 mRNA CTD PMID:23557933 NCBI chr 3:151,841,506...151,896,205
Ensembl chr 3:151,853,911...151,896,204 		JBrowse link
G Bap1 BRCA1 associated deubiquitinase 1 decreases expression ISO resveratrol results in decreased expression of BAP1 mRNA CTD PMID:12569576 NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,452,974...6,461,952 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression
multiple interactions 		EXP
ISO 		Resveratrol results in decreased expression of BARD1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BARD1 mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873 		JBrowse link
G Barhl2 BarH-like homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BARHL2 mRNA CTD PMID:23557933 NCBI chr14:3,485,309...3,490,206
Ensembl chr14:3,485,309...3,490,197 		JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BARX2 mRNA CTD PMID:23557933 NCBI chr 8:38,509,277...38,576,978
Ensembl chr 8:38,509,277...38,576,978 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases activity
affects expression
multiple interactions
decreases expression
increases expression
increases localization
affects localization
affects folding
increases response to substance 		ISO
EXP 		resveratrol results in increased activity of BAX protein
resveratrol affects the expression of BAX mRNA
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cisplatin affects the localization of BAX protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; [FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Cisplatin affects the localization of BAX protein]; Resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Resveratrol inhibits the reaction [ERCC6 gene mutant form results in increased expression of BAX protein]; Resveratrol inhibits the reaction [glyoxylic acid results in increased expression of BAX protein]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]
Resveratrol results in decreased expression of BAX; Resveratrol results in decreased expression of BAX mRNA; Resveratrol results in decreased expression of BAX protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]]; [Resveratrol co-treated with Propofol] results in decreased expression of BAX; [Resveratrol co-treated with Testosterone] results in increased expression of BAX protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; Resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [acetamiprid results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]; Resveratrol inhibits the reaction [chromium hexavalent ion results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in increased expression of BAX protein]]; Resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Paraquat results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of BAX]; Resveratrol promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein]
[allyl sulfide co-treated with Resveratrol] results in increased expression of BAX mRNA; [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Resveratrol results in increased localization of BAX protein]; [Doxorubicin co-treated with Resveratrol] results in increased expression of BAX mRNA; [Doxorubicin co-treated with Resveratrol] results in increased expression of BAX protein; [Plant Extracts co-treated with Resveratrol] results in decreased expression of BAX mRNA; [Raloxifene Hydrochloride co-treated with Resveratrol] results in increased expression of BAX mRNA; [Resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein; [Resveratrol results in decreased expression of MTA1 protein] which results in increased expression of BAX protein; [Resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to BAX promoter]; [Resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]]; BAX protein promotes the reaction [Resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [Resveratrol results in increased localization of BAX protein]; CASP2 protein affects the reaction [Resveratrol affects the folding of BAX protein]; CTSD protein affects the reaction [Resveratrol promotes the reaction [BAX protein binds to BAX protein]]; MRK 003 affects the reaction [Resveratrol results in increased expression of BAX]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of BAX protein]; Resveratrol inhibits the reaction [cudraflavone B results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Ethanol results in increased expression of BAX protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [MFGE8 protein results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of BAX mRNA]; Resveratrol inhibits the reaction [Rotenone results in increased expression of BAX protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Resveratrol promotes the reaction [BAX protein binds to BAX protein]; Resveratrol results in increased expression of and affects the localization of BAX protein; Resveratrol results in increased expression of and results in increased localization of BAX protein; SB 203580 promotes the reaction [Resveratrol results in increased activity of BAX protein]; TP53 affects the reaction [Resveratrol results in increased expression of BAX protein]
resveratrol results in increased expression of BAX protein
resveratrol results in decreased expression of BAX mRNA; resveratrol results in decreased expression of BAX protein
resveratrol results in increased localization of BAX protein
resveratrol affects the localization of BAX protein
Resveratrol results in increased expression of BAX mRNA; Resveratrol results in increased expression of BAX protein
Resveratrol analog results in increased expression of BAX protein; Resveratrol results in increased expression of BAX; Resveratrol results in increased expression of BAX mRNA; Resveratrol results in increased expression of BAX protein
resveratrol affects the folding of BAX protein
BAX protein results in increased susceptibility to resveratrol 		CTD PMID:12632486 PMID:12902349 PMID:14749477 PMID:15633232 PMID:15637762 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Baz2b bromodomain adjacent to zinc finger domain, 2B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BAZ2B mRNA CTD PMID:23557933 NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions
increases expression 		ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cisplatin results in increased expression of BBC3 protein]]; pifithrin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cisplatin results in increased expression of BBC3 protein]]]; Resveratrol inhibits the reaction [Cisplatin results in increased expression of BBC3 protein]
Resveratrol results in increased expression of BBC3 mRNA; Resveratrol results in increased expression of BBC3 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of BBC3 mRNA; Erlotinib Hydrochloride promotes the reaction [Resveratrol results in increased expression of BBC3 protein]; Resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased expression of BBC3 protein] 		CTD PMID:17636462 PMID:21593185 PMID:23557933 PMID:25533949 PMID:25895606 More... NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of BBOX1 mRNA
[resveratrol co-treated with Streptozocin] results in decreased expression of BBOX1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064 		JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BBS1 mRNA CTD PMID:19167446 NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:211,615,533...211,633,468 		JBrowse link
G Bbs2 Bardet-Biedl syndrome 2 multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of BBS2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BBS2 mRNA CTD PMID:23557933 PMID:26667767 NCBI chr19:10,915,566...10,950,911
Ensembl chr19:10,915,476...10,950,921 		JBrowse link
G Bbs4 Bardet-Biedl syndrome 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BBS4 mRNA CTD PMID:23557933 NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:68,627,656...68,661,358 		JBrowse link
G Bcam basal cell adhesion molecule (Lutheran blood group) multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BCAM mRNA CTD PMID:23557933 NCBI chr 1:88,542,971...88,557,358
Ensembl chr 1:88,542,972...88,557,888 		JBrowse link
G Bcan brevican multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BCAN mRNA CTD PMID:23557933 NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314 		JBrowse link
G Bcap31 B-cell receptor-associated protein 31 increases expression ISO resveratrol results in increased expression of BCAP31 mRNA CTD PMID:19371625 NCBI chr  X:156,548,911...156,581,002
Ensembl chr  X:156,548,911...156,579,371 		JBrowse link
G Bcar3 BCAR3 adaptor protein, NSP family member multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of BCAR3 mRNA CTD PMID:19167446 NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302 		JBrowse link
G Bcas2 BCAS2, pre-mRNA processing factor decreases expression ISO resveratrol results in decreased expression of BCAS2 protein CTD PMID:25505154 NCBI chr 2:193,381,000...193,388,881
Ensembl chr 2:193,380,982...193,388,878 		JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BCAS3 mRNA CTD PMID:19167446 NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,711,525...71,170,803 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 increases expression ISO resveratrol results in increased expression of BCAT2 mRNA CTD PMID:22610192 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BCCIP mRNA CTD PMID:23557933 NCBI chr 1:197,942,535...197,954,948
Ensembl chr 1:197,942,190...197,956,378 		JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases expression 		ISO [Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein]
resveratrol results in increased expression of BCHE mRNA 		CTD PMID:18586690 PMID:20663516 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BCKDHB mRNA CTD PMID:23557933 NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor multiple interactions ISO resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA] CTD PMID:23452621 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases phosphorylation
multiple interactions
increases expression
decreases expression
decreases response to substance 		EXP
ISO 		resveratrol results in increased phosphorylation of BCL2 protein
[Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Plant Extracts co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Resveratrol affects the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Arginine results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Arginine results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [glyoxylic acid results in decreased expression of BCL2 protein]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]
Resveratrol results in increased expression of BCL2; Resveratrol results in increased expression of BCL2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in increased expression of BCL2 protein]; [1-Methyl-4-phenylpyridinium co-treated with Resveratrol] results in increased expression of BCL2 mRNA; [MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [Resveratrol results in increased phosphorylation of BCL2 protein]; [Resveratrol co-treated with Propofol] results in increased expression of BCL2; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Resveratrol inhibits the reaction [acetamiprid results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [chromium hexavalent ion results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Gallic Acid results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of BCL2 protein]]; Resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]
[allyl sulfide co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Benzo(a)pyrene co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Doxorubicin co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Doxorubicin co-treated with Resveratrol] results in decreased expression of BCL2 protein; [Resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; [Resveratrol co-treated with Raloxifene Hydrochloride] results in decreased expression of BCL2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]; BCL2 protein inhibits the reaction [Resveratrol affects the localization of CYCS protein]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to CREBBP protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to DAXX protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to SP100 protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to SUMO1 protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to TP53 protein]]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of BIRC2 protein]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of BIRC3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PARP1 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PLCG1 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased degradation of PLCG1 protein]; chelerythrine inhibits the reaction [Resveratrol affects the expression of BCL2 protein]; diphenyleneiodonium inhibits the reaction [Resveratrol affects the expression of BCL2 protein]; MIR21 mRNA inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; NQO2 protein promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Resveratrol results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [MIR21 mRNA results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Sorafenib results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Temozolomide results in decreased expression of BCL2 protein]; Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]]; Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PARP1 protein]]; Vorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to Resveratrol]
resveratrol results in decreased expression of BCL2; resveratrol results in decreased expression of BCL2 mRNA
resveratrol results in increased expression of BCL2 mRNA; resveratrol results in increased expression of BCL2 protein
Resveratrol results in decreased expression of BCL2 mRNA; Resveratrol results in decreased expression of BCL2 protein
[Resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein; Resveratrol analog results in decreased expression of BCL2 protein; Resveratrol results in decreased expression of BCL2; Resveratrol results in decreased expression of BCL2 mRNA; Resveratrol results in decreased expression of BCL2 protein
BCL2 protein results in decreased susceptibility to resveratrol 		CTD PMID:11577002 PMID:12060119 PMID:12510025 PMID:12632486 PMID:12689943 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		resveratrol results in decreased expression of BCL2A1 protein
[resveratrol co-treated with Streptozocin] results in increased expression of BCL2A1 mRNA
resveratrol results in increased expression of BCL2A1 mRNA 		CTD PMID:17164350 PMID:25888808 PMID:25905778 NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions
increases expression
decreases response to substance
affects localization 		ISO
EXP 		resveratrol results in decreased expression of BCL2L1 protein
resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein]
resveratrol results in decreased expression of BCL2L1 mRNA; resveratrol results in decreased expression of BCL2L1 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2L1]]; pifithrin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2L1]]]; resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2L1]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2L1 protein]; resveratrol inhibits the reaction [Nicotine results in decreased expression of BCL2L1 mRNA]; SIRT1 mutant form inhibits the reaction [resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2L1]]
resveratrol results in increased expression of BCL2L1 mRNA
[clofarabine co-treated with resveratrol] inhibits the reaction [BCL2L1 mutant form results in increased expression of MCL1 protein]; [clofarabine co-treated with resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP3 protein]; [clofarabine co-treated with resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP7 protein]; [clofarabine co-treated with resveratrol] promotes the reaction [BCL2L1 mutant form results in increased cleavage of CASP3 protein]; BCL2L1 protein affects the reaction [[clofarabine co-treated with resveratrol] results in increased activity of CASP3 protein]; BCL2L1 protein affects the reaction [[clofarabine co-treated with resveratrol] results in increased activity of CASP7 protein]; resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA]; resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein]; resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA]; resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein]; resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA]; resveratrol inhibits the reaction [STAT3 protein results in increased expression of BCL2L1 protein]; resveratrol promotes the reaction [sorafenib results in decreased expression of BCL2L1 protein]
BCL2L1 protein results in decreased susceptibility to resveratrol
resveratrol results in increased expression of BCL2L1 mRNA; resveratrol results in increased expression of BCL2L1 protein
resveratrol affects the localization of BCL2L1 protein 		CTD PMID:11577002 PMID:12569576 PMID:12689943 PMID:14749477 PMID:16490592 More... NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions
increases expression
increases response to substance 		ISO
EXP 		BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein]; FOXO1 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form]; FOXO3 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form]; FOXO4 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form]; resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein]; resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2L11 protein alternative form]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]
resveratrol results in increased expression of BCL2L11 protein; resveratrol results in increased expression of BCL2L11 protein alternative form
BCL2L11 protein results in increased susceptibility to resveratrol 		CTD PMID:17636462 PMID:20026400 PMID:21179458 PMID:21980390 PMID:22245142 More... NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l12 Bcl2 like 12 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of BCL2L12 mRNA CTD PMID:19167446 NCBI chr 1:104,608,753...104,617,472
Ensembl chr 1:104,608,753...104,617,472 		JBrowse link
G Bcl2l13 Bcl2-like 13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BCL2L13 mRNA CTD PMID:23557933 NCBI chr 4:155,728,284...155,785,058
Ensembl chr 4:155,728,284...155,781,158 		JBrowse link
G Bcl2l2 Bcl2-like 2 multiple interactions
increases expression 		ISO resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein]
resveratrol results in increased expression of BCL2L2 mRNA 		CTD PMID:22748497 PMID:22971900 PMID:24557422 NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379 		JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of BCL3 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA] 		CTD PMID:19167446 PMID:23452621 PMID:25905778 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression
multiple interactions
decreases expression 		ISO resveratrol results in increased expression of BCL6 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of BCL6 mRNA]
resveratrol results in decreased expression of BCL6 protein 		CTD PMID:12002526 PMID:12569576 PMID:17088997 PMID:31298478 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bcl6b BCL6B, transcription repressor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BCL6B mRNA CTD PMID:23557933 NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631 		JBrowse link
G Bcl9l BCL9 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BCL9L mRNA CTD PMID:23557933 NCBI chr 8:53,708,770...53,738,880
Ensembl chr 8:53,708,770...53,737,395 		JBrowse link
G Bclaf3 BCLAF1 and THRAP3 family member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BCLAF3 mRNA CTD PMID:23557933 NCBI chr  X:39,065,842...39,137,521
Ensembl chr  X:39,072,840...39,137,448 		JBrowse link
G Bcor BCL6 co-repressor decreases expression EXP resveratrol results in decreased expression of BCOR mRNA CTD PMID:25905778 NCBI chr  X:13,282,431...13,402,254
Ensembl chr  X:13,360,376...13,402,254 		JBrowse link
G Bcr BCR activator of RhoGEF and GTPase multiple interactions ISO purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]]; resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] CTD PMID:22397755 NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333 		JBrowse link
G Bcs1l BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone increases expression ISO resveratrol results in increased expression of BCS1L mRNA CTD PMID:22610192 NCBI chr 9:83,614,045...83,618,052
Ensembl chr 9:83,613,975...83,618,257 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of BDH1 mRNA CTD PMID:25905778 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636 		JBrowse link
G Bdkrb2 bradykinin receptor B2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of BDKRB2 mRNA; resveratrol results in decreased expression of BDKRB2 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of BDKRB2 mRNA 		CTD PMID:18089832 PMID:23557933 NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions
decreases expression
increases expression
affects expression 		ISO
EXP 		Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of BDNF protein]
resveratrol results in decreased expression of BDNF protein
[Ethanol co-treated with Resveratrol] results in increased expression of BDNF mRNA; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased cleavage of BDNF protein]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BDNF mRNA]; Resveratrol promotes the reaction [Ethanol results in increased expression of BDNF protein]
resveratrol results in increased expression of BDNF mRNA; resveratrol results in increased expression of BDNF protein
resveratrol affects the expression of BDNF 		CTD PMID:23105098 PMID:23770283 PMID:23850968 PMID:24125781 PMID:33978298 More... NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bdp1 BDP1 general transcription factor IIIB subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BDP1 mRNA CTD PMID:23557933 NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241 		JBrowse link
G Bean1 brain expressed, associated with NEDD4, 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BEAN1 mRNA CTD PMID:23557933 NCBI chr19:745,993...792,853
Ensembl chr19:745,993...793,039 		JBrowse link
G Becn1 beclin 1 multiple interactions
decreases expression
increases expression
affects response to substance 		ISO
EXP 		[Doxorubicin co-treated with Resveratrol] results in decreased expression of BECN1 protein; BECN1 protein affects the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form]; BECN1 protein affects the reaction [Resveratrol affects the metabolism of MAP1LC3B protein]; BECN1 protein affects the reaction [Resveratrol inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]]; BECN1 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; BECN1 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; BECN1 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]; BECN1 protein affects the reaction [Resveratrol results in increased degradation of SNCA protein]; BECN1 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Resveratrol promotes the reaction [TP53 protein binds to BECN1 protein]
[Resveratrol co-treated with Benzo(a)pyrene] results in increased expression of BECN1 protein; [Resveratrol co-treated with Glucose] results in increased expression of BECN1 protein
resveratrol results in decreased expression of BECN1 protein
Resveratrol results in increased expression of BECN1 protein
Resveratrol analog results in increased expression of BECN1; Resveratrol results in increased expression of BECN1 mRNA
BECN1 protein affects the susceptibility to resveratrol 		CTD PMID:21778691 PMID:23088850 PMID:23273518 PMID:23680031 PMID:24145604 More... NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bend3 BEN domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BEND3 mRNA CTD PMID:23557933 NCBI chr20:48,562,383...48,599,194
Ensembl chr20:48,576,311...48,596,808 		JBrowse link
G Best4 bestrophin 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BEST4 mRNA CTD PMID:23557933 NCBI chr 5:135,858,774...135,865,624
Ensembl chr 5:135,860,018...135,863,707 		JBrowse link
G Bet1 Bet1 golgi vesicular membrane trafficking protein increases expression ISO resveratrol results in increased expression of BET1 protein CTD PMID:18089832 NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164 		JBrowse link
G Bex3 brain expressed X-linked 3 increases expression ISO resveratrol results in increased expression of BEX3 mRNA CTD PMID:22610192 NCBI chr  X:104,064,896...104,066,425
Ensembl chr  X:104,064,515...104,075,906 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
increases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA]; [Calcitriol co-treated with resveratrol] results in increased expression of BGLAP mRNA; fulvestrant inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA]
resveratrol results in increased expression of BGLAP mRNA; resveratrol results in increased expression of BGLAP protein 		CTD PMID:16267019 PMID:16813520 PMID:16964405 PMID:17689939 PMID:21713995 More... NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bgn biglycan multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BGN mRNA CTD PMID:23557933 NCBI chr  X:156,348,633...156,360,797
Ensembl chr  X:156,348,615...156,360,799 		JBrowse link
G Bhlhe23 basic helix-loop-helix family, member e23 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BHLHE23 mRNA CTD PMID:23557933 NCBI chr 3:188,266,572...188,268,786
Ensembl chr 3:188,238,188...188,269,089 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BHLHE40 mRNA CTD PMID:19167446 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO Resveratrol promotes the reaction [titanium dioxide results in increased expression of BHMT mRNA] CTD PMID:31298478 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Bicd2 BICD cargo adaptor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BICD2 mRNA CTD PMID:23557933 NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305 		JBrowse link
G Bicra BRD4 interacting chromatin remodeling complex associated protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRA mRNA CTD PMID:23557933 NCBI chr 1:85,790,093...85,867,656
Ensembl chr 1:85,790,093...85,864,306 		JBrowse link
G Bicral BICRA like chromatin remodeling complex associated protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRAL mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BICRAL mRNA CTD PMID:23557933 NCBI chr 9:21,597,886...21,682,985
Ensembl chr 9:21,597,855...21,682,983 		JBrowse link
G Bid BH3 interacting domain death agonist increases expression
increases cleavage
multiple interactions
decreases expression
increases localization 		ISO resveratrol results in increased expression of BID protein
resveratrol results in increased cleavage of BID protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of BID mRNA; [Resveratrol co-treated with TNFSF10 protein] results in increased cleavage of BID protein; [Resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein; [TNFSF10 protein co-treated with Resveratrol] results in increased cleavage of BID protein
resveratrol results in decreased expression of BID protein
resveratrol results in increased localization of BID protein 		CTD PMID:16617056 PMID:16731767 PMID:18222423 PMID:18276737 PMID:19423619 More... NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bik BCL2-interacting killer multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA CTD PMID:19167446 NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317 		JBrowse link
G Bin3 bridging integrator 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BIN3 mRNA CTD PMID:23557933 NCBI chr15:51,583,474...51,622,329
Ensembl chr15:51,583,481...51,622,329 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression
decreases expression
multiple interactions 		ISO resveratrol results in increased expression of BIRC2 mRNA
resveratrol results in decreased expression of BIRC2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of BIRC2 mRNA; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of BIRC2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein] 		CTD PMID:11577002 PMID:12569576 PMID:23452621 PMID:23557933 PMID:25550561 More... NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions
decreases expression 		ISO BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC3 protein]; resveratrol promotes the reaction [SIRT1 protein binds to BIRC3 promoter] CTD PMID:11577002 PMID:15152190 PMID:24090995 PMID:25550561 PMID:26911335 More... NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression
decreases expression 		ISO
EXP 		BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP3 protein]; BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP9 protein]; Resveratrol results in decreased expression of and results in decreased phosphorylation of BIRC5 protein; SIRT1 protein affects the reaction [Resveratrol results in decreased expression of BIRC5 protein]; Wortmannin promotes the reaction [Resveratrol results in decreased expression of BIRC5 protein]
Resveratrol results in increased expression of BIRC5 mRNA
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with Resveratrol] results in decreased expression of BIRC5 protein; [Coumestrol co-treated with Resveratrol] results in increased expression of BIRC5 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of BIRC5 mRNA; [Resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 mRNA; [Resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 protein; [Resveratrol co-treated with Sorafenib] results in decreased expression of BIRC5 protein; Erlotinib Hydrochloride promotes the reaction [Resveratrol results in decreased expression of BIRC5 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Resveratrol results in increased expression of BIRC5 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]; Resveratrol promotes the reaction [Erlotinib Hydrochloride results in decreased expression of BIRC5 protein]
resveratrol results in increased expression of BIRC5 mRNA
resveratrol results in decreased expression of BIRC5 mRNA; resveratrol results in decreased expression of BIRC5 protein 		CTD PMID:15763656 PMID:15837718 PMID:16081268 PMID:17007014 PMID:17164350 More... NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Birc7 baculoviral IAP repeat-containing 7 decreases expression ISO resveratrol results in decreased expression of BIRC7 protein CTD PMID:25550561 NCBI chr 3:188,425,392...188,430,174
Ensembl chr 3:188,425,392...188,430,174 		JBrowse link
G Blcap BLCAP, apoptosis inducing factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BLCAP mRNA CTD PMID:23557933 NCBI chr 3:166,642,676...166,656,924
Ensembl chr 3:166,642,677...166,652,829 		JBrowse link
G Blm BLM RecQ like helicase decreases expression
multiple interactions 		EXP
ISO 		Resveratrol results in decreased expression of BLM mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210 		JBrowse link
G Blnk B-cell linker multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of BLNK mRNA; [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of BLNK mRNA CTD PMID:19167446 PMID:26667767 NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:249,703,072...249,770,533 		JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BLOC1S2 mRNA CTD PMID:23557933 NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873 		JBrowse link
G Bltp2 bridge-like lipid transfer protein family member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BLTP2 mRNA CTD PMID:23557933 NCBI chr10:63,654,072...63,683,282
Ensembl chr10:63,654,104...63,683,282 		JBrowse link
G Bltp3b bridge-like lipid transfer protein family member 3B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BLTP3B mRNA CTD PMID:23557933 NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083 		JBrowse link
G Blvra biliverdin reductase A increases expression EXP resveratrol results in increased expression of BLVRA mRNA CTD PMID:25905778 NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 multiple interactions ISO Resveratrol inhibits the reaction [Sodium Fluoride results in decreased expression of BMAL1 protein] CTD PMID:36063856 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmerb1 bMERB domain containing 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of BMERB1 mRNA CTD PMID:19167446 NCBI chr10:2,286,999...2,453,890
Ensembl chr10:2,287,000...2,453,728 		JBrowse link
G Bmf Bcl2 modifying factor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BMF mRNA CTD PMID:19167446 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258 		JBrowse link
G Bmp10 bone morphogenetic protein 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BMP10 mRNA CTD PMID:23557933 NCBI chr 4:121,423,936...121,439,094
Ensembl chr 4:121,429,199...121,435,728 		JBrowse link
G Bmp15 bone morphogenetic protein 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BMP15 mRNA CTD PMID:23557933 NCBI chr  X:18,840,943...18,846,006
Ensembl chr  X:18,840,829...18,847,438 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression
increases expression 		ISO AG 1879 inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]; AG 1879 inhibits the reaction [Resveratrol results in increased expression of BMP2 protein]; FOXA1 protein promotes the reaction [Resveratrol results in increased expression of BMP2 protein]; Fulvestrant inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]; Fulvestrant inhibits the reaction [Resveratrol results in increased expression of BMP2 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of BMP2 mRNA]; Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]; Tamoxifen inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]
resveratrol results in decreased expression of BMP2 mRNA
resveratrol results in increased expression of BMP2 mRNA
resveratrol results in increased expression of BMP2 mRNA; resveratrol results in increased expression of BMP2 protein
[Dietary Fats co-treated with Resveratrol] results in increased expression of BMP2 mRNA 		CTD PMID:16973825 PMID:17513867 PMID:25338179 PMID:29197120 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp2k BMP-2 inducible kinase multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of BMP2K mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BMP2K mRNA CTD PMID:23557933 PMID:26667767 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657 		JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions
increases expression 		ISO resveratrol inhibits the reaction [BMP4 protein results in increased expression of VEGFA mRNA]; resveratrol inhibits the reaction [BMP4 protein results in increased secretion of VEGFA protein]
resveratrol results in increased expression of BMP4 mRNA 		CTD PMID:24435444 PMID:25888808 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA CTD PMID:19167446 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp6 bone morphogenetic protein 6 decreases expression ISO resveratrol results in decreased expression of BMP6 mRNA CTD PMID:12002526 NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261 		JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of BMP7 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of BMP7 mRNA; Resveratrol promotes the reaction [BMP7 protein results in increased chemical synthesis of Proteoglycans] CTD PMID:19167446 PMID:22252971 PMID:23557933 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bmp8b bone morphogenetic protein 8b multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BMP8B mRNA CTD PMID:23557933 NCBI chr 5:140,671,117...140,696,450
Ensembl chr 5:140,671,211...140,696,448 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BMPR2 mRNA CTD PMID:19167446 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Bnip1 BCL2 interacting protein 1 increases expression ISO resveratrol results in increased expression of BNIP1 mRNA CTD PMID:19371625 NCBI chr10:16,891,317...16,903,561
Ensembl chr10:16,891,317...16,903,561 		JBrowse link
G Bnip2 BCL2 interacting protein 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of BNIP2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of BNIP2 mRNA 		CTD PMID:12569576 PMID:23557933 NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368 		JBrowse link
G Boc BOC cell adhesion associated, oncogene regulated multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BOC mRNA CTD PMID:23557933 NCBI chr11:69,628,703...69,704,009
Ensembl chr11:69,628,660...69,704,004 		JBrowse link
G Bod1l1 biorientation of chromosomes in cell division 1-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BOD1L mRNA CTD PMID:23557933 NCBI chr14:73,320,880...73,375,662
Ensembl chr14:73,320,832...73,375,658 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK increases expression ISO resveratrol results in increased expression of BOK mRNA CTD PMID:15767336 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833 		JBrowse link
G Bora bora, aurora kinase A activator multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of BORA mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BORA mRNA CTD PMID:19167446 PMID:23557933 NCBI chr15:82,205,467...82,243,499
Ensembl chr15:82,205,697...82,244,052 		JBrowse link
G Bpifb1 BPI fold containing family B, member 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BPIFB1 mRNA CTD PMID:23557933 NCBI chr 3:163,133,151...163,166,420
Ensembl chr 3:163,133,151...163,166,419 		JBrowse link
G Bpifb3 BPI fold containing family B, member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BPIFB3 mRNA CTD PMID:23557933 NCBI chr 3:162,861,234...162,875,850
Ensembl chr 3:162,861,234...162,875,850 		JBrowse link
G Bpnt2 3'(2'), 5'-bisphosphate nucleotidase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BPNT2 mRNA CTD PMID:23557933 NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase decreases expression ISO resveratrol results in decreased expression of BRAF protein modified form CTD PMID:25280562 NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931 		JBrowse link
G Brap BRCA1 associated protein multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of BRAP mRNA]
[Plant Extracts co-treated with Resveratrol] results in increased expression of BRAP mRNA 		CTD PMID:23557933 PMID:31298478 NCBI chr12:40,535,232...40,561,726
Ensembl chr12:40,535,232...40,561,726 		JBrowse link
G Brca1 BRCA1, DNA repair associated decreases expression
multiple interactions
increases expression
affects localization 		EXP
ISO 		Resveratrol results in decreased expression of BRCA1 mRNA
[Coumestrol co-treated with Resveratrol] results in increased expression of BRCA1 mRNA; [Estradiol co-treated with Resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; [Plant Extracts co-treated with Resveratrol] results in increased expression of BRCA1 mRNA; PARP1 protein affects the reaction [Resveratrol results in increased expression of BRCA1 protein]; Resveratrol affects the expression of and affects the phosphorylation of BRCA1 protein; Resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [AHR protein results in decreased expression of BRCA1]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter]; STF-118804 inhibits the reaction [Resveratrol results in increased expression of BRCA1 protein]
resveratrol results in increased expression of BRCA1 mRNA; resveratrol results in increased expression of BRCA1 protein
resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter]
resveratrol affects the localization of BRCA1 protein 		CTD PMID:15149879 PMID:19167446 PMID:19559722 PMID:20631324 PMID:22197621 More... NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Brca2 BRCA2, DNA repair associated affects expression
decreases expression
increases expression
multiple interactions 		EXP
ISO 		resveratrol affects the expression of BRCA2 mRNA
Resveratrol results in decreased expression of BRCA2 mRNA
resveratrol results in decreased expression of BRCA2 mRNA
resveratrol results in increased expression of BRCA2 mRNA
[Coumestrol co-treated with Resveratrol] results in increased expression of BRCA2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BRCA2 mRNA 		CTD PMID:15149879 PMID:15748624 PMID:19167446 PMID:23557933 PMID:25667456 More... NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194 		JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex subunit 3 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of BRCC3 mRNA
resveratrol results in decreased expression of BRCC3 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185 		JBrowse link
G Brd3 bromodomain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BRD3 mRNA CTD PMID:23557933 NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629 		JBrowse link
G Brd9 bromodomain containing 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BRD9 mRNA CTD PMID:23557933 NCBI chr 1:31,158,546...31,185,812
Ensembl chr 1:31,158,546...31,186,125 		JBrowse link
G Brf1 BRF1 general transcription factor IIIB subunit decreases expression ISO resveratrol results in decreased expression of BRF1 mRNA CTD PMID:12002526 PMID:12569576 NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386 		JBrowse link
G Bri3bp Bri3 binding protein increases expression ISO resveratrol results in increased expression of BRI3BP protein CTD PMID:25505154 NCBI chr12:36,838,098...36,849,919
Ensembl chr12:36,838,098...36,849,919 		JBrowse link
G Brinp1 BMP/retinoic acid inducible neural specific 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BRINP1 mRNA CTD PMID:23557933 NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256 		JBrowse link
G Brinp3 BMP/retinoic acid inducible neural specific 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BRINP3 mRNA CTD PMID:23557933 NCBI chr13:60,964,127...61,397,044
Ensembl chr13:60,966,100...61,397,039 		JBrowse link
G Brix1 biogenesis of ribosomes BRX1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BXDC2 mRNA CTD PMID:23557933 NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BRWD1 mRNA CTD PMID:23557933 NCBI chr11:48,756,174...48,853,692
Ensembl chr11:48,756,811...48,848,256 		JBrowse link
G Brwd3 bromodomain and WD repeat domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BRWD3 mRNA CTD PMID:23557933 NCBI chr  X:77,843,766...77,937,240
Ensembl chr  X:77,848,982...77,937,745 		JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin increases expression ISO resveratrol results in increased expression of BSCL2 protein CTD PMID:25505154 NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536 		JBrowse link
G Bsg basigin decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of BSG protein
2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in decreased expression of BSG protein]; resveratrol inhibits the reaction [BSG protein results in increased expression of and results in increased secretion of IL18 protein]; resveratrol inhibits the reaction [BSG protein results in increased expression of IL18 mRNA]; resveratrol inhibits the reaction [IL18 protein results in increased expression of BSG mRNA]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG] 		CTD PMID:17007354 PMID:17055343 PMID:18647594 PMID:19561311 NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression
increases expression 		ISO resveratrol results in decreased expression of BST2 mRNA
resveratrol results in increased expression of BST2 mRNA 		CTD PMID:23840623 PMID:25888808 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Bsx brain specific homeobox multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BSX mRNA CTD PMID:23557933 NCBI chr 8:50,151,204...50,154,960
Ensembl chr 8:50,151,204...50,154,960 		JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BTBD3 mRNA CTD PMID:23557933 NCBI chr 3:146,044,053...146,074,189
Ensembl chr 3:146,044,096...146,074,635 		JBrowse link
G Btf3 basic transcription factor 3 decreases expression ISO resveratrol results in decreased expression of BTF3 protein CTD PMID:25505154 NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125 		JBrowse link
G Btf3l4 basic transcription factor 3-like 4 decreases expression ISO resveratrol results in decreased expression of BTF3L4 protein CTD PMID:25505154 NCBI chr 5:128,796,594...128,816,219
Ensembl chr 5:128,796,594...128,816,602 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BTG1 mRNA CTD PMID:19167446 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA CTD PMID:19167446 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btk Bruton tyrosine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BTK mRNA; Resveratrol inhibits the reaction [COL1A1 protein promotes the reaction [PTPN11 protein binds to BTK protein]]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of BTK protein] CTD PMID:23557933 PMID:26482867 NCBI chr  X:102,016,070...102,055,448
Ensembl chr  X:102,016,074...102,055,143 		JBrowse link
G Btn1a1 butyrophilin, subfamily 1, member A1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BTN1A1 mRNA CTD PMID:23557933 NCBI chr17:42,080,217...42,092,286
Ensembl chr17:42,081,527...42,092,276 		JBrowse link
G Btn2a2 butyrophilin, subfamily 2, member A2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BTN2A2 mRNA CTD PMID:23557933 NCBI chr17:42,048,842...42,060,650
Ensembl chr17:42,048,842...42,060,650 		JBrowse link
G Btnl9 butyrophilin-like 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of BTNL9 mRNA CTD PMID:23557933 NCBI chr10:33,967,098...33,990,304
Ensembl chr10:33,970,675...33,990,354 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of BUB1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BUB1 mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of BUB1B mRNA; resveratrol results in decreased expression of BUB1B protein
resveratrol results in increased expression of BUB1B mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BUB1B mRNA 		CTD PMID:15767336 PMID:18089832 PMID:19167446 NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796 		JBrowse link
G Bub3 BUB3 mitotic checkpoint protein increases expression ISO resveratrol results in increased expression of BUB3 mRNA CTD PMID:12002526 NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028 		JBrowse link
G Bud13 BUD13 homolog multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of BUD13 mRNA CTD PMID:23557933 NCBI chr 8:55,471,818...55,487,652
Ensembl chr 8:55,471,810...55,487,649 		JBrowse link
G Bud31 BUD31 homolog decreases expression ISO resveratrol results in decreased expression of BUD31 protein CTD PMID:25505154 NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039 		JBrowse link
G Bysl bystin-like decreases expression ISO resveratrol results in decreased expression of BYSL protein CTD PMID:25505154 NCBI chr 9:20,880,341...20,890,092
Ensembl chr 9:20,880,026...20,890,900 		JBrowse link
G Bzw1 basic leucine zipper and W2 domains 1 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of BZW1 mRNA CTD PMID:26667767 NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684 		JBrowse link
G C10h16orf89 similar to human chromosome 16 open reading frame 89 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C16ORF89 mRNA CTD PMID:23557933 NCBI chr10:10,856,320...10,877,515
Ensembl chr10:10,868,419...10,877,515 		JBrowse link
G C10h5orf15 similar to human chromosome 5 open reading frame 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C5ORF15 mRNA CTD PMID:23557933 NCBI chr10:37,064,889...37,077,493
Ensembl chr10:37,064,728...37,077,493 		JBrowse link
G C11h21orf91 similar to human chromosome 21 open reading frame 91 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C21ORF91 mRNA CTD PMID:23557933 NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415 		JBrowse link
G C11h3orf38 similar to human chromosome 3 open reading frame 38 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C3ORF38 mRNA CTD PMID:23557933 NCBI chr11:15,930,504...15,935,152
Ensembl chr11:15,783,138...15,935,152 		JBrowse link
G C11h3orf52 similar to human chromosome 3 open reading frame 52 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of C3ORF52 mRNA CTD PMID:26667767 NCBI chr11:68,629,570...68,654,874
Ensembl chr11:68,629,570...68,654,868 		JBrowse link
G C11h3orf70 similar to human chromosome 3 open reading frame 70 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C3ORF70 mRNA CTD PMID:23557933 NCBI chr11:92,850,327...92,900,608
Ensembl chr11:92,850,327...92,900,608 		JBrowse link
G C13h1orf115 similar to human chromosome 1 open reading frame 115 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF115 mRNA CTD PMID:19167446 NCBI chr13:98,953,841...98,963,577
Ensembl chr13:98,953,843...98,963,810 		JBrowse link
G C13h1orf116 similar to human chromosome 1 open reading frame 116 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1ORF116 mRNA
resveratrol results in increased expression of C1ORF116 mRNA 		CTD PMID:23557933 PMID:25888808 NCBI chr13:44,739,716...44,753,695
Ensembl chr13:44,727,092...44,754,009 		JBrowse link
G C14h7orf57 similar to human chromosome 7 open reading frame 57 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C7ORF57 mRNA CTD PMID:23557933 NCBI chr14:87,962,231...87,982,043
Ensembl chr14:87,959,540...87,982,040 		JBrowse link
G C15h14orf119 similar to human chromosome 14 open reading frame 119 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C14ORF119 mRNA CTD PMID:23557933 NCBI chr15:32,116,220...32,121,425
Ensembl chr15:32,116,021...32,122,416 		JBrowse link
G C15h14orf93 similar to human chromosome 14 open reading frame 93 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C14ORF93 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of C14ORF93 mRNA CTD PMID:23557933 NCBI chr15:32,007,591...32,034,337
Ensembl chr15:32,007,595...32,034,289 		JBrowse link
G C15h8orf74 similar to human chromosome 8 open reading frame 74 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C8ORF74 mRNA CTD PMID:23557933 NCBI chr15:42,384,768...42,401,641
Ensembl chr15:42,384,768...42,401,641 		JBrowse link
G C17h6orf52 similar to human chromosome 6 open reading frame 52 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C6ORF52 mRNA CTD PMID:23557933 NCBI chr17:23,959,124...23,981,978
Ensembl chr17:23,968,478...23,981,976 		JBrowse link
G C17h6orf62 similar to human chromosome 6 open reading frame 62 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C6ORF62 mRNA CTD PMID:23557933 NCBI chr17:40,684,236...40,695,874
Ensembl chr17:40,684,236...40,704,043 		JBrowse link
G C18h18orf21 similar to human chromosome 18 open reading frame 21 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of RMP24 mRNA CTD PMID:23557933 NCBI chr18:16,054,038...16,062,645
Ensembl chr18:16,053,880...16,064,239 		JBrowse link
G C19h16orf86 similar to human chromosome 16 open reading frame 86 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C16ORF86 mRNA CTD PMID:23557933 NCBI chr19:50,506,505...50,508,415
Ensembl chr19:50,505,546...50,508,414 		JBrowse link
G C19h19orf67 similar to human chromosome 19 open reading frame 67 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C19ORF67 mRNA CTD PMID:23557933 NCBI chr19:41,051,577...41,054,875
Ensembl chr19:41,051,577...41,054,955 		JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C1GALT1C1 mRNA CTD PMID:23557933 NCBI chr  X:122,243,736...122,248,217
Ensembl chr  X:122,234,454...122,248,422 		JBrowse link
G C1h10orf120 similar to human chromosome 10 open reading frame 120 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C10ORF120 mRNA CTD PMID:23557933 NCBI chr 1:195,340,624...195,343,676
Ensembl chr 1:195,340,624...195,343,676 		JBrowse link
G C1h10orf88 similar to human chromosome 10 open reading frame 88 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C10ORF88 mRNA CTD PMID:23557933 NCBI chr 1:195,555,517...195,580,177
Ensembl chr 1:195,562,392...195,579,576 		JBrowse link
G C1h11orf16 similar to human chromosome 11 open reading frame 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C11ORF16 mRNA CTD PMID:23557933 NCBI chr 1:173,177,827...173,188,958
Ensembl chr 1:173,177,834...173,188,919 		JBrowse link
G C1h11orf42 similar to human chromosome 11 open reading frame 42 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C11ORF42 mRNA CTD PMID:23557933 NCBI chr 1:169,134,309...169,137,772
Ensembl chr 1:169,134,311...169,138,682 		JBrowse link
G C1h11orf86 similar to human chromosome 11 open reading frame 86 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C11ORF86 mRNA CTD PMID:23557933 NCBI chr 1:211,213,429...211,225,624
Ensembl chr 1:211,213,445...211,229,116 		JBrowse link
G C1h16orf54 similar to human chromosome 16 open reading frame 54 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C16ORF54 mRNA CTD PMID:23557933 NCBI chr 1:191,132,972...191,135,653
Ensembl chr 1:191,132,030...191,135,910 		JBrowse link
G C1h16orf92 similar to human chromosome 16 open reading frame 92 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C16ORF92 mRNA CTD PMID:23557933 NCBI chr 1:190,870,546...190,871,557 JBrowse link
G C1h9orf40 similar to human chromosome 9 open reading frame 40 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of C9ORF40 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of C9ORF40 mRNA 		CTD PMID:19167446 PMID:19371625 NCBI chr 1:225,555,300...225,559,509
Ensembl chr 1:225,555,280...225,559,693 		JBrowse link
G C1qa complement C1q A chain decreases expression
multiple interactions
increases expression 		ISO
EXP 		resveratrol results in decreased expression of C1QA mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of C1QA mRNA
resveratrol results in increased expression of C1QA mRNA 		CTD PMID:19555370 PMID:25905778 NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732 		JBrowse link
G C1qb complement C1q B chain multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of C1QB mRNA
resveratrol results in increased expression of C1QB mRNA 		CTD PMID:25905778 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qc complement C1q C chain multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of C1QC mRNA
resveratrol results in increased expression of C1QC mRNA 		CTD PMID:25905778 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468 		JBrowse link
G C1ql1 complement C1q like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QL1 mRNA CTD PMID:23557933 NCBI chr10:88,402,219...88,409,649
Ensembl chr10:88,402,219...88,409,649 		JBrowse link
G C1ql3 complement C1q like 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QL3 mRNA CTD PMID:23557933 NCBI chr17:81,028,418...81,038,244
Ensembl chr17:81,028,418...81,038,244 		JBrowse link
G C1ql4 complement C1q like 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QL4 mRNA CTD PMID:23557933 NCBI chr 7:132,122,537...132,125,609
Ensembl chr 7:132,122,537...132,125,609 		JBrowse link
G C1qtnf1 C1q and TNF related 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QTNF1 mRNA CTD PMID:23557933 NCBI chr10:104,159,021...104,180,253
Ensembl chr10:104,158,886...104,180,251 		JBrowse link
G C1qtnf4 C1q and TNF related 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QTNF4 mRNA CTD PMID:23557933 NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587 		JBrowse link
G C1qtnf5 C1q and TNF related 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QTNF5 mRNA CTD PMID:23557933 NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912 		JBrowse link
G C20h6orf15 similar to human chromosome 6 open reading frame 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C6ORF15 mRNA CTD PMID:23557933 NCBI chr20:3,177,040...3,178,596
Ensembl chr20:3,177,040...3,178,596 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C2CD2 mRNA CTD PMID:23557933 NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016 		JBrowse link
G C2cd3 C2 domain containing 3 centriole elongation regulator multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C2CD3 mRNA CTD PMID:23557933 NCBI chr 1:164,127,304...164,225,088
Ensembl chr 1:164,127,281...164,225,086 		JBrowse link
G C2cd4c C2 calcium-dependent domain containing 4C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C2CD4C mRNA CTD PMID:23557933 NCBI chr 7:10,742,534...10,746,033
Ensembl chr 7:10,742,545...10,751,973 		JBrowse link
G C2h1orf52 similar to human chromosome 1 open reading frame 52 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C1ORF52 mRNA CTD PMID:23557933 NCBI chr 2:237,510,974...237,520,346
Ensembl chr 2:237,513,711...237,520,346 		JBrowse link
G C2h1orf56 similar to human chromosome 1 open reading frame 56 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1ORF56 mRNA CTD PMID:23557933 NCBI chr 2:185,503,792...185,507,385
Ensembl chr 2:185,503,793...185,507,385 		JBrowse link
G C2h4orf46 similar to human chromosome 4 open reading frame 46 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of C4ORF46 mRNA CTD PMID:19167446 NCBI chr 2:167,061,141...167,064,273
Ensembl chr 2:167,060,941...167,064,271 		JBrowse link
G C2h5orf22 similar to human chromosome 5 open reading frame 22 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C5ORF22 mRNA CTD PMID:23557933 NCBI chr 2:63,576,348...63,591,764
Ensembl chr 2:63,576,348...63,591,585 		JBrowse link
G C3 complement C3 increases expression ISO resveratrol results in increased expression of C3 mRNA
resveratrol results in increased expression of C3 protein 		CTD PMID:25888808 PMID:25954969 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C3h11orf91 similar to human chromosome 11 open reading frame 91 decreases expression ISO resveratrol results in decreased expression of C11ORF91 mRNA CTD PMID:25888808 NCBI chr 3:110,934,488...110,941,511
Ensembl chr 3:110,939,526...110,941,508 		JBrowse link
G C3h15orf48 similar to human chromosome 15 open reading frame 48 increases expression ISO Resveratrol results in increased expression of COXFA4L3 mRNA CTD PMID:17257620 NCBI chr 3:130,173,535...130,177,088
Ensembl chr 3:130,173,416...130,177,089 		JBrowse link
G C3h15orf62 similar to human chromosome 15 open reading frame 62 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C15ORF62 mRNA CTD PMID:23557933 NCBI chr 3:126,618,025...126,621,250
Ensembl chr 3:126,617,606...126,626,606 		JBrowse link
G C3h9orf50 similar to human chromosome 9 open reading frame 50 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C9ORF50 mRNA CTD PMID:23557933 NCBI chr 3:34,477,535...34,484,791
Ensembl chr 3:34,478,508...34,484,805 		JBrowse link
G C4b complement C4B decreases expression ISO resveratrol results in decreased expression of C4B mRNA CTD PMID:19555370 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C4bpb complement component 4 binding protein, beta increases expression ISO resveratrol results in increased expression of C4BPB mRNA CTD PMID:25888808 NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793 		JBrowse link
G C4h3orf22 similar to human chromosome 3 open reading frame 22 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C3ORF22 mRNA CTD PMID:23557933 NCBI chr 4:124,374,885...124,379,380
Ensembl chr 4:124,375,807...124,379,379 		JBrowse link
G C5 complement C5 multiple interactions
decreases response to substance 		ISO [resveratrol results in decreased activity of SPHK1 protein] inhibits the reaction [C5 protein results in increased activity of RELA protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein]; resveratrol inhibits the reaction [[C5 protein results in increased activity of and results in increased localization of SPHK1 protein] which results in increased abundance of Calcium]; resveratrol inhibits the reaction [C5 protein results in increased activity of RELA protein]; resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein]; resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein]; resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein]; resveratrol inhibits the reaction [C5 protein results in increased expression of TNF protein]; resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol results in decreased activity of [C5 protein results in increased localization of and results in increased activity of PLD1 protein]
Resveratrol inhibits the reaction [[C5 protein results in increased activity of and results in increased localization of SPHK1 protein] which results in increased abundance of Calcium]; Resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [C5 protein results in increased expression of TNF protein]; Resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Resveratrol promotes the reaction [titanium dioxide results in increased expression of HC mRNA]
resveratrol results in decreased susceptibility to C5 protein 		CTD PMID:18776917 PMID:19284563 PMID:19346296 PMID:31298478 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5h1orf50 similar to human chromosome 1 open reading frame 50 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C1ORF50 mRNA CTD PMID:23557933 NCBI chr 5:138,122,595...138,126,973
Ensembl chr 5:138,122,236...138,127,240 		JBrowse link
G C6h14orf132 similar to human chromosome 14 open reading frame 132 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C14ORF132 mRNA CTD PMID:23557933 NCBI chr 6:130,130,176...130,163,153
Ensembl chr 6:130,130,794...130,158,762 		JBrowse link
G C6h14orf180 similar to human chromosome 14 open reading frame 180 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C14ORF180 mRNA CTD PMID:23557933 NCBI chr 6:137,378,336...137,393,892 JBrowse link
G C7h12orf50 similar to human chromosome 12 open reading frame 50 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C12ORF50 mRNA CTD PMID:23557933 NCBI chr 7:37,296,242...37,329,893
Ensembl chr 7:37,292,758...37,329,889 		JBrowse link
G C7h8orf82 similar to human chromosome 8 open reading frame 82 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C8ORF82 mRNA CTD PMID:23557933 NCBI chr 7:110,324,408...110,326,752
Ensembl chr 7:110,324,409...110,326,752 		JBrowse link
G C8g complement C8 gamma chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C8G mRNA CTD PMID:23557933 NCBI chr 3:28,718,648...28,720,232 JBrowse link
G C8h11orf87 similar to human chromosome 11 open reading frame 87 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C11ORF87 mRNA CTD PMID:23557933 NCBI chr 8:61,958,626...61,966,119
Ensembl chr 8:61,957,676...61,968,365 		JBrowse link
G C8h3orf62 similar to human chromosome 3 open reading frame 62 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of C3ORF62 mRNA CTD PMID:23557933 NCBI chr 8:117,958,583...117,963,137
Ensembl chr 8:117,958,576...117,963,201 		JBrowse link
G C9h2orf66 similar to human chromosome 2 open reading frame 66 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of C2ORF66 mRNA CTD PMID:23557933 NCBI chr 9:63,440,494...63,444,210
Ensembl chr 9:63,442,741...63,444,089 		JBrowse link
G C9h2orf69 similar to human chromosome 2 open reading frame 69 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of C2ORF69 mRNA CTD PMID:19167446 NCBI chr 9:66,444,084...66,452,720
Ensembl chr 9:66,444,112...66,453,983 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in decreased expression of CAR3 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CAR3 mRNA] 		CTD PMID:25905778 PMID:31298478 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Ca4 carbonic anhydrase 4 increases expression EXP resveratrol results in increased expression of CA4 mRNA CTD PMID:19228061 NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916 		JBrowse link
G Ca9 carbonic anhydrase 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CA9 mRNA CTD PMID:23557933 NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626 		JBrowse link
G Caap1 caspase activity and apoptosis inhibitor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAAP1 mRNA CTD PMID:23557933 NCBI chr 5:114,428,991...114,530,047
Ensembl chr 5:114,432,379...114,530,047 		JBrowse link
G Cab39 calcium binding protein 39 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAB39 mRNA CTD PMID:23557933 NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542 		JBrowse link
G Cabp1 calcium binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CABP1 mRNA CTD PMID:23557933 NCBI chr12:47,045,914...47,109,614
Ensembl chr12:47,085,292...47,109,611 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C decreases expression ISO resveratrol results in decreased expression of CACNA1C mRNA CTD PMID:22610192 NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNA1S mRNA CTD PMID:23557933 NCBI chr13:50,045,668...50,115,903
Ensembl chr13:50,045,668...50,115,903 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 decreases expression ISO resveratrol results in decreased expression of CACNA2D1 mRNA CTD PMID:22610192 NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147 		JBrowse link
G Cacng1 calcium voltage-gated channel auxiliary subunit gamma 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNG1 mRNA CTD PMID:23557933 NCBI chr10:93,152,558...93,165,246
Ensembl chr10:93,152,248...93,165,417 		JBrowse link
G Cacng2 calcium voltage-gated channel auxiliary subunit gamma 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNG2 mRNA CTD PMID:23557933 NCBI chr 7:111,451,605...111,579,071
Ensembl chr 7:111,455,006...111,577,757 		JBrowse link
G Cacng5 calcium voltage-gated channel auxiliary subunit gamma 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNG5 mRNA CTD PMID:23557933 NCBI chr10:93,327,142...93,369,244
Ensembl chr10:93,327,150...93,336,667 		JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNG7 mRNA CTD PMID:23557933 NCBI chr 1:74,715,483...74,746,669
Ensembl chr 1:74,715,483...74,746,669 		JBrowse link
G Cacng8 calcium voltage-gated channel auxiliary subunit gamma 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACNG8 mRNA CTD PMID:23557933 NCBI chr 1:74,670,767...74,691,003
Ensembl chr 1:74,669,766...74,694,015 		JBrowse link
G Cactin cactin, spliceosome C complex subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CACTIN mRNA CTD PMID:23557933 NCBI chr 7:9,042,125...9,047,807
Ensembl chr 7:9,042,129...9,047,558 		JBrowse link
G Cacybp calcyclin binding protein multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA
resveratrol results in decreased expression of CACYBP mRNA 		CTD PMID:19167446 PMID:25905778 NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase increases expression ISO resveratrol results in increased expression of CAD protein CTD PMID:25505154 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Calca calcitonin-related polypeptide alpha decreases expression EXP resveratrol results in decreased expression of CALCA protein CTD PMID:27093858 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calcr calcitonin receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CALCR mRNA CTD PMID:19167446 NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:32,615,958...32,691,075 		JBrowse link
G Calm2 calmodulin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CALM2 mRNA CTD PMID:23557933 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Calr calreticulin decreases expression
affects secretion
multiple interactions 		ISO resveratrol results in decreased expression of CALR mRNA
resveratrol affects the secretion of CALR protein
resveratrol inhibits the reaction [arsenic trioxide results in increased expression of CALR protein] 		CTD PMID:12002526 PMID:24802182 PMID:25107562 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Calu calumenin affects secretion
multiple interactions 		ISO resveratrol affects the secretion of CALU protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CALU mRNA 		CTD PMID:23557933 PMID:24802182 NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha multiple interactions ISO resveratrol inhibits the reaction [Streptozocin results in increased expression of and results in increased phosphorylation of and results in increased activity of CAMK2A protein] CTD PMID:20424226 NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAMK2D mRNA CTD PMID:23557933 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA CTD PMID:19167446 NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058 		JBrowse link
G Camk2n2 calcium/calmodulin-dependent protein kinase II inhibitor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CAMK2N2 mRNA CTD PMID:23557933 NCBI chr11:93,792,112...93,796,153
Ensembl chr11:93,794,095...93,795,222 		JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV multiple interactions EXP [KN 62 results in decreased activity of CAMK4 protein] which results in decreased susceptibility to resveratrol CTD PMID:23435869 NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193 		JBrowse link
G Camp cathelicidin antimicrobial peptide multiple interactions
increases expression 		ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol promotes the reaction [resveratrol results in increased expression of CAMP mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]; AZD 6244 promotes the reaction [Calcitriol promotes the reaction [resveratrol results in increased expression of CAMP mRNA]]; AZD 6244 promotes the reaction [resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]; calcipotriene promotes the reaction [resveratrol results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [resveratrol results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [resveratrol results in increased expression of CAMP protein]; paricalcitol promotes the reaction [resveratrol results in increased expression of CAMP mRNA]; resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP protein]; SB 203580 promotes the reaction [Calcitriol promotes the reaction [resveratrol results in increased expression of CAMP mRNA]]; SB 203580 promotes the reaction [resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]
resveratrol results in increased expression of CAMP mRNA; resveratrol results in increased expression of CAMP protein 		CTD PMID:24039193 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Camsap3 calmodulin regulated spectrin-associated protein family, member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CAMSAP3 mRNA CTD PMID:23557933 NCBI chr12:6,440,959...6,464,582
Ensembl chr12:6,441,152...6,464,582 		JBrowse link
G Camta2 calmodulin binding transcription activator 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CAMTA2 mRNA CTD PMID:23557933 NCBI chr10:55,882,071...55,900,575
Ensembl chr10:55,882,071...55,900,179 		JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAND1 mRNA CTD PMID:23557933 NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655 		JBrowse link
G Canx calnexin multiple interactions ISO resveratrol inhibits the reaction [arsenic trioxide results in increased expression of CANX protein] CTD PMID:25107562 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Cap2 cyclase associated actin cytoskeleton regulatory protein 2 decreases expression ISO resveratrol results in decreased expression of CAP2 mRNA CTD PMID:15280659 NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563 		JBrowse link
G Capg capping actin protein, gelsolin like multiple interactions
increases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CAPG mRNA
resveratrol results in increased expression of CAPG mRNA 		CTD PMID:25888808 PMID:25905778 NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672 		JBrowse link
G Capn15 calpain 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CAPN15 mRNA CTD PMID:23557933 NCBI chr10:15,477,311...15,503,913
Ensembl chr10:15,477,313...15,503,913 		JBrowse link
G Capn3 calpain 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAPN3 mRNA CTD PMID:23557933 NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638 		JBrowse link
G Capn6 calpain 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CAPN6 mRNA CTD PMID:23557933 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capn9 calpain 9 increases expression ISO resveratrol results in increased expression of CAPN9 mRNA CTD PMID:19371625 NCBI chr19:69,446,847...69,483,810
Ensembl chr19:69,446,847...69,483,810 		JBrowse link
G Capns1 calpain, small subunit 1 increases expression ISO resveratrol results in increased expression of CAPNS1 protein CTD PMID:25505154 NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:94,572,083...94,583,368 		JBrowse link
G Caprin1 cell cycle associated protein 1 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CAPRIN1 mRNA
resveratrol results in decreased expression of CAPRIN1 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 decreases expression ISO resveratrol results in decreased expression of CAPZA2 protein CTD PMID:25505154 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Capzb capping actin protein of muscle Z-line subunit beta decreases expression ISO resveratrol results in decreased expression of CAPZB protein CTD PMID:25505154 NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619 		JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CA2 mRNA CTD PMID:19167446 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Car7 carbonic anhydrase 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CA7 mRNA CTD PMID:23557933 NCBI chr19:435,520...444,927
Ensembl chr19:435,522...452,384 		JBrowse link
G Card14 caspase recruitment domain family, member 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CARD14 mRNA CTD PMID:23557933 NCBI chr10:105,064,941...105,100,132
Ensembl chr10:105,064,941...105,100,132 		JBrowse link
G Carf calcium responsive transcription factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CARF mRNA CTD PMID:23557933 NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479 		JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 increases expression ISO resveratrol results in increased expression of CARHSP1 protein CTD PMID:25505154 NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770 		JBrowse link
G Cars2 cysteinyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CARS2 mRNA CTD PMID:23557933 NCBI chr16:84,649,617...84,689,254
Ensembl chr16:84,645,627...84,690,192 		JBrowse link
G Caskin1 CASK interacting protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CASKIN1 mRNA CTD PMID:23557933 NCBI chr10:14,016,780...14,037,927
Ensembl chr10:14,018,012...14,037,924 		JBrowse link
G Caskin2 cask-interacting protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CASKIN2 mRNA CTD PMID:23557933 NCBI chr10:101,526,131...101,540,362
Ensembl chr10:101,526,195...101,540,349 		JBrowse link
G Casp1 caspase 1 multiple interactions
increases expression 		ISO
EXP 		[aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] promotes the reaction [[tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to Resveratrol]; [Plant Extracts co-treated with Resveratrol] results in increased expression of CASP1 mRNA; [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] promotes the reaction [[aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to Resveratrol]; [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to Resveratrol; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of CASP1 mRNA]; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased secretion of and results in increased activity of CASP1 protein]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased cleavage of CASP1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA]
resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CASP1 mRNA]; resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CASP1 protein]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 protein]
resveratrol results in increased expression of CASP1 protein
resveratrol results in increased expression of CASP1 mRNA
[Resveratrol results in increased activity of SIRT1 protein] which results in decreased cleavage of and results in decreased activity of CASP1 protein; Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of and results in increased cleavage of CASP1 protein]; Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of CASP1 mRNA] 		CTD PMID:9680369 PMID:20370652 PMID:23452621 PMID:23557933 PMID:24149798 More... NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp12 caspase 12 multiple interactions
affects expression
increases expression 		EXP
ISO 		Resveratrol inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP12 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased cleavage of CASP12 protein]
resveratrol affects the expression of CASP12 mRNA
CASP12 mutant form inhibits the reaction [Resveratrol results in increased cleavage of PARP1 protein]; Resveratrol inhibits the reaction [Ethanol results in increased activity of CASP12 protein]; Resveratrol inhibits the reaction [Ethanol results in increased expression of CASP12 protein modified form]; Resveratrol inhibits the reaction [Thapsigargin results in increased activity of CASP12 protein]; Resveratrol inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein]
resveratrol results in increased expression of CASP12 protein 		CTD PMID:17959022 PMID:24224909 PMID:24264887 PMID:31433112 PMID:34302886 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp2 caspase 2 multiple interactions
increases expression
decreases expression 		ISO [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP2 protein; CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein]; CASP2 protein affects the reaction [resveratrol affects the folding of BAX protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of CASP2 mRNA]; resveratrol results in increased cleavage of and results in increased activity of CASP2 protein; SUMO1 protein affects the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of CASP2 mRNA]]; SUMO1 protein affects the reaction [resveratrol results in increased expression of CASP2 mRNA]
resveratrol results in decreased expression of CASP2 protein 		CTD PMID:15763656 PMID:16617056 PMID:18089832 PMID:25436977 PMID:25667456 More... NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022 		JBrowse link
G Casp3 caspase 3 affects expression
increases activity
decreases activity
decreases expression
multiple interactions
increases expression
increases cleavage 		EXP
ISO 		resveratrol affects the expression of CASP3 mRNA
resveratrol results in increased activity of CASP3 protein
resveratrol results in decreased activity of CASP3 protein
resveratrol results in decreased expression of CASP3; resveratrol results in decreased expression of CASP3 protein; resveratrol results in decreased expression of CASP3 protein modified form
resveratrol affects the expression of CASP3 protein modified form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in decreased expression of CASP3 protein modified form]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]]; [Resveratrol co-treated with Estradiol] results in increased activity of CASP3 protein; [Resveratrol co-treated with Propofol] results in decreased expression of CASP3; [Resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CASP3 protein modified form; [Sirolimus co-treated with Resveratrol] results in increased cleavage of CASP3 protein; CASP3 protein affects the reaction [Resveratrol results in decreased expression of SLC9A1 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]]; RAB7A protein promotes the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]]; Resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of and results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [acetamiprid results in increased expression of CASP3 mRNA]; Resveratrol inhibits the reaction [acetamiprid results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [bisphenol A analog results in increased expression of CASP3 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Doxorubicin results in increased expression of CASP3]; Resveratrol inhibits the reaction [Ethanol results in increased expression of CASP3]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of CASP3 mRNA]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in increased cleavage of CASP3 protein]]; Resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 mRNA]; Resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Rotenone results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Testosterone results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP3 protein]; Resveratrol results in increased expression of and results in increased cleavage of and results in increased activity of CASP3 protein; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP3 protein]]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] promotes the reaction [[tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to Resveratrol]; [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to Resveratrol; [benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP3 protein] which results in decreased susceptibility to Resveratrol; [Clofarabine co-treated with Resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP3 protein]; [Clofarabine co-treated with Resveratrol] promotes the reaction [BCL2L1 mutant form results in increased cleavage of CASP3 protein]; [Clofarabine co-treated with Resveratrol] results in increased activity of CASP3 protein; [Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP3 protein]; [Resveratrol co-treated with Clofarabine] results in increased cleavage of and results in increased activity of CASP3 protein; [Resveratrol co-treated with Clofarabine] results in increased expression of CASP3 protein modified form; [Resveratrol co-treated with Panobinostat] results in increased cleavage of CASP3 protein; [Resveratrol co-treated with Quercetin] results in increased cleavage of CASP3 protein; [Resveratrol co-treated with Raloxifene Hydrochloride] results in decreased expression of CASP3 mRNA; [Resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; [Resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Resveratrol co-treated with Vorinostat] results in increased cleavage of CASP3 protein; [Resveratrol results in increased activity of CASP3 protein] which affects the activity of SLC4A1 protein; [Resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein; [Resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein; [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] promotes the reaction [[aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to Resveratrol]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of CASP3 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]; ATF3 protein promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2L1 protein affects the reaction [[Clofarabine co-treated with Resveratrol] results in increased activity of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Resveratrol results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Resveratrol results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP3 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] results in increased activity of CASP3 protein]; Capsaicin promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; CTSD protein affects the reaction [Resveratrol results in increased activity of CASP3 protein]; Erlotinib Hydrochloride promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; MCL1 mutant form promotes the reaction [[Resveratrol co-treated with Clofarabine] results in increased cleavage of CASP3 protein]; MIR126 mRNA promotes the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; MRK 003 affects the reaction [Resveratrol results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of CASP3 protein]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [cudraflavone B results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Dopamine results in increased cleavage of and results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Ethanol results in increased expression of CASP3 protein modified form]; Resveratrol inhibits the reaction [Fluorouracil results in decreased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [MFGE8 protein results in increased expression of CASP3 protein modified form]; Resveratrol inhibits the reaction [Niacinamide results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Rotenone results in increased cleavage of CASP3 protein]; Resveratrol promotes the reaction [2,3-N-octanoylsphingosine results in increased activity of CASP3 protein]; Resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; Resveratrol promotes the reaction [Capsaicin results in increased activity of CASP3 protein]; Resveratrol promotes the reaction [CASP3 protein results in increased degradation of CTNNB1 protein]; Resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased activity of CASP3 protein]; Resveratrol promotes the reaction [Sorafenib results in increased cleavage of CASP3 protein]; Resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]; Resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP3 protein]; Resveratrol results in increased activity of and results in increased cleavage of CASP3 protein; Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein; SB 203580 promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; SH-6 compound promotes the reaction [Resveratrol results in increased activity of CASP3 protein]; sirtinol inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]]; ZBTB7A protein inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Resveratrol results in decreased expression of CASP3 protein modified form]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; [Resveratrol results in increased activity of SIRT1 protein] which results in decreased cleavage of and results in decreased activity of CASP3 protein; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Resveratrol results in increased cleavage of CASP3 protein]; BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP3 protein]; CASP3 protein affects the reaction [Resveratrol results in decreased expression of SLC9A1 mRNA]; CASP3 protein affects the reaction [Resveratrol results in decreased expression of SLC9A1 protein]; NFE2L2 protein affects the reaction [Resveratrol inhibits the reaction [Dietary Fats results in increased activity of CASP3 protein]]; pifithrin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]]]; PRKAA2 protein affects the reaction [Resveratrol results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Acetylcysteine results in increased expression of CASP3 protein modified form]; Resveratrol inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [CDK5R1 protein results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [glyoxylic acid results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Nicotine results in increased expression of CASP3 mRNA]; Resveratrol inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [Pyruvaldehyde results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Sodium Fluoride results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased activity of CASP3 protein]; Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein; SIRT1 protein affects the reaction [Resveratrol results in increased cleavage of CASP3 protein]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; Wortmannin promotes the reaction [Resveratrol results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]
[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein; resveratrol analog results in increased activity of CASP3 protein; resveratrol results in increased activity of CASP3 protein
resveratrol results in decreased expression of CASP3 mRNA; resveratrol results in decreased expression of CASP3 protein; resveratrol results in decreased expression of CASP3 protein modified form
Resveratrol analog results in increased expression of CASP3 protein; Resveratrol results in increased expression of CASP3; Resveratrol results in increased expression of CASP3 mRNA; Resveratrol results in increased expression of CASP3 protein; Resveratrol results in increased expression of CASP3 protein modified form
resveratrol results in increased cleavage of CASP3 protein
Resveratrol cotreated with Sunitinib increases expression of Casp3 mRNA in breast epithelium 		CTD
RGD		 PMID:9680369 PMID:11481417 PMID:11577002 PMID:11681415 PMID:12002526 More... RGD:150537096 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 affects response to substance
multiple interactions
increases cleavage
increases activity 		ISO CASP4 protein affects the susceptibility to resveratrol
resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of CASP4 mRNA]; resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased secretion of and results in increased activity of CASP4 protein]
resveratrol results in increased cleavage of CASP4 protein
resveratrol results in increased activity of CASP4 protein 		CTD PMID:20198347 PMID:20717957 PMID:24149798 PMID:24264887 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp6 caspase 6 increases activity
multiple interactions
decreases activity 		ISO
EXP 		Resveratrol results in increased activity of CASP6 protein
CASP6 protein affects the reaction [resveratrol results in decreased expression of SLC9A1 protein]; CAT protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP6 protein]; Phenanthrolines inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP6 protein]; resveratrol results in increased expression of and results in increased cleavage of and results in increased activity of CASP6 protein
resveratrol results in decreased activity of CASP6 protein
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone promotes the reaction [resveratrol results in decreased activity of CASP6 protein]; CASP6 protein affects the reaction [resveratrol results in decreased expression of SLC9A1 mRNA]; CASP6 protein affects the reaction [resveratrol results in decreased expression of SLC9A1 protein]; resveratrol promotes the reaction [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP6 protein]
resveratrol results in increased activity of CASP6 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CASP6 mRNA; [Resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP6 protein; BAX protein promotes the reaction [Resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]]; Resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]; Resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]; Resveratrol results in increased cleavage of and results in increased activity of CASP6 protein; TP53 affects the reaction [Resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]]; TP53 affects the reaction [Resveratrol results in increased activity of CASP6 protein]; TP53 protein promotes the reaction [Resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] 		CTD PMID:15763656 PMID:16518869 PMID:18497562 PMID:18951995 PMID:20940732 More... NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases activity
increases expression
decreases activity
increases cleavage 		ISO
EXP 		[Clofarabine co-treated with Resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP7 protein]; [Clofarabine co-treated with Resveratrol] results in increased activity of CASP7 protein; [Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]; [Resveratrol co-treated with Clofarabine] results in increased activity of CASP7 protein; [Resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP7 protein; ATF3 protein promotes the reaction [Resveratrol results in increased activity of CASP7 protein]; BCL2L1 protein affects the reaction [[Clofarabine co-treated with Resveratrol] results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] results in increased activity of CASP7 protein]; Resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]; Resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP7 protein]
resveratrol results in increased activity of CASP7 protein
[resveratrol co-treated with Estradiol] results in increased activity of CASP7 protein; resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP7 protein]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP7 protein]]
resveratrol results in increased expression of CASP7
resveratrol results in decreased activity of CASP7 protein
resveratrol results in increased cleavage of CASP7 protein 		CTD PMID:14749477 PMID:17823925 PMID:18424637 PMID:19738051 PMID:19959636 More... NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 increases expression
multiple interactions
affects localization
decreases expression
increases activity
increases cleavage
affects response to substance
decreases activity 		ISO
EXP 		Resveratrol results in increased expression of CASP8 mRNA
Resveratrol inhibits the reaction [bisphenol A analog results in increased expression of CASP8 mRNA]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in increased expression of CASP8 protein]]; Resveratrol inhibits the reaction [Paraquat results in increased expression of CASP8 protein]
resveratrol affects the localization of CASP8 protein
resveratrol results in decreased expression of CASP8 protein modified form
resveratrol results in increased activity of CASP8 protein
resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP8 protein]
[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein; [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein; resveratrol results in increased activity of CASP8 protein
resveratrol results in increased cleavage of CASP8 protein
CASP8 protein affects the susceptibility to resveratrol
resveratrol results in increased expression of CASP8 mRNA
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with Resveratrol] results in increased cleavage of CASP8 protein; [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Resveratrol results in increased localization of BAK1 protein]; [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Resveratrol results in increased localization of BAX protein]; [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to Resveratrol; [Resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein; [Resveratrol co-treated with Panobinostat] results in increased cleavage of CASP8 protein; [Resveratrol co-treated with Raloxifene Hydrochloride] results in decreased expression of CASP8 mRNA; [Resveratrol co-treated with SB 203580] results in increased activity of CASP8 protein; [Resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein; [Resveratrol co-treated with Vorinostat] results in increased cleavage of CASP8 protein; [Resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein]; Capsaicin promotes the reaction [Resveratrol results in decreased expression of CASP8 protein]; CASP8 protein affects the susceptibility to [Resveratrol co-treated with Panobinostat]; CASP8 protein affects the susceptibility to [Resveratrol co-treated with Vorinostat]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Resveratrol co-treated with Panobinostat] results in increased cleavage of CASP8 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Resveratrol co-treated with Vorinostat] results in increased cleavage of CASP8 protein]; Nystatin inhibits the reaction [Resveratrol affects the localization of CASP8 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]; Resveratrol promotes the reaction [Capsaicin results in decreased expression of CASP8 protein]; Resveratrol promotes the reaction [FAS protein binds to CASP8 protein]; Resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; Resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein]; Resveratrol results in increased cleavage of and results in increased activity of CASP8 protein; Resveratrol results in increased localization of and results in increased activity of CASP8 protein
resveratrol results in decreased activity of CASP8 protein 		CTD PMID:12902349 PMID:12925042 PMID:14749477 PMID:15763656 PMID:16617056 More... NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA
resveratrol results in decreased expression of CASP8AP2 mRNA 		CTD PMID:19167446 PMID:25905778 NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases activity
decreases expression
increases cleavage
increases expression
decreases activity 		EXP
ISO 		Resveratrol inhibits the reaction [bisphenol A analog results in increased expression of CASP9 mRNA]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of CASP9 mRNA]
Resveratrol results in increased activity of CASP9 protein
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein; [Doxorubicin co-treated with resveratrol] results in increased expression of CASP9 mRNA; [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein; [resveratrol co-treated with panobinostat] results in increased cleavage of CASP9 protein; [resveratrol co-treated with SB 203580] results in increased activity of CASP9 protein; [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol results in increased cleavage of CASP9 protein]; resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein]; resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein]; resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein]; resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein]; resveratrol results in increased cleavage of and results in increased activity of CASP9 protein; sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein]
resveratrol results in decreased expression of CASP9 protein modified form
resveratrol results in increased expression of CASP9 protein
Resveratrol results in increased cleavage of CASP9 protein
resveratrol results in decreased activity of CASP9 protein
[Resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein; Resveratrol analog results in increased activity of CASP9 protein; Resveratrol results in increased activity of CASP9 protein
BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP9 protein]; Resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein]; Resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP9 protein]; Resveratrol results in increased cleavage of and results in increased activity of CASP9 protein; SIRT1 protein affects the reaction [Resveratrol results in increased cleavage of CASP9 protein] 		CTD PMID:11406544 PMID:12902349 PMID:14749477 PMID:15763656 PMID:15827328 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Casr calcium-sensing receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CASR mRNA CTD PMID:23557933 NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167 		JBrowse link
G Cat catalase increases activity
decreases expression
decreases activity
increases expression
multiple interactions
affects expression 		ISO
EXP 		resveratrol results in increased activity of CAT protein
resveratrol results in decreased expression of CAT mRNA
resveratrol analog results in decreased activity of CAT protein; resveratrol results in decreased activity of CAT protein
resveratrol results in increased expression of CAT; resveratrol results in increased expression of CAT mRNA; resveratrol results in increased expression of CAT protein
CAT protein inhibits the reaction [Resveratrol results in decreased expression of SLC9A1 protein]; CAT protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP6 protein]; Resveratrol affects the reaction [sulfoxaflor results in decreased activity of CAT protein]; Resveratrol analog inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of CAT mRNA]; Resveratrol inhibits the reaction [1,2-Dimethylhydrazine results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in decreased expression of and results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [APP protein modified form results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of CAT protein]; Resveratrol inhibits the reaction [CCK protein results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Diazinon results in decreased expression of CAT protein]; Resveratrol inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased activity of CAT protein]; Resveratrol inhibits the reaction [Fluoxetine results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Gentamicins results in increased activity of CAT protein]; Resveratrol inhibits the reaction [Glucose results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of CAT protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of and results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of CAT mRNA]; Resveratrol inhibits the reaction [Triiodothyronine results in decreased activity of CAT protein]; Resveratrol promotes the reaction [Streptozocin results in decreased expression of CAT mRNA]; Resveratrol results in decreased expression of and results in increased activity of CAT protein; Resveratrol results in increased expression of and results in increased activity of CAT protein
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in decreased expression of CAT protein; [Resveratrol co-treated with Tetracyclines] inhibits the reaction [Paraquat results in decreased activity of CAT protein]; CAT protein affects the reaction [Resveratrol results in decreased expression of SLC9A1 mRNA]; CAT protein affects the reaction [Resveratrol results in decreased expression of SLC9A1 protein]; Resveratrol affects the reaction [Lead affects the activity of CAT protein]; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CAT protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Isoflurane results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased activity of CAT protein]; Resveratrol inhibits the reaction [Paraquat results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Smoke analog results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of CAT protein]; Resveratrol inhibits the reaction [Titanium results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]; Resveratrol promotes the reaction [Titanium results in increased expression of CAT mRNA]; SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]]
dorsomorphin inhibits the reaction [Resveratrol results in increased expression of CAT protein]; PRKN gene mutant form inhibits the reaction [Resveratrol results in increased expression of CAT mRNA]; Resveratrol inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [selenium-cisplatin conjugate results in decreased activity of CAT protein]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA]
resveratrol results in increased expression of CAT; resveratrol results in increased expression of CAT mRNA; resveratrol results in increased expression of CAT protein; resveratrol results in increased expression of CAT protein alternative form
resveratrol affects the expression of CAT mRNA 		CTD PMID:12797471 PMID:15748624 PMID:15930895 PMID:16169743 PMID:16269870 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Catip ciliogenesis associated TTC17 interacting protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CATIP mRNA CTD PMID:23557933 NCBI chr 9:83,395,095...83,402,743
Ensembl chr 9:83,394,896...83,402,740 		JBrowse link
G Catsper4 cation channel, sperm associated 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CATSPER4 mRNA CTD PMID:23557933 NCBI chr 5:151,711,415...151,731,083
Ensembl chr 5:151,711,194...151,730,750 		JBrowse link
G Cav1 caveolin 1 affects transport
decreases expression
multiple interactions
increases phosphorylation
increases response to substance
increases expression 		ISO
EXP 		CAV1 protein affects the transport of resveratrol
resveratrol results in decreased expression of CAV1 protein
Resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein]
resveratrol results in increased phosphorylation of CAV1 protein
[Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA; [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide; resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]
CAV1 protein results in increased susceptibility to resveratrol
resveratrol results in increased expression of CAV1 protein 		CTD PMID:18266981 PMID:18296501 PMID:19167446 PMID:19321006 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav3 caveolin 3 multiple interactions
increases expression 		EXP
ISO 		resveratrol inhibits the reaction [Streptozocin inhibits the reaction [CAV3 protein binds to SLC2A4 protein]]; resveratrol inhibits the reaction [Streptozocin results in decreased expression of CAV3 protein]
resveratrol results in increased expression of CAV3 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CAV3 mRNA 		CTD PMID:18266981 PMID:23557933 NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:147,137,797...147,153,967 		JBrowse link
G Cbarp CACN subunit beta associated regulatory protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CBARP mRNA CTD PMID:23557933 NCBI chr 7:10,217,314...10,225,855
Ensembl chr 7:10,217,328...10,225,854 		JBrowse link
G Cbfa2t3 CBFA2/RUNX1 partner transcriptional co-repressor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CBFA2T3 mRNA CTD PMID:23557933 NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136 		JBrowse link
G Cbfb core-binding factor subunit beta multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CBFB mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CBFB mRNA CTD PMID:19167446 PMID:23557933 NCBI chr19:49,955,133...50,002,661
Ensembl chr19:49,959,096...50,002,657 		JBrowse link
G Cbl Cbl proto-oncogene decreases expression ISO resveratrol results in decreased expression of CBL mRNA CTD PMID:25667456 NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067 		JBrowse link
G Cbr1 carbonyl reductase 1 multiple interactions
affects binding 		ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA]
[Resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 protein]
CBR1 protein binds to Resveratrol 		CTD PMID:24064738 PMID:24975222 PMID:31298478 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Cbr2 carbonyl reductase 2 increases expression ISO Resveratrol results in increased expression of CBR2 protein CTD PMID:25505154 NCBI chr10:106,508,964...106,511,614
Ensembl chr10:106,509,136...106,511,180 		JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO resveratrol results in increased expression of CBR3 protein CTD PMID:25505154 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558 		JBrowse link
G Cbs cystathionine beta synthase multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CBS mRNA
Resveratrol results in decreased expression of CBS mRNA 		CTD PMID:23557933 PMID:35577173 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Cbx1 chromobox 1 decreases expression EXP resveratrol results in decreased expression of CBX1 mRNA CTD PMID:25905778 NCBI chr10:82,266,746...82,286,431
Ensembl chr10:82,266,759...82,287,242 		JBrowse link
G Cbx5 chromobox 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA CTD PMID:19167446 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118 		JBrowse link
G Cbx6 chromobox 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CBX6 mRNA CTD PMID:23557933 NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413 		JBrowse link
G Cbx7 chromobox 7 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CBX7 mRNA; CBX7 protein inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; CBX7 protein inhibits the reaction [Resveratrol results in increased expression of CDKN2A protein]
Resveratrol results in decreased expression of CBX7 protein 		CTD PMID:23557933 PMID:32621571 NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346 		JBrowse link
G Ccar2 cell cycle and apoptosis regulator 2 affects response to substance
multiple interactions 		ISO CCAR2 protein affects the susceptibility to resveratrol
[resveratrol inhibits the reaction [CCAR2 protein binds to and results in decreased activity of SIRT1 protein]] which results in increased activity of SIRT1 protein; resveratrol inhibits the reaction [CCAR2 protein binds to and results in decreased activity of SIRT1 protein] 		CTD PMID:24252177 NCBI chr15:51,622,519...51,637,911
Ensembl chr15:51,622,464...51,637,774 		JBrowse link
G Ccdc106 coiled-coil domain containing 106 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC106 mRNA CTD PMID:23557933 NCBI chr 1:77,808,723...77,812,816
Ensembl chr 1:77,808,723...77,852,105 		JBrowse link
G Ccdc116 coiled-coil domain containing 116 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC116 mRNA CTD PMID:23557933 NCBI chr11:97,346,927...97,354,827
Ensembl chr11:97,346,675...97,354,824 		JBrowse link
G Ccdc117 coiled-coil domain containing 117 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CCDC117 mRNA] 		CTD PMID:19167446 PMID:31298478 NCBI chr14:84,614,282...84,623,648
Ensembl chr14:84,614,283...84,624,087 		JBrowse link
G Ccdc12 coiled-coil domain containing 12 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CCDC12 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC12 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:119,513,007...119,564,802
Ensembl chr 8:119,514,094...119,564,802 		JBrowse link
G Ccdc120 coiled-coil domain containing 120 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC120 mRNA CTD PMID:23557933 NCBI chr  X:17,437,219...17,443,716
Ensembl chr  X:17,425,624...17,444,717 		JBrowse link
G Ccdc127 coiled-coil domain containing 127 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC127 mRNA CTD PMID:23557933 NCBI chr 1:30,757,010...30,764,473
Ensembl chr 1:30,757,010...30,764,473 		JBrowse link
G Ccdc137 coiled-coil domain containing 137 decreases expression ISO resveratrol results in decreased expression of CCDC137 protein CTD PMID:25505154 NCBI chr10:106,229,099...106,235,502
Ensembl chr10:106,229,099...106,235,502 		JBrowse link
G Ccdc14 coiled-coil domain containing 14 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CCDC14 mRNA CTD PMID:19167446 NCBI chr11:79,557,267...79,593,128
Ensembl chr11:79,557,274...79,593,285 		JBrowse link
G Ccdc149 coiled-coil domain containing 149 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC149 mRNA CTD PMID:23557933 NCBI chr14:62,722,567...62,817,778
Ensembl chr14:62,722,600...62,817,777 		JBrowse link
G Ccdc15 coiled-coil domain containing 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC15 mRNA CTD PMID:23557933 NCBI chr 8:45,165,297...45,257,641
Ensembl chr 8:45,134,596...45,277,989 		JBrowse link
G Ccdc154 coiled-coil domain containing 154 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC154 mRNA CTD PMID:23557933 NCBI chr10:14,681,938...14,691,757
Ensembl chr10:14,681,923...14,691,759 		JBrowse link
G Ccdc18 coiled-coil domain containing 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC18 mRNA CTD PMID:23557933 NCBI chr14:1,646,725...1,752,581
Ensembl chr14:1,646,809...1,750,470 		JBrowse link
G Ccdc186 coiled-coil domain containing 186 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC186 mRNA CTD PMID:23557933 NCBI chr 1:265,840,429...265,878,082
Ensembl chr 1:265,843,039...265,877,131 		JBrowse link
G Ccdc191 coiled-coil domain containing 191 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC191 mRNA CTD PMID:23557933 NCBI chr11:70,241,562...70,312,288
Ensembl chr11:70,241,562...70,312,431 		JBrowse link
G Ccdc27 coiled-coil domain containing 27 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC27 mRNA CTD PMID:23557933 NCBI chr 5:169,867,706...169,881,820
Ensembl chr 5:169,867,709...169,881,888 		JBrowse link
G Ccdc28b coiled coil domain containing 28B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC28B mRNA CTD PMID:23557933 NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629 		JBrowse link
G Ccdc47 coiled-coil domain containing 47 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC47 mRNA CTD PMID:23557933 NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626 		JBrowse link
G Ccdc50 coiled-coil domain containing 50 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC50 mRNA CTD PMID:23557933 NCBI chr11:86,837,624...86,900,164
Ensembl chr11:86,837,624...86,899,980 		JBrowse link
G Ccdc70 coiled-coil domain containing 70 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC70 mRNA CTD PMID:23557933 NCBI chr16:76,739,795...76,745,019
Ensembl chr16:76,738,323...76,745,869 		JBrowse link
G Ccdc77 coiled-coil domain containing 77 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC77 mRNA CTD PMID:23557933 NCBI chr 4:155,206,402...155,238,235
Ensembl chr 4:155,193,275...155,239,207 		JBrowse link
G Ccdc78 coiled-coil domain containing 78 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC78 mRNA CTD PMID:23557933 NCBI chr10:15,312,403...15,316,800
Ensembl chr10:15,311,868...15,319,425 		JBrowse link
G Ccdc80 coiled-coil domain containing 80 decreases expression ISO Resveratrol results in decreased expression of CCDC80 mRNA CTD PMID:25888808 NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844 		JBrowse link
G Ccdc85a coiled-coil domain containing 85A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC85A mRNA CTD PMID:23557933 NCBI chr14:106,327,580...106,560,205
Ensembl chr14:106,327,580...106,560,165 		JBrowse link
G Ccdc85c coiled-coil domain containing 85C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC85C mRNA CTD PMID:23557933 NCBI chr 6:132,877,851...132,948,744
Ensembl chr 6:132,879,562...132,948,623 		JBrowse link
G Ccdc88a coiled coil domain containing 88A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC88A mRNA CTD PMID:23557933 NCBI chr14:107,304,654...107,456,104
Ensembl chr14:107,305,199...107,453,285 		JBrowse link
G Ccdc88b coiled-coil domain containing 88B increases expression ISO resveratrol results in increased expression of CCDC88B protein CTD PMID:25505154 NCBI chr 1:213,466,139...213,482,099
Ensembl chr 1:213,461,963...213,522,302 		JBrowse link
G Ccdc90b coiled-coil domain containing 90B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC90B mRNA CTD PMID:23557933 NCBI chr 1:156,045,192...156,058,750
Ensembl chr 1:156,045,138...156,061,403 		JBrowse link
G Ccdc92 coiled-coil domain containing 92 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC92 mRNA CTD PMID:23557933 NCBI chr12:37,457,676...37,484,080
Ensembl chr12:37,457,068...37,484,327 		JBrowse link
G Ccdc93 coiled-coil domain containing 93 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC93 mRNA CTD PMID:23557933 NCBI chr13:35,160,354...35,233,877
Ensembl chr13:35,160,363...35,233,875 		JBrowse link
G Ccdc97 coiled-coil domain containing 97 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC97 mRNA CTD PMID:23557933 NCBI chr 1:90,347,003...90,354,809
Ensembl chr 1:90,347,008...90,354,764 		JBrowse link
G Cck cholecystokinin multiple interactions EXP resveratrol inhibits the reaction [CCK protein results in decreased activity of CAT protein] CTD PMID:16499907 NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686 		JBrowse link
G Cckar cholecystokinin A receptor multiple interactions EXP resveratrol inhibits the reaction [8-sulfocholecystokinin octapeptide results in increased activity of CCKAR protein] CTD PMID:24630973 NCBI chr14:61,505,270...61,513,618
Ensembl chr14:61,505,270...61,513,618 		JBrowse link
G Cckbr cholecystokinin B receptor affects phosphorylation EXP resveratrol affects the phosphorylation of CCKBR protein CTD PMID:15134381 NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745 		JBrowse link
G Ccl1 C-C motif chemokine ligand 1 multiple interactions
decreases expression 		ISO
EXP 		resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CCL1]
resveratrol results in decreased expression of CCL1 protein 		CTD PMID:16679317 PMID:22507635 NCBI chr10:67,625,962...67,628,740
Ensembl chr10:67,625,962...67,628,790 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 decreases expression
decreases secretion
multiple interactions 		ISO resveratrol results in decreased expression of CCL11 protein
resveratrol results in decreased secretion of CCL11 protein
resveratrol results in decreased expression of CCL11 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL11 mRNA; Resveratrol inhibits the reaction [IL13 protein results in increased expression of CCL11 mRNA]; Resveratrol inhibits the reaction [IL13 protein results in increased secretion of CCL11 protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased secretion of CCL11 protein] 		CTD PMID:17872969 PMID:22254182 PMID:23557933 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 multiple interactions ISO resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL12 protein] CTD PMID:22118570 NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL17 mRNA CTD PMID:23557933 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases secretion
decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased secretion of CCL2 protein
resveratrol results in decreased expression of CCL2 mRNA; resveratrol results in decreased expression of CCL2 protein
resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]; resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA]; resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein]; resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein]; resveratrol inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA]; resveratrol inhibits the reaction [Streptozocin results in increased expression of CCL2 protein]
[Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; garcinol promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; garcinol promotes the reaction [Resveratrol results in decreased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; parthenolide inhibits the reaction [Resveratrol results in decreased expression of CCL2 mRNA]; Pertussis Toxin inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]; Pertussis Toxin inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]]; Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL2 protein]; Resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [Oxalic Acid results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Particulate Matter results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]
[Resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA; Resveratrol inhibits the reaction [Arginine results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Calcium Chloride results in increased phosphorylation of CCL2 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA]
resveratrol analog results in decreased expression of CCL2 mRNA; resveratrol results in decreased expression of CCL2 protein 		CTD PMID:15652768 PMID:15734790 PMID:16212921 PMID:16806235 PMID:17191021 More... NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases response to substance ISO resveratrol results in decreased susceptibility to CCL20 protein CTD PMID:21340626 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl21 C-C motif chemokine ligand 21 increases expression EXP resveratrol results in increased expression of CCL21 mRNA CTD PMID:25905778 NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540 		JBrowse link
G Ccl22 C-C motif chemokine ligand 22 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CCL22 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL22 mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359 		JBrowse link
G Ccl26 C-C motif chemokine ligand 26 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL26 mRNA
resveratrol results in increased expression of CCL26 mRNA 		CTD PMID:23557933 PMID:25888808 NCBI chr12:26,745,972...26,750,924 JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL3 mRNA; Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL3 protein]; Resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein]; Resveratrol inhibits the reaction [CCL3 protein affects the localization of Calcium]
resveratrol results in decreased expression of CCL3 mRNA
resveratrol results in decreased expression of CCL3 protein
[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL3 mRNA; resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein] 		CTD PMID:16212921 PMID:16806235 PMID:17872969 PMID:19284563 PMID:19346296 More... NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL4 mRNA
resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL4 protein] 		CTD PMID:16806235 PMID:24895526 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 decreases expression
multiple interactions 		ISO resveratrol analog results in decreased expression of CCL5 mRNA; resveratrol results in decreased expression of CCL5 protein
resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL5 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein]
resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL5 mRNA]; tin protoporphyrin IX inhibits the reaction [resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL5 mRNA]] 		CTD PMID:15652768 PMID:17872969 PMID:21807089 PMID:24041027 PMID:24707119 More... NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression ISO resveratrol results in increased expression of CCL7 mRNA CTD PMID:11588890 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 multiple interactions EXP [Resveratrol co-treated with Streptozocin] results in increased expression of CCL6 mRNA CTD PMID:25905778 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccn2 cellular communication network factor 2 affects expression
multiple interactions
decreases expression 		EXP
ISO 		Resveratrol affects the expression of CCN2 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CCN2 mRNA
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in decreased expression of CCN2 protein; Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]
Resveratrol results in decreased expression of CCN2 mRNA 		CTD PMID:17875610 PMID:23224687 PMID:23557933 PMID:26891083 PMID:31062909 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CCN5 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCN5 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna1 cyclin A1 increases expression ISO resveratrol results in increased expression of CCNA1 mRNA CTD PMID:12154049 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccna2 cyclin A2 increases expression
decreases expression 		ISO
EXP 		resveratrol metabolite results in increased expression of CCNA2 mRNA; resveratrol results in increased expression of CCNA2; resveratrol results in increased expression of CCNA2 protein
resveratrol results in decreased expression of CCNA2 protein
resveratrol results in decreased expression of CCNA2 mRNA; resveratrol results in decreased expression of CCNA2 protein 		CTD PMID:11481417 PMID:11507064 PMID:11895924 PMID:15583814 PMID:15767336 More... NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 increases expression
decreases expression
affects expression
multiple interactions 		ISO resveratrol results in increased expression of CCNB1 protein
resveratrol results in decreased expression of CCNB1 mRNA
resveratrol affects the expression of CCNB1 protein
resveratrol results in decreased expression of CCNB1 mRNA; resveratrol results in decreased expression of CCNB1 protein
[Coumestrol co-treated with Resveratrol] results in increased expression of CCNB1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CCNB1 mRNA; [Resveratrol co-treated with Temozolomide] results in increased expression of CCNB1 protein; Resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein]; Resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein] 		CTD PMID:11577002 PMID:11895924 PMID:12392819 PMID:17050787 PMID:18089832 More... NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of CCNB2 mRNA
resveratrol results in increased expression of CCNB2 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnc cyclin C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCNC mRNA CTD PMID:23557933 NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
increases expression
affects expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of CCND1 mRNA]; [2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with Resveratrol] results in decreased expression of CCND1 protein; [Benzo(a)pyrene co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [bisphenol A co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [Estradiol co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [Glucose co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [hexabromocyclododecane co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [Methoxychlor co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [nonylphenol co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [octylphenol co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCND1 mRNA; [Resveratrol co-treated with Clofarabine] results in decreased expression of CCND1 protein; [Resveratrol co-treated with nano-diamino-tetrac] inhibits the reaction [Thyroxine results in increased expression of CCND1 mRNA]; [Temozolomide co-treated with Resveratrol] results in decreased expression of CCND1 protein; acetylleucyl-leucyl-norleucinal inhibits the reaction [Resveratrol results in increased degradation of CCND1 protein]; FOXO1 protein affects the reaction [Resveratrol results in decreased expression of CCND1 protein]; FOXO3 protein affects the reaction [Resveratrol results in decreased expression of CCND1 protein]; FOXO4 protein affects the reaction [Resveratrol results in decreased expression of CCND1 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Resveratrol results in decreased expression of CCND1 mRNA]; nano-diamino-tetrac promotes the reaction [Resveratrol results in decreased expression of CCND1 mRNA]; Resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of CCND1 protein]; Resveratrol inhibits the reaction [Estradiol results in increased expression of CCND1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 mRNA]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CCND1 mRNA]; Resveratrol inhibits the reaction [STAT3 protein results in increased expression of CCND1 protein]; Resveratrol inhibits the reaction [Thyroxine results in increased expression of CCND1 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein]; Resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein]; Resveratrol results in decreased expression of and results in increased degradation of CCND1 protein; SUMO1 protein affects the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Resveratrol results in decreased expression of CCND1 mRNA]]; SUMO1 protein affects the reaction [Resveratrol results in decreased expression of CCND1 mRNA]
resveratrol results in decreased expression of CCND1 protein
resveratrol results in decreased expression of CCND1 mRNA; resveratrol results in decreased expression of CCND1 protein
Resveratrol inhibits the reaction [Acetaminophen results in decreased expression of CCND1 protein]; Resveratrol inhibits the reaction [Arginine results in increased expression of CCND1 mRNA]; Resveratrol inhibits the reaction [Arginine results in increased expression of CCND1 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of CCND1 mRNA]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of CCND1 protein]
resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 protein]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CCND1 mRNA]
resveratrol metabolite results in increased expression of CCND1 mRNA; resveratrol results in increased expression of CCND1 mRNA
resveratrol affects the expression of CCND1 protein
Resveratrol results in increased expression of CCND1 mRNA; Resveratrol results in increased expression of CCND1 protein
Resveratrol analog results in decreased expression of CCND1 mRNA; Resveratrol analog results in decreased expression of CCND1 protein; Resveratrol metabolite results in decreased expression of CCND1 protein; Resveratrol results in decreased expression of CCND1; Resveratrol results in decreased expression of CCND1 mRNA; Resveratrol results in decreased expression of CCND1 protein 		CTD PMID:9581680 PMID:11481417 PMID:11588890 PMID:11895924 PMID:12392819 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 decreases expression ISO resveratrol results in decreased expression of CCND2 protein
resveratrol results in decreased expression of CCND2 mRNA; resveratrol results in decreased expression of CCND2 protein 		CTD PMID:11588890 PMID:15122319 PMID:18347188 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO
EXP 		resveratrol results in decreased expression of CCND3 protein CTD PMID:18089832 PMID:22104698 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Ccne1 cyclin E1 affects expression
decreases expression
multiple interactions
increases expression 		ISO
EXP 		resveratrol affects the expression of CCNE1 protein
resveratrol results in decreased expression of CCNE1 protein
resveratrol inhibits the reaction [Glucose results in increased expression of CCNE1 protein]
resveratrol results in decreased expression of CCNE1 mRNA
resveratrol inhibits the reaction [TNF protein results in increased expression of CCNE1 protein]
resveratrol results in increased expression of CCNE1 protein 		CTD PMID:11481417 PMID:11507064 PMID:11577002 PMID:12392819 PMID:15670636 More... NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccne2 cyclin E2 decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of CCNE2 mRNA
resveratrol results in increased expression of CCNE2 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CCNE2 mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882 		JBrowse link
G Ccnf cyclin F decreases expression ISO resveratrol results in decreased expression of CCNF mRNA CTD PMID:24330398 NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837 		JBrowse link
G Ccng1 cyclin G1 affects expression
increases expression 		ISO resveratrol affects the expression of CCNG1 protein
resveratrol results in increased expression of CCNG1 mRNA 		CTD PMID:16081268 PMID:16369916 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccnk cyclin K decreases expression ISO resveratrol results in decreased expression of CCNK protein CTD PMID:25505154 NCBI chr 6:132,854,428...132,877,604
Ensembl chr 6:132,854,700...132,877,602 		JBrowse link
G Ccno cyclin O multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCNO mRNA CTD PMID:23557933 NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:46,350,717...46,367,113 		JBrowse link
G Ccnt1 cyclin T1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCNT1 mRNA CTD PMID:23557933 NCBI chr 7:131,566,176...131,596,988
Ensembl chr 7:131,566,176...131,596,938 		JBrowse link
G Ccnt2 cyclin T2 multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of CCNT2 mRNA
resveratrol results in increased expression of CCNT2 mRNA 		CTD PMID:19228061 PMID:23557933 NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488 		JBrowse link
G Ccp110 centriolar coiled-coil protein 110 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CCP110 mRNA CTD PMID:19167446 NCBI chr 1:182,475,571...182,504,235
Ensembl chr 1:182,476,422...182,504,232 		JBrowse link
G Ccpg1 cell cycle progression 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCPG1 mRNA CTD PMID:23557933 NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 multiple interactions ISO [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCR1 mRNA CTD PMID:16806235 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Ccr2 C-C motif chemokine receptor 2 decreases expression
multiple interactions 		ISO Resveratrol results in decreased expression of CCR2 mRNA; Resveratrol results in decreased expression of CCR2 protein
[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCR2 mRNA 		CTD PMID:16806235 PMID:17499741 NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059 		JBrowse link
G Ccr4 C-C motif chemokine receptor 4 multiple interactions ISO [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCR4 mRNA CTD PMID:16806235 NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642 		JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions ISO Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CCR5 mRNA] CTD PMID:30165701 NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594 		JBrowse link
G Ccr6 C-C motif chemokine receptor 6 decreases expression ISO resveratrol results in decreased expression of CCR6 mRNA; resveratrol results in decreased expression of CCR6 protein CTD PMID:21340626 NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions
affects expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCT2 mRNA
resveratrol affects the expression of CCT2 protein 		CTD PMID:23255428 PMID:23557933 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cct4 chaperonin containing TCP1 subunit 4 affects expression EXP resveratrol affects the expression of CCT4 mRNA CTD PMID:15748624 NCBI chr14:101,193,057...101,205,935
Ensembl chr14:101,192,772...101,205,770 		JBrowse link
G Cct5 chaperonin containing TCP1 subunit 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCT5 mRNA CTD PMID:23557933 NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:84,302,623...84,313,779 		JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CCT8 mRNA CTD PMID:23557933 NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328 		JBrowse link
G Cct8l2 chaperonin containing TCP1 subunit 8 like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCT8L1 mRNA CTD PMID:23557933 NCBI chr 4:10,338,882...10,340,818
Ensembl chr 4:10,336,884...10,344,906 		JBrowse link
G Cd14 CD14 molecule multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of CD14 mRNA; [Resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA; [Resveratrol co-treated with Lipopolysaccharides] results in increased expression of CD14 protein
resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CD14 protein]
resveratrol results in decreased expression of CD14 protein
resveratrol results in increased expression of CD14 protein 		CTD PMID:15135313 PMID:16267019 PMID:20035708 PMID:23557933 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd163 CD163 molecule multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CD163 mRNA CTD PMID:25905778 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd200r1l CD200 receptor 1-like multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CD200R1L mRNA CTD PMID:25905778 NCBI chr11:69,348,638...69,366,916
Ensembl chr11:69,312,691...69,365,041 		JBrowse link
G Cd209d CD209d molecule multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CD209 mRNA]
resveratrol results in decreased expression of CD209 protein 		CTD PMID:17938187 NCBI chr12:6,689,002...6,695,452
Ensembl chr12:6,689,002...6,698,976 		JBrowse link
G Cd24 CD24 molecule multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CD24 mRNA
resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CD24A protein] 		CTD PMID:19167446 PMID:20715097 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd274 CD274 molecule multiple interactions
decreases expression 		ISO [NSC 74859 co-treated with Resveratrol] results in decreased expression of PDL1 protein; [Resveratrol co-treated with nano-diamino-tetrac] inhibits the reaction [Thyroxine results in increased expression of PDL1 mRNA]; [Resveratrol co-treated with nano-diamino-tetrac] results in decreased expression of PDL1 mRNA; nano-diamino-tetrac promotes the reaction [Resveratrol results in decreased expression of PDL1 protein]; NSC 74859 promotes the reaction [Resveratrol results in decreased expression of PDL1 protein]; Resveratrol inhibits the reaction [Thyroxine results in increased expression of PDL1 mRNA]; Resveratrol inhibits the reaction [Thyroxine results in increased expression of PDL1 protein]
Resveratrol results in decreased expression of PDL1 mRNA; Resveratrol results in decreased expression of PDL1 protein 		CTD PMID:31336132 PMID:31883986 NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951 		JBrowse link
G Cd276 Cd276 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CD276 mRNA CTD PMID:23557933 NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505 		JBrowse link
G Cd2ap CD2-associated protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CD2AP mRNA CTD PMID:23557933 NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968 		JBrowse link
G Cd300lg Cd300 molecule-like family member G multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CD300LG mRNA CTD PMID:23557933 NCBI chr10:87,492,078...87,509,452
Ensembl chr10:87,492,106...87,508,585 		JBrowse link
G Cd34 CD34 molecule multiple interactions ISO Resveratrol affects the reaction [Doxorubicin results in decreased expression of CD34 protein] CTD PMID:36925030 NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315 		JBrowse link
G Cd36 CD36 molecule multiple interactions
decreases expression
increases expression 		ISO
EXP 		resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CD36 mRNA]
resveratrol results in decreased expression of CD36 mRNA
resveratrol results in decreased expression of CD36 protein
resveratrol results in increased expression of CD36 mRNA
resveratrol promotes the reaction [Dietary Fats results in increased expression of CD36 mRNA]
resveratrol inhibits the reaction [Dietary Fats affects the expression of CD36 mRNA]
resveratrol results in increased expression of CD36 mRNA; resveratrol results in increased expression of CD36 protein 		CTD PMID:17086191 PMID:17938187 PMID:21632075 PMID:21715682 PMID:23041272 More... NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd38 CD38 molecule increases expression ISO resveratrol results in increased expression of CD38 mRNA; resveratrol results in increased expression of CD38 protein CTD PMID:18089832 PMID:25888808 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions ISO
EXP 		resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD3E protein]
Resveratrol inhibits the reaction [sulfoxaflor results in increased expression of CD3E mRNA]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CD3E mRNA 		CTD PMID:20715097 PMID:23557933 PMID:33733559 NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876 		JBrowse link
G Cd4 Cd4 molecule multiple interactions
increases expression 		ISO [Resveratrol co-treated with beta-1,3-glucan] results in increased expression of CD4 protein; [Resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD4 mRNA; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CD4 protein]
resveratrol results in increased expression of CD4 protein 		CTD PMID:16806235 PMID:17690738 PMID:20715097 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Cd40 CD40 molecule multiple interactions EXP
ISO 		resveratrol inhibits the reaction [Cholesterol, Dietary results in increased expression of CD40 protein]
prolinedithiocarbamate promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CD40 mRNA]]; prolinedithiocarbamate promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CD40 protein]]; resveratrol inhibits the reaction [TNF protein results in increased expression of CD40 mRNA]; resveratrol promotes the reaction [prolinedithiocarbamate inhibits the reaction [TNF protein results in increased expression of CD40 mRNA]]; resveratrol promotes the reaction [prolinedithiocarbamate inhibits the reaction [TNF protein results in increased expression of CD40 protein]] 		CTD PMID:21574786 PMID:22717288 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd40lg CD40 ligand multiple interactions EXP resveratrol inhibits the reaction [Cholesterol, Dietary results in increased expression of CD40LG protein] CTD PMID:21574786 NCBI chr  X:140,164,341...140,176,057
Ensembl chr  X:140,164,302...140,176,475 		JBrowse link
G Cd44 CD44 molecule multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD44 protein]
resveratrol results in decreased expression of CD44 protein
[Coumestrol co-treated with Resveratrol] results in increased expression of CD44 mRNA; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] 		CTD PMID:19047049 PMID:19167446 PMID:20715097 PMID:22692956 PMID:25505154 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd46 CD46 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CD46 mRNA CTD PMID:23557933 NCBI chr13:109,104,122...109,134,903 JBrowse link
G Cd47 Cd47 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CD47 mRNA CTD PMID:23557933 NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272 		JBrowse link
G Cd53 Cd53 molecule multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CD53 mRNA CTD PMID:25905778 NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593 		JBrowse link
G Cd5l Cd5 molecule-like multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CD5L mRNA CTD PMID:25905778 NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926 		JBrowse link
G Cd63 Cd63 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CD63 mRNA CTD PMID:23557933 NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938 		JBrowse link
G Cd68 Cd68 molecule multiple interactions ISO
EXP 		[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD68 mRNA; resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CD68 mRNA]
[resveratrol co-treated with Streptozocin] results in increased expression of CD68 mRNA 		CTD PMID:16806235 PMID:21530968 PMID:25905778 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd69 Cd69 molecule increases expression
decreases expression 		ISO resveratrol results in increased expression of CD69 protein
resveratrol results in decreased expression of CD69 protein 		CTD PMID:17088997 PMID:21807089 NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:164,411,485...164,419,509 		JBrowse link
G Cd7 Cd7 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CD7 mRNA CTD PMID:23557933 NCBI chr10:106,802,373...106,805,269
Ensembl chr10:106,802,383...106,805,294 		JBrowse link
G Cd72 Cd72 molecule decreases expression ISO resveratrol results in decreased expression of CD72 mRNA CTD PMID:20730501 NCBI chr 5:62,493,155...62,500,779
Ensembl chr 5:62,493,161...62,500,519 		JBrowse link
G Cd74 CD74 molecule increases expression ISO resveratrol results in increased expression of CD74 protein CTD PMID:25505154 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd80 Cd80 molecule decreases expression ISO resveratrol results in decreased expression of CD80 mRNA; resveratrol results in decreased expression of CD80 protein CTD PMID:14996416 PMID:22962611 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd81 Cd81 molecule multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CD81 mRNA CTD PMID:23557933 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092 		JBrowse link
G Cd86 CD86 molecule multiple interactions
increases expression
decreases expression 		ISO
EXP 		[resveratrol co-treated with Lipopolysaccharides] results in increased expression of CD86 protein
resveratrol results in increased expression of CD86 mRNA; resveratrol results in increased expression of CD86 protein
[resveratrol co-treated with Streptozocin] results in increased expression of CD86 mRNA
resveratrol results in decreased expression of CD86 mRNA; resveratrol results in decreased expression of CD86 protein 		CTD PMID:14996416 PMID:15135313 PMID:15827377 PMID:22962611 PMID:25905778 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cd8a CD8 subunit alpha multiple interactions ISO resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CD8A protein] CTD PMID:20715097 NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358 		JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDADC1 mRNA CTD PMID:23557933 NCBI chr15:37,902,789...37,934,853
Ensembl chr15:37,886,258...37,931,920 		JBrowse link
G Cdc123 cell division cycle 123 decreases expression ISO resveratrol results in decreased expression of CDC123 mRNA CTD PMID:12002526 NCBI chr17:77,368,376...77,412,659
Ensembl chr17:77,368,397...77,412,659 		JBrowse link
G Cdc23 cell division cycle 23 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC23 mRNA CTD PMID:23557933 NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646 		JBrowse link
G Cdc25a cell division cycle 25A multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of CDC25A mRNA
Resveratrol results in decreased expression of CDC25A mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188 		JBrowse link
G Cdc25b cell division cycle 25B decreases expression ISO resveratrol results in decreased expression of CDC25B protein CTD PMID:18089832 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions
decreases expression
increases phosphorylation 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of CDC25C mRNA; [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein; Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDC25C protein]
Resveratrol results in decreased expression of CDC25C mRNA 		CTD PMID:15975956 PMID:19167446 PMID:33775663 NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292 		JBrowse link
G Cdc26 cell division cycle 26 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC26 mRNA CTD PMID:23557933 NCBI chr 5:80,861,658...80,875,326
Ensembl chr 5:80,861,659...80,875,326 		JBrowse link
G Cdc27 cell division cycle 27 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CDC27 protein
resveratrol results in decreased expression of CDC27 mRNA; resveratrol results in decreased expression of CDC27 protein
[Coumestrol co-treated with Resveratrol] results in increased expression of CDC27 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC27 mRNA 		CTD PMID:15767336 PMID:18089832 PMID:19167446 PMID:23557933 PMID:25505154 NCBI chr10:89,900,676...89,949,770
Ensembl chr10:89,900,684...89,949,770 		JBrowse link
G Cdc40 cell division cycle 40 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC40 mRNA CTD PMID:23557933 NCBI chr20:45,855,739...45,908,239
Ensembl chr20:45,855,739...45,907,978 		JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [resveratrol co-treated with beta-1,3-glucan] results in increased expression of CDC42 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 protein]
resveratrol promotes the reaction [CDC42 protein binds to Guanosine Triphosphate]; resveratrol results in increased activity of and affects the localization of CDC42 protein 		CTD PMID:15217905 PMID:17690738 PMID:24659233 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC42BPB mRNA CTD PMID:23557933 NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570 		JBrowse link
G Cdc42ep5 CDC42 effector protein 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDC42EP5 mRNA CTD PMID:23557933 NCBI chr 1:79,108,036...79,110,550 JBrowse link
G Cdc45 cell division cycle 45 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CDC45 mRNA CTD PMID:19167446 NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981 		JBrowse link
G Cdc5l cell division cycle 5-like decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CDC5L protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CDC5L mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 9:23,062,397...23,100,901
Ensembl chr 9:23,062,205...23,100,899 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CDC6 mRNA
[Coumestrol co-treated with Resveratrol] results in increased expression of CDC6 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC6 mRNA 		CTD PMID:15767336 PMID:19167446 PMID:23557933 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241 		JBrowse link
G Cdc7 cell division cycle 7 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDC7 mRNA CTD PMID:19167446 NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656 		JBrowse link
G Cdc73 cell division cycle 73 decreases expression EXP resveratrol results in decreased expression of CDC73 mRNA CTD PMID:25905778 NCBI chr13:57,897,924...58,000,031
Ensembl chr13:57,883,983...57,999,978 		JBrowse link
G Cdca2 cell division cycle associated 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA2 mRNA CTD PMID:19167446 NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639 		JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA3 mRNA CTD PMID:19167446 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca4 cell division cycle associated 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA4 mRNA CTD PMID:19167446 NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580 		JBrowse link
G Cdca5 cell division cycle associated 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA5 mRNA CTD PMID:19167446 NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309 		JBrowse link
G Cdca7l cell division cycle associated 7 like multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA7L mRNA CTD PMID:19167446 NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843 		JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDCA8 mRNA
resveratrol results in increased expression of CDCA8 mRNA 		CTD PMID:19167446 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283 		JBrowse link
G Cdcp2 CUB domain containing protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDCP2 mRNA CTD PMID:23557933 NCBI chr 5:127,106,380...127,124,243
Ensembl chr 5:127,106,345...127,123,027 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
increases expression
decreases expression 		ISO Resveratrol inhibits the reaction [Cadmium results in decreased expression of CDH1 protein]; Resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CDH1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of CDH1 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of CDH1 protein]; Resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; Resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]
resveratrol results in increased expression of CDH1 mRNA; resveratrol results in increased expression of CDH1 protein
resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of CDH1 protein]
resveratrol results in decreased expression of CDH1 protein 		CTD PMID:18089832 PMID:20637737 PMID:20706672 PMID:22692956 PMID:23146760 More... NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh12 cadherin 12 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDH12 mRNA CTD PMID:19167446 NCBI chr 2:72,201,859...73,436,039
Ensembl chr 2:72,886,532...73,436,039 		JBrowse link
G Cdh15 cadherin 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDH15 mRNA CTD PMID:23557933 NCBI chr19:67,812,169...67,834,986
Ensembl chr19:67,812,164...67,834,985 		JBrowse link
G Cdh16 cadherin 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDH16 mRNA CTD PMID:23557933 NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934 		JBrowse link
G Cdh2 cadherin 2 increases expression
decreases expression
multiple interactions 		ISO resveratrol results in increased expression of CDH2 protein
Resveratrol results in decreased expression of CDH2 mRNA; Resveratrol results in decreased expression of CDH2 protein
Resveratrol inhibits the reaction [Cadmium results in increased expression of CDH2 protein]; Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of CDH2 mRNA]; Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of CDH2 protein] 		CTD PMID:22692956 PMID:23992306 PMID:24330398 PMID:34488496 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh22 cadherin 22 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDH22 mRNA CTD PMID:23557933 NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:174,264,869...174,390,142 		JBrowse link
G Cdh23 cadherin-related 23 increases expression ISO resveratrol results in increased expression of CDH23 mRNA CTD PMID:25888808 NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332 		JBrowse link
G Cdh5 cadherin 5 affects localization
multiple interactions 		ISO resveratrol affects the localization of CDH5 protein
NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of CDH5 protein]]; resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of CDH5 protein] 		CTD PMID:14573751 PMID:22314268 PMID:25979658 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdh6 cadherin 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDH6 mRNA CTD PMID:23557933 NCBI chr 2:63,801,630...63,952,309
Ensembl chr 2:63,806,135...63,952,287 		JBrowse link
G Cdhr2 cadherin-related family member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDHR2 mRNA CTD PMID:23557933 NCBI chr17:9,881,979...9,917,698
Ensembl chr17:9,881,979...9,917,698 		JBrowse link
G Cdip1 cell death-inducing p53 target 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDIP1 mRNA CTD PMID:23557933 NCBI chr10:11,278,213...11,303,415
Ensembl chr10:11,293,827...11,303,415 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions
increases phosphorylation
decreases expression
increases expression
affects expression
affects phosphorylation 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA; [temozolomide co-treated with resveratrol] results in decreased phosphorylation of CDK1 protein; Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDK1 protein]; resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein]; resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein]
resveratrol results in decreased expression of CDK1 mRNA; resveratrol results in decreased expression of CDK1 protein
resveratrol results in increased expression of CDK1 mRNA; resveratrol results in increased expression of CDK1 protein
resveratrol affects the expression of CDK1 protein
resveratrol affects the phosphorylation of CDK1 protein 		CTD PMID:11577002 PMID:12392819 PMID:15134381 PMID:15767336 PMID:15975956 More... NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk10 cyclin-dependent kinase 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDK10 mRNA CTD PMID:23557933 NCBI chr19:68,168,040...68,184,923
Ensembl chr19:68,169,874...68,177,599 		JBrowse link
G Cdk12 cyclin-dependent kinase 12 affects phosphorylation ISO resveratrol affects the phosphorylation of CDK12 protein CTD PMID:25311616 NCBI chr10:83,697,174...83,793,676
Ensembl chr10:83,767,206...83,777,183
Ensembl chr10:83,767,206...83,777,183 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression
decreases activity
increases expression 		ISO
EXP 		[bisphenol A co-treated with resveratrol] results in decreased expression of CDK2 mRNA; [Estradiol co-treated with resveratrol] results in decreased expression of CDK2 mRNA; [hexabromocyclododecane co-treated with resveratrol] results in decreased expression of CDK2 mRNA; [Methoxychlor co-treated with resveratrol] results in decreased expression of CDK2 mRNA; [nonylphenol co-treated with resveratrol] results in decreased expression of CDK2 mRNA; [octylphenol co-treated with resveratrol] results in decreased expression of CDK2 mRNA; resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK2 protein]; resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]]
resveratrol results in decreased expression of CDK2 protein
resveratrol results in decreased expression of CDK2 mRNA; resveratrol results in decreased expression of CDK2 protein
resveratrol results in decreased activity of CDK2 protein
resveratrol results in increased expression of CDK2 		CTD PMID:11507064 PMID:12690110 PMID:15122319 PMID:15583814 PMID:16317118 More... NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk20 cyclin-dependent kinase 20 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDK20 mRNA CTD PMID:23557933 NCBI chr17:706,863...717,828
Ensembl chr17:706,865...713,567 		JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDK2AP2 mRNA CTD PMID:23557933 NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions
decreases expression
affects expression 		ISO resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein]; resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK4 protein]; resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]]; resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein]; resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein]
resveratrol results in decreased expression of CDK4 mRNA; resveratrol results in decreased expression of CDK4 protein
resveratrol affects the expression of CDK4 protein 		CTD PMID:11481417 PMID:12392819 PMID:12569576 PMID:15122319 PMID:16317118 More... NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5 cyclin-dependent kinase 5 multiple interactions
decreases activity 		ISO
EXP 		resveratrol inhibits the reaction [TNF protein results in increased activity of CDK5 protein]; resveratrol results in decreased expression of and results in decreased activity of CDK5 protein
resveratrol results in decreased activity of CDK5 protein
[resveratrol results in decreased expression of CDK5R1 protein] which results in decreased activity of CDK5 protein 		CTD PMID:21736731 PMID:23129026 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777 		JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 multiple interactions
decreases expression 		ISO
EXP 		[U 0126 co-treated with Resveratrol] results in decreased expression of CDK5R1 mRNA; pyrazolanthrone inhibits the reaction [Resveratrol results in decreased expression of CDK5R1 mRNA]; Resveratrol inhibits the reaction [CDK5R1 protein results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [CDK5R1 protein results in increased expression of and results in increased acetylation of TRP53 protein]; Resveratrol inhibits the reaction [CDK5R1 protein results in increased expression of GFAP protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CDK5R1 mRNA]; SB 203580 inhibits the reaction [Resveratrol results in decreased expression of CDK5R1 mRNA]
[resveratrol results in decreased expression of CDK5R1 protein] which results in decreased activity of CDK5 protein
resveratrol results in decreased expression of CDK5R1 mRNA; resveratrol results in decreased expression of CDK5R1 protein 		CTD PMID:17581637 PMID:21736731 NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272 		JBrowse link
G Cdk5r2 cyclin-dependent kinase 5 regulatory subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDK5R2 mRNA CTD PMID:23557933 NCBI chr 9:83,864,922...83,866,390
Ensembl chr 9:83,864,726...83,867,618 		JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CDK5RAP2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CDK5RAP2 mRNA
resveratrol results in increased expression of CDK5RAP2 mRNA 		CTD PMID:19167446 PMID:23557933 PMID:25436977 NCBI chr 5:88,807,402...88,976,005
Ensembl chr 5:88,807,402...88,976,069 		JBrowse link
G Cdk5rap3 CDK5 regulatory subunit associated protein 3 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDK5RAP3 mRNA
resveratrol results in increased expression of CDK5RAP3 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr10:82,390,845...82,402,814
Ensembl chr10:82,390,845...82,400,001 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of CDK6 protein
resveratrol results in decreased expression of CDK6 mRNA; resveratrol results in decreased expression of CDK6 protein
resveratrol results in increased expression of CDK6 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CDK6 mRNA 		CTD PMID:15122319 PMID:16761963 PMID:18347188 PMID:23557933 PMID:23750556 More... NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdk8 cyclin-dependent kinase 8 increases expression ISO resveratrol results in increased expression of CDK8 mRNA CTD PMID:18586690 NCBI chr12:13,851,024...13,919,017
Ensembl chr12:13,851,024...13,917,992 		JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CDKL5 mRNA CTD PMID:19167446 NCBI chr  X:37,566,320...37,796,766
Ensembl chr  X:37,566,378...37,796,760 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression
increases expression
multiple interactions
increases activity
affects expression 		ISO
EXP 		Resveratrol results in decreased expression of CDKN1A; Resveratrol results in decreased expression of CDKN1A mRNA
resveratrol results in decreased expression of CDKN1A mRNA; resveratrol results in decreased expression of CDKN1A protein
Resveratrol analog results in increased expression of CDKN1A protein; Resveratrol metabolite results in increased expression of CDKN1A protein; Resveratrol results in increased expression of CDKN1A mRNA; Resveratrol results in increased expression of CDKN1A protein
[Resveratrol co-treated with Dietary Fats] results in increased expression of CDKN1A protein; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]
resveratrol results in increased activity of CDKN1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Resveratrol co-treated with Clofarabine] results in decreased expression of CDKN1A protein]; [Benzo(a)pyrene co-treated with Resveratrol] results in increased expression of CDKN1A mRNA; [Doxorubicin co-treated with Resveratrol] results in increased expression of CDKN1A mRNA; [Doxorubicin co-treated with Resveratrol] results in increased expression of CDKN1A protein; [Mitomycin co-treated with Resveratrol] results in increased expression of CDKN1A; [Resveratrol co-treated with Clofarabine] results in decreased expression of CDKN1A protein; [Resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]] which results in increased expression of CDKN1A mRNA; [Resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to CDKN1A promoter]; [Resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein] which results in increased expression of CDKN1A mRNA; [Resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of CDKN1A protein; Cladribine promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; Cycloheximide inhibits the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; Decitabine promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; fludarabine promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; HRAS protein promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; pifithrin inhibits the reaction [Resveratrol results in increased expression of CDKN1A mRNA]; Resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Etoposide results in increased expression of CDKN1A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CDKN1A mRNA]; Resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Vincristine results in increased expression of CDKN1A mRNA]; Resveratrol promotes the reaction [Cladribine results in increased expression of CDKN1A mRNA]; Resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]; Resveratrol promotes the reaction [fludarabine results in increased expression of CDKN1A mRNA]; Resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]]; Resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]]; Resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A mRNA]; Resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A protein]; Resveratrol promotes the reaction [TP53 protein binds to CDKN1A promoter]; TP53 protein promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]
Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; TP53 protein promotes the reaction [Resveratrol results in increased expression of CDKN1A mRNA]
resveratrol affects the expression of CDKN1A protein 		CTD PMID:11889192 PMID:12131363 PMID:12154049 PMID:12392819 PMID:12690110 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of CDKN1B mRNA; [Resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein; FOXO1 protein affects the reaction [Resveratrol results in increased expression of CDKN1B protein]; FOXO3 protein affects the reaction [Resveratrol results in increased expression of CDKN1B protein]; FOXO4 protein affects the reaction [Resveratrol results in increased expression of CDKN1B protein]; Resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein]; Resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; Resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter]
resveratrol results in decreased expression of CDKN1B mRNA
resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]
resveratrol results in increased expression of CDKN1B mRNA; resveratrol results in increased expression of CDKN1B protein 		CTD PMID:15829497 PMID:16761963 PMID:17050787 PMID:17088997 PMID:17513867 More... NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C increases expression ISO resveratrol results in increased expression of CDKN1C mRNA CTD PMID:12569576 PMID:20878097 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A decreases expression
multiple interactions
increases expression 		ISO resveratrol results in decreased expression of CDKN2A mRNA
CBX7 protein inhibits the reaction [Resveratrol results in increased expression of CDKN2A protein]; PARP1 protein affects the reaction [Resveratrol results in increased expression of CDKN2A protein] 		CTD PMID:17804521 PMID:25533949 PMID:32621571 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CDKN2B mRNA
resveratrol results in increased expression of CDKN2B mRNA 		CTD PMID:19167446 PMID:25888808 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO resveratrol results in decreased expression of CDKN2C protein CTD PMID:23525482 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDKN3 mRNA
resveratrol results in increased expression of CDKN3 mRNA 		CTD PMID:19167446 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CDR2 mRNA CTD PMID:23557933 NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863 		JBrowse link
G Cdsn corneodesmosin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CDSN mRNA CTD PMID:23557933 NCBI chr20:3,184,142...3,188,962
Ensembl chr20:3,183,808...3,188,962 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDT1 mRNA CTD PMID:19167446 NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194 		JBrowse link
G Cdv3 carnitine deficiency-associated gene expressed in ventricle 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA CTD PMID:19167446 NCBI chr 8:112,812,898...112,826,073
Ensembl chr 8:112,813,952...112,826,056 		JBrowse link
G Cdx1 caudal type homeo box 1 decreases expression ISO resveratrol results in decreased expression of CDX1 mRNA CTD PMID:20878097 NCBI chr18:56,742,970...56,761,299
Ensembl chr18:56,742,984...56,761,299 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 increases expression ISO resveratrol results in increased expression of CEACAM1 mRNA CTD PMID:15280659 PMID:25888808 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam19 CEA cell adhesion molecule 19 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CEACAM19 mRNA CTD PMID:23557933 NCBI chr 1:88,670,054...88,678,900
Ensembl chr 1:88,670,054...88,678,874 		JBrowse link
G Ceacam20 CEA cell adhesion molecule 20 multiple interactions ISO Resveratrol affects the reaction [sodium arsenate affects the expression of CEACAM20 protein] CTD PMID:37797956 NCBI chr 1:88,750,010...88,771,679
Ensembl chr 1:88,750,000...88,772,779 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression ISO resveratrol metabolite results in decreased expression of CEBPA mRNA; resveratrol results in decreased expression of CEBPA mRNA; resveratrol results in decreased expression of CEBPA protein CTD PMID:22935344 PMID:22945685 PMID:23525482 PMID:25338179 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression 		ISO resveratrol promotes the reaction [Lipopolysaccharides results in increased expression of CEBPB protein]
resveratrol metabolite results in decreased expression of CEBPB mRNA; resveratrol results in decreased expression of CEBPB mRNA; resveratrol results in decreased expression of CEBPB protein 		CTD PMID:17316017 PMID:22945685 PMID:24036142 PMID:25338179 PMID:25505154 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions
increases expression
decreases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CEBPD mRNA
resveratrol results in increased expression of CEBPD mRNA
resveratrol results in decreased expression of CEBPD mRNA 		CTD PMID:15280659 PMID:19371625 PMID:25905778 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma multiple interactions ISO resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPG mRNA]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPG protein] CTD PMID:17316017 NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283 		JBrowse link
G Cel carboxyl ester lipase decreases expression
decreases activity
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of CEL mRNA
resveratrol results in decreased activity of CEL protein
resveratrol results in decreased expression of and results in decreased secretion of and results in decreased activity of CEL protein 		CTD PMID:16099206 NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:32,281,518...32,289,019 		JBrowse link
G Cela2a chymotrypsin like elastase 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CELA2A mRNA CTD PMID:23557933 NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208 		JBrowse link
G Celf3 CUGBP, Elav-like family member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CELF3 mRNA CTD PMID:23557933 NCBI chr 2:184,805,078...184,819,189
Ensembl chr 2:184,805,081...184,819,187 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CELF5 mRNA CTD PMID:23557933 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CELSR2 mRNA CTD PMID:19167446 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CELSR3 mRNA CTD PMID:23557933 NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:118,409,136...118,436,847 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CEMIP mRNA CTD PMID:23557933 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768 		JBrowse link
G Cend1 cell cycle exit and neuronal differentiation 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CEND1 mRNA CTD PMID:23557933 NCBI chr 1:205,954,713...205,957,710
Ensembl chr 1:205,953,197...205,957,944 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPA mRNA CTD PMID:19167446 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpe centromere protein E decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CENPE mRNA
[Coumestrol co-treated with Resveratrol] results in increased expression of CENPE mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CENPE mRNA 		CTD PMID:15767336 PMID:19167446 PMID:23557933 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cenpf centromere protein F decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CENPF mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CENPF mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cenph centromere protein H multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA CTD PMID:19167446 NCBI chr 2:33,630,738...33,644,258
Ensembl chr 2:33,630,738...33,644,242 		JBrowse link
G Cenpl centromere protein L multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPL mRNA CTD PMID:19167446 NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250 		JBrowse link
G Cenpm centromere protein M increases expression
multiple interactions 		ISO resveratrol results in increased expression of CENPM mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CENPM mRNA 		CTD PMID:19167446 NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866 		JBrowse link
G Cenpn centromere protein N multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CENPN mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CENPN mRNA CTD PMID:19167446 PMID:23557933 NCBI chr19:61,880,101...61,902,850
Ensembl chr19:61,877,148...61,902,918 		JBrowse link
G Cenpo centromere protein O multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CENPO mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CENPO mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853 		JBrowse link
G Cenpq centromere protein Q multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPQ mRNA CTD PMID:19167446 NCBI chr 9:27,454,339...27,469,371
Ensembl chr 9:27,454,252...27,469,366 		JBrowse link
G Cenps centromere protein S multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPS mRNA CTD PMID:19167446 NCBI chr 5:164,847,009...164,856,705 JBrowse link
G Cenpu centromere protein U multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPU mRNA CTD PMID:19167446 NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662 		JBrowse link
G Cenpw centromere protein W multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPW mRNA CTD PMID:19167446 NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109 		JBrowse link
G Cep120 centrosomal protein 120 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP120 mRNA CTD PMID:23557933 NCBI chr18:49,326,266...49,388,380
Ensembl chr18:49,326,266...49,388,243 		JBrowse link
G Cep128 centrosomal protein 128 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CEP128 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP128 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:115,681,712...116,057,167 		JBrowse link
G Cep135 centrosomal protein 135 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP135 mRNA CTD PMID:23557933 NCBI chr14:31,884,774...31,950,050
Ensembl chr14:31,884,781...31,950,050 		JBrowse link
G Cep152 centrosomal protein 152 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA
resveratrol results in increased expression of CEP152 mRNA 		CTD PMID:19167446 NCBI chr 3:133,243,979...133,332,271
Ensembl chr 3:133,263,174...133,331,655
Ensembl chr 3:133,263,174...133,331,655 		JBrowse link
G Cep162 centrosomal protein 162 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP162 mRNA CTD PMID:23557933 NCBI chr 8:97,029,677...97,088,243
Ensembl chr 8:97,029,677...97,088,207 		JBrowse link
G Cep20 centrosomal protein 20 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP20 mRNA CTD PMID:23557933 NCBI chr10:1,221,294...1,243,144
Ensembl chr10:1,221,371...1,245,241 		JBrowse link
G Cep290 centrosomal protein 290 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP290 mRNA CTD PMID:23557933 NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955 		JBrowse link
G Cep295 centrosomal protein 295 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP295 mRNA CTD PMID:23557933 NCBI chr 8:20,437,967...20,475,968
Ensembl chr 8:20,437,338...20,476,115 		JBrowse link
G Cep350 centrosomal protein 350 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP350 mRNA CTD PMID:23557933 NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673 		JBrowse link
G Cep43 centrosomal protein 43 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP43 mRNA CTD PMID:23557933 NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:55,082,712...55,111,509 		JBrowse link
G Cep55 centrosomal protein 55 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA CTD PMID:19167446 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890 		JBrowse link
G Cep57 centrosomal protein 57 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP57 mRNA
resveratrol results in increased expression of CEP57 mRNA 		CTD PMID:19167446 NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890 		JBrowse link
G Cep78 centrosomal protein 78 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP78 mRNA CTD PMID:19167446 NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120 		JBrowse link
G Cep83 centrosomal protein 83 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP83 mRNA CTD PMID:23557933 NCBI chr 7:31,167,198...31,276,513
Ensembl chr 7:31,167,216...31,276,716 		JBrowse link
G Cep85 centrosomal protein 85 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP85 mRNA CTD PMID:23557933 NCBI chr 5:151,640,316...151,687,891
Ensembl chr 5:151,639,282...151,687,860 		JBrowse link
G Cep85l centrosomal protein 85-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP85L mRNA CTD PMID:23557933 NCBI chr20:33,111,114...33,282,182
Ensembl chr20:33,115,438...33,282,238 		JBrowse link
G Cep95 centrosomal protein 95 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CEP95 mRNA CTD PMID:23557933 NCBI chr10:92,231,829...92,259,813
Ensembl chr10:92,231,512...92,259,810 		JBrowse link
G Cerk ceramide kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CERK mRNA CTD PMID:23557933 NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570 		JBrowse link
G Cers1 ceramide synthase 1 increases expression ISO resveratrol results in increased expression of CERS1 mRNA CTD PMID:20401667 NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480 		JBrowse link
G Cers2 ceramide synthase 2 increases expression ISO resveratrol results in increased expression of CERS2 mRNA CTD PMID:20401667 NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839 		JBrowse link
G Cers4 ceramide synthase 4 increases expression ISO resveratrol results in increased expression of CERS4 mRNA CTD PMID:20401667 NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070 		JBrowse link
G Cers5 ceramide synthase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CERS5 mRNA CTD PMID:23557933 NCBI chr 7:132,738,834...132,776,920
Ensembl chr 7:132,738,834...132,776,786 		JBrowse link
G Cers6 ceramide synthase 6 increases expression ISO resveratrol results in increased expression of CERS6 mRNA CTD PMID:20401667 NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544 		JBrowse link
G Cert1 ceramide transporter 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CERT1 mRNA CTD PMID:23557933 NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729 		JBrowse link
G Ces1c carboxylesterase 1C affects expression EXP Resveratrol affects the expression of CES1C mRNA CTD PMID:15748624 NCBI chr19:30,099,383...30,128,531
Ensembl chr19:30,099,323...30,128,528 		JBrowse link
G Ces2c carboxylesterase 2C multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CES2C mRNA CTD PMID:25905778 NCBI chr 1:270,377,201...270,384,768
Ensembl chr 1:270,374,913...270,384,801 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CES2H mRNA] CTD PMID:31298478 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Ces3a carboxylesterase 3a multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of CES3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CES3 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CES3B mRNA] 		CTD PMID:23557933 PMID:26667767 PMID:31298478 NCBI chr19:49,902,312...49,910,484 JBrowse link
G Cfap107 cilia and flagella associated protein 107 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CFAP107 mRNA CTD PMID:23557933 NCBI chr 5:161,495,655...161,514,751
Ensembl chr 5:161,495,655...161,514,751 		JBrowse link
G Cfap276 cilia and flagella associated protein 276 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CFAP276 mRNA CTD PMID:23557933 NCBI chr 2:198,854,129...198,871,406
Ensembl chr 2:198,854,129...198,866,036 		JBrowse link
G Cfap36 cilia and flagella associated protein 36 increases expression ISO resveratrol results in increased expression of CFAP36 protein CTD PMID:25505154 NCBI chr14:107,166,932...107,192,531
Ensembl chr14:107,166,947...107,192,406 		JBrowse link
G Cfap410 cilia and flagella associated protein 410 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CFAP410 mRNA CTD PMID:23557933 NCBI chr20:10,687,506...10,694,366
Ensembl chr20:10,687,506...10,694,366 		JBrowse link
G Cfap44 cilia and flagella associated protein 44 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CFAP44 mRNA CTD PMID:23557933 NCBI chr11:69,704,997...69,789,998
Ensembl chr11:69,705,719...69,789,905 		JBrowse link
G Cfap57 cilia and flagella associated protein 57 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CFAP57 mRNA CTD PMID:23557933 NCBI chr 5:137,359,787...137,433,472
Ensembl chr 5:137,359,653...137,436,733 		JBrowse link
G Cfd complement factor D affects secretion
increases expression 		ISO
EXP 		resveratrol affects the secretion of CFD protein
resveratrol results in increased expression of CFD mRNA 		CTD PMID:24802182 PMID:25905778 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfh complement factor H decreases expression EXP resveratrol results in decreased expression of CFH mRNA CTD PMID:25905778 NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532 		JBrowse link
G Cfl1 cofilin 1 decreases expression ISO resveratrol results in decreased expression of CFL1 protein CTD PMID:22349766 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cfl2 cofilin 2 decreases expression ISO resveratrol results in decreased expression of CFL2 protein CTD PMID:25505154 NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions
decreases expression
decreases cleavage
increases expression 		ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CFLAR mRNA]
resveratrol results in decreased expression of CFLAR protein
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with Resveratrol] results in decreased expression of CFLAR protein; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]; TNFSF10 protein promotes the reaction [Resveratrol results in decreased expression of CFLAR protein]
resveratrol results in decreased cleavage of CFLAR protein
resveratrol results in increased expression of CFLAR mRNA 		CTD PMID:16081268 PMID:17872969 PMID:18222423 PMID:18444175 PMID:20097879 More... NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Cfp complement factor properdin multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CFP mRNA CTD PMID:25905778 NCBI chr  X:3,715,551...3,721,113
Ensembl chr  X:3,710,425...3,721,112 		JBrowse link
G Cftr CF transmembrane conductance regulator increases activity
multiple interactions 		ISO resveratrol results in increased activity of CFTR protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CFTR mRNA 		CTD PMID:23557933 PMID:24282612 PMID:25946147 NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide multiple interactions EXP
ISO 		[[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein; [resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CGA mRNA; [Resveratrol analog co-treated with CGA protein] results in increased secretion of Progesterone; [Resveratrol co-treated with CGA protein] results in increased secretion of Progesterone; Resveratrol analog inhibits the reaction [CGA protein results in increased expression of STAR protein]; Resveratrol analog inhibits the reaction [CGA protein results in increased secretion of Testosterone]; Resveratrol inhibits the reaction [CGA protein results in increased secretion of Testosterone] 		CTD PMID:19603415 PMID:23557933 NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464 		JBrowse link
G Cgas cyclic GMP-AMP synthase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CGAS mRNA CTD PMID:23557933 NCBI chr 8:88,172,559...88,187,538
Ensembl chr 8:88,174,512...88,185,859 		JBrowse link
G Cggbp1 CGG triplet repeat binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CGGBP1 mRNA CTD PMID:23557933 NCBI chr11:16,012,251...16,019,388
Ensembl chr11:16,011,456...16,020,356 		JBrowse link
G Chac2 ChaC glutathione specific gamma-glutamylcyclotransferase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CHAC2 mRNA CTD PMID:19167446 NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469 		JBrowse link
G Chadl chondroadherin-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHADL mRNA CTD PMID:23557933 NCBI chr 7:115,085,447...115,097,565
Ensembl chr 7:115,085,165...115,097,435 		JBrowse link
G Chaf1a chromatin assembly factor 1 subunit A multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of CHAF1A mRNA
resveratrol results in decreased expression of CHAF1A protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868 		JBrowse link
G Chat choline O-acetyltransferase multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHAT mRNA
resveratrol results in increased expression of CHAT protein 		CTD PMID:23075401 PMID:23557933 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416 		JBrowse link
G Chchd1 coiled-coil-helix-coiled-coil-helix domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHCHD1 mRNA CTD PMID:23557933 NCBI chr15:3,641,973...3,643,155
Ensembl chr15:3,641,981...3,643,155 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHCHD10 mRNA CTD PMID:23557933 NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677 		JBrowse link
G Chchd2 coiled-coil-helix-coiled-coil-helix domain containing 2 decreases expression ISO Resveratrol results in decreased expression of CHCHD2 protein CTD PMID:25505154 NCBI chr12:32,464,847...32,470,871
Ensembl chr12:32,464,824...32,470,871 		JBrowse link
G Chchd3 coiled-coil-helix-coiled-coil-helix domain containing 3 increases expression ISO resveratrol results in increased expression of CHCHD3 protein CTD PMID:25505154 NCBI chr 4:62,327,574...62,584,085
Ensembl chr 4:62,327,576...62,584,035 		JBrowse link
G Chchd7 coiled-coil-helix-coiled-coil-helix domain containing 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHCHD7 mRNA CTD PMID:23557933 NCBI chr 5:21,754,719...21,759,274
Ensembl chr 5:21,754,719...21,759,274 		JBrowse link
G Chct1 CHD1 helical C-terminal domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHCT1 mRNA CTD PMID:23557933 NCBI chr10:70,537,206...70,548,972
Ensembl chr10:70,537,127...70,548,963 		JBrowse link
G Chd1 chromodomain helicase DNA binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHD1 mRNA CTD PMID:23557933 NCBI chr 1:65,334,905...65,402,270
Ensembl chr 1:65,335,218...65,401,280 		JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHD1L mRNA CTD PMID:23557933 NCBI chr 2:187,819,869...187,906,359
Ensembl chr 2:187,811,954...187,890,477 		JBrowse link
G Chek1 checkpoint kinase 1 decreases expression
affects expression
increases expression
multiple interactions 		EXP
ISO 		Resveratrol results in decreased expression of CHEK1 mRNA
resveratrol affects the expression of CHEK1 protein
resveratrol results in increased expression of CHEK1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA; [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein; Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]
resveratrol results in decreased expression of CHEK1 mRNA 		CTD PMID:15975956 PMID:18089832 PMID:19167446 PMID:33775663 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions
increases phosphorylation 		ISO 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [resveratrol promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of CHEK2 protein]]; [Coumestrol co-treated with resveratrol] results in increased expression of CHEK2 mRNA; [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein; [temozolomide co-treated with resveratrol] results in increased phosphorylation of CHEK2 protein; Acetylcysteine inhibits the reaction [resveratrol results in increased phosphorylation of CHEK2 protein]; Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of CHEK2 protein]; resveratrol promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of CHEK2 protein]; resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] CTD PMID:15975956 PMID:19167446 PMID:20080969 PMID:23152798 PMID:23445485 More... NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Chfr checkpoint with forkhead and ring finger domains multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHFR mRNA CTD PMID:23557933 NCBI chr12:52,164,214...52,197,860
Ensembl chr12:52,164,217...52,197,703 		JBrowse link
G Chga chromogranin A decreases expression ISO resveratrol results in decreased expression of CHGA protein CTD PMID:21184191 NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237 		JBrowse link
G Chgb chromogranin B increases expression ISO resveratrol results in increased expression of CHGB mRNA CTD PMID:25888808 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chi3l1 chitinase 3 like 1 multiple interactions
decreases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in decreased expression of CHI3L1 protein]
resveratrol results in decreased expression of CHI3L1 mRNA; resveratrol results in decreased expression of CHI3L1 protein 		CTD PMID:21029458 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Chml CHM like Rab escort protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHML mRNA CTD PMID:23557933 NCBI chr13:90,141,880...90,152,097
Ensembl chr13:90,131,514...90,151,265 		JBrowse link
G Chmp5 charged multivesicular body protein 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHMP5 mRNA CTD PMID:23557933 NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:60,877,341...60,894,511 		JBrowse link
G Chodl chondrolectin increases expression EXP resveratrol results in increased expression of CHODL mRNA CTD PMID:25905778 NCBI chr11:31,141,030...31,163,342
Ensembl chr11:31,141,021...31,163,334 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHORDC1 mRNA CTD PMID:23557933 NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chp1 calcineurin-like EF-hand protein 1 increases expression ISO resveratrol results in increased expression of CHP1 protein CTD PMID:25505154 NCBI chr 3:126,989,800...127,025,071
Ensembl chr 3:126,989,579...127,042,443 		JBrowse link
G Chpf chondroitin polymerizing factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHPF mRNA CTD PMID:23557933 NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523 		JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRDL2 mRNA CTD PMID:23557933 NCBI chr 1:163,755,316...163,782,758
Ensembl chr 1:163,755,316...163,782,757 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions EXP resveratrol inhibits the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to and results in increased activity of CHRM1 protein] CTD PMID:19967050 NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 increases expression ISO resveratrol results in increased expression of CHRM2 mRNA CTD PMID:21937650 NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464 		JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3 multiple interactions EXP resveratrol promotes the reaction [CHRM3 protein binds to GJA1 protein] CTD PMID:17520802 NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304 		JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRM4 mRNA CTD PMID:23557933 NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771 		JBrowse link
G Chrna3 cholinergic receptor nicotinic alpha 3 subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNA3 mRNA CTD PMID:23557933 NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNA4 mRNA
resveratrol results in increased expression of CHRNA4 mRNA 		CTD PMID:12569576 PMID:23557933 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNA7 mRNA
Resveratrol inhibits the reaction [acetamiprid results in decreased expression of CHRNA7 mRNA] 		CTD PMID:23557933 PMID:39067744 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Chrnb1 cholinergic receptor nicotinic beta 1 subunit multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNB1 mRNA
resveratrol results in decreased expression of CHRNB1 protein 		CTD PMID:18089832 PMID:23557933 NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107 		JBrowse link
G Chrnb3 cholinergic receptor nicotinic beta 3 subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNB3 mRNA CTD PMID:23557933 NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225 		JBrowse link
G Chrnd cholinergic receptor nicotinic delta subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRND mRNA CTD PMID:23557933 NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745 		JBrowse link
G Chrng cholinergic receptor nicotinic gamma subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNG mRNA CTD PMID:23557933 NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092 		JBrowse link
G Chst14 carbohydrate sulfotransferase 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHST14 mRNA CTD PMID:23557933 NCBI chr 3:126,370,348...126,372,405
Ensembl chr 3:126,370,348...126,372,777 		JBrowse link
G Chst4 carbohydrate sulfotransferase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHST4 mRNA CTD PMID:23557933 NCBI chr19:54,900,914...54,911,735
Ensembl chr19:54,882,719...54,916,648 		JBrowse link
G Chst6 carbohydrate sulfotransferase 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHST6 mRNA CTD PMID:23557933 NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306 		JBrowse link
G Chtf18 chromosome transmission fidelity factor 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CHTF18 mRNA CTD PMID:23557933 NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685 		JBrowse link
G Chtop chromatin target of PRMT1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CHTOP mRNA CTD PMID:23557933 NCBI chr 2:178,278,848...178,291,142
Ensembl chr 2:178,278,848...178,290,348 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions
decreases phosphorylation 		ISO [Benzo(a)pyrene co-treated with Resveratrol] results in decreased expression of CHUK mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CHUK mRNA; Resveratrol inhibits the reaction [Niacinamide results in increased activity of CHUK protein]; Resveratrol inhibits the reaction [TNF protein results in increased activity of CHUK protein]
resveratrol results in decreased phosphorylation of CHUK protein
resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CHUK protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CHUK protein] 		CTD PMID:15489888 PMID:16474181 PMID:22118570 PMID:23557933 PMID:24289642 More... NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273 		JBrowse link
G Ciao2b cytosolic iron-sulfur assembly component 2B increases expression ISO Resveratrol results in increased expression of CIAO2B protein CTD PMID:25505154 NCBI chr19:350,644...352,518
Ensembl chr19:350,653...352,518 		JBrowse link
G Cibar2 CBY1 interacting BAR domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CIBAR2 mRNA CTD PMID:23557933 NCBI chr19:65,126,231...65,138,015
Ensembl chr19:65,125,383...65,138,032 		JBrowse link
G Cic capicua transcriptional repressor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CIC mRNA CTD PMID:23557933 NCBI chr 1:89,980,660...90,008,357
Ensembl chr 1:89,981,743...90,008,354 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a multiple interactions
increases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CIDEA mRNA
resveratrol results in increased expression of CIDEA mRNA
PRKAA1 gene mutant form inhibits the reaction [resveratrol results in increased expression of CIDEA mRNA]; resveratrol inhibits the reaction [Dietary Fats affects the expression of CIDEA mRNA] 		CTD PMID:17086191 PMID:25761413 PMID:25905778 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cilp cartilage intermediate layer protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CILP mRNA CTD PMID:23557933 NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409 		JBrowse link
G Cilp2 cartilage intermediate layer protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CILP2 mRNA CTD PMID:23557933 NCBI chr16:19,573,821...19,581,100
Ensembl chr16:19,573,908...19,581,100 		JBrowse link
G Cimap1c ciliary microtubule associated protein 1C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CIMAP1C mRNA CTD PMID:23557933 NCBI chr 8:66,144,726...66,176,985
Ensembl chr 8:66,144,726...66,181,546 		JBrowse link
G Cimap1d CIMAP1 family member D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CIMAP1D mRNA CTD PMID:23557933 NCBI chr 7:10,700,067...10,715,742
Ensembl chr 7:10,700,510...10,715,738 		JBrowse link
G Cimip2a ciliary microtubule inner protein 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CIMIP2A mRNA CTD PMID:23557933 NCBI chr 3:28,429,413...28,437,210
Ensembl chr 3:28,431,410...28,436,125 		JBrowse link
G Cip2a cellular inhibitor of PP2A multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CIP2A mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CIP2A mRNA CTD PMID:19167446 PMID:23557933 NCBI chr11:65,255,123...65,285,914
Ensembl chr11:65,255,123...65,285,914 		JBrowse link
G Cipc CLOCK-interacting pacemaker multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CIPC mRNA CTD PMID:23557933 NCBI chr 6:112,325,980...112,344,692
Ensembl chr 6:112,325,671...112,344,692 		JBrowse link
G Cisd2 CDGSH iron sulfur domain 2 increases expression ISO resveratrol results in increased expression of CISD2 protein CTD PMID:25505154 NCBI chr 2:226,502,517...226,527,325
Ensembl chr 2:226,502,517...226,540,080 		JBrowse link
G Cit citron rho-interacting serine/threonine kinase decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CIT protein
[Coumestrol co-treated with resveratrol] results in increased expression of CIT mRNA 		CTD PMID:18089832 PMID:19167446 NCBI chr12:46,263,881...46,425,642
Ensembl chr12:46,266,369...46,424,656 		JBrowse link
G Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CITED1 mRNA CTD PMID:23557933 NCBI chr  X:71,390,328...71,395,023
Ensembl chr  X:71,390,331...71,393,649 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CKAP2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CKAP2 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckap2l cytoskeleton associated protein 2-like multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2L mRNA CTD PMID:19167446 NCBI chr 3:136,950,390...136,977,503
Ensembl chr 3:136,950,381...136,977,565 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 increases expression EXP resveratrol results in increased expression of CKAP4 mRNA CTD PMID:25905778 NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624 		JBrowse link
G Ckap5 cytoskeleton associated protein 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CKAP5 mRNA CTD PMID:23557933 NCBI chr 3:97,946,966...98,049,050
Ensembl chr 3:97,947,031...98,049,049 		JBrowse link
G Ckmt2 creatine kinase, mitochondrial 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CKMT2 mRNA CTD PMID:23557933 NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CKS1B mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CKS1B mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CKS2 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA 		CTD PMID:15767336 PMID:19167446 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLASP2 mRNA CTD PMID:23557933 NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:122,555,524...122,737,587 		JBrowse link
G Clca1 chloride channel accessory 1 multiple interactions
decreases expression 		ISO Resveratrol inhibits the reaction [OVAL protein results in increased expression of CLCA1 protein]
Resveratrol results in decreased expression of CLCA1 protein 		CTD PMID:26549244 NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714 		JBrowse link
G Clcc1 chloride channel CLIC-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLCC1 mRNA CTD PMID:23557933 NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLCF1 mRNA
resveratrol results in decreased expression of CLCF1 mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064 		JBrowse link
G Clcn5 chloride voltage-gated channel 5 increases expression
multiple interactions 		ISO resveratrol results in increased expression of CLCN5 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CLCN5 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr  X:17,857,260...18,011,844
Ensembl chr  X:17,857,260...18,011,844 		JBrowse link
G Clcn7 chloride voltage-gated channel 7 increases expression ISO resveratrol results in increased expression of CLCN7 protein CTD PMID:25505154 NCBI chr10:14,656,261...14,681,632
Ensembl chr10:14,656,245...14,681,631 		JBrowse link
G Clcnkb chloride voltage-gated channel Kb multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLCNKB mRNA CTD PMID:23557933 NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900 		JBrowse link
G Cldn1 claudin 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		Resveratol increases expression of CLDN1 mRNA in distal colon
Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of CLDN1 mRNA]; Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of CLDN1 protein]
resveratrol results in increased expression of CLDN1 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CLDN1 mRNA
resveratrol results in decreased expression of CLDN1 mRNA 		CTD
RGD		 PMID:17257620 PMID:19167446 PMID:34614429 PMID:35156769 PMID:31189495 RGD:26884351 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn11 claudin 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN11 mRNA CTD PMID:23557933 NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539 		JBrowse link
G Cldn15 claudin 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN15 mRNA CTD PMID:23557933 NCBI chr12:25,334,849...25,345,104
Ensembl chr12:25,334,849...25,343,477 		JBrowse link
G Cldn19 claudin 19 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN19 mRNA CTD PMID:23557933 NCBI chr 5:138,148,234...138,155,672
Ensembl chr 5:138,148,501...138,155,666 		JBrowse link
G Cldn2 claudin 2 multiple interactions
increases expression 		ISO resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CLDN2 protein]
resveratrol results in increased expression of CLDN2 protein 		CTD PMID:26310874 NCBI chr  X:108,248,383...108,258,847
Ensembl chr  X:108,237,676...108,262,377 		JBrowse link
G Cldn23 claudin 23 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN23 mRNA CTD PMID:23557933 NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957 		JBrowse link
G Cldnd1 claudin domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLDND1 mRNA CTD PMID:23557933 NCBI chr11:55,352,321...55,358,779
Ensembl chr11:55,352,321...55,358,907 		JBrowse link
G Clec11a C-type lectin domain containing 11A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLEC11A mRNA CTD PMID:23557933 NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784 		JBrowse link
G Clec3b C-type lectin domain family 3, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLEC3B mRNA CTD PMID:23557933 NCBI chr 8:131,687,575...131,693,292 JBrowse link
G Clec4f C-type lectin domain family 4, member F multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CLEC4F mRNA
Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CLEC4F mRNA] 		CTD PMID:25905778 PMID:31298478 NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438 		JBrowse link
G Clec7a C-type lectin domain containing 7A multiple interactions ISO resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CLEC7A mRNA] CTD PMID:17938187 NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919 		JBrowse link
G Clgn calmegin affects expression EXP resveratrol affects the expression of CLGN mRNA CTD PMID:15748624 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Clic1 chloride intracellular channel 1 increases expression ISO resveratrol results in increased expression of CLIC1 protein CTD PMID:25505154 NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367 		JBrowse link
G Clip3 CAP-GLY domain containing linker protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLIP3 mRNA CTD PMID:23557933 NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642 		JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLIP4 mRNA CTD PMID:23557933 NCBI chr 6:29,359,628...29,449,365
NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271 		JBrowse link
G Clk2 CDC-like kinase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLK2 mRNA CTD PMID:23557933 NCBI chr 2:176,868,423...176,880,412
Ensembl chr 2:176,869,490...176,880,411 		JBrowse link
G Clk4 CDC-like kinase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLK4 mRNA CTD PMID:23557933 NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372 		JBrowse link
G Cln3 CLN3 lysosomal/endosomal transmembrane protein, battenin increases expression ISO resveratrol results in increased expression of CLN3 mRNA CTD PMID:22610192 NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:190,586,650...190,597,929 		JBrowse link
G Clock clock circadian regulator multiple interactions ISO Resveratrol inhibits the reaction [Sodium Fluoride results in decreased expression of CLOCK protein] CTD PMID:36063856 NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872 		JBrowse link
G Clpsl2 colipase-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLPSL2 mRNA CTD PMID:23557933 NCBI chr20:6,609,832...6,612,655
Ensembl chr20:6,608,490...6,612,655 		JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLPX mRNA CTD PMID:23557933 NCBI chr 8:74,700,602...74,740,244
Ensembl chr 8:74,700,662...74,744,762 		JBrowse link
G Clrn1 clarin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLRN1 mRNA CTD PMID:23557933 NCBI chr 2:145,233,941...145,280,855
Ensembl chr 2:145,233,941...145,280,855 		JBrowse link
G Clrn3 clarin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLRN3 mRNA CTD PMID:23557933 NCBI chr 1:199,748,863...199,764,486
Ensembl chr 1:199,748,864...199,764,486 		JBrowse link
G Clta clathrin, light chain A affects secretion ISO resveratrol affects the secretion of CLTA protein CTD PMID:24802182 NCBI chr 5:63,022,046...63,059,223
Ensembl chr 5:63,041,184...63,059,215 		JBrowse link
G Cltc clathrin heavy chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CLTC mRNA CTD PMID:23557933 NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691 		JBrowse link
G Clu clusterin multiple interactions
increases expression 		ISO MIR137 mRNA affects the reaction [resveratrol results in increased expression of CLU mRNA] CTD PMID:25505154 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Clul1 clusterin like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLUL1 mRNA CTD PMID:23557933 NCBI chr 9:120,791,105...120,816,680
Ensembl chr 9:120,791,105...120,816,680 		JBrowse link
G Clybl citramalyl-CoA lyase multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of CLYBL mRNA CTD PMID:26667767 NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345 		JBrowse link
G Cmbl carboxymethylenebutenolidase homolog multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of CMBL mRNA CTD PMID:26667767 NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880 		JBrowse link
G Cmc2 C-x(9)-C motif containing 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CMC2 mRNA CTD PMID:19167446 NCBI chr19:61,852,126...61,880,768
Ensembl chr19:61,852,126...61,881,019 		JBrowse link
G Cmss1 cms1 ribosomal small subunit homolog multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA CTD PMID:19167446 NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755 		JBrowse link
G Cmtr1 cap methyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CMTR1 mRNA CTD PMID:23557933 NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263 		JBrowse link
G Cnbd2 cyclic nucleotide binding domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNBD2 mRNA CTD PMID:23557933 NCBI chr 3:165,279,157...165,357,582
Ensembl chr 3:165,279,204...165,361,688 		JBrowse link
G Cnbp CCHC-type zinc finger, nucleic acid binding protein increases expression
decreases expression 		ISO resveratrol results in increased expression of CNBP mRNA
resveratrol results in decreased expression of CNBP protein 		CTD PMID:12154049 PMID:25505154 NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:121,860,105...121,869,010 		JBrowse link
G Cndp1 carnosine dipeptidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNDP1 mRNA CTD PMID:23557933 NCBI chr18:80,254,499...80,305,845
Ensembl chr18:80,255,784...80,282,643 		JBrowse link
G Cndp2 carnosine dipeptidase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CNDP2 mRNA CTD PMID:23557933 NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900 		JBrowse link
G Cnfn cornifelin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNFN mRNA CTD PMID:23557933 NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556 		JBrowse link
G Cnih2 cornichon family AMPA receptor auxiliary protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNIH2 mRNA CTD PMID:23557933 NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437 		JBrowse link
G Cnih3 cornichon family AMPA receptor auxiliary protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNIH3 mRNA CTD PMID:23557933 NCBI chr13:95,548,440...95,739,500
Ensembl chr13:95,598,998...95,772,064 		JBrowse link
G Cnn1 calponin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNN1 mRNA CTD PMID:23557933 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnot10 CCR4-NOT transcription complex, subunit 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CNOT10 mRNA CTD PMID:23557933 NCBI chr 8:123,158,675...123,208,389
Ensembl chr 8:123,158,679...123,208,167 		JBrowse link
G Cnot6 CCR4-NOT transcription complex, subunit 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CNOT6 mRNA CTD PMID:23557933 NCBI chr10:34,479,892...34,532,166
Ensembl chr10:34,481,938...34,524,416 		JBrowse link
G Cnot7 CCR4-NOT transcription complex, subunit 7 decreases expression EXP resveratrol results in decreased expression of CNOT7 mRNA CTD PMID:25905778 NCBI chr16:58,478,882...58,498,046
Ensembl chr16:58,478,900...58,498,046 		JBrowse link
G Cnst consortin, connexin sorting protein multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CNST mRNA]
[Plant Extracts co-treated with Resveratrol] results in increased expression of CNST mRNA 		CTD PMID:23557933 PMID:31298478 NCBI chr13:93,828,694...93,905,497
Ensembl chr13:93,828,687...93,905,490 		JBrowse link
G Cntd1 cyclin N-terminal domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNTD1 mRNA CTD PMID:23557933 NCBI chr10:86,721,692...86,732,074 JBrowse link
G Cntln centlein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CNTLN mRNA CTD PMID:23557933 NCBI chr 5:104,340,801...104,622,491
Ensembl chr 5:104,342,173...104,630,976 		JBrowse link
G Cntn1 contactin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNTN1 mRNA CTD PMID:23557933 NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:125,142,696...125,440,391 		JBrowse link
G Cntn5 contactin 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CNTN5 mRNA CTD PMID:23557933 NCBI chr 8:15,017,424...16,249,418
Ensembl chr 8:15,018,927...15,969,060 		JBrowse link
G Cntrl centriolin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CNTRL mRNA CTD PMID:23557933 NCBI chr 3:38,825,575...38,897,835
Ensembl chr 3:38,825,624...38,897,833 		JBrowse link
G Coa6 cytochrome c oxidase assembly factor 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COA6 mRNA CTD PMID:23557933 NCBI chr19:71,293,066...71,295,668
Ensembl chr19:71,278,765...71,296,015 		JBrowse link
G Coa7 cytochrome c oxidase assembly factor 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COA7 mRNA CTD PMID:23557933 NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664 		JBrowse link
G Cobl cordon-bleu WH2 repeat protein increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of COBL mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of COBL mRNA 		CTD PMID:19228061 PMID:23557933 NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257 		JBrowse link
G Cog2 component of oligomeric golgi complex 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COG2 mRNA CTD PMID:23557933 NCBI chr19:69,391,305...69,430,072
Ensembl chr19:69,391,326...69,426,620 		JBrowse link
G Cog3 component of oligomeric golgi complex 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COG3 mRNA CTD PMID:23557933 NCBI chr15:57,389,994...57,480,454
Ensembl chr15:57,390,238...57,480,097 		JBrowse link
G Cog4 component of oligomeric golgi complex 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COG4 mRNA CTD PMID:23557933 NCBI chr19:55,729,854...55,763,902
Ensembl chr19:55,728,796...55,764,169 		JBrowse link
G Cog6 component of oligomeric golgi complex 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COG6 mRNA CTD PMID:23557933 NCBI chr 2:139,212,459...139,249,505
Ensembl chr 2:139,211,678...139,249,737 		JBrowse link
G Cog7 component of oligomeric golgi complex 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COG7 mRNA CTD PMID:23557933 NCBI chr 1:185,921,053...185,980,711
Ensembl chr 1:185,889,348...185,983,421 		JBrowse link
G Col10a1 collagen type X alpha 1 chain multiple interactions EXP
ISO 		Resveratrol inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased expression of COL10A1 protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of COL10A1 mRNA 		CTD PMID:23557933 PMID:29653943 NCBI chr20:39,737,536...39,744,518
Ensembl chr20:39,716,822...39,751,440 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of COL12A1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL12A1 mRNA CTD PMID:23557933 PMID:26667767 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col15a1 collagen type XV alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL15A1 mRNA CTD PMID:23557933 NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170 		JBrowse link
G Col17a1 collagen type XVII alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL17A1 mRNA CTD PMID:23557933 NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL18A1 mRNA
resveratrol results in decreased expression of COL18A1 mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression
decreases expression
multiple interactions
affects secretion 		ISO
EXP 		resveratrol results in increased expression of COL1A1 mRNA
resveratrol results in decreased expression of COL1A1 mRNA; resveratrol results in decreased expression of COL1A1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of COL1A1 mRNA; Niacinamide inhibits the reaction [Resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]]; Resveratrol inhibits the reaction [COL1A1 protein promotes the reaction [PTPN11 protein binds to BTK protein]]; Resveratrol inhibits the reaction [COL1A1 protein promotes the reaction [PTPN11 protein binds to SYK protein]]; Resveratrol inhibits the reaction [COL1A1 protein promotes the reaction [PTPN11 protein binds to VAV1 protein]]; Resveratrol inhibits the reaction [COL1A1 protein results in increased oxidation of and results in decreased activity of PTPN11 protein]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of BTK protein]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of NCF1 protein]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of PLCG2 protein]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of SYK protein]; Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of VAV1 protein]; Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]
resveratrol affects the secretion of COL1A1 protein
resveratrol inhibits the reaction [[cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of COL1A1 mRNA]; resveratrol inhibits the reaction [Carbon Tetrachloride affects the expression of COL1A1 mRNA]
Resveratrol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA]; Resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL1A1 mRNA] 		CTD PMID:19167446 PMID:19228061 PMID:22086758 PMID:23262250 PMID:23297412 More... NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression
affects secretion
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of COL1A2 mRNA
resveratrol affects the secretion of COL1A2 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of COL1A2 mRNA; Niacinamide inhibits the reaction [Resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mRNA]]; Resveratrol inhibits the reaction [TGFB2 protein promotes the reaction [EP300 protein binds to COL1A2 promoter]]; Resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mRNA]
resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL1A2 mRNA]; resveratrol inhibits the reaction [IGF1 protein results in increased expression of COL1A2 mRNA] 		CTD PMID:19228061 PMID:23297412 PMID:23557933 PMID:24782617 PMID:24802182 More... NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col26a1 collagen type XXVI alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL26A1 mRNA CTD PMID:23557933 NCBI chr12:25,429,362...25,575,205
Ensembl chr12:25,429,387...25,575,206 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL27A1 mRNA CTD PMID:23557933 NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502 		JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL2A1 mRNA; [Resveratrol co-treated with Curcumin] results in increased expression of COL2A1 protein; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]]; Resveratrol inhibits the reaction [IL1B protein results in decreased expression of COL2A1 protein]
[Hyaluronic Acid co-treated with resveratrol] results in increased expression of COL2A1 mRNA; resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of CYP1A1 mRNA]; resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of CYP1A1 protein]; resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of IL10 protein]; resveratrol inhibits the reaction [tetrandrine inhibits the reaction [COL2A1 protein results in increased expression of IL17A protein]]; resveratrol inhibits the reaction [tetrandrine inhibits the reaction [COL2A1 protein results in increased expression of TNF protein]]
resveratrol results in increased expression of COL2A1 protein 		CTD PMID:17404069 PMID:19889203 PMID:23557933 PMID:23595953 PMID:26526931 More... NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627 		JBrowse link
G Col3a1 collagen type III alpha 1 chain decreases expression
affects secretion
increases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of COL3A1 mRNA
resveratrol affects the secretion of COL3A1 protein
resveratrol results in increased expression of COL3A1 protein
resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL3A1 mRNA] 		CTD PMID:19228061 PMID:22936809 PMID:23297412 PMID:24317052 PMID:24802182 More... NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL4A4 mRNA CTD PMID:23557933 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL4A6 mRNA CTD PMID:23557933 NCBI chr  X:109,554,945...109,905,987
Ensembl chr  X:109,552,651...109,905,944 		JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression ISO resveratrol results in decreased expression of COL5A1 mRNA CTD PMID:19167446 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a3 collagen type V alpha 3 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL5A3 mRNA CTD PMID:23557933 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain affects secretion ISO resveratrol affects the secretion of COL6A1 protein CTD PMID:24802182 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain affects secretion ISO resveratrol affects the secretion of COL6A2 protein CTD PMID:24802182 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain decreases expression EXP resveratrol results in decreased expression of COL6A3 mRNA CTD PMID:19228061 NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Col6a6 collagen type VI alpha 6 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL6A6 mRNA CTD PMID:23557933 NCBI chr 8:115,196,833...115,352,161
Ensembl chr 8:115,197,464...115,352,136 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL7A1 mRNA CTD PMID:23557933 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL8A1 mRNA CTD PMID:23557933 NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229 		JBrowse link
G Col9a3 collagen type IX alpha 3 chain multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL9A3 mRNA CTD PMID:23557933 NCBI chr 3:188,089,337...188,112,034
Ensembl chr 3:188,089,403...188,112,270 		JBrowse link
G Colec11 collectin sub-family member 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COLEC11 mRNA CTD PMID:23557933 NCBI chr 6:50,952,357...50,984,845
Ensembl chr 6:50,952,357...50,999,493 		JBrowse link
G Commd10 COMM domain containing 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COMMD10 mRNA CTD PMID:23557933 NCBI chr18:41,927,802...42,061,384
Ensembl chr18:41,921,694...42,086,729 		JBrowse link
G Commd3 COMM domain containing 3 increases expression
multiple interactions 		ISO resveratrol results in increased expression of COMMD3 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of COMMD3 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610 		JBrowse link
G Commd7 COMM domain containing 7 increases expression ISO resveratrol results in increased expression of COMMD7 protein CTD PMID:25505154 NCBI chr 3:162,559,762...162,574,543
Ensembl chr 3:162,554,374...162,574,692 		JBrowse link
G Commd8 COMM domain containing 8 increases expression ISO resveratrol results in increased expression of COMMD8 protein CTD PMID:25505154 NCBI chr14:36,403,000...36,413,577
Ensembl chr14:36,403,022...36,413,574 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of COMT mRNA CTD PMID:19167446 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Comtd1 catechol-O-methyltransferase domain containing 1 increases expression ISO resveratrol results in increased expression of COMTD1 protein CTD PMID:25505154 NCBI chr15:2,509,121...2,512,232
Ensembl chr15:2,509,032...2,512,232 		JBrowse link
G Copb1 COPI coat complex subunit beta 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COPB1 mRNA CTD PMID:23557933 NCBI chr 1:177,838,751...177,876,688
Ensembl chr 1:177,838,752...177,872,840 		JBrowse link
G Copb2 COPI coat complex subunit beta 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COPB2 mRNA CTD PMID:23557933 NCBI chr 8:108,040,687...108,062,810
Ensembl chr 8:108,040,693...108,064,550 		JBrowse link
G Cope COPI coat complex subunit epsilon multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COPE mRNA CTD PMID:23557933 NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212 		JBrowse link
G Cops2 COP9 signalosome subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COPS2 mRNA CTD PMID:23557933 NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369 		JBrowse link
G Cops3 COP9 signalosome subunit 3 increases expression ISO resveratrol results in increased expression of COPS3 mRNA CTD PMID:12002526 NCBI chr10:45,117,664...45,151,868
Ensembl chr10:45,117,657...45,152,074 		JBrowse link
G Cops5 COP9 signalosome subunit 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COPS5 mRNA CTD PMID:23557933 NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387 		JBrowse link
G Coq2 coenzyme Q2, polyprenyltransferase multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of COQ2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of COQ2 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr14:9,245,777...9,265,784
Ensembl chr14:9,245,803...9,265,783 		JBrowse link
G Coq7 coenzyme Q7, hydroxylase increases expression
multiple interactions 		ISO resveratrol results in increased expression of COQ7 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of COQ7 mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:182,269,399...182,285,508 		JBrowse link
G Coq8a coenzyme Q8A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COQ8A mRNA CTD PMID:23557933 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Coro1a coronin 1A increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of CORO1A mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of CORO1A mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102 		JBrowse link
G Coro1b coronin 1B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CORO1B mRNA CTD PMID:19167446 NCBI chr 1:210,872,437...210,877,876
Ensembl chr 1:210,871,841...210,877,876 		JBrowse link
G Coro1c coronin 1C increases expression ISO resveratrol results in increased expression of CORO1C mRNA CTD PMID:19371625 NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716 		JBrowse link
G Coro2a coronin 2A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CORO2A mRNA CTD PMID:19167446 NCBI chr 5:65,623,820...65,677,483
Ensembl chr 5:65,623,823...65,654,602 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of COTL1 mRNA
resveratrol results in increased expression of COTL1 mRNA 		CTD PMID:25905778 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox15 cytochrome c oxidase assembly homolog COX15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COX15 mRNA CTD PMID:23557933 NCBI chr 1:252,554,811...252,571,471
Ensembl chr 1:252,554,811...252,571,471 		JBrowse link
G Cox19 cytochrome c oxidase assembly factor COX19 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COX19 mRNA CTD PMID:23557933 NCBI chr12:20,417,389...20,426,868
Ensembl chr12:20,417,341...20,426,868 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		resveratrol results in increased expression of COX4I1 mRNA; resveratrol results in increased expression of COX4I1 protein
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased expression of COX4I1 protein]; HMOX1 mutant form inhibits the reaction [resveratrol results in increased expression of COX4I1 protein]; lipopolysaccharide, E coli O55-B5 promotes the reaction [resveratrol results in increased expression of COX4I1 protein]; resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]; tin protoporphyrin IX inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [resveratrol results in increased expression of COX4I1 protein]]; tin protoporphyrin IX inhibits the reaction [resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]]; tin protoporphyrin IX inhibits the reaction [resveratrol results in increased expression of COX4I1 protein]
resveratrol results in decreased expression of COX4I1 protein
resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of COX4I1 protein]; tin protoporphyrin IX inhibits the reaction [resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of COX4I1 protein]]; tin protoporphyrin IX inhibits the reaction [resveratrol results in increased expression of COX4I1 protein] 		CTD PMID:21715682 PMID:24041027 PMID:25505154 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624 		JBrowse link
G Cox4i2 cytochrome c oxidase subunit 4i2 increases expression ISO resveratrol results in increased expression of COX4I2 mRNA CTD PMID:22610192 NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:161,689,017...161,699,602 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression
increases expression 		ISO resveratrol results in decreased expression of COX5A protein
resveratrol results in increased expression of COX5A mRNA 		CTD PMID:17112576 PMID:25505154 NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions
increases expression 		ISO SIRT1 protein affects the reaction [Resveratrol results in increased expression of COX5B mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of COX5B mRNA] CTD PMID:34216621 NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403 		JBrowse link
G Cox6a1 cytochrome c oxidase subunit 6A1 increases expression ISO resveratrol results in increased expression of COX6A1 mRNA CTD PMID:22610192 NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768 		JBrowse link
G Cox6b1 cytochrome c oxidase subunit 6B1 increases expression ISO resveratrol results in increased expression of COX6B1 mRNA CTD PMID:22610192 NCBI chr 1:95,002,513...95,011,516
Ensembl chr 1:95,001,707...95,011,431
Ensembl chr 5:95,001,707...95,011,431 		JBrowse link
G Cox6c cytochrome c oxidase subunit 6C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COX6C mRNA CTD PMID:23557933 NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166 		JBrowse link
G Cox7a1 cytochrome c oxidase subunit 7A1 increases expression ISO resveratrol results in increased expression of COX7A1 mRNA CTD PMID:22610192 NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889 		JBrowse link
G Cox7a2 cytochrome c oxidase subunit 7A2 increases expression ISO resveratrol results in increased expression of COX7A2 mRNA CTD PMID:22610192 NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512
Ensembl chr 8:55,514,261...55,514,512 		JBrowse link
G Cox7b cytochrome c oxidase subunit 7B multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COX7B mRNA
Resveratrol results in increased expression of COX7B mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr  X:75,149,036...75,155,285
Ensembl chr  X:75,148,996...75,155,284 		JBrowse link
G Cox7c cytochrome c oxidase subunit 7C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of COX7C mRNA CTD PMID:23557933 NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170 		JBrowse link
G Cox8a cytochrome c oxidase subunit 8A increases expression ISO resveratrol results in increased expression of COX8A mRNA CTD PMID:22610192 NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623 		JBrowse link
G Cox8c cytochrome c oxidase subunit 8C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of COX8C mRNA CTD PMID:23557933 NCBI chr 6:127,793,379...127,794,702
Ensembl chr 6:127,793,379...127,794,702 		JBrowse link
G Cpa5 carboxypeptidase A5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPA5 mRNA CTD PMID:23557933 NCBI chr 4:60,197,123...60,216,883
Ensembl chr 4:60,197,152...60,216,875 		JBrowse link
G Cpd carboxypeptidase D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CPD mRNA CTD PMID:23557933 NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CPEB2 mRNA CTD PMID:19167446 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cplx1 complexin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPLX1 mRNA CTD PMID:23557933 NCBI chr14:1,329,073...1,360,781
Ensembl chr14:1,329,032...1,360,769 		JBrowse link
G Cplx2 complexin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPLX2 mRNA CTD PMID:23557933 NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467 		JBrowse link
G Cplx3 complexin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPLX3 mRNA CTD PMID:23557933 NCBI chr 8:66,899,438...66,906,200
Ensembl chr 8:66,899,438...66,906,200 		JBrowse link
G Cpn1 carboxypeptidase N subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPN1 mRNA CTD PMID:23557933 NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664 		JBrowse link
G Cpne5 copine 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPNE5 mRNA CTD PMID:23557933 NCBI chr20:7,208,389...7,290,959
Ensembl chr20:7,208,389...7,292,064 		JBrowse link
G Cpne7 copine 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPNE7 mRNA CTD PMID:23557933 NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197 		JBrowse link
G Cpne8 copine 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CPNE8 mRNA CTD PMID:23557933 NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060 		JBrowse link
G Cpo carboxypeptidase O multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPO mRNA CTD PMID:23557933 NCBI chr 9:72,813,802...72,832,056 JBrowse link
G Cpped1 calcineurin-like phosphoesterase domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CPPED1 mRNA CTD PMID:23557933 NCBI chr10:4,135,601...4,328,039
Ensembl chr10:4,208,463...4,231,065 		JBrowse link
G Cpq carboxypeptidase Q multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of PGCP mRNA CTD PMID:23557933 NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137 		JBrowse link
G Cpsf1 cleavage and polyadenylation specific factor 1 decreases expression ISO resveratrol results in decreased expression of CPSF1 protein CTD PMID:25505154 NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644 		JBrowse link
G Cpsf6 cleavage and polyadenylation specific factor 6 decreases expression EXP resveratrol results in decreased expression of CPSF6 mRNA CTD PMID:25905778 NCBI chr 7:54,798,452...54,887,711
Ensembl chr 7:54,842,490...54,873,998 		JBrowse link
G Cpsf7 cleavage and polyadenylation specific factor 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPSF7 mRNA CTD PMID:23557933 NCBI chr 1:216,592,745...216,616,860
Ensembl chr 1:216,592,463...216,616,855 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions
increases expression
increases activity 		ISO
EXP 		[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT1A mRNA; [Resveratrol co-treated with Dietary Fats] results in increased expression of CPT1A mRNA; Resveratrol inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]
[Resveratrol co-treated with Streptozocin] results in decreased expression of CPT1A mRNA; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of CPT1A mRNA]; Resveratrol promotes the reaction [Triiodothyronine results in increased expression of CPT1A mRNA]
resveratrol results in increased expression of CPT1A mRNA; resveratrol results in increased expression of CPT1A protein
resveratrol promotes the reaction [Triiodothyronine results in increased expression of CPT1A mRNA]
resveratrol results in increased activity of CPT1A protein 		CTD PMID:18755807 PMID:21109418 PMID:23209300 PMID:23274094 PMID:25905778 More... NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpt1c carnitine palmitoyltransferase 1c multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPT1C mRNA CTD PMID:23557933 NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:104,579,298...104,593,763 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions ISO [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT2 mRNA; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CPT2 mRNA] CTD PMID:36432690 PMID:37759824 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818 		JBrowse link
G Cptp ceramide-1-phosphate transfer protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CPTP mRNA CTD PMID:23557933 NCBI chr 5:171,757,181...171,761,271
Ensembl chr 5:171,757,181...171,761,266 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO resveratrol results in increased expression of CRABP2 mRNA
resveratrol results in increased expression of CRABP2 protein 		CTD PMID:12002526 PMID:15280659 PMID:25505154 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Cracr2b calcium release activated channel regulator 2B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRACR2B mRNA CTD PMID:23557933 NCBI chr 1:205,987,957...205,993,515
Ensembl chr 1:205,990,507...205,993,516 		JBrowse link
G Crb2 crumbs cell polarity complex component 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRB2 mRNA CTD PMID:23557933 NCBI chr 3:41,946,694...41,974,629
Ensembl chr 3:41,947,325...41,974,629 		JBrowse link
G Crcp CGRP receptor component multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CRCP mRNA CTD PMID:23557933 NCBI chr12:32,260,108...32,315,116
Ensembl chr12:32,260,143...32,315,237 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions
increases phosphorylation
increases activity
decreases phosphorylation 		ISO
EXP 		resveratrol inhibits the reaction [CREB1 protein binds to MMP2 promoter]; resveratrol results in increased phosphorylation of and results in increased activity of CREB1 protein
[Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of CREB1 protein]]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of CREB1 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CREB1 protein]; wortmannin inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CREB1 protein]]
resveratrol results in increased phosphorylation of CREB1 protein
3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Resveratrol inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein]]; Okadaic Acid inhibits the reaction [Resveratrol inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein]]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CREB1 mRNA]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of CREB1 protein]; Resveratrol inhibits the reaction [Colforsin promotes the reaction [CREB1 protein binds to POU1F1 promoter]]; Resveratrol inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein]; SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein]]
resveratrol results in increased activity of CREB1 protein
resveratrol results in decreased phosphorylation of CREB1 protein 		CTD PMID:18222423 PMID:20080969 PMID:22363816 PMID:22952890 PMID:23292070 More... NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb3l2 cAMP responsive element binding protein 3-like 2 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CREB3L2 mRNA] CTD PMID:31298478 NCBI chr 4:66,874,623...66,990,962
Ensembl chr 4:66,387,126...66,990,832 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CREB3L3 mRNA CTD PMID:23557933 NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778 		JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CREB3L4 mRNA CTD PMID:19167446 NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485 		JBrowse link
G Crebbp CREB binding protein multiple interactions
increases expression 		ISO
EXP 		resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to RELA protein]]
resveratrol inhibits the reaction [CREBBP protein results in increased acetylation of FOXO1 protein]
resveratrol results in increased expression of CREBBP mRNA
BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]]; CREBBP mutant form inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; fulvestrant inhibits the reaction [[TNF protein co-treated with resveratrol] promotes the reaction [CREBBP protein binds to IL6 promoter]]; resveratrol promotes the reaction [PML protein binds to CREBBP protein]; resveratrol promotes the reaction [TNF protein promotes the reaction [CREBBP protein binds to IL6 promoter]]; resveratrol promotes the reaction [TP53 protein binds to PML protein binds to CREBBP protein] 		CTD PMID:15149879 PMID:16474181 PMID:19631782 PMID:19740748 PMID:24771768 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crebzf CREB/ATF bZIP transcription factor decreases expression EXP resveratrol results in decreased expression of CREBZF mRNA CTD PMID:25905778 NCBI chr 1:153,829,544...153,836,073
Ensembl chr 1:153,829,448...153,845,122 		JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of CRELD2 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CRELD2 mRNA] 		CTD PMID:25905778 PMID:31298478 NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228 		JBrowse link
G Crem cAMP responsive element modulator decreases expression EXP resveratrol results in decreased expression of CREM mRNA CTD PMID:25905778 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRHR1 mRNA CTD PMID:23557933 NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466 		JBrowse link
G Crhr2 corticotropin releasing hormone receptor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRHR2 mRNA CTD PMID:23557933 NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of CRIM1 mRNA CTD PMID:26667767 NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416 		JBrowse link
G Crip1 cysteine rich protein 1 decreases expression
increases expression 		ISO resveratrol results in decreased expression of CRIP1 mRNA
resveratrol results in increased expression of CRIP1 protein 		CTD PMID:18089832 PMID:19371625 NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672 		JBrowse link
G Crip2 cysteine-rich protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA CTD PMID:19167446 NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRLF1 mRNA CTD PMID:23557933 NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970 		JBrowse link
G Crnkl1 crooked neck pre-mRNA splicing factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CRNKL1 mRNA CTD PMID:23557933 NCBI chr 3:153,764,718...153,807,973
Ensembl chr 6:6,894,292...6,896,635
Ensembl chr 3:6,894,292...6,896,635 		JBrowse link
G Crnn cornulin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRNN mRNA CTD PMID:23557933 NCBI chr 2:181,427,384...181,432,142
Ensembl chr 2:181,429,481...181,431,993 		JBrowse link
G Crot carnitine O-octanoyltransferase multiple interactions
decreases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in decreased expression of CROT mRNA
resveratrol results in decreased expression of CROT mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of CROT mRNA
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CROT mRNA; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CROT mRNA] 		CTD PMID:23557933 PMID:25905778 PMID:36432690 PMID:37759824 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064 		JBrowse link
G Crp C-reactive protein multiple interactions
decreases expression 		ISO
EXP 		[Resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of CRP mRNA]
resveratrol results in decreased expression of CRP protein
resveratrol inhibits the reaction [Fructose results in increased expression of CRP protein]
Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CRP protein] 		CTD PMID:17388968 PMID:23298135 PMID:24012391 PMID:24319627 PMID:25108154 More... NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Crtac1 cartilage acidic protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRTAC1 mRNA CTD PMID:23557933 NCBI chr 1:251,040,963...251,182,920
Ensembl chr 1:251,028,143...251,182,689 		JBrowse link
G Crtc2 CREB regulated transcription coactivator 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRTC2 mRNA CTD PMID:23557933 NCBI chr 2:178,007,233...178,017,397
Ensembl chr 2:178,007,240...178,017,389 		JBrowse link
G Crtc3 CREB regulated transcription coactivator 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRTC3 mRNA CTD PMID:23557933 NCBI chr 1:143,962,038...144,064,324
Ensembl chr 1:143,962,038...144,064,288 		JBrowse link
G Crx cone-rod homeobox multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRX mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CRX mRNA CTD PMID:23557933 NCBI chr 1:85,667,971...85,681,852
Ensembl chr 1:85,667,971...85,681,852 		JBrowse link
G Cry1 cryptochrome circadian regulator 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CRY1 mRNA CTD PMID:23557933 NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822 		JBrowse link
G Cryaa crystallin, alpha A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYAA mRNA CTD PMID:23557933 NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654 		JBrowse link
G Cryab crystallin, alpha B increases expression ISO resveratrol results in increased expression of CRYAB mRNA CTD PMID:25280562 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Cryba2 crystallin, beta A2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYBA2 mRNA CTD PMID:23557933 NCBI chr 9:83,895,921...83,906,651
Ensembl chr 9:83,895,922...83,899,131 		JBrowse link
G Crybb2 crystallin, beta B2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYBB2 mRNA CTD PMID:23557933 NCBI chr12:49,230,192...49,240,116
Ensembl chr12:49,230,192...49,240,116 		JBrowse link
G Crybg1 crystallin beta-gamma domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CRYBG1 mRNA CTD PMID:23557933 NCBI chr20:49,007,673...49,204,040
Ensembl chr20:49,007,929...49,204,047 		JBrowse link
G Crybg3 crystallin beta-gamma domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CRYBG3 mRNA CTD PMID:23557933 NCBI chr11:54,218,399...54,330,962
Ensembl chr11:54,208,444...54,330,960 		JBrowse link
G Cryga crystallin, gamma A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYGA mRNA CTD PMID:23557933 NCBI chr 9:73,975,914...74,006,614
Ensembl chr 9:73,975,914...74,003,290 		JBrowse link
G Crygc crystallin, gamma C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYGC mRNA CTD PMID:23557933 NCBI chr 9:73,945,332...73,947,367
Ensembl chr 9:73,945,334...73,947,367 		JBrowse link
G Crygn crystallin, gamma N multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CRYGN mRNA CTD PMID:23557933 NCBI chr 4:11,286,475...11,294,002
Ensembl chr 4:11,286,475...11,294,002 		JBrowse link
G Cryz crystallin zeta affects expression
increases expression 		EXP
ISO 		resveratrol affects the expression of CRYZ mRNA
resveratrol results in increased expression of CRYZ mRNA 		CTD PMID:15748624 PMID:22610192 NCBI chr 2:246,211,707...246,239,472
Ensembl chr 2:246,211,156...246,239,470 		JBrowse link
G Cryzl1 crystallin zeta like 1 increases expression ISO resveratrol results in increased expression of CRYZL1 mRNA CTD PMID:22610192 NCBI chr11:44,419,099...44,464,366
Ensembl chr11:44,419,103...44,463,793 		JBrowse link
G Cs citrate synthase increases expression
multiple interactions
increases activity 		EXP
ISO 		resveratrol results in increased expression of CS mRNA
resveratrol results in increased expression of CS protein
Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of CS protein]
resveratrol results in increased activity of CS protein
resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased activity of CS protein] 		CTD PMID:21715682 PMID:23536519 PMID:24041027 PMID:25505154 PMID:26027833 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csdc2 cold shock domain containing C2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CSDC2 mRNA CTD PMID:23557933 NCBI chr 7:115,332,134...115,346,599
Ensembl chr 7:115,332,128...115,346,596 		JBrowse link
G Csde1 cold shock domain containing E1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSDE1 mRNA CTD PMID:23557933 NCBI chr 2:193,234,546...193,271,301
Ensembl chr 2:193,243,526...193,271,301 		JBrowse link
G Cse1l chromosome segregation 1 like multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CSE1L mRNA CTD PMID:19167446 NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions
decreases expression 		ISO [Resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA; [Resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A mRNA]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A protein]; Resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased localization of RELA protein]
resveratrol analog results in decreased expression of CSF1 mRNA 		CTD PMID:15652768 PMID:16267019 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468 		JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CSF1R mRNA
[resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA
resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF1R protein] 		CTD PMID:16267019 PMID:22118570 PMID:25905778 NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806 		JBrowse link
G Csf2 colony stimulating factor 2 decreases expression
multiple interactions
increases expression 		ISO resveratrol analog results in decreased expression of CSF2 mRNA
[Resveratrol co-treated with Tetracyclines] inhibits the reaction [Paraquat results in increased expression of CSF2 protein]
Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CSF2 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein]; Resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein]; Resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein]
resveratrol results in increased expression of CSF2 mRNA 		CTD PMID:15180920 PMID:15280659 PMID:15652768 PMID:20801891 PMID:23981542 More... NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csf3 colony stimulating factor 3 multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CSF3 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF3 protein]
resveratrol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CSF3 protein]
resveratrol analog results in decreased expression of CSF3 mRNA 		CTD PMID:15652768 PMID:22646800 PMID:24707119 PMID:24895526 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSGALNACT1 mRNA CTD PMID:23557933 NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1A1 mRNA CTD PMID:23557933 NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538 		JBrowse link
G Csnk1g1 casein kinase 1, gamma 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CSNK1G1 mRNA CTD PMID:19167446 NCBI chr 8:75,334,751...75,472,339
Ensembl chr 8:75,334,895...75,467,515 		JBrowse link
G Csnk1g2 casein kinase 1, gamma 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1G2 mRNA CTD PMID:23557933 NCBI chr 7:9,727,430...9,746,341
Ensembl chr 7:9,727,431...9,745,741 		JBrowse link
G Csnk1g3 casein kinase 1, gamma 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1G3 mRNA CTD PMID:23557933 NCBI chr18:49,497,839...49,584,828
Ensembl chr18:49,497,839...49,584,828 		JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 increases expression
decreases expression 		ISO
EXP 		resveratrol results in increased expression of CSNK2A2 mRNA
Resveratrol results in decreased expression of CSNK2A2 mRNA 		CTD PMID:19371625 PMID:33775663 NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136 		JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CSPG5 mRNA CTD PMID:23557933 NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907 		JBrowse link
G Csrnp2 cysteine and serine rich nuclear protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CSRNP2 mRNA CTD PMID:19167446 NCBI chr 7:133,473,027...133,488,868
Ensembl chr 7:133,473,027...133,488,868 		JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 decreases expression ISO resveratrol results in decreased expression of CSRP1 protein CTD PMID:25505154 NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CSRP2 mRNA CTD PMID:23557933 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 increases expression ISO resveratrol results in increased expression of CSRP3 mRNA CTD PMID:22975027 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Csta cystatin A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CSTA mRNA CTD PMID:19167446 NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822 		JBrowse link
G Cstf1 cleavage stimulation factor subunit 1 decreases expression ISO resveratrol results in decreased expression of CSTF1 protein CTD PMID:25505154 NCBI chr 3:181,562,953...181,574,727
Ensembl chr 3:181,562,955...181,574,727 		JBrowse link
G Cstf2 cleavage stimulation factor subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CSTF2 mRNA CTD PMID:23557933 NCBI chr  X:101,546,809...101,572,760
Ensembl chr  X:101,546,819...101,572,764 		JBrowse link
G Ct47b1 cancer/testis antigen family 47, member B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CT47B1 mRNA CTD PMID:23557933 NCBI chr  X:120,517,223...120,520,951
Ensembl chr  X:120,517,250...120,520,945 		JBrowse link
G Ct55 cancer/testis antigen 55 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CT55 mRNA CTD PMID:23557933 NCBI chr  X:138,525,325...138,538,521
Ensembl chr  X:138,519,259...138,538,551 		JBrowse link
G Ctbs chitobiase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CTBS mRNA CTD PMID:23557933 NCBI chr 2:238,000,800...238,015,368
Ensembl chr 2:238,000,842...238,015,475 		JBrowse link
G Ctcf CCCTC-binding factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CTCF mRNA CTD PMID:23557933 NCBI chr19:50,431,478...50,481,013
Ensembl chr19:50,431,689...50,481,012 		JBrowse link
G Ctdnep1 CTD nuclear envelope phosphatase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DULLARD mRNA CTD PMID:23557933 NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852 		JBrowse link
G Ctdspl2 CTD small phosphatase like 2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CTDSPL2 protein
[Coumestrol co-treated with resveratrol] results in increased expression of CTDSPL2 mRNA 		CTD PMID:19167446 PMID:25505154 NCBI chr 3:129,365,709...129,424,232
Ensembl chr 3:129,368,938...129,424,232 		JBrowse link
G Ctf1 cardiotrophin 1 multiple interactions EXP resveratrol inhibits the reaction [sunitinib increases expression of mRNA in rat cardiomyocytes]
resveratrol inhibits the reaction [sunitinib results in increased expression of CTF1 mRNA] 		CTD
RGD		 PMID:24247421 PMID:24247421 RGD:401793741 NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:191,757,477...191,776,395 		JBrowse link
G Cth cystathionine gamma-lyase increases expression EXP Resveratrol results in increased expression of CTH mRNA CTD PMID:35577173 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Cthrc1 collagen triple helix repeat containing 1 increases expression ISO resveratrol results in increased expression of CTHRC1 mRNA CTD PMID:25888808 NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654 		JBrowse link
G Ctnna1 catenin alpha 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CTNNA1 mRNA CTD PMID:23557933 NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007 		JBrowse link
G Ctnnal1 catenin alpha-like 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CTNNAL1 mRNA CTD PMID:19167446 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctnnb1 catenin beta 1 affects localization
increases stability
multiple interactions
decreases expression
increases degradation
increases expression 		EXP
ISO 		resveratrol affects the localization of CTNNB1 protein
Resveratrol results in increased stability of CTNNB1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased stability of CTNNB1 protein]; [Resveratrol co-treated with Excitatory Amino Acid Agents] results in increased stability of CTNNB1 protein; CTNNB1 protein promotes the reaction [Resveratrol results in decreased susceptibility to Excitatory Amino Acid Agents]; CTNNB1 protein promotes the reaction [Resveratrol results in increased expression of SOD2 protein]; Resveratrol inhibits the reaction [Sodium Fluoride results in increased expression of CTNNB1 protein]; Resveratrol inhibits the reaction [TCF4 protein binds to CTNNB1 protein]; Resveratrol inhibits the reaction [WNT3A protein promotes the reaction [TCF4 protein binds to CTNNB1 protein]]; Resveratrol results in decreased expression of and affects the localization of CTNNB1 protein
[[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein; [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein; [Resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein; [Resveratrol results in increased localization of and results in increased activity of CTNNB1 protein] which results in increased expression of VEGFA mRNA; [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein; CTNNB1 protein promotes the reaction [Resveratrol results in increased expression of VEGFA protein]; lactacystin inhibits the reaction [Resveratrol results in increased degradation of CTNNB1 protein]; MALAT1 protein affects the reaction [Resveratrol inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein]]; MALAT1 protein inhibits the reaction [Resveratrol affects the localization of CTNNB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein]; Resveratrol inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein]; Resveratrol inhibits the reaction [Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]]; Resveratrol inhibits the reaction [Oxygen deficiency affects the localization of CTNNB1 protein]; Resveratrol inhibits the reaction [TCF4 protein binds to CTNNB1 protein]; Resveratrol promotes the reaction [CASP3 protein results in increased degradation of CTNNB1 protein]; Resveratrol results in decreased activity of [TCF4 protein co-treated with CTNNB1 protein]; Resveratrol results in decreased expression of and affects the localization of CTNNB1 protein; Resveratrol results in increased localization of and results in increased activity of CTNNB1 protein
[resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein
resveratrol results in decreased expression of CTNNB1 mRNA; resveratrol results in decreased expression of CTNNB1 protein
resveratrol results in increased degradation of CTNNB1 protein
resveratrol results in increased expression of CTNNB1 mRNA 		CTD PMID:11895924 PMID:17188708 PMID:18347188 PMID:19047049 PMID:20542495 More... NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctnnbl1 catenin, beta like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CTNNBL1 mRNA CTD PMID:23557933 NCBI chr 3:166,807,899...166,968,932
Ensembl chr 3:166,807,858...166,968,931 		JBrowse link
G Ctnnd1 catenin delta 1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of CTNND1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CTNND1 mRNA
resveratrol results in increased expression of CTNND1 protein 		CTD PMID:19167446 PMID:23557933 PMID:24330398 NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189 		JBrowse link
G Ctnnd2 catenin delta 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CTNND2 mRNA CTD PMID:19167446 NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409 		JBrowse link
G Ctps1 CTP synthase 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CTPS1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CTPS1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465 		JBrowse link
G Ctps2 CTP synthase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CTPS2 mRNA CTD PMID:23557933 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505 		JBrowse link
G Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CTR9 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CTR9 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 1:174,571,952...174,601,974
Ensembl chr 1:174,571,928...174,602,130 		JBrowse link
G Ctrb1 chymotrypsinogen B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CTRB2 mRNA CTD PMID:23557933 NCBI chr19:56,562,220...56,566,978
Ensembl chr19:56,562,220...56,566,978 		JBrowse link
G Ctsd cathepsin D multiple interactions
increases expression
decreases expression
increases secretion
affects expression
affects response to substance 		ISO [resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein; CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein]; CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]]; CTSD protein affects the reaction [resveratrol results in increased activity of CASP3 protein]; ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein]; resveratrol results in increased expression of and results in increased metabolism of and affects the localization of CTSD protein
resveratrol metabolite results in increased expression of CTSD mRNA; resveratrol results in increased expression of CTSD; resveratrol results in increased expression of CTSD mRNA; resveratrol results in increased expression of CTSD protein
resveratrol results in decreased expression of CTSD mRNA
resveratrol results in increased secretion of CTSD protein
resveratrol affects the expression of CTSD mRNA
CTSD protein affects the susceptibility to resveratrol 		CTD PMID:10402233 PMID:14750165 PMID:16081268 PMID:16393696 PMID:17116725 More... NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctsh cathepsin H multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CTSH mRNA CTD PMID:19167446 NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181 		JBrowse link
G Ctsk cathepsin K multiple interactions ISO resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] CTD PMID:16267019 NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582 		JBrowse link
G Ctss cathepsin S multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CTSS mRNA CTD PMID:25905778 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440 		JBrowse link
G Ctsw cathepsin W multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CTSW mRNA CTD PMID:23557933 NCBI chr 1:212,201,904...212,208,028
Ensembl chr 1:212,201,904...212,205,292 		JBrowse link
G Cttn cortactin decreases expression ISO resveratrol results in decreased expression of CTTN protein CTD PMID:25505154 NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211 		JBrowse link
G Cttnbp2 cortactin binding protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CTTNBP2 mRNA CTD PMID:23557933 NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:47,766,870...47,930,540 		JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 NCBI chr 2:195,196,318...195,244,792
Ensembl chr 2:195,196,318...195,243,181 		JBrowse link
G Cul1 cullin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CUL1 mRNA CTD PMID:23557933 NCBI chr 4:77,551,781...77,634,210
Ensembl chr 4:77,551,787...77,621,760 		JBrowse link
G Cul3 cullin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CUL3 mRNA CTD PMID:23557933 NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427 		JBrowse link
G Cul4a cullin 4A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CUL4A mRNA CTD PMID:23557933 NCBI chr16:83,086,688...83,124,503
Ensembl chr16:83,086,921...83,124,457 		JBrowse link
G Cul5 cullin 5 increases expression
multiple interactions 		ISO resveratrol results in increased expression of CUL5 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CUL5 mRNA 		CTD PMID:20949323 PMID:23557933 NCBI chr 8:62,909,150...62,974,641
Ensembl chr 8:62,912,193...62,965,463 		JBrowse link
G Cux1 cut-like homeobox 1 decreases expression ISO resveratrol results in decreased expression of CUX1 mRNA CTD PMID:19371625 NCBI chr12:25,728,393...26,062,497
Ensembl chr12:25,743,733...26,062,497 		JBrowse link
G Cwc25 CWC25 spliceosome-associated protein homolog multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CWC25 mRNA CTD PMID:23557933 NCBI chr10:83,232,052...83,256,722
Ensembl chr10:83,232,052...83,256,722 		JBrowse link
G Cwf19l1 CWF19 like cell cycle control factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CWF19L1 mRNA CTD PMID:23557933 NCBI chr 1:252,946,934...252,970,194
Ensembl chr 1:252,946,934...252,970,168 		JBrowse link
G Cwf19l2 CWF19 like cell cycle control factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CWF19L2 mRNA CTD PMID:23557933 NCBI chr 6:6,036,158...6,102,686
Ensembl chr 6:6,026,861...6,102,635 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CX3CL1 mRNA; Resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein]
resveratrol results in decreased expression of CX3CL1 mRNA
resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] 		CTD PMID:16614140 PMID:23224687 PMID:23557933 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 multiple interactions
decreases secretion
decreases expression 		EXP
ISO 		chromium mesoporphyrin inhibits the reaction [resveratrol results in decreased activity of CXCL1 protein]; chromium mesoporphyrin inhibits the reaction [resveratrol results in decreased expression of CXCL1 protein]; fulvestrant inhibits the reaction [resveratrol results in decreased expression of CXCL1 protein]; resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 mRNA]; resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 protein]; SB 203580 inhibits the reaction [resveratrol results in decreased expression of CXCL1 protein]; wortmannin inhibits the reaction [resveratrol results in decreased activity of CXCL1 protein]
resveratrol results in decreased secretion of CXCL1 protein
resveratrol results in decreased expression of CXCL1 mRNA
resveratrol results in decreased expression of CXCL1 mRNA; resveratrol results in decreased expression of CXCL1 protein 		CTD PMID:15734790 PMID:18277952 PMID:20036306 PMID:20117814 PMID:21192278 More... NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases expression
multiple interactions
decreases secretion 		ISO resveratrol results in decreased expression of CXCL10 mRNA; resveratrol results in decreased expression of CXCL10 protein
resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; resveratrol inhibits the reaction [PD168393 results in increased expression of CXCL10 mRNA]; resveratrol inhibits the reaction [PD168393 results in increased secretion of CXCL10 protein]; resveratrol inhibits the reaction [TNF protein results in increased secretion of CXCL10 protein]
resveratrol results in decreased secretion of CXCL10 protein 		CTD PMID:21189227 PMID:21756928 PMID:21807089 PMID:21967610 PMID:26066604 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of CXCL12 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CXCL12 mRNA; Resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium]; Resveratrol inhibits the reaction [CXCL12 protein results in increased secretion of VEGFA protein]
resveratrol results in increased expression of CXCL12 mRNA 		CTD PMID:16212921 PMID:19167446 PMID:23557933 PMID:25815440 PMID:28396216 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 decreases expression ISO resveratrol results in decreased expression of CXCL14 mRNA CTD PMID:19555370 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
decreases secretion
decreases expression
increases expression 		EXP
ISO 		chromium mesoporphyrin inhibits the reaction [Resveratrol results in decreased activity of CXCL2 protein]; chromium mesoporphyrin inhibits the reaction [Resveratrol results in decreased expression of CXCL2 protein]; Fulvestrant inhibits the reaction [Resveratrol results in decreased expression of CXCL2 protein]; Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 mRNA]; SB 203580 inhibits the reaction [Resveratrol results in decreased expression of CXCL2 protein]; Wortmannin inhibits the reaction [Resveratrol results in decreased activity of CXCL2 protein]
resveratrol results in decreased secretion of CXCL2 protein
Resveratrol results in decreased expression of CXCL2 mRNA; Resveratrol results in decreased expression of CXCL2 protein
resveratrol results in increased expression of CXCL2 mRNA
resveratrol results in decreased expression of CXCL2 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CXCL2 mRNA 		CTD PMID:15734790 PMID:18277952 PMID:19228061 PMID:20117814 PMID:21192278 More... NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression
multiple interactions
decreases secretion 		ISO
EXP 		resveratrol results in decreased expression of CXCL1 mRNA
KHSRP gene mutant form inhibits the reaction [resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of CXCL1 mRNA]]; resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of CXCL1 mRNA]
resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL3 mRNA]
resveratrol results in decreased secretion of CXCL1 protein 		CTD PMID:15734790 PMID:22933405 PMID:25352548 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CXCL6 mRNA
resveratrol results in decreased expression of CXCL6 mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 decreases expression ISO resveratrol results in decreased expression of CXCL9 mRNA CTD PMID:21189227 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CXCR3 mRNA
resveratrol results in decreased expression of CXCR3 protein 		CTD PMID:21807089 PMID:23557933 NCBI chr  X:70,884,293...70,886,944
Ensembl chr  X:70,883,958...70,886,871 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of CXCR4 mRNA; resveratrol results in decreased expression of CXCR4 protein
resveratrol inhibits the reaction [cobaltous chloride results in increased expression of CXCR4 protein]; SIRT1 protein inhibits the reaction [resveratrol results in decreased expression of CXCR4 protein] 		CTD PMID:15280659 PMID:25815440 PMID:26959057 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO resveratrol results in increased expression of CYB5A mRNA CTD PMID:22610192 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYB5B mRNA CTD PMID:23557933 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of CYB5R1 protein
[Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA 		CTD PMID:19167446 PMID:25505154 NCBI chr13:48,401,061...48,407,466
Ensembl chr13:48,399,106...48,407,465 		JBrowse link
G Cyb5r2 cytochrome b5 reductase 2 increases expression ISO resveratrol results in increased expression of CYB5R2 mRNA CTD PMID:25888808 NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:171,067,614...171,075,904 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 increases expression ISO resveratrol results in increased expression of CYB5R3 protein CTD PMID:25505154 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cyb5rl cytochrome b5 reductase-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYB5RL mRNA CTD PMID:23557933 NCBI chr 5:127,075,034...127,097,551
Ensembl chr 5:127,074,535...127,097,518 		JBrowse link
G Cyba cytochrome b-245 alpha chain decreases expression
increases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of CYBA mRNA
resveratrol results in increased expression of CYBA mRNA
resveratrol inhibits the reaction [Oxalic Acid results in increased expression of CYBA mRNA]
[resveratrol co-treated with Streptozocin] results in increased expression of CYBA mRNA; GW 6471 inhibits the reaction [resveratrol inhibits the reaction [Niacinamide results in increased expression of CYBA mRNA]]; resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of CYBA protein]; resveratrol inhibits the reaction [Niacinamide results in increased expression of CYBA mRNA] 		CTD PMID:20081535 PMID:22245600 PMID:22610192 PMID:23422569 PMID:24145091 More... NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain decreases expression
multiple interactions
increases expression 		EXP
ISO 		Resveratrol results in decreased expression of CYBB mRNA
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of CYBB protein]
Resveratrol results in decreased expression of CYBB mRNA; Resveratrol results in decreased expression of CYBB protein
Resveratrol results in increased expression of CYBB mRNA
Resveratrol inhibits the reaction [Titanium results in increased expression of CYBB mRNA]
[Plant Extracts co-treated with Resveratrol] results in increased expression of CYBB mRNA 		CTD PMID:19478208 PMID:20081535 PMID:20610621 PMID:23557933 PMID:23593274 More... NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cyc1 cytochrome c-1 decreases expression
increases expression 		ISO resveratrol results in decreased expression of CYC1 mRNA
resveratrol results in increased expression of CYC1 mRNA 		CTD PMID:21270273 PMID:22610192 NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657 		JBrowse link
G Cycs cytochrome c, somatic decreases expression
multiple interactions
increases expression
affects localization 		EXP
ISO 		resveratrol results in decreased expression of CYCS protein
[resveratrol co-treated with Paclitaxel] affects the localization of CYCS protein; BCL2 protein inhibits the reaction [resveratrol affects the localization of CYCS protein]; CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein]; PRKN gene mutant form promotes the reaction [resveratrol results in increased expression of CYCS mRNA]; resveratrol inhibits the reaction [MFGE8 protein affects the localization of CYCS protein]
resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium affects the localization of CYCS protein]
resveratrol results in increased expression of CYCS mRNA; resveratrol results in increased expression of CYCS protein
dorsomorphin inhibits the reaction [Resveratrol results in increased expression of CYCS protein]; PRKAA1 gene mutant form inhibits the reaction [Resveratrol results in increased expression of CYCS protein]; Resveratrol inhibits the reaction [4-hydroxy-2-nonenal affects the localization of CYCS protein] 		CTD PMID:11577002 PMID:14749477 PMID:15827328 PMID:16095586 PMID:16322078 More... NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip1 cytoplasmic FMR1 interacting protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYFIP1 mRNA CTD PMID:23557933 NCBI chr 1:115,842,754...115,935,163
Ensembl chr 1:115,846,661...115,951,292 		JBrowse link
G Cygb cytoglobin decreases expression ISO resveratrol results in decreased expression of CYGB mRNA CTD PMID:20706672 NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272 		JBrowse link
G Cylc1 cylicin 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYLC1 mRNA CTD PMID:23557933 NCBI chr  X:80,224,288...80,313,698
Ensembl chr  X:80,224,316...80,313,698 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 increases expression
multiple interactions
decreases expression
decreases acetylation 		EXP
ISO 		resveratrol results in increased expression of CYP11A1 mRNA
resveratrol results in increased expression of CYP11A1 protein
[Simvastatin co-treated with resveratrol] results in decreased expression of CYP11A1 mRNA; resveratrol inhibits the reaction [Fluoxetine results in decreased expression of CYP11A1 mRNA]
resveratrol results in decreased expression of CYP11A1 mRNA
SIRT3 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein]; SIRT3 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein]; SIRT5 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein]; SIRT5 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein] 		CTD PMID:22585829 PMID:24524197 PMID:26348076 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
decreases expression
decreases activity 		EXP
ISO 		[[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein; [resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein; resveratrol promotes the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA]; Simvastatin promotes the reaction [resveratrol results in decreased expression of CYP17A1 mRNA]
resveratrol analog results in decreased expression of CYP17A1 mRNA; resveratrol results in decreased expression of CYP17A1 mRNA
resveratrol analog results in decreased activity of CYP17A1 protein; resveratrol results in decreased activity of CYP17A1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP17A1 mRNA 		CTD PMID:19603415 PMID:22719052 PMID:23557933 PMID:24524197 PMID:24610083 More... NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases expression
decreases activity
multiple interactions
increases expression 		ISO
EXP 		resveratrol results in decreased expression of CYP19A1 mRNA
resveratrol analog results in decreased activity of CYP19A1 protein; resveratrol metabolite results in decreased activity of CYP19A1 protein; resveratrol results in decreased activity of CYP19A1 protein
Resveratrol inhibits the reaction [Dinoprostone results in increased expression of CYP19A1 protein]; Resveratrol inhibits the reaction [Estradiol promotes the reaction [ESR1 results in increased expression of CYP19A1 mRNA alternative form]]; Resveratrol inhibits the reaction [Estradiol promotes the reaction [ESR1 results in increased expression of CYP19A1 protein]]; Resveratrol inhibits the reaction [Estradiol results in increased expression of CYP19A1 mRNA alternative form]; Resveratrol inhibits the reaction [Estradiol results in increased expression of CYP19A1 protein]; Resveratrol inhibits the reaction [MAPK3 results in increased expression of CYP19A1 protein]
resveratrol analog results in increased expression of CYP19A1 mRNA
resveratrol results in increased expression of CYP19A1 mRNA; resveratrol results in increased expression of CYP19A1 protein 		CTD PMID:16611627 PMID:17766065 PMID:17910019 PMID:18462857 PMID:20527891 More... NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases activity
increases degradation
decreases expression
affects metabolic processing
affects expression
increases activity 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP1A1 mRNA; [Resveratrol results in decreased activity of AHR protein] inhibits the reaction [Sunitinib results in increased expression of CYP1A1 mRNA]; AHR mutant form inhibits the reaction [Resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]; AHR mutant form inhibits the reaction [Resveratrol results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Resveratrol results in increased expression of CYP1A1 protein]; beta-Naphthoflavone promotes the reaction [Resveratrol results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [[Benzo(a)pyrene results in increased activity of AHR protein] promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Resveratrol inhibits the reaction [[oltipraz promotes the reaction [AHR protein binds to CYP1A1 promoter]] which results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [AHR protein binds to CYP1A1 promoter]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [CYP1A1 protein affects the chemical synthesis of 2-hydroxyestradiol]; Resveratrol inhibits the reaction [CYP1A1 protein affects the metabolism of Estradiol]; Resveratrol inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [harman results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [oltipraz results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [pyrazolanthrone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [T-2 Toxin results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1A1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; Resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]
resveratrol results in increased expression of CYP1A1 protein
resveratrol results in increased expression of CYP1A1 mRNA; resveratrol results in increased expression of CYP1A1 protein
resveratrol results in decreased activity of CYP1A1 protein
[Resveratrol co-treated with Streptozocin] results in increased expression of CYP1A1 mRNA; Resveratrol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Sunitinib results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
resveratrol results in increased degradation of CYP1A1 mRNA
resveratrol metabolite results in decreased activity of CYP1A1 protein; resveratrol results in decreased activity of CYP1A1 protein
resveratrol decreases expression of mRNA in kidney of male offspring from pregnant dams treated with 2,3,7,8-tetrachlorodibenzodioxine and dexamethasone
resveratrol inhibits the reaction [sunitinib increases expression of mRNA in rat cardiomyocytes]
CYP1A1 protein affects the metabolism of resveratrol
resveratrol affects the expression of CYP1A1 mRNA
resveratrol results in decreased expression of CYP1A1 mRNA; resveratrol results in decreased expression of CYP1A1 protein
resveratrol results in increased activity of CYP1A1 protein
resveratrol results in decreased expression of CYP1A1; resveratrol results in decreased expression of CYP1A1 mRNA 		CTD
RGD		 PMID:9860486 PMID:9865727 PMID:10496959 PMID:10496962 PMID:11279601 More... RGD:401793709, RGD:401793741 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
decreases expression
affects metabolic processing
decreases activity 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP1A2 mRNA; Imipramine inhibits the reaction [Resveratrol results in decreased activity of CYP1A2 protein]; NADP promotes the reaction [Resveratrol results in decreased activity of CYP1A2 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]; Resveratrol inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [pyrazolanthrone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine]
resveratrol results in decreased expression of CYP1A2 mRNA
[resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA
CYP1A2 protein affects the metabolism of resveratrol
resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein]; resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein]; resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA]
resveratrol analog results in decreased activity of CYP1A2 protein; resveratrol results in decreased activity of CYP1A2 protein 		CTD PMID:10496959 PMID:11714871 PMID:15276085 PMID:16544949 PMID:16684708 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
decreases activity
affects expression
decreases expression
affects metabolic processing 		ISO [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Resveratrol co-treated with Benzo(a)pyrene] results in decreased expression of CYP1B1 protein; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]
resveratrol results in decreased activity of CYP1B1 protein
resveratrol affects the expression of CYP1B1 protein
resveratrol results in decreased expression of CYP1B1; resveratrol results in decreased expression of CYP1B1 mRNA; resveratrol results in decreased expression of CYP1B1 protein
CYP1B1 protein affects the metabolism of resveratrol
[Coumestrol co-treated with Resveratrol] results in increased expression of CYP1B1 mRNA; Resveratrol binds to and results in decreased activity of CYP1B1 protein; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of CYP1B1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1B1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [CYP1B1 protein affects the chemical synthesis of 4-hydroxyestradiol]; Resveratrol inhibits the reaction [CYP1B1 protein affects the metabolism of Estradiol]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] 		CTD PMID:11279601 PMID:11714871 PMID:14990334 PMID:15142886 PMID:15162144 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 multiple interactions
increases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of CYP26A1 mRNA
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in increased expression of CYP26A1 mRNA]; Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP26A1 mRNA]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP26A1 mRNA 		CTD PMID:23557933 PMID:25905778 PMID:29990529 PMID:31298478 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CYP26B1 mRNA CTD PMID:25905778 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of CYP27A1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of CYP27A1 protein]; ADORA2A protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein]; PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 mRNA]; PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein]; ZM 241385 inhibits the reaction [resveratrol results in increased expression of CYP27A1 protein]
resveratrol results in increased expression of CYP27A1 mRNA; resveratrol results in increased expression of CYP27A1 protein 		CTD PMID:22610192 PMID:23041272 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP2A13 mRNA CTD PMID:23557933 NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 decreases activity
multiple interactions 		ISO Resveratrol results in decreased activity of CYP2A4 protein
Resveratrol inhibits the reaction [Dietary Fats affects the expression of CYP2A4 mRNA] 		CTD PMID:17086191 PMID:18420780 NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CYP2B1 mRNA CTD PMID:25905778 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 decreases activity ISO Resveratrol results in decreased activity of CYP2B10 protein CTD PMID:18420780 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP2C18 mRNA CTD PMID:23557933 NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions
affects expression
decreases activity 		ISO
EXP 		Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP2C29 mRNA]
Resveratrol affects the expression of CYP2C29 mRNA
Resveratrol results in decreased activity of CYP2C29 protein
resveratrol inhibits the reaction [CYP2C19 protein results in increased metabolism of Mephenytoin]
resveratrol results in decreased activity of CYP2C19 protein 		CTD PMID:12569440 PMID:15748624 PMID:18420780 PMID:31298478 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO Resveratrol results in decreased activity of CYP2C8 protein CTD PMID:30394306
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 affects expression EXP Resveratrol affects the expression of CYP2D9 mRNA CTD PMID:15748624 NCBI chr 7:115,789,026...115,793,430
Ensembl chr 7:115,789,023...115,793,479 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 multiple interactions
decreases activity 		ISO resveratrol inhibits the reaction [CYP2D6 protein results in increased metabolism of Dextromethorphan]
resveratrol results in decreased activity of CYP2D22 protein
resveratrol inhibits the reaction [Paraquat results in decreased expression of CYP2D22 protein]
resveratrol results in decreased activity of CYP2D6 protein 		CTD PMID:18420780 PMID:20716633 PMID:22334051 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity
increases expression
multiple interactions
affects expression 		ISO
EXP 		resveratrol analog results in decreased activity of CYP2E1 protein; resveratrol results in decreased activity of CYP2E1 protein
resveratrol results in increased expression of CYP2E1 mRNA
Resveratrol inhibits the reaction [CYP2E1 protein results in increased metabolism of Chlorzoxazone]; Resveratrol inhibits the reaction [hydroquinone results in increased expression of CYP2E1 mRNA]; Resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP2E1 protein]; Resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP2E1 mRNA]
resveratrol affects the expression of CYP2E1 mRNA 		CTD PMID:15748624 PMID:16684708 PMID:18420780 PMID:18789925 PMID:22610192 More... NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYP2R1 mRNA CTD PMID:23557933 NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity
increases expression
multiple interactions 		ISO Resveratrol results in decreased activity of CYP3A4 protein
Resveratrol results in increased expression of CYP3A4 mRNA
[Resveratrol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Buspirone]; Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone] 		CTD PMID:12569440 PMID:17210444 PMID:18420780 PMID:20716633 PMID:21524698 More... NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of CYP4A1 mRNA CTD PMID:25905778 NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP4B1 mRNA CTD PMID:23557933 NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116 		JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression
multiple interactions 		ISO resveratrol results in increased expression of CYP51 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of CYP51A1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
increases expression 		ISO
EXP 		[Resveratrol results in increased activity of NR1H3 protein] which results in increased expression of CYP7A1 mRNA; geranylgeranyl pyrophosphate inhibits the reaction [Resveratrol results in increased expression of CYP7A1 mRNA]; NR1H3 protein promotes the reaction [Resveratrol results in increased expression of CYP7A1 mRNA]; Resveratrol promotes the reaction [titanium dioxide results in decreased expression of CYP7A1 mRNA]; Resveratrol results in increased expression of and results in increased activity of CYP7A1 protein
resveratrol results in increased expression of CYP7A1 mRNA
resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] 		CTD PMID:22607622 PMID:23146569 PMID:25418378 PMID:31298478 NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP7B1 mRNA] CTD PMID:31298478 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in decreased expression of CYP8B1 mRNA; Streptozocin inhibits the reaction [resveratrol results in increased expression of CYP8B1 mRNA] CTD PMID:25905778 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689 		JBrowse link
G Cyren cell cycle regulator of NHEJ multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYREN mRNA CTD PMID:23557933 NCBI chr 4:64,514,477...64,519,896
Ensembl chr 4:64,514,477...64,518,742 		JBrowse link
G Cysltr2 cysteinyl leukotriene receptor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CYSLTR2 mRNA CTD PMID:23557933 NCBI chr15:54,599,043...54,638,314
Ensembl chr15:54,598,818...54,713,597 		JBrowse link
G Cysrt1 cysteine rich tail 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYSRT1 mRNA CTD PMID:23557933 NCBI chr 3:28,452,359...28,456,006
Ensembl chr 3:28,451,219...28,456,118 		JBrowse link
G Cyyr1 cysteine and tyrosine rich 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of CYYR1 mRNA CTD PMID:25905778 NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473 		JBrowse link
G Czib CXXC motif containing zinc binding protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of CZIB mRNA CTD PMID:23557933 NCBI chr 5:127,875,408...127,885,100
Ensembl chr 5:127,877,173...127,886,538 		JBrowse link
G Dab1 DAB adaptor protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DAB1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DAB1 mRNA CTD PMID:23557933 NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584 		JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DACT2 mRNA CTD PMID:23557933 NCBI chr 1:63,854,182...63,864,153
Ensembl chr 1:63,854,182...63,864,255 		JBrowse link
G Dact3 dishevelled-binding antagonist of beta-catenin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DACT3 mRNA CTD PMID:23557933 NCBI chr 1:86,674,989...86,686,722
Ensembl chr 1:86,674,734...86,687,421 		JBrowse link
G Dag1 dystroglycan 1 decreases expression ISO resveratrol results in decreased expression of DAG1 protein
resveratrol results in decreased expression of DAG1 mRNA 		CTD PMID:18089832 PMID:22610192 NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199 		JBrowse link
G Dao D-amino-acid oxidase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DAO mRNA CTD PMID:23557933 NCBI chr12:48,252,900...48,275,964
Ensembl chr12:48,252,902...48,273,300 		JBrowse link
G Dapk1 death associated protein kinase 1 increases activity
increases expression 		ISO resveratrol results in increased activity of DAPK1 protein
resveratrol results in increased expression of DAPK1 mRNA; resveratrol results in increased expression of DAPK1 protein 		CTD PMID:23800064 NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581 		JBrowse link
G Dapl1 death associated protein-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DAPL1 mRNA CTD PMID:23557933 NCBI chr 3:64,369,734...64,389,677
Ensembl chr 3:64,369,546...64,389,677 		JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DARS1 mRNA
Resveratrol results in increased expression of DARS1 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Daxx death-domain associated protein multiple interactions
decreases expression 		ISO BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]]; resveratrol promotes the reaction [PML protein binds to DAXX protein]
resveratrol results in decreased expression of DAXX mRNA 		CTD PMID:12002526 PMID:19631782 NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720 		JBrowse link
G Dbf4 DBF4-CDC7 kinase regulatory subunit multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA CTD PMID:19167446 NCBI chr 4:26,631,491...26,656,080
Ensembl chr 4:26,631,514...26,656,562 		JBrowse link
G Dbf4b DBF4B-CDC7 kinase regulatory subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DBF4B mRNA CTD PMID:23557933 NCBI chr10:88,209,913...88,219,336 JBrowse link
G Dbh dopamine beta-hydroxylase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DBH mRNA CTD PMID:23557933 NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316 		JBrowse link
G Dbn1 drebrin 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of DBN1 mRNA CTD PMID:19167446 NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbr1 debranching RNA lariats 1 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of DBR1 mRNA
resveratrol results in decreased expression of DBR1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 8:109,018,364...109,030,092
Ensembl chr 8:109,018,325...109,031,406 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 increases expression ISO resveratrol results in increased expression of DBT mRNA CTD PMID:22610192 NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525 		JBrowse link
G Dcaf12l1 DDB1 and CUL4 associated factor 12-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DCAF12L1 mRNA CTD PMID:23557933 NCBI chr  X:128,572,969...128,576,588
Ensembl chr  X:128,572,811...128,577,222 		JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA CTD PMID:19167446 NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110 		JBrowse link
G Dcakd dephospho-CoA kinase domain containing increases expression ISO resveratrol results in increased expression of DCAKD protein CTD PMID:25505154 NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118 		JBrowse link
G Dck deoxycytidine kinase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DCK mRNA CTD PMID:19167446 NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326 		JBrowse link
G Dclk1 doublecortin-like kinase 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of DCLK1 protein
[Coumestrol co-treated with Resveratrol] results in decreased expression of DCLK1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of DCLK1 mRNA 		CTD PMID:19167446 PMID:23557933 PMID:25505154 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dclre1a DNA cross-link repair 1A decreases expression
multiple interactions 		EXP
ISO 		Resveratrol results in decreased expression of DCLRE1A mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr 1:265,575,087...265,594,987
Ensembl chr 1:265,575,087...265,593,899 		JBrowse link
G Dclre1b DNA cross-link repair 1B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1B mRNA CTD PMID:19167446 NCBI chr 2:193,998,350...194,006,873
Ensembl chr 2:193,998,354...194,006,864 		JBrowse link
G Dcp2 decapping mRNA 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DCP2 mRNA CTD PMID:23557933 NCBI chr18:37,001,615...37,037,949
Ensembl chr18:37,001,615...37,049,939 		JBrowse link
G Dcps decapping enzyme, scavenger decreases expression ISO resveratrol results in decreased expression of DCPS protein CTD PMID:25505154 NCBI chr 8:41,729,507...41,782,222
Ensembl chr 8:41,724,563...41,782,222 		JBrowse link
G Dcst1 DC-STAMP domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DCST1 mRNA CTD PMID:23557933 NCBI chr 2:177,063,083...177,079,914
Ensembl chr 2:177,063,083...177,079,927 		JBrowse link
G Dct dopachrome tautomerase decreases expression ISO resveratrol results in decreased expression of DCT protein CTD PMID:17460731 NCBI chr15:101,469,159...101,508,029
Ensembl chr15:101,469,159...101,508,029 		JBrowse link
G Dctn1 dynactin subunit 1 affects expression ISO resveratrol affects the expression of DCTN1 protein CTD PMID:22234583 NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:117,219,349...117,261,528 		JBrowse link
G Dctn3 dynactin subunit 3 increases expression ISO resveratrol results in increased expression of DCTN3 protein CTD PMID:25505154 NCBI chr 5:61,676,950...61,684,958
Ensembl chr 5:61,676,950...61,684,903 		JBrowse link
G Dctn4 dynactin subunit 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DCTN4 mRNA CTD PMID:23557933 NCBI chr18:56,251,187...56,279,844
Ensembl chr18:56,252,780...56,279,842 		JBrowse link
G Dctn5 dynactin subunit 5 increases expression ISO resveratrol results in increased expression of DCTN5 protein CTD PMID:25505154 NCBI chr 1:186,120,415...186,137,146
Ensembl chr 1:186,119,913...186,137,146 		JBrowse link
G Dctn6 dynactin subunit 6 increases expression ISO resveratrol results in increased expression of DCTN6 mRNA CTD PMID:22610192 NCBI chr16:64,780,759...64,799,766
Ensembl chr16:64,780,735...64,801,060 		JBrowse link
G Dcun1d2 defective in cullin neddylation 1 domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DCUN1D2 mRNA CTD PMID:23557933 NCBI chr16:82,956,493...82,983,308
Ensembl chr16:82,956,339...82,983,307 		JBrowse link
G Dcun1d3 defective in cullin neddylation 1 domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DCUN1D3 mRNA CTD PMID:23557933 NCBI chr 1:183,674,364...183,717,002
Ensembl chr 1:75,527,981...75,529,932
Ensembl chr 1:75,527,981...75,529,932 		JBrowse link
G Dcun1d5 defective in cullin neddylation 1 domain containing 5 increases expression
multiple interactions 		ISO resveratrol results in increased expression of DCUN1D5 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DCUN1D5 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:12,697,160...12,718,242
Ensembl chr 8:12,697,127...12,718,991 		JBrowse link
G Dcx doublecortin increases expression ISO resveratrol results in increased expression of DCX protein CTD PMID:18089832 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DCXR mRNA CTD PMID:23557933 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Dda1 DET1 and DDB1 associated 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DDA1 mRNA CTD PMID:23557933 NCBI chr16:18,190,280...18,197,914
Ensembl chr16:18,190,306...18,197,913 		JBrowse link
G Ddah2 DDAH family member 2, ADMA-independent multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA CTD PMID:19167446 NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183 		JBrowse link
G Ddb2 damage specific DNA binding protein 2 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Coumestrol co-treated with Resveratrol] results in increased expression of DDB2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DDB2 mRNA
resveratrol results in increased expression of DDB2 mRNA
Resveratrol results in decreased expression of DDB2 mRNA 		CTD PMID:19167446 PMID:23557933 PMID:25888808 PMID:33775663 NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066 		JBrowse link
G Ddc dopa decarboxylase increases expression ISO resveratrol results in increased expression of DDC mRNA CTD PMID:18586690 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806 		JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDHD1 mRNA CTD PMID:23557933 NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DDIAS mRNA CTD PMID:19167446 NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 affects response to substance
multiple interactions
decreases expression
increases expression 		ISO
EXP 		DDIT3 protein affects the susceptibility to resveratrol
[Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Resveratrol inhibits the reaction [Acrolein results in increased expression of DDIT3 protein]
[resveratrol results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein; Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [resveratrol results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [resveratrol promotes the reaction [arsenic trioxide results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [resveratrol results in increased expression of DDIT3 protein]; arsenic trioxide promotes the reaction [resveratrol results in increased expression of DDIT3 protein]; Cycloserine inhibits the reaction [resveratrol results in increased expression of DDIT3 protein]; pyrazolanthrone inhibits the reaction [resveratrol results in increased expression of DDIT3 mRNA]; pyrazolanthrone inhibits the reaction [resveratrol results in increased expression of DDIT3 protein]; resveratrol inhibits the reaction [Ethanol results in increased expression of DDIT3 protein]; resveratrol promotes the reaction [arsenic trioxide results in increased expression of DDIT3 protein]; resveratrol promotes the reaction [SP1 protein binds to DDIT3 promoter]; thermozymocidin inhibits the reaction [resveratrol results in increased expression of DDIT3 protein]
Resveratrol results in decreased expression of DDIT3 mRNA; Resveratrol results in decreased expression of DDIT3 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in decreased expression of DDIT3 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of DDIT3 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of DDIT3 protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of DDIT3 mRNA]
resveratrol results in increased expression of DDIT3 mRNA; resveratrol results in increased expression of DDIT3 protein 		CTD PMID:17049495 PMID:17914584 PMID:20198347 PMID:21321189 PMID:22898769 More... NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of DDIT4 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DDIT4 mRNA 		CTD PMID:19167446 PMID:25905778 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddn dendrin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DDN mRNA CTD PMID:23557933 NCBI chr 7:131,832,270...131,836,252
Ensembl chr 7:131,832,271...131,836,294 		JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression ISO resveratrol results in increased expression of DDOST protein CTD PMID:25505154 NCBI chr 5:155,805,612...155,812,728
Ensembl chr 5:155,805,454...155,813,121 		JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DDR1 mRNA CTD PMID:23557933 NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276 		JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 decreases expression ISO resveratrol results in decreased expression of DDR2 mRNA CTD PMID:25667456 NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288 		JBrowse link
G Ddx1 DEAD-box helicase 1 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX1 mRNA
resveratrol results in decreased expression of DDX1 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:41,725,367...41,758,302 		JBrowse link
G Ddx10 DEAD-box helicase 10 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DDX10 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX10 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:62,384,876...62,539,585
Ensembl chr 8:62,384,876...62,539,585 		JBrowse link
G Ddx17 DEAD-box helicase 17 decreases expression ISO resveratrol results in decreased expression of DDX17 protein CTD PMID:25505154 NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747 		JBrowse link
G Ddx18 DEAD-box helicase 18 decreases expression ISO resveratrol results in decreased expression of DDX18 protein CTD PMID:25505154 NCBI chr13:35,282,391...35,296,038
Ensembl chr13:35,282,467...35,295,972 		JBrowse link
G Ddx19a DEAD-box helicase 19A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX19A mRNA CTD PMID:23557933 NCBI chr19:55,851,854...55,872,209
Ensembl chr19:55,851,854...55,872,209 		JBrowse link
G Ddx20 DEAD-box helicase 20 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX20 mRNA CTD PMID:23557933 NCBI chr 2:195,847,105...195,859,989
Ensembl chr 2:195,847,105...195,855,461 		JBrowse link
G Ddx21 DExD-box helicase 21 multiple interactions
decreases expression 		ISO
EXP 		[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of DDX21 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX21 mRNA
resveratrol results in decreased expression of DDX21 mRNA
resveratrol results in decreased expression of DDX21 protein 		CTD PMID:23557933 PMID:25505154 PMID:25905778 PMID:26667767 NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Ddx23 DEAD-box helicase 23 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX23 mRNA
resveratrol results in decreased expression of DDX23 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 7:131,676,636...131,693,917
Ensembl chr 7:131,676,636...131,689,074 		JBrowse link
G Ddx27 DEAD-box helicase 27 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DDX27 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX27 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:176,163,220...176,182,418
Ensembl chr 3:176,163,203...176,182,410 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked multiple interactions ISO Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of DDX3X protein]
[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX3X mRNA 		CTD PMID:23557933 PMID:34614429 NCBI chr  X:12,152,346...12,165,983
Ensembl chr  X:12,152,346...12,165,983 		JBrowse link
G Ddx42 DEAD-box helicase 42 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX42 mRNA
resveratrol results in decreased expression of DDX42 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr10:91,648,719...91,680,730
Ensembl chr10:91,648,248...91,680,729 		JBrowse link
G Ddx46 DEAD-box helicase 46 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX46 mRNA CTD PMID:23557933 NCBI chr17:8,947,237...8,993,705
Ensembl chr17:8,947,237...8,990,247 		JBrowse link
G Ddx50 DExD-box helicase 50 decreases expression ISO resveratrol results in decreased expression of DDX50 protein CTD PMID:25505154 NCBI chr20:31,104,354...31,133,652
Ensembl chr20:31,104,354...31,133,652 		JBrowse link
G Ddx52 DExD-box helicase 52 decreases expression EXP resveratrol results in decreased expression of DDX52 mRNA CTD PMID:25905778 NCBI chr10:69,322,062...69,344,856
Ensembl chr10:69,322,114...69,428,714 		JBrowse link
G Ddx54 DEAD-box helicase 54 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DDX54 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of DDX54 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr12:41,595,298...41,610,560
Ensembl chr12:41,595,555...41,611,053 		JBrowse link
G Ddx55 DEAD-box helicase 55 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DDX55 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX55 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr12:37,695,444...37,711,198
Ensembl chr12:37,695,444...37,711,198 		JBrowse link
G Ddx60 DEXD/H-box helicase 60 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX60 mRNA CTD PMID:23557933 NCBI chr16:33,087,940...33,208,843
Ensembl chr16:33,087,988...33,208,839 		JBrowse link
G Decr1 2,4-dienoyl-CoA reductase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DECR1 mRNA CTD PMID:23557933 NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033 		JBrowse link
G Defa5 defensin alpha 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEFA5 mRNA CTD PMID:23557933 NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318 		JBrowse link
G Defb18 defensin beta 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEFB113 mRNA CTD PMID:23557933 NCBI chr 9:28,348,776...28,349,793
Ensembl chr 9:28,348,776...28,349,793 		JBrowse link
G Defb26 defensin beta 26 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEFB125 mRNA CTD PMID:23557933 NCBI chr 3:161,437,500...161,441,234
Ensembl chr 3:161,437,500...161,441,234 		JBrowse link
G Defb36 defensin beta 36 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEFB123 mRNA CTD PMID:23557933 NCBI chr 3:161,538,276...161,547,107
Ensembl chr 3:161,538,178...161,548,694 		JBrowse link
G Defb44 defensin beta 44 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEFB136 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DEFB136 mRNA CTD PMID:23557933 NCBI chr15:41,487,871...41,489,562
Ensembl chr15:41,487,871...41,489,562 		JBrowse link
G Defb5 defensin beta 5 multiple interactions ISO [Resveratrol results in increased activity of SIRT1 protein] which results in increased expression of DEFB4A mRNA CTD PMID:24894820 NCBI chr16:77,315,424...77,317,828
Ensembl chr16:77,315,424...77,317,828 		JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DEGS1 mRNA CTD PMID:23557933 NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302 		JBrowse link
G Degs2 delta(4)-desaturase, sphingolipid 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DEGS2 mRNA CTD PMID:23557933 NCBI chr 6:133,360,449...133,377,677
Ensembl chr 6:133,360,457...133,364,422 		JBrowse link
G Dek DEK proto-oncogene decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DEK mRNA
resveratrol results in decreased expression of DEK protein
[Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA 		CTD PMID:12002526 PMID:19167446 PMID:25505154 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dennd10 DENN domain containing 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DENND10 mRNA CTD PMID:23557933 NCBI chr 1:269,937,023...269,960,506
Ensembl chr 1:269,936,895...269,962,853 		JBrowse link
G Dennd11 DENN domain containing 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DENND11 mRNA CTD PMID:23557933 NCBI chr 4:70,163,869...70,232,731
Ensembl chr 4:70,163,869...70,195,800 		JBrowse link
G Dennd2c DENN domain containing 2C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DENND2C mRNA CTD PMID:23557933 NCBI chr 2:193,310,822...193,378,986
Ensembl chr 2:193,335,230...193,378,978 		JBrowse link
G Dennd3 DENN domain containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DENND3 mRNA CTD PMID:23557933 NCBI chr 7:107,304,860...107,362,573
Ensembl chr 7:107,220,192...107,362,573 		JBrowse link
G Depdc1 DEP domain containing 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DEPDC1 mRNA CTD PMID:19167446 NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein affects response to substance
multiple interactions
decreases expression 		ISO DEPTOR protein affects the susceptibility to resveratrol
[Coumestrol co-treated with Resveratrol] results in increased expression of DEPTOR mRNA
resveratrol promotes the reaction [MTOR protein binds to DEPTOR protein]
resveratrol results in decreased expression of DEPTOR mRNA 		CTD PMID:19167446 PMID:19371625 PMID:20851890 NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041 		JBrowse link
G Dera deoxyribose-phosphate aldolase multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of DERA mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DERA mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 4:172,394,971...172,473,746
Ensembl chr 4:172,394,962...172,490,142 		JBrowse link
G Derl1 derlin 1 increases expression ISO resveratrol results in increased expression of DERL1 protein CTD PMID:25505154 NCBI chr 7:91,293,963...91,316,639
Ensembl chr 7:91,258,382...91,316,678 		JBrowse link
G Derl3 derlin 3 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DERL3 mRNA] CTD PMID:31298478 NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477 		JBrowse link
G Des desmin multiple interactions EXP
ISO 		resveratrol inhibits the reaction [Carbon Tetrachloride affects the expression of DES protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of DES mRNA 		CTD PMID:23262250 PMID:23557933 NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Desi1 desumoylating isopeptidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DESI1 mRNA CTD PMID:23557933 NCBI chr 7:115,401,613...115,422,974
Ensembl chr 7:115,401,624...115,423,172 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha decreases expression
increases expression 		ISO resveratrol results in decreased expression of DFFA mRNA
resveratrol results in increased expression of DFFA mRNA 		CTD PMID:12002526 PMID:12569576 NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728 		JBrowse link
G Dgat2l6 diacylglycerol O-acyltransferase 2-like 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DGAT2L6 mRNA CTD PMID:23557933 NCBI chr  X:69,654,519...69,678,049
Ensembl chr  X:69,654,519...69,678,049 		JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression ISO resveratrol results in increased expression of DGKA mRNA CTD PMID:25888808 NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569 		JBrowse link
G Dgke diacylglycerol kinase epsilon multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DGKE mRNA CTD PMID:23557933 NCBI chr10:74,348,931...74,374,509
Ensembl chr10:74,350,246...74,374,478 		JBrowse link
G Dgkh diacylglycerol kinase, eta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DGKH mRNA CTD PMID:23557933 NCBI chr15:60,390,279...60,559,777
Ensembl chr15:60,402,004...60,560,218 		JBrowse link
G Dgkz diacylglycerol kinase zeta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DGKZ mRNA CTD PMID:23557933 NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951 		JBrowse link
G Dguok deoxyguanosine kinase increases expression ISO resveratrol results in increased expression of DGUOK mRNA CTD PMID:22610192 NCBI chr 4:117,544,784...117,572,414
Ensembl chr 4:117,544,773...117,572,414 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of DHCR7 mRNA
resveratrol results in increased expression of DHCR7 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382 		JBrowse link
G Dhfr dihydrofolate reductase multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of DHFR mRNA
resveratrol results in increased expression of DHFR protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Dhodh dihydroorotate dehydrogenase multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHODH mRNA
resveratrol results in increased expression of DHODH mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496 		JBrowse link
G Dhrs1 dehydrogenase/reductase 1 increases expression ISO resveratrol results in increased expression of DHRS1 protein CTD PMID:25505154 NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734 		JBrowse link
G Dhrs2 dehydrogenase/reductase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DHRS2 mRNA CTD PMID:19167446 NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 increases expression ISO resveratrol results in increased expression of DHRS3 mRNA CTD PMID:19371625 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhrs4 dehydrogenase/reductase 4 increases expression ISO resveratrol results in increased expression of DHRS4 protein CTD PMID:25505154 NCBI chr15:32,924,482...32,948,103
Ensembl chr15:32,936,522...32,948,101 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 multiple interactions
increases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in decreased expression of DHRS7 mRNA
resveratrol results in increased expression of DHRS7 protein 		CTD PMID:25505154 PMID:25905778 NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744 		JBrowse link
G Dhx15 DEAH-box helicase 15 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DHX15 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DHX15 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828 		JBrowse link
G Dhx16 DEAH-box helicase 16 decreases expression ISO resveratrol results in decreased expression of DHX16 protein CTD PMID:25505154 NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,866,804...2,879,751 		JBrowse link
G Dhx32 DEAH-box helicase 32 (putative) multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX32 mRNA CTD PMID:23557933 NCBI chr 1:197,954,503...198,013,779
Ensembl chr 1:197,954,503...198,007,489 		JBrowse link
G Dhx33 DEAH-box helicase 33 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX33 mRNA CTD PMID:23557933 NCBI chr10:56,206,680...56,223,189
Ensembl chr10:56,206,680...56,223,143 		JBrowse link
G Dhx35 DEAH-box helicase 35 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX35 mRNA CTD PMID:23557933 NCBI chr 3:167,869,971...167,927,300
Ensembl chr 3:167,870,055...167,927,300 		JBrowse link
G Dhx36 DEAH-box helicase 36 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX36 mRNA CTD PMID:23557933 NCBI chr 2:149,006,089...149,044,192
Ensembl chr 2:149,006,089...149,044,191 		JBrowse link
G Dhx38 DEAH-box helicase 38 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX38 mRNA
resveratrol results in decreased expression of DHX38 protein 		CTD PMID:18089832 PMID:23557933 NCBI chr19:54,422,418...54,439,434
Ensembl chr19:54,422,418...54,439,423 		JBrowse link
G Dhx57 DExH-box helicase 57 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX57 mRNA CTD PMID:23557933 NCBI chr 6:20,474,889...20,528,556
Ensembl chr 6:20,477,191...20,528,556 		JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of DHX9 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DHX9 mRNA
resveratrol results in decreased expression of DHX9 mRNA 		CTD PMID:23557933 PMID:25505154 PMID:25905778 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein affects localization
increases expression
multiple interactions
decreases expression 		ISO resveratrol affects the localization of DIABLO protein
resveratrol results in increased expression of DIABLO protein
[resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein
resveratrol results in decreased expression of DIABLO protein 		CTD PMID:14749477 PMID:15837718 PMID:17636462 PMID:17872969 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Diaph2 diaphanous-related formin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIAPH2 mRNA CTD PMID:23557933 NCBI chr  X:96,700,535...97,528,080
Ensembl chr  X:96,700,726...97,528,080 		JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DIAPH3 mRNA CTD PMID:19167446 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Dicer1 dicer 1 ribonuclease III multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DICER1 mRNA CTD PMID:23557933 NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252 		JBrowse link
G Dimt1 DIM1 rRNA methyltransferase and ribosome maturation factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIMT1L mRNA CTD PMID:23557933 NCBI chr 2:40,076,622...40,101,792
Ensembl chr 2:40,076,570...40,101,787 		JBrowse link
G Dio1 iodothyronine deiodinase 1 multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in decreased expression of DIO1 mRNA
Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of DIO1 mRNA]; Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DIO1 mRNA] 		CTD PMID:25905778 PMID:27260466 PMID:31298478 NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771 		JBrowse link
G Dio2 iodothyronine deiodinase 2 decreases activity ISO resveratrol results in decreased activity of DIO2 protein CTD PMID:17327447 NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Dio3 iodothyronine deiodinase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DIO3 mRNA CTD PMID:23557933 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985 		JBrowse link
G Dip2b disco-interacting protein 2 homolog B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIP2B mRNA CTD PMID:23557933 NCBI chr 7:133,053,393...133,231,430
Ensembl chr 7:133,053,401...133,228,874 		JBrowse link
G Dipk1c divergent protein kinase domain 1C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DIPK1C mRNA CTD PMID:23557933 NCBI chr18:80,362,854...80,384,774
Ensembl chr18:80,362,982...80,386,551 		JBrowse link
G Dipk2a divergent protein kinase domain 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIPK2A mRNA CTD PMID:23557933 NCBI chr 8:103,950,345...103,969,461
Ensembl chr 8:103,909,931...103,969,461 		JBrowse link
G Diras2 DIRAS family GTPase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DIRAS2 mRNA CTD PMID:23557933 NCBI chr17:12,882,224...12,913,366
Ensembl chr17:12,880,385...12,914,291 		JBrowse link
G Dis3 DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIS3 mRNA CTD PMID:23557933 NCBI chr15:82,231,922...82,258,299
Ensembl chr15:82,231,283...82,258,333 		JBrowse link
G Dis3l DIS3-like exosome 3'-5' exoribonuclease multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DIS3L mRNA CTD PMID:23557933 NCBI chr 8:73,699,185...73,735,581
Ensembl chr 8:73,699,185...73,735,527 		JBrowse link
G Disp2 dispatched RND transporter family member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DISP2 mRNA CTD PMID:23557933 NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of DKC1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DKC1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr  X:157,751,651...157,757,796
Ensembl chr  Y:380,743...385,405
Ensembl chr  X:380,743...385,405 		JBrowse link
G Dkk3 dickkopf WNT signaling pathway inhibitor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DKK3 mRNA CTD PMID:23557933 NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression ISO resveratrol results in increased expression of DLAT protein CTD PMID:25505154 NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:59,868,214...59,900,818
Ensembl chr 1:59,868,214...59,900,818 		JBrowse link
G Dld dihydrolipoamide dehydrogenase affects secretion
multiple interactions
increases expression 		ISO resveratrol affects the secretion of DLD protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of DLD mRNA
resveratrol results in increased expression of DLD mRNA 		CTD PMID:15582268 PMID:23557933 PMID:24802182 NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions ISO [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of DLG1 mRNA; resveratrol promotes the reaction [geranylgeranylacetone results in increased expression of DLG1 mRNA] CTD PMID:21232033 NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions EXP Resveratrol inhibits the reaction [APP protein modified form results in decreased expression of DLG4 protein]; Resveratrol inhibits the reaction [Morphine results in increased expression of [GRIN1 protein binds to GRIN2B protein binds to DLG4 protein]]; Resveratrol inhibits the reaction [Oxidopamine results in decreased expression of DLG4 protein] CTD PMID:22713680 PMID:25654502 PMID:34302886 NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839 		JBrowse link
G Dlgap4 DLG associated protein 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLGAP4 mRNA CTD PMID:23557933 NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604 		JBrowse link
G Dlgap5 DLG associated protein 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DLGAP5 mRNA CTD PMID:19167446 NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLK1 mRNA CTD PMID:23557933 NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529 		JBrowse link
G Dlk2 delta like non-canonical Notch ligand 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLK2 mRNA CTD PMID:23557933 NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149 		JBrowse link
G Dll3 delta like canonical Notch ligand 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLL3 mRNA CTD PMID:23557933 NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406 		JBrowse link
G Dll4 delta like canonical Notch ligand 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLL4 mRNA CTD PMID:23557933 NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763 		JBrowse link
G Dlst dihydrolipoamide S-succinyltransferase increases expression ISO resveratrol results in increased expression of DLST protein CTD PMID:25505154 NCBI chr 6:110,489,576...110,512,841
Ensembl chr 6:110,489,392...110,514,357 		JBrowse link
G Dlx1 distal-less homeobox 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX1 mRNA CTD PMID:23557933 NCBI chr 3:76,763,864...76,768,454
Ensembl chr 3:76,763,500...76,768,447 		JBrowse link
G Dlx2 distal-less homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX2 mRNA CTD PMID:23557933 NCBI chr 3:76,777,912...76,781,255
Ensembl chr 3:76,777,912...76,781,255 		JBrowse link
G Dlx3 distal-less homeobox 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX3 mRNA CTD PMID:23557933 NCBI chr10:80,561,335...80,566,730
Ensembl chr10:80,561,335...80,566,711 		JBrowse link
G Dlx4 distal-less homeobox 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX4 mRNA CTD PMID:23557933 NCBI chr10:80,581,878...80,587,272
Ensembl chr10:80,582,303...80,587,294 		JBrowse link
G Dlx6 distal-less homeobox 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX6 mRNA CTD PMID:23557933 NCBI chr 4:35,951,005...35,956,354
Ensembl chr 4:35,951,005...35,956,354 		JBrowse link
G Dmac1 distal membrane arm assembly component 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMAC1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DMAC1 mRNA CTD PMID:23557933 NCBI chr 5:94,288,900...94,290,053
Ensembl chr 5:94,280,654...94,290,119 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 multiple interactions
increases expression 		EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of DMBT1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of DMBT1 mRNA
resveratrol results in increased expression of DMBT1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dmbt1l1 deleted in malignant brain tumors 1 like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMBT1L1 mRNA CTD PMID:23557933 NCBI chr 1:195,380,082...195,514,521
Ensembl chr 1:195,380,001...195,514,710 		JBrowse link
G Dmbx1 diencephalon/mesencephalon homeobox 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMBX1 mRNA CTD PMID:23557933 NCBI chr 5:134,630,968...134,639,781
Ensembl chr 5:134,630,968...134,639,781 		JBrowse link
G Dmd dystrophin decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of DMD mRNA
resveratrol inhibits the reaction [DMD gene mutant form results in decreased expression of ATP2A2 mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of ACTA2 mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL1A1 mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL1A2 mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL3A1 mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of EP300 protein]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of NPPA mRNA]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of TGFB1 mRNA] 		CTD PMID:22610192 PMID:23297412 PMID:26930420 NCBI chr  X:51,070,098...53,437,845
Ensembl chr  X:51,070,273...53,437,835 		JBrowse link
G Dmkn dermokine multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMKN mRNA
resveratrol results in increased expression of DMKN mRNA 		CTD PMID:23557933 PMID:25888808 NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439 		JBrowse link
G Dmrtc1a DMRT-like family C1a multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMRTC1 mRNA CTD PMID:23557933 NCBI chr  X:71,861,910...71,892,508
Ensembl chr  X:71,861,661...71,892,507 		JBrowse link
G Dmrtc2 DMRT-like family C2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMRTC2 mRNA CTD PMID:23557933 NCBI chr 1:89,594,120...89,601,761
Ensembl chr 1:89,594,215...89,601,762 		JBrowse link
G Dmtf1 cyclin D binding myb-like transcription factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DMTF1 mRNA CTD PMID:23557933 NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:25,865,447...25,905,943 		JBrowse link
G Dmxl1 Dmx-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DMXL1 mRNA CTD PMID:23557933 NCBI chr18:45,179,505...45,349,999
Ensembl chr18:45,179,551...45,356,406 		JBrowse link
G Dmxl2 Dmx-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DMXL2 mRNA CTD PMID:23557933 NCBI chr 8:63,637,314...63,803,911
Ensembl chr 8:63,637,314...63,781,116 		JBrowse link
G Dnaaf3 dynein, axonemal, assembly factor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DNAAF3 mRNA CTD PMID:23557933 NCBI chr 1:78,333,985...78,342,034
Ensembl chr 1:78,333,971...78,342,685 		JBrowse link
G Dnaaf5 dynein, axonemal, assembly factor 5 increases expression ISO resveratrol results in increased expression of DNAAF5 protein CTD PMID:25505154 NCBI chr12:20,567,482...20,606,600
Ensembl chr12:20,531,267...20,607,607 		JBrowse link
G Dnaaf9 dynein axonemal assembly factor 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAAF9 mRNA CTD PMID:23557933 NCBI chr 3:138,370,971...138,505,711
Ensembl chr 3:138,372,531...138,505,695 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 increases expression ISO resveratrol results in increased expression of DNAJA1 protein CTD PMID:25505154 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnaja2 DnaJ heat shock protein family (Hsp40) member A2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJA2 mRNA CTD PMID:23557933 NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB1 mRNA] CTD PMID:31298478 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 increases expression ISO resveratrol results in increased expression of DNAJB11 protein CTD PMID:25505154 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajb13 DnaJ heat shock protein family (Hsp40) member B13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DNAJB13 mRNA CTD PMID:23557933 NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093 		JBrowse link
G Dnajb14 DnaJ heat shock protein family (Hsp40) member B14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJB14 mRNA CTD PMID:23557933 NCBI chr 2:229,032,415...229,075,905
Ensembl chr 2:229,032,286...229,075,922 		JBrowse link
G Dnajb3 DnaJ heat shock protein family (Hsp40) member B3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DNAJB3 mRNA CTD PMID:23557933 NCBI chr 9:96,243,345...96,244,358
Ensembl chr 9:96,243,071...96,244,408 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB4 mRNA] CTD PMID:31298478 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression
multiple interactions 		ISO resveratrol results in increased expression of DNAJB9 protein
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB9 mRNA] 		CTD PMID:25505154 PMID:31298478 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344 		JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC10 mRNA CTD PMID:23557933 NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368 		JBrowse link
G Dnajc16 DnaJ heat shock protein family (Hsp40) member C16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC16 mRNA CTD PMID:23557933 NCBI chr 5:159,355,279...159,389,267
Ensembl chr 5:159,361,314...159,389,298 		JBrowse link
G Dnajc18 DnaJ heat shock protein family (Hsp40) member C18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC18 mRNA CTD PMID:23557933 NCBI chr18:27,543,438...27,577,535
Ensembl chr18:27,543,438...27,577,535 		JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC21 mRNA CTD PMID:23557933 NCBI chr 2:61,146,669...61,173,908
Ensembl chr 2:61,145,142...61,174,126 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC3 mRNA CTD PMID:23557933 NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643 		JBrowse link
G Dnajc4 DnaJ heat shock protein family (Hsp40) member C4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DNAJC4 mRNA CTD PMID:23557933 NCBI chr 1:213,607,397...213,611,614
Ensembl chr 1:213,607,399...213,611,729 		JBrowse link
G Dnajc7 DnaJ heat shock protein family (Hsp40) member C7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC7 mRNA CTD PMID:23557933 NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489 		JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC8 mRNA CTD PMID:23557933 NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA CTD PMID:19167446 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dnal1 dynein, axonemal, light chain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAL1 mRNA CTD PMID:23557933 NCBI chr 6:109,478,941...109,515,201
Ensembl chr 6:109,478,858...109,513,148 		JBrowse link
G Dnase2 deoxyribonuclease 2, lysosomal increases expression EXP resveratrol results in increased expression of DNASE2 mRNA CTD PMID:25905778 NCBI chr19:40,149,505...40,152,225
Ensembl chr19:40,149,505...40,152,225 		JBrowse link
G Dnd1 DND microRNA-mediated repression inhibitor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DND1 mRNA CTD PMID:23557933 NCBI chr18:28,652,712...28,655,336
Ensembl chr18:28,652,712...28,655,336 		JBrowse link
G Dnm1l dynamin 1-like multiple interactions EXP
ISO 		resveratrol inhibits the reaction [Rotenone results in decreased expression of DNM1L mRNA]; resveratrol inhibits the reaction [Rotenone results in decreased expression of DNM1L protein]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [manganese chloride promotes the reaction [PPARGC1A protein binds to DNM1L promoter]]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [manganese chloride results in increased expression of DNM1L mRNA]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [manganese chloride results in increased expression of DNM1L protein]]; Resveratrol inhibits the reaction [manganese chloride promotes the reaction [PPARGC1A protein binds to DNM1L promoter]]; Resveratrol inhibits the reaction [manganese chloride results in increased expression of DNM1L mRNA]; Resveratrol inhibits the reaction [manganese chloride results in increased expression of DNM1L protein]
[Plant Extracts co-treated with Resveratrol] results in increased expression of DNM1L mRNA 		CTD PMID:23557933 PMID:26770656 PMID:34738708 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Dnm2 dynamin 2 increases expression ISO resveratrol results in increased expression of DNM2 protein CTD PMID:25505154 NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with Resveratrol] results in increased expression of DNMT1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DNMT1 mRNA; [Resveratrol co-treated with pterostilbene] results in decreased expression of DNMT1 mRNA; Resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]
resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]]
resveratrol results in decreased expression of DNMT1 mRNA; resveratrol results in decreased expression of DNMT1 protein 		CTD PMID:19167446 PMID:20631324 PMID:21801466 PMID:22197621 PMID:23557933 More... NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions
decreases expression 		ISO [resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]]
resveratrol results in decreased expression of DNMT3A mRNA 		CTD PMID:22197621 PMID:23593078 PMID:26459286 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta multiple interactions
affects expression
increases expression
decreases expression 		ISO
EXP 		pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]]
resveratrol affects the expression of DNMT3B mRNA
resveratrol results in increased expression of DNMT3B mRNA 		CTD PMID:22197621 PMID:23593078 PMID:24447120 PMID:26459286 PMID:26934322 NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Doc2a double C2 domain alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DOC2A mRNA CTD PMID:23557933 NCBI chr 1:190,887,306...190,893,057
Ensembl chr 1:190,888,214...190,893,384 		JBrowse link
G Dock4 dedicator of cytokinesis 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DOCK4 mRNA CTD PMID:23557933 NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772 		JBrowse link
G Dock8 dedicator of cytokinesis 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DOCK8 mRNA CTD PMID:23557933 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833 		JBrowse link
G Dok4 docking protein 4 increases expression ISO resveratrol results in increased expression of DOK4 mRNA CTD PMID:19371625 NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190 		JBrowse link
G Donson DNA replication fork stabilization factor DONSON multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of DONSON mRNA
resveratrol results in increased expression of DONSON mRNA 		CTD PMID:19167446 NCBI chr11:44,405,794...44,419,099
Ensembl chr11:44,405,804...44,418,791 		JBrowse link
G Dop1a DOP1 leucine zipper like protein A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DOP1A mRNA CTD PMID:23557933 NCBI chr 8:96,295,302...96,397,951
Ensembl chr 8:96,295,328...96,398,652 		JBrowse link
G Dpm1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic increases expression ISO resveratrol results in increased expression of DPM1 protein CTD PMID:25505154 NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 multiple interactions EXP Resveratrol inhibits the reaction [bisphenol A results in increased expression of DPP4 protein] CTD PMID:37570835 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DPP6 mRNA CTD PMID:23557933 NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209 		JBrowse link
G Dpp7 dipeptidylpeptidase 7 increases expression EXP resveratrol results in increased expression of DPP7 mRNA CTD PMID:25905778 NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492 		JBrowse link
G Dpp8 dipeptidylpeptidase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DPP8 mRNA CTD PMID:23557933 NCBI chr 8:74,445,815...74,501,017
Ensembl chr 8:74,445,835...74,501,017 		JBrowse link
G Dpy19l3 dpy-19 like C-mannosyltransferase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DPY19L3 mRNA CTD PMID:23557933 NCBI chr 1:97,487,206...97,554,232
Ensembl chr 1:97,487,206...97,554,232 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DPYD mRNA CTD PMID:23557933 NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DPYSL2 mRNA CTD PMID:23557933 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Dram1 DNA-damage regulated autophagy modulator 1 increases expression ISO resveratrol results in increased expression of DRAM1 mRNA CTD PMID:23750556 NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354 		JBrowse link
G Draxin dorsal inhibitory axon guidance protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRAXIN mRNA CTD PMID:23557933 NCBI chr 5:163,813,308...163,846,609
Ensembl chr 5:163,816,502...163,855,174 		JBrowse link
G Drd1 dopamine receptor D1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRD1 mRNA CTD PMID:23557933 NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166 		JBrowse link
G Drd2 dopamine receptor D2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRD2 mRNA CTD PMID:23557933 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339 		JBrowse link
G Drd4 dopamine receptor D4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRD4 mRNA CTD PMID:23557933 NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458 		JBrowse link
G Drd5 dopamine receptor D5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRD5 mRNA CTD PMID:23557933 NCBI chr14:76,700,244...76,703,344
Ensembl chr14:76,700,241...76,703,466 		JBrowse link
G Drosha drosha ribonuclease III multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DROSHA mRNA CTD PMID:23557933 NCBI chr 2:63,591,885...63,703,688
Ensembl chr 2:63,591,968...63,703,687 		JBrowse link
G Dsc2 desmocollin 2 increases expression ISO resveratrol results in increased expression of DSC2 mRNA CTD PMID:11588890 NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466 		JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DSCC1 mRNA CTD PMID:19167446 NCBI chr 7:88,372,349...88,390,815
Ensembl chr 7:88,372,146...88,387,973 		JBrowse link
G Dsg1 desmoglein 1 decreases expression ISO resveratrol results in decreased expression of DSG1 protein CTD PMID:18089832 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Dsg2 desmoglein 2 decreases expression ISO resveratrol results in decreased expression of DSG2 mRNA CTD PMID:22610192 NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590 		JBrowse link
G Dsn1 DSN1 component of MIS12 kinetochore complex multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of DSN1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DSN1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890 		JBrowse link
G Dst dystonin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DST mRNA CTD PMID:23557933 NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533 		JBrowse link
G Dstn destrin, actin depolymerizing factor affects expression ISO resveratrol affects the expression of DSTN protein CTD PMID:22234583 NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769 		JBrowse link
G Dtna dystrobrevin, alpha multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of DTNA mRNA CTD PMID:19167446 NCBI chr18:14,862,801...15,218,993
Ensembl chr18:14,862,818...15,218,993 		JBrowse link
G Dtymk deoxythymidylate kinase increases expression ISO resveratrol results in increased expression of DTYMK protein CTD PMID:25505154 NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504 		JBrowse link
G Duox1 dual oxidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUOX1 mRNA CTD PMID:23557933 NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187 		JBrowse link
G Duoxa1 dual oxidase maturation factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUOXA1 mRNA CTD PMID:23557933 NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829 		JBrowse link
G Duoxa2 dual oxidase maturation factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUOXA2 mRNA CTD PMID:23557933 NCBI chr 3:129,698,938...129,702,656
Ensembl chr 3:129,698,092...129,702,656 		JBrowse link
G Dusp1 dual specificity phosphatase 1 decreases expression
affects response to substance
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of DUSP1 mRNA
DUSP1 protein affects the susceptibility to Resveratrol
DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DUSP1 mRNA]
[Coumestrol co-treated with resveratrol] results in decreased expression of DUSP1 mRNA; DUSP1 protein inhibits the reaction [resveratrol results in increased activity of EGR1 protein] 		CTD PMID:19167446 PMID:19228061 PMID:25645941 PMID:30844440 PMID:31298478 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp10 dual specificity phosphatase 10 increases expression
multiple interactions 		ISO resveratrol results in increased expression of DUSP10 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DUSP10 mRNA 		CTD PMID:17151092 PMID:19167446 NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304 		JBrowse link
G Dusp15 dual specificity phosphatase 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUSP15 mRNA CTD PMID:23557933 NCBI chr 3:161,868,746...161,880,432
Ensembl chr 3:161,868,749...161,879,250 		JBrowse link
G Dusp18 dual specificity phosphatase 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DUSP18 mRNA CTD PMID:23557933 NCBI chr14:83,013,850...83,035,168
Ensembl chr14:83,011,014...83,056,929 		JBrowse link
G Dusp21 dual specificity phosphatase 21 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUSP21 mRNA CTD PMID:23557933 NCBI chr  X:7,070,910...7,071,766
Ensembl chr  X:7,070,910...7,071,766 		JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression
decreases expression 		ISO resveratrol results in increased expression of DUSP3 protein
resveratrol results in decreased expression of DUSP3 protein 		CTD PMID:18089832 PMID:25505154 NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063 		JBrowse link
G Dusp8 dual specificity phosphatase 8 increases expression ISO resveratrol results in increased expression of DUSP8 mRNA CTD PMID:15280659 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of DUT mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DUT mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956 		JBrowse link
G Dux4 double homeobox 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DUX4 mRNA CTD PMID:23557933 NCBI chr16:1,565,290...1,575,317
Ensembl chr16:1,567,553...1,575,468 		JBrowse link
G Dvl1 dishevelled segment polarity protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DVL1 mRNA CTD PMID:23557933 NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DYNC1H1 mRNA CTD PMID:23557933 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Dync2i1 dynein 2 intermediate chain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DYNC2I1 mRNA CTD PMID:23557933 NCBI chr 6:143,276,441...143,333,006
Ensembl chr 6:143,276,441...143,331,773 		JBrowse link
G Dynll1 dynein light chain LC8-type 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of DYNLL1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of DYNLL1 mRNA 		CTD PMID:12154049 PMID:23557933 NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861 		JBrowse link
G Dynlrb1 dynein light chain roadblock-type 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DYNLRB1 mRNA CTD PMID:23557933 NCBI chr 3:164,197,892...164,224,409
Ensembl chr 3:164,202,953...164,224,409 		JBrowse link
G Dynlt2b dynein light chain Tctex-type 2B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of DYNLT2B mRNA CTD PMID:23557933 NCBI chr11:81,864,195...81,872,555
Ensembl chr11:81,864,195...81,872,555 		JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DYNLT3 mRNA; [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of DYNLT3 mRNA CTD PMID:19167446 PMID:26667767 NCBI chr  X:16,000,425...16,009,632
Ensembl chr  X:16,000,395...16,009,627 		JBrowse link
G Dyrk1a dual specificity tyrosine phosphorylation regulated kinase 1A decreases expression ISO resveratrol results in decreased expression of DYRK1A mRNA CTD PMID:12569576 NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DYRK2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DYRK2 mRNA CTD PMID:23557933 NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942 		JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DYRK3 mRNA CTD PMID:23557933 NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249 		JBrowse link
G Dzip1 DAZ interacting zinc finger protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DZIP1 mRNA CTD PMID:23557933 NCBI chr15:102,363,392...102,417,085
Ensembl chr15:102,363,392...102,417,085 		JBrowse link
G Dzip1l DAZ interacting zinc finger protein 1-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DZIP1L mRNA CTD PMID:23557933 NCBI chr 8:109,067,466...109,108,390
Ensembl chr 8:109,067,775...109,108,393 		JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F1 mRNA CTD PMID:19167446 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G E2f2 E2F transcription factor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F2 mRNA CTD PMID:19167446 NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087 		JBrowse link
G E2f3 E2F transcription factor 3 decreases expression ISO resveratrol results in decreased expression of E2F3 protein CTD PMID:23954321 NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725 		JBrowse link
G E2f6 E2F transcription factor 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of E2F6 mRNA CTD PMID:23557933 NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428 		JBrowse link
G E2f7 E2F transcription factor 7 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F7 mRNA CTD PMID:19167446 NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055 		JBrowse link
G E2f8 E2F transcription factor 8 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA CTD PMID:19167446 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G E4f1 E4F transcription factor 1 increases expression ISO resveratrol results in increased expression of E4F1 mRNA CTD PMID:12002526 NCBI chr10:13,978,975...13,999,646
Ensembl chr10:13,978,990...13,990,506 		JBrowse link
G Ebf2 EBF transcription factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EBF2 mRNA CTD PMID:23557933 NCBI chr15:45,610,949...45,809,828
Ensembl chr15:45,610,949...45,809,822 		JBrowse link
G Ebf4 EBF family member 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EBF4 mRNA CTD PMID:23557933 NCBI chr 3:137,951,310...138,019,682
Ensembl chr 3:137,951,335...138,019,665 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EBNA1BP2 mRNA CTD PMID:23557933 NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EBP mRNA CTD PMID:19167446 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:16,971,405...16,977,781 		JBrowse link
G Ece1 endothelin converting enzyme 1 decreases expression
decreases activity 		ISO resveratrol results in decreased expression of ECE1 mRNA
resveratrol results in decreased activity of ECE1 protein 		CTD PMID:21554123 NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719 		JBrowse link
G Ecel1 endothelin converting enzyme-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ECEL1 mRNA CTD PMID:23557933 NCBI chr 9:95,267,417...95,276,508
Ensembl chr 9:95,264,618...95,274,575 		JBrowse link
G Ech1 enoyl-CoA hydratase 1 affects secretion ISO resveratrol affects the secretion of ECH1 protein CTD PMID:24802182 NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440 		JBrowse link
G Eci1 enoyl-CoA delta isomerase 1 increases expression ISO resveratrol results in increased expression of ECI1 mRNA CTD PMID:22610192 NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773 		JBrowse link
G Eci2 enoyl-CoA delta isomerase 2 increases expression ISO resveratrol results in increased expression of ECI2 protein CTD PMID:25505154 NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161 		JBrowse link
G Ecpas Ecm29 proteasome adaptor and scaffold multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ECPAS mRNA CTD PMID:23557933 NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908 		JBrowse link
G Ect2 epithelial cell transforming 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ECT2 mRNA CTD PMID:19167446 NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626 		JBrowse link
G Edaradd EDAR associated via death domain multiple interactions ISO resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA] CTD PMID:23452621 NCBI chr17:92,850,791...92,894,808
Ensembl chr17:92,831,613...92,894,361 		JBrowse link
G Edc4 enhancer of mRNA decapping 4 increases expression ISO resveratrol results in increased expression of EDC4 protein CTD PMID:25505154 NCBI chr19:50,683,924...50,695,916
Ensembl chr19:50,683,897...50,697,620 		JBrowse link
G Edem2 ER degradation enhancing alpha-mannosidase like protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EDEM2 mRNA CTD PMID:23557933 NCBI chr 3:164,661,741...164,687,559
Ensembl chr 3:164,661,742...164,687,559 		JBrowse link
G Edem3 ER degradation enhancing alpha-mannosidase like protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EDEM3 mRNA CTD PMID:23557933 NCBI chr13:66,403,022...66,470,496
Ensembl chr13:66,408,590...66,472,270 		JBrowse link
G Edn1 endothelin 1 multiple interactions
decreases expression
decreases secretion 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in decreased expression of EDN1 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of EDN1 protein]; resveratrol inhibits the reaction [Uric Acid results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Uric Acid results in increased expression of EDN1 protein]
[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of EDN1 mRNA
resveratrol results in decreased expression of EDN1 mRNA
resveratrol results in decreased secretion of EDN1 protein
resveratrol inhibits the reaction [AGT protein results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Fructose results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]] 		CTD PMID:11755377 PMID:14623829 PMID:15878161 PMID:16535856 PMID:16806235 More... NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn2 endothelin 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of EDN2 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of EDN2 mRNA 		CTD PMID:23557933 PMID:25888808 NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070 		JBrowse link
G Ednra endothelin receptor type A multiple interactions EXP Resveratrol inhibits the reaction [Smoke results in increased expression of EDNRA protein]; Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EDNRA protein] CTD PMID:36183783 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions EXP Resveratrol inhibits the reaction [Smoke results in increased expression of EDNRB protein]; Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EDNRB protein] CTD PMID:36183783 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Edrf1 erythroid differentiation regulatory factor 1 increases expression ISO resveratrol results in increased expression of EDRF1 mRNA CTD PMID:17257620 NCBI chr 1:197,869,873...197,908,693
Ensembl chr 1:197,870,962...197,908,731 		JBrowse link
G Eea1 early endosome antigen 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EEA1 mRNA CTD PMID:23557933 NCBI chr 7:32,441,281...32,608,808
Ensembl chr 7:32,441,272...32,608,476 		JBrowse link
G Eed embryonic ectoderm development decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EED protein
[Coumestrol co-treated with Resveratrol] results in increased expression of EED mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of EED mRNA 		CTD PMID:19167446 PMID:23557933 PMID:25505154 NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of EEF1A1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EEF1A1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eef1a2 eukaryotic translation elongation factor 1 alpha 2 decreases expression ISO resveratrol results in decreased expression of EEF1A2 protein CTD PMID:19738051 NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712 		JBrowse link
G Eef1akmt2 EEF1A lysine methyltransferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EEF1AKMT2 mRNA CTD PMID:23557933 NCBI chr 1:197,009,919...197,071,033
Ensembl chr 1:197,046,930...197,071,013 		JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 increases expression ISO resveratrol results in increased expression of EEF1E1 protein CTD PMID:25505154 NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 increases phosphorylation
decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased phosphorylation of EEF2 protein
resveratrol results in decreased expression of EEF2 protein
resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of EEF2 protein]
resveratrol results in decreased expression of EEF2 mRNA
resveratrol results in increased phosphorylation of and results in decreased activity of EEF2 protein 		CTD PMID:18562309 PMID:19765649 PMID:22349766 PMID:25394677 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase multiple interactions
increases expression 		ISO
EXP 		resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EEF2K protein]
resveratrol results in increased expression of EEF2K mRNA 		CTD PMID:19765649 PMID:25905778 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048 		JBrowse link
G Eeig2 EEIG family member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EEIG2 mRNA CTD PMID:23557933 NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449 		JBrowse link
G Efcab2 EF-hand calcium binding domain 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of DRC8 mRNA CTD PMID:23557933 NCBI chr13:92,683,182...92,769,939
Ensembl chr13:92,684,086...92,782,558 		JBrowse link
G Efcab7 EF-hand calcium binding domain 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EFCAB7 mRNA CTD PMID:23557933 NCBI chr 5:119,640,841...119,691,566
Ensembl chr 5:119,640,761...119,691,563 		JBrowse link
G Efcc1 EF-hand and coiled-coil domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EFCC1 mRNA CTD PMID:23557933 NCBI chr 4:121,745,547...121,778,475
Ensembl chr 4:121,745,633...121,775,220 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions
affects secretion 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EFEMP1 mRNA
resveratrol affects the secretion of EFEMP1 protein 		CTD PMID:23557933 PMID:24802182 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efhd1 EF-hand domain family, member D1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of EFHD1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of EFHD1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798 		JBrowse link
G Efhd2 EF-hand domain family, member D2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EFHD2 mRNA CTD PMID:23557933 NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:159,443,960...159,460,369 		JBrowse link
G Efl1 elongation factor like GTPase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EFL1 mRNA CTD PMID:23557933 NCBI chr 1:146,047,734...146,172,719
Ensembl chr 1:146,048,592...146,173,532 		JBrowse link
G Efna1 ephrin A1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA CTD PMID:19167446 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efnb2 ephrin B2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of EFNB2 mRNA CTD PMID:19167446 NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208 		JBrowse link
G Efr3a EFR3 homolog A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EFR3A mRNA CTD PMID:23557933 NCBI chr 7:99,441,764...99,522,454
Ensembl chr 7:99,441,767...99,522,454 		JBrowse link
G Eftud2 elongation factor Tu GTP binding domain containing 2 increases phosphorylation
decreases expression 		ISO resveratrol results in increased phosphorylation of EFTUD2 protein
resveratrol results in decreased expression of EFTUD2 protein 		CTD PMID:25311616 PMID:25505154 NCBI chr10:88,304,992...88,352,229
Ensembl chr10:88,304,992...88,346,299 		JBrowse link
G Egf epidermal growth factor multiple interactions
decreases expression
decreases activity 		ISO
EXP 		EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]; EGF protein inhibits the reaction [Resveratrol results in decreased phosphorylation of EGFR protein]; EGF protein inhibits the reaction [Resveratrol results in decreased phosphorylation of ERBB2 protein]; EGF protein inhibits the reaction [Resveratrol results in increased expression of FOS mRNA]; EGF protein inhibits the reaction [Resveratrol results in increased expression of JUN mRNA]; EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]; EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]; EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]; Gefitinib promotes the reaction [Resveratrol inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]; Gefitinib promotes the reaction [Resveratrol inhibits the reaction [EGF protein results in increased expression of PLAU mRNA]]; midostaurin inhibits the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]; PRKCA protein affects the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]; PRKCA protein affects the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]; PRKCA protein affects the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]; Resveratrol inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [EGF protein results in increased expression of PLAU mRNA]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein]; Resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Resveratrol promotes the reaction [Gefitinib inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]; Resveratrol promotes the reaction [Gefitinib inhibits the reaction [EGF protein results in increased expression of PLAU mRNA]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]
PTPN11 protein affects the reaction [resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]]
resveratrol results in decreased expression of EGF mRNA
resveratrol inhibits the reaction [EGF protein results in increased expression of MUC5AC mRNA]; resveratrol inhibits the reaction [EGF protein results in increased expression of MUC5AC protein]; resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased localization of GAB1 protein]; resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
resveratrol results in decreased activity of EGF protein 		CTD PMID:14739659 PMID:15542774 PMID:15849355 PMID:16343977 PMID:16626303 More... NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfl7 EGF-like-domain, multiple 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EGFL7 mRNA CTD PMID:23557933 NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:29,802,690...29,814,951 		JBrowse link
G Egfr epidermal growth factor receptor affects localization
multiple interactions
decreases expression
increases activity
decreases phosphorylation
increases phosphorylation
increases degradation
affects binding 		ISO resveratrol affects the localization of EGFR protein; resveratrol affects the localization of EGFR protein modified form
Resveratrol inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EGFR protein]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR]; Resveratrol promotes the reaction [Ursolic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR]]; Ursolic Acid promotes the reaction [Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR]]
resveratrol results in decreased expression of EGFR mRNA; resveratrol results in decreased expression of EGFR protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of EGFR mRNA; [Resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein; AR protein affects the reaction [[Resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein]; EGF protein inhibits the reaction [Resveratrol results in decreased phosphorylation of EGFR protein]; PD168393 inhibits the reaction [Resveratrol results in increased phosphorylation of EGFR protein]; Resveratrol inhibits the reaction [EGR protein results in increased phosphorylation of EGFR protein]; Resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EGFR protein]; Resveratrol inhibits the reaction [TGFA protein affects the localization of EGFR protein]; Resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Resveratrol results in decreased expression of and results in decreased phosphorylation of EGFR protein
resveratrol results in increased activity of EGFR protein
resveratrol results in decreased phosphorylation of EGFR protein
resveratrol results in increased phosphorylation of EGFR protein
resveratrol results in increased degradation of EGFR protein
resveratrol binds to EGFR protein 		CTD PMID:15802018 PMID:16343977 PMID:20729295 PMID:21967610 PMID:23127547 More... NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EGLN1 protein
[resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of EGLN1 protein 		CTD PMID:22245592 NCBI chr19:69,765,276...69,804,681 JBrowse link
G Egr1 early growth response 1 increases expression
affects expression
multiple interactions
affects localization
affects response to substance 		ISO
EXP 		resveratrol results in increased expression of EGR1 mRNA; resveratrol results in increased expression of EGR1 protein
resveratrol affects the expression of EGR1 mRNA
resveratrol inhibits the reaction [TNF protein results in increased expression of EGR1 mRNA]
resveratrol affects the localization of EGR1 protein
EGR1 protein affects the susceptibility to resveratrol
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of and results in increased activity of EGR1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; [resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]] which results in increased expression of CDKN1A mRNA; ARAF protein affects the reaction [resveratrol results in increased expression of and results in increased activity of EGR1 protein]; Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; DUSP1 protein inhibits the reaction [resveratrol results in increased activity of EGR1 protein]; ELK1 protein affects the reaction [resveratrol results in increased expression of EGR1 protein]; resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]; resveratrol results in increased expression of and results in increased activity of EGR1 protein; SB 203580 promotes the reaction [resveratrol results in increased expression of EGR1 mRNA] 		CTD PMID:12482581 PMID:12690110 PMID:12706485 PMID:16081268 PMID:16280599 More... NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr3 early growth response 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA CTD PMID:19167446 NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712 		JBrowse link
G Egr4 early growth response 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EGR4 mRNA CTD PMID:23557933 NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368 		JBrowse link
G Ehbp1 EH domain binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EHBP1 mRNA CTD PMID:23557933 NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579 		JBrowse link
G Ehbp1l1 EH domain binding protein 1-like 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of EHBP1L1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of EHBP1L1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:212,423,447...212,443,598 		JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EHD2 mRNA CTD PMID:23557933 NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943 		JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression ISO resveratrol results in increased expression of EI24 mRNA
resveratrol results in increased expression of EI24 protein 		CTD PMID:12569576 PMID:25505154 PMID:26341291 NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214 		JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EID1 mRNA CTD PMID:23557933 NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:133,370,474...133,378,434 		JBrowse link
G Eif1 eukaryotic translation initiation factor 1 decreases expression ISO resveratrol results in decreased expression of EIF1 protein CTD PMID:25505154 NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654 		JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF1AX mRNA CTD PMID:23557933 NCBI chr  X:39,307,320...39,322,023
Ensembl chr  X:39,307,137...39,322,021 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2A mRNA CTD PMID:23557933 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2AK2 mRNA
resveratrol results in decreased expression of EIF2AK2 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases phosphorylation
multiple interactions 		ISO
EXP 		resveratrol results in increased phosphorylation of EIF2AK3 protein
Resveratrol inhibits the reaction [Acrolein results in increased phosphorylation of EIF2AK3 protein]; Resveratrol inhibits the reaction [titanium dioxide results in increased expression of EIF2AK3 mRNA]
[resveratrol co-treated with Dietary Fats] results in decreased phosphorylation of EIF2AK3 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2AK3 mRNA; Resveratrol inhibits the reaction [Ethanol results in increased expression of EIF2AK3 protein modified form] 		CTD PMID:23557933 PMID:24224909 PMID:24264887 PMID:26055348 PMID:31298478 More... NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2ak4 eukaryotic translation initiation factor 2 alpha kinase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2AK4 mRNA CTD PMID:23557933 NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574 		JBrowse link
G Eif2b1 eukaryotic translation initiation factor 2B subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2B1 mRNA CTD PMID:23557933 NCBI chr12:37,686,149...37,694,830
Ensembl chr12:37,686,559...37,708,078 		JBrowse link
G Eif2b3 eukaryotic translation initiation factor 2B subunit gamma multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2B3 mRNA CTD PMID:23557933 NCBI chr 5:135,728,764...135,795,276
Ensembl chr 5:135,728,959...135,799,914 		JBrowse link
G Eif2b4 eukaryotic translation initiation factor 2B subunit delta increases expression ISO resveratrol results in increased expression of EIF2B4 mRNA CTD PMID:19371625 NCBI chr 6:30,903,148...30,908,803
Ensembl chr 6:30,903,219...30,908,800 		JBrowse link
G Eif2b5 eukaryotic translation initiation factor 2B subunit epsilon multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2B5 mRNA CTD PMID:23557933 NCBI chr11:93,898,814...93,909,431
Ensembl chr11:93,898,814...93,908,800 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation 		ISO Resveratrol inhibits the reaction [Acrolein results in increased phosphorylation of EIF2S1 protein]
resveratrol results in increased phosphorylation of EIF2S1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2S1 mRNA; Resveratrol inhibits the reaction [Ethanol results in increased expression of EIF2S1 protein modified form] 		CTD PMID:17914584 PMID:22898769 PMID:23557933 PMID:24224909 PMID:34813903 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2S2 mRNA CTD PMID:23557933 NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570 		JBrowse link
G Eif2s3 eukaryotic translation initiation factor 2 subunit gamma multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF2S3 mRNA CTD PMID:23557933 NCBI chr  X:62,910,292...62,933,936
Ensembl chr  X:62,910,293...62,934,489 		JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF3J mRNA CTD PMID:23557933 NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246 		JBrowse link
G Eif3k eukaryotic translation initiation factor 3, subunit K multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF3K mRNA CTD PMID:23557933 NCBI chr 1:93,387,628...93,397,551
Ensembl chr 1:93,387,628...93,397,802 		JBrowse link
G Eif3l eukaryotic translation initiation factor 3, subunit L increases expression EXP resveratrol results in increased expression of EIF3L mRNA CTD PMID:19228061 NCBI chr 7:112,522,222...112,544,063
Ensembl chr 7:112,507,831...112,544,062 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases expression ISO resveratrol results in increased expression of EIF4A1 protein CTD PMID:25505154 NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602 		JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EIF4A2 mRNA
resveratrol results in decreased expression of EIF4A2 mRNA 		CTD PMID:15767336 PMID:23557933 NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions
decreases phosphorylation
decreases expression 		ISO
EXP 		[resveratrol co-treated with Sirolimus] results in decreased phosphorylation of EIF4B protein
[Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein
resveratrol results in decreased phosphorylation of EIF4B protein
resveratrol results in decreased expression of EIF4B protein
[resveratrol co-treated with Sirolimus] inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein]; [Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein 		CTD PMID:24304514 PMID:25311616 PMID:25505154 NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions ISO resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4E protein]
resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4E protein] 		CTD PMID:15297429 PMID:19765649 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions
decreases activity
decreases phosphorylation
decreases expression 		ISO
EXP 		[[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of EIF4EBP1 protein; resveratrol inhibits the reaction [TNF protein results in decreased phosphorylation of EIF4EBP1 protein]
resveratrol results in decreased activity of EIF4EBP1 protein
resveratrol results in decreased phosphorylation of EIF4EBP1 protein
resveratrol results in decreased expression of EIF4EBP1 protein modified form
resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4EBP1 protein]
[resveratrol results in increased activity of SIRT1 protein] which results in decreased phosphorylation of EIF4EBP1 protein; Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of EIF4EBP1 protein]; resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein]; resveratrol results in decreased phosphorylation of and results in increased expression of EIF4EBP1 protein 		CTD PMID:15297429 PMID:19928762 PMID:20080969 PMID:20169165 PMID:20332614 More... NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 multiple interactions ISO resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 decreases expression ISO resveratrol results in decreased expression of EIF4G2 protein CTD PMID:18089832 NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO resveratrol results in decreased expression of EIF5 mRNA CTD PMID:19167446 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Eif5a eukaryotic translation initiation factor 5A decreases acetylation
increases expression 		ISO resveratrol results in decreased acetylation of EIF5A protein
resveratrol results in increased expression of EIF5A protein 		CTD PMID:18089832 PMID:22349766 NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330 		JBrowse link
G Eif6 eukaryotic translation initiation factor 6 decreases expression ISO resveratrol results in decreased expression of EIF6 protein CTD PMID:25505154 NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525 		JBrowse link
G Elac1 elaC ribonuclease Z 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELAC1 mRNA CTD PMID:23557933 NCBI chr18:69,596,475...69,617,206
Ensembl chr18:69,598,827...69,616,175 		JBrowse link
G Elac2 elaC ribonuclease Z 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELAC2 mRNA CTD PMID:23557933 NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069 		JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of ELAPOR1 mRNA CTD PMID:19167446 NCBI chr 2:198,777,323...198,856,497
Ensembl chr 2:198,777,323...198,856,497 		JBrowse link
G Elavl1 ELAV like RNA binding protein 1 multiple interactions
increases expression 		ISO ELAVL1 mutant form inhibits the reaction [resveratrol results in increased expression of MAT2B protein]; ELAVL1 mutant form inhibits the reaction [resveratrol results in increased expression of SIRT1 protein]; MAT2B mutant form inhibits the reaction [resveratrol results in increased expression of ELAVL1 protein]; resveratrol promotes the reaction [ELAVL1 protein binds to MAT2B mRNA]; resveratrol promotes the reaction [MAT2B protein binds to ELAVL1 protein]; resveratrol results in increased expression of and results in increased stability of ELAVL1 protein; SIRT1 mutant form inhibits the reaction [resveratrol results in increased expression of ELAVL1 protein]
resveratrol results in increased expression of ELAVL1 mRNA 		CTD PMID:23814050 NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631 		JBrowse link
G Elf2 E74 like ETS transcription factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELF2 mRNA CTD PMID:23557933 NCBI chr 2:137,445,787...137,536,512
Ensembl chr 2:137,445,788...137,470,355 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ELF3 mRNA CTD PMID:23557933 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Elk1 ETS transcription factor ELK1 multiple interactions
increases activity 		ISO ELK1 protein affects the reaction [resveratrol results in increased expression of EGR1 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]
resveratrol results in increased activity of ELK1 protein 		CTD PMID:23452621 PMID:25645941 NCBI chr  X:3,692,367...3,709,252
Ensembl chr  X:3,693,293...3,709,249 		JBrowse link
G Elmod2 ELMO domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELMOD2 mRNA CTD PMID:23557933 NCBI chr19:41,690,713...41,710,194
Ensembl chr19:41,690,762...41,710,194
Ensembl chr18:41,690,762...41,710,194 		JBrowse link
G Eloa elongin A decreases expression ISO resveratrol results in decreased expression of ELOA protein CTD PMID:25505154 NCBI chr 5:153,513,246...153,530,819
Ensembl chr 5:153,515,066...153,530,916 		JBrowse link
G Eloa2l elongin A2 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ELOA3P mRNA CTD PMID:23557933 NCBI chr16:14,096,161...14,098,105
Ensembl chr16:14,096,161...14,098,104 		JBrowse link
G Eloc elongin C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELOC mRNA CTD PMID:23557933 NCBI chr 5:7,444,769...7,461,187
Ensembl chr20:25,752,857...25,753,279 		JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO resveratrol results in increased expression of ELOVL1 protein CTD PMID:25505154 NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352 		JBrowse link
G Elovl2 ELOVL fatty acid elongase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL2 mRNA CTD PMID:19167446 NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601 		JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 multiple interactions
increases expression 		ISO PRKAA1 gene mutant form inhibits the reaction [Resveratrol results in increased expression of ELOVL3 mRNA]; Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ELOVL3 mRNA]
resveratrol results in increased expression of ELOVL3 mRNA 		CTD PMID:25761413 PMID:31298478 NCBI chr 1:254,938,731...254,942,559
Ensembl chr 1:254,938,731...254,942,559 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL5 mRNA
resveratrol results in increased expression of ELOVL5 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions
increases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of ELOVL6 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ELOVL6 mRNA
resveratrol results in increased expression of ELOVL6 protein 		CTD PMID:19167446 PMID:23557933 PMID:25505154 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL7 mRNA CTD PMID:19167446 NCBI chr 2:41,522,695...41,592,021
Ensembl chr 2:41,522,738...41,592,020 		JBrowse link
G Elp1 elongator acetyltransferase complex subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELP1 mRNA CTD PMID:23557933 NCBI chr 5:76,248,545...76,300,985
Ensembl chr 5:76,248,550...76,300,985 		JBrowse link
G Elp2 elongator acetyltransferase complex subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELP2 mRNA CTD PMID:23557933 NCBI chr18:16,160,686...16,196,307
Ensembl chr18:16,160,671...16,196,414 		JBrowse link
G Elp4 elongator acetyltransferase complex subunit 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ELP4 mRNA CTD PMID:23557933 NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963 		JBrowse link
G Elp5 elongator acetyltransferase complex subunit 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA CTD PMID:19167446 NCBI chr10:55,191,223...55,202,949
Ensembl chr10:55,191,227...55,203,617 		JBrowse link
G Emc1 ER membrane protein complex subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EMC1 mRNA CTD PMID:23557933 NCBI chr 5:156,891,773...156,917,092
Ensembl chr 5:156,891,773...156,917,092 		JBrowse link
G Emc2 ER membrane protein complex subunit 2 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of TTC35 mRNA
resveratrol results in increased expression of EMC2 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 7:76,471,899...76,508,866
Ensembl chr 7:76,471,899...76,510,178 		JBrowse link
G Emc4 ER membrane protein complex subunit 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EMC4 mRNA CTD PMID:23557933 NCBI chr 3:119,624,100...119,633,170
Ensembl chr 3:119,624,100...119,629,118 		JBrowse link
G Emc8 ER membrane protein complex subunit 8 increases expression ISO resveratrol results in increased expression of EMC8 mRNA CTD PMID:22610192 NCBI chr19:65,620,365...65,630,328
Ensembl chr19:65,620,375...65,630,235 		JBrowse link
G Emc9 ER membrane protein complex subunit 9 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EMC9 mRNA CTD PMID:19167446 NCBI chr15:33,041,840...33,046,056
Ensembl chr15:33,041,842...33,046,102 		JBrowse link
G Emd emerin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EMD mRNA CTD PMID:23557933 NCBI chr  X:157,190,438...157,193,479
Ensembl chr  X:157,189,819...157,197,095 		JBrowse link
G Eme2 essential meiotic structure-specific endonuclease subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EME2 mRNA CTD PMID:23557933 NCBI chr10:14,413,661...14,420,489
Ensembl chr10:14,417,735...14,420,489 		JBrowse link
G Emg1 EMG1 N1-specific pseudouridine methyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EMG1 mRNA CTD PMID:23557933 NCBI chr 4:159,195,545...159,203,826
Ensembl chr 4:159,195,564...159,203,826 		JBrowse link
G Emilin2 elastin microfibril interfacer 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EMILIN2 mRNA CTD PMID:23557933 NCBI chr 9:118,607,312...118,667,087
Ensembl chr 9:118,606,891...118,666,957 		JBrowse link
G Emx2 empty spiracles homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EMX2 mRNA CTD PMID:23557933 NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671 		JBrowse link
G En1 engrailed homeobox 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EN1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of EN1 mRNA 		CTD PMID:20878097 PMID:23557933 NCBI chr13:34,303,684...34,309,269
Ensembl chr13:34,303,702...34,309,269 		JBrowse link
G En2 engrailed homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EN2 mRNA CTD PMID:23557933 NCBI chr 4:7,954,953...7,960,793
Ensembl chr 4:7,954,953...7,960,793 		JBrowse link
G Enah ENAH, actin regulator multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ENAH mRNA CTD PMID:23557933 NCBI chr13:96,149,437...96,269,841
Ensembl chr13:96,149,437...96,269,796 		JBrowse link
G Enc1 ectodermal-neural cortex 1 decreases expression
multiple interactions
increases expression 		ISO resveratrol results in decreased expression of ENC1 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA; [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ENC1 mRNA
resveratrol results in increased expression of ENC1 mRNA 		CTD PMID:12002526 PMID:12569576 PMID:19167446 PMID:26667767 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Endod1 endonuclease domain containing 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ENDOD1 mRNA CTD PMID:19167446 NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007 		JBrowse link
G Endog endonuclease G multiple interactions
affects localization 		ISO PD 150606 inhibits the reaction [resveratrol affects the localization of ENDOG protein] CTD PMID:16617056 PMID:20484155 NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573 		JBrowse link
G Eno1 enolase 1 decreases expression ISO resveratrol results in decreased expression of ENO1 mRNA CTD PMID:15582268 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Eno2 enolase 2 decreases expression
increases expression 		ISO
EXP 		resveratrol results in decreased expression of ENO2 mRNA
resveratrol results in increased expression of ENO2 protein 		CTD PMID:15582268 PMID:24464877 NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220 		JBrowse link
G Eno3 enolase 3 decreases expression ISO resveratrol results in decreased expression of ENO3 mRNA CTD PMID:15582268 NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540 		JBrowse link
G Enosf1 enolase superfamily member 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ENOSF1 mRNA CTD PMID:23557933
G Enpep glutamyl aminopeptidase multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of ENPEP mRNA CTD PMID:25905778 NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of ENPP2 mRNA CTD PMID:25905778 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Enpp4 ectonucleotide pyrophosphatase/phosphodiesterase 4 increases expression EXP resveratrol results in increased expression of ENPP4 mRNA CTD PMID:19228061 NCBI chr 9:24,386,351...24,396,248
Ensembl chr 9:24,360,272...24,396,152 		JBrowse link
G Entpd3 ectonucleoside triphosphate diphosphohydrolase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ENTPD3 mRNA CTD PMID:23557933 NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ENTPD5 mRNA CTD PMID:23557933 NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495 		JBrowse link
G Entpd8 ectonucleoside triphosphate diphosphohydrolase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ENTPD8 mRNA CTD PMID:23557933 NCBI chr 3:28,283,392...28,295,686
Ensembl chr 3:28,285,777...28,293,686 		JBrowse link
G Entrep2 endosomal transmembrane epsin interactor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ENTREP2 mRNA CTD PMID:23557933 NCBI chr 1:127,699,636...128,111,850
Ensembl chr 1:127,699,636...128,111,850 		JBrowse link
G Entrep3 endosomal transmembrane epsin interactor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ENTREP3 mRNA CTD PMID:23557933 NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047 		JBrowse link
G Eogt EGF domain specific O-linked N-acetylglucosamine transferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EOGT mRNA CTD PMID:23557933 NCBI chr 4:131,275,587...131,313,243
Ensembl chr 4:131,276,573...131,311,926 		JBrowse link
G Eola2 endothelium and lymphocyte associated ASCH domain 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EOLA2 mRNA CTD PMID:23557933 NCBI chr  X:154,108,628...154,113,426
Ensembl chr  X:154,108,836...154,113,436 		JBrowse link
G Ep300 E1A binding protein p300 decreases expression
increases expression
multiple interactions
affects expression 		ISO
EXP 		resveratrol results in decreased expression of EP300 mRNA; resveratrol results in decreased expression of EP300 protein
resveratrol results in increased expression of EP300 mRNA
resveratrol inhibits the reaction [Phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]]; resveratrol inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of EP300 protein]]; resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of EP300 protein]; resveratrol inhibits the reaction [Doxorubicin results in increased expression of EP300 protein]; SIRT1 mutant form inhibits the reaction [resveratrol results in decreased expression of EP300 protein]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of EP300 protein]]
resveratrol affects the expression of EP300 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]]; [[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein; [[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of RELA protein; [Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]; EP300 protein inhibits the reaction [Resveratrol results in decreased expression of ZBTB7A mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA]; Resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein]; Resveratrol inhibits the reaction [EP300 protein binds to ZBTB7A promoter]; Resveratrol inhibits the reaction [TGFB2 protein promotes the reaction [EP300 protein binds to COL1A2 promoter]]; Resveratrol inhibits the reaction [TGFB2 protein results in increased expression of EP300 protein]; Resveratrol inhibits the reaction [TNF protein promotes the reaction [EP300 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein results in increased expression of EP300 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of EP300 protein]; Resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein] 		CTD PMID:12002526 PMID:12569576 PMID:16928824 PMID:19047049 PMID:23297412 More... NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Epb41l1 erythrocyte membrane protein band 4.1-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPB41L1 mRNA CTD PMID:23557933 NCBI chr 3:165,389,295...165,512,821
Ensembl chr 3:165,389,293...165,510,498 		JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of EPB41L2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EPB41L2 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:21,682,335...21,857,105 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of EPB41L3 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of EPB41L3 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Epc1 enhancer of polycomb homolog 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EPC1 mRNA CTD PMID:23557933 NCBI chr17:59,198,513...59,289,535
Ensembl chr17:59,197,677...59,289,519 		JBrowse link
G Epcam epithelial cell adhesion molecule multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of EPCAM mRNA CTD PMID:25905778 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epha1 Eph receptor A1 increases expression ISO resveratrol results in increased expression of EPHA1 mRNA CTD PMID:12154049 NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474 		JBrowse link
G Epha4 Eph receptor A4 increases expression ISO resveratrol results in increased expression of EPHA4 mRNA CTD PMID:12569576 NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
affects expression
multiple interactions 		ISO resveratrol results in increased expression of EPHX1 mRNA; resveratrol results in increased expression of EPHX1 protein
resveratrol affects the expression of EPHX1 mRNA
resveratrol promotes the reaction [Benzo(a)pyrene results in increased activity of EPHX1 protein] 		CTD PMID:11279601 PMID:16484233 PMID:18089832 PMID:23525482 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions
increases expression 		ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of EPHX2 mRNA
resveratrol results in increased expression of EPHX2 mRNA 		CTD PMID:25436977 PMID:26667767 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Epm2aip1 EPM2A interacting protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EPM2AIP1 mRNA CTD PMID:23557933 NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458 		JBrowse link
G Epn2 epsin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPN2 mRNA CTD PMID:23557933 NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,697,238...46,759,092 		JBrowse link
G Epn3 epsin 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPN3 mRNA CTD PMID:23557933 NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235 		JBrowse link
G Epo erythropoietin multiple interactions ISO resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Epor erythropoietin receptor multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of EPOR mRNA
resveratrol results in increased expression of EPOR mRNA 		CTD PMID:19228061 PMID:23557933 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322 		JBrowse link
G Eppin epididymal peptidase inhibitor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPPIN mRNA CTD PMID:23557933 NCBI chr 3:173,731,739...173,738,651
Ensembl chr 3:173,731,739...173,738,651 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EPRS1 mRNA CTD PMID:23557933 NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509 		JBrowse link
G Eps15 epidermal growth factor receptor pathway substrate 15 increases expression ISO resveratrol results in increased expression of EPS15 mRNA CTD PMID:12002526 NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856 		JBrowse link
G Eps8 EGFR pathway substrate 8, signaling adaptor decreases expression ISO resveratrol results in decreased expression of EPS8 protein CTD PMID:25505154 NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160 		JBrowse link
G Eps8l2 EPS8 signaling adaptor L2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPS8L2 mRNA CTD PMID:23557933 NCBI chr 1:205,875,825...205,901,109
Ensembl chr 1:205,875,801...205,901,101 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions
decreases phosphorylation
decreases expression
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB2 mRNA; EGF protein inhibits the reaction [resveratrol results in decreased phosphorylation of ERBB2 protein]; Estradiol promotes the reaction [resveratrol results in increased expression of ERBB2 protein]
resveratrol results in decreased expression of ERBB2
resveratrol results in increased expression of ERBB2 mRNA; resveratrol results in increased expression of ERBB2 protein
resveratrol results in decreased expression of ERBB2; resveratrol results in decreased expression of ERBB2 mRNA; resveratrol results in decreased expression of ERBB2 protein 		CTD PMID:15688416 PMID:16488535 PMID:19167446 PMID:20729295 PMID:25448084 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 decreases expression ISO resveratrol results in decreased expression of ERBB3 mRNA CTD PMID:19371625 NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB4 mRNA CTD PMID:19167446 NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772 		JBrowse link
G Erc2 ELKS/RAB6-interacting/CAST family member 2 decreases phosphorylation ISO resveratrol results in decreased phosphorylation of ERC2 protein CTD PMID:25311616 NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions
decreases expression
affects response to substance 		ISO
EXP 		4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [resveratrol results in increased expression of ERCC1 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [resveratrol results in increased expression of ERCC1 protein]; Pemetrexed inhibits the reaction [resveratrol results in increased stability of and results in increased expression of ERCC1 mRNA]; Pemetrexed inhibits the reaction [resveratrol results in increased stability of and results in increased expression of ERCC1 protein]; resveratrol results in increased stability of and results in increased expression of ERCC1 mRNA; resveratrol results in increased stability of and results in increased expression of ERCC1 protein
Resveratrol results in decreased expression of ERCC1 mRNA
ERCC1 protein affects the susceptibility to resveratrol 		CTD PMID:23912706 PMID:33775663 NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120 		JBrowse link
G Ercc3 ERCC excision repair 3, TFIIH core complex helicase subunit multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC3 mRNA
resveratrol results in increased expression of ERCC3 mRNA 		CTD PMID:19371625 PMID:23557933 NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC4 mRNA CTD PMID:23557933 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC5 mRNA CTD PMID:23557933 NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084 		JBrowse link
G Ercc6 ERCC excision repair 6, chromatin remodeling factor multiple interactions ISO resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2 protein]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2L1 protein]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of SIRT1 protein]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in increased abundance of Poly Adenosine Diphosphate Ribose]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in increased acetylation of RELA protein]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in increased acetylation of TRP53 protein]; resveratrol inhibits the reaction [ERCC6 gene mutant form results in increased expression of BAX protein] CTD PMID:25440059 NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895 		JBrowse link
G Ercc6l ERCC excision repair 6 like, spindle assembly checkpoint helicase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA CTD PMID:19167446 NCBI chr  X:71,285,380...71,301,186
Ensembl chr  X:71,285,380...71,301,186 		JBrowse link
G Ercc6l2 ERCC excision repair 6 like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC6L2 mRNA CTD PMID:23557933 NCBI chr17:1,055,881...1,323,207
Ensembl chr17:1,222,139...1,316,056 		JBrowse link
G Ercc8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC8 mRNA CTD PMID:23557933 NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294 		JBrowse link
G Erich1 glutamate-rich 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERICH1 mRNA CTD PMID:23557933 NCBI chr16:82,203,536...82,271,361
Ensembl chr16:82,203,610...82,272,989 		JBrowse link
G Erlin2 ER lipid raft associated 2 increases expression ISO resveratrol results in increased expression of ERLIN2 protein CTD PMID:25505154 NCBI chr16:71,720,486...71,736,999
Ensembl chr16:71,721,364...71,736,503 		JBrowse link
G Ermard ER membrane-associated RNA degradation multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERMARD mRNA CTD PMID:23557933 NCBI chr 1:64,656,414...64,675,803
Ensembl chr 1:64,656,529...64,675,806 		JBrowse link
G Ermp1 endoplasmic reticulum metallopeptidase 1 increases expression ISO resveratrol results in increased expression of ERMP1 protein CTD PMID:25505154 NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of ERN1 protein
resveratrol inhibits the reaction [Ethanol results in increased expression of ERN1 protein modified form] 		CTD PMID:24224909 PMID:24264887 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha multiple interactions
decreases expression 		ISO
EXP 		ERO1A protein inhibits the reaction [Resveratrol results in decreased secretion of ADIPOQ protein]
[Plant Extracts co-treated with Resveratrol] results in increased expression of ERO1A mRNA
resveratrol results in decreased expression of ERO1A mRNA 		CTD PMID:17452443 PMID:19228061 PMID:23557933 NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039 		JBrowse link
G Ero1b endoplasmic reticulum oxidoreductase 1 beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ERO1B mRNA CTD PMID:23557933 NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERRFI1 mRNA
resveratrol results in decreased expression of ERRFI1 mRNA 		CTD PMID:19167446 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432 		JBrowse link
G Ervfrd-1 endogenous retrovirus group FRD member 1, envelope multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ERVFRD-1 mRNA CTD PMID:23557933 NCBI chr12:27,787,680...27,794,732
Ensembl chr12:27,787,680...27,794,732 		JBrowse link
G Esco1 establishment of sister chromatid cohesion N-acetyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ESCO1 mRNA CTD PMID:23557933 NCBI chr18:1,904,748...1,959,609
Ensembl chr18:1,904,762...1,959,805 		JBrowse link
G Esf1 ESF1 nucleolar pre-rRNA processing protein homolog multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ESF1 mRNA CTD PMID:23557933 NCBI chr 3:147,908,405...147,961,567
Ensembl chr 3:147,908,405...147,961,485 		JBrowse link
G Espl1 extra spindle pole bodies like 1, separase multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of ESPL1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESPL1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570 		JBrowse link
G Espn espin multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESPN mRNA
resveratrol results in increased expression of ESPN mRNA 		CTD PMID:19371625 PMID:23557933 NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984 		JBrowse link
G Espnl espin-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESPNL mRNA CTD PMID:23557933 NCBI chr 9:99,358,907...99,385,439
Ensembl chr 9:99,359,578...99,384,342 		JBrowse link
G Esr1 estrogen receptor 1 affects response to substance
affects binding
increases expression
decreases expression
multiple interactions
affects localization
increases phosphorylation
increases degradation
increases response to substance
increases activity 		EXP
ISO 		ESR1 protein affects the susceptibility to resveratrol
resveratrol analog binds to ESR1 protein; resveratrol binds to ESR1 protein
resveratrol results in increased expression of ESR1 mRNA
resveratrol analog results in decreased expression of ESR1 mRNA; resveratrol analog results in decreased expression of ESR1 protein; resveratrol results in decreased expression of ESR1; resveratrol results in decreased expression of ESR1 mRNA; resveratrol results in decreased expression of ESR1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of ESR1 protein]; [Resveratrol co-treated with pterostilbene] results in increased expression of ESR1 mRNA; [Resveratrol co-treated with pterostilbene] results in increased expression of ESR1 protein; [Resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide; AG 1879 inhibits the reaction [Resveratrol affects the localization of ESR1 protein]; AG 1879 inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]; AG 1879 inhibits the reaction [Resveratrol results in increased activity of ESR1 protein]; AG 1879 inhibits the reaction [Resveratrol results in increased phosphorylation of ESR1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol results in increased degradation of ESR1 protein]; ESR1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; ESR1 protein affects the reaction [Resveratrol affects the secretion of CTSD protein]; ESR1 protein affects the reaction [Resveratrol results in increased expression of VDR mRNA]; ESR1 protein promotes the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; ESR1 protein promotes the reaction [Resveratrol results in increased phosphorylation of SRC protein]; FOXA1 protein promotes the reaction [Resveratrol results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [ESR1 protein results in increased susceptibility to Resveratrol]; Fulvestrant inhibits the reaction [Resveratrol analog binds to and results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [Resveratrol binds to and results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]; Resveratrol analog binds to and results in increased activity of ESR1 protein; Resveratrol binds to and results in decreased activity of ESR1 protein; Resveratrol binds to and results in increased activity of ESR1 protein; Resveratrol inhibits the reaction [bisphenol A results in increased expression of ESR1 mRNA]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of ESR1 protein]; Resveratrol inhibits the reaction [Estradiol binds to and results in increased activity of ESR1 protein]; Resveratrol inhibits the reaction [Estradiol binds to ESR1 protein]; Resveratrol inhibits the reaction [Estradiol promotes the reaction [ESR1 results in increased expression of CYP19A1 mRNA alternative form]]; Resveratrol inhibits the reaction [Estradiol promotes the reaction [ESR1 results in increased expression of CYP19A1 protein]]; Resveratrol inhibits the reaction [Estradiol results in increased expression of ESR1 mRNA]; Resveratrol inhibits the reaction [Estradiol results in increased expression of ESR1 protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1A1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 enhancer]]; Resveratrol metabolite binds to and results in decreased activity of ESR1 protein; Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]; Resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]; Resveratrol promotes the reaction [ESR1 protein binds to GREB1 enhancer]; Resveratrol promotes the reaction [Estradiol results in increased activity of ESR1 protein]; Resveratrol promotes the reaction [NCOA2 protein binds to ESR1 protein]; Resveratrol results in increased expression of and results in increased localization of ESR1 protein; Tamoxifen inhibits the reaction [Resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]]
resveratrol affects the localization of ESR1 protein
resveratrol results in increased phosphorylation of ESR1 protein
[4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol binds to and results in increased activity of ESR1 protein] inhibits the reaction [resveratrol results in decreased expression of PRL protein]; [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol binds to and results in increased activity of ESR1 protein] which results in decreased susceptibility to resveratrol; ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of INSR protein]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR1 mRNA]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]; resveratrol results in increased phosphorylation of and results in increased activity of ESR1 protein
resveratrol results in increased degradation of ESR1 protein
ESR1 protein results in increased susceptibility to resveratrol
resveratrol results in increased activity of ESR1 protein; resveratrol results in increased activity of ESR1 protein mutant form 		CTD PMID:9391166 PMID:10854714 PMID:11014220 PMID:11218048 PMID:11507064 More... NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
increases expression
affects binding
affects response to substance
decreases expression
increases activity 		ISO
EXP 		ESR2 protein promotes the reaction [resveratrol analog results in decreased expression of MYC protein]; fulvestrant inhibits the reaction [resveratrol results in increased activity of ESR2 protein]; resveratrol binds to and results in decreased activity of ESR2 protein; resveratrol binds to and results in increased activity of ESR2 protein; resveratrol inhibits the reaction [Estradiol binds to ESR2 protein]; resveratrol promotes the reaction [Estradiol results in increased activity of ESR2 protein]
Resveratrol analog results in increased expression of ESR2 mRNA; Resveratrol analog results in increased expression of ESR2 protein; Resveratrol results in increased expression of ESR2 mRNA; Resveratrol results in increased expression of ESR2 protein
resveratrol analog binds to ESR2 protein; resveratrol binds to ESR2 protein
ESR2 protein affects the susceptibility to resveratrol
ESR2 gene mutant form inhibits the reaction [resveratrol results in increased expression of SOD2 protein]; ESR2 protein affects the reaction [resveratrol results in increased expression of SOD2 protein]
resveratrol results in decreased expression of ESR2 protein
[2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] inhibits the reaction [resveratrol results in decreased expression of PRL protein]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR2 mRNA]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR2 protein]; resveratrol binds to and results in increased activity of ESR2 protein; resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 protein]
resveratrol results in increased expression of ESR2 protein 		CTD PMID:11014220 PMID:11507064 PMID:12765243 PMID:15084758 PMID:15149879 More... NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESRP1 mRNA CTD PMID:23557933 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrra estrogen related receptor, alpha increases expression
multiple interactions 		ISO resveratrol results in increased expression of ESRRA mRNA; resveratrol results in increased expression of ESRRA protein
resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein]; SIRT1 protein promotes the reaction [resveratrol results in increased expression of ESRRA mRNA] 		CTD PMID:19934007 PMID:23090186 PMID:24365713 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Etfa electron transfer flavoprotein subunit alpha increases expression
multiple interactions 		ISO resveratrol results in increased expression of ETFA protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ETFA mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080 		JBrowse link
G Etfb electron transfer flavoprotein subunit beta increases expression ISO resveratrol results in increased expression of ETFB mRNA; resveratrol results in increased expression of ETFB protein CTD PMID:22610192 PMID:25505154 NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659 		JBrowse link
G Etfdh electron transfer flavoprotein dehydrogenase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ETFDH mRNA CTD PMID:23557933 NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770 		JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase increases expression ISO resveratrol results in increased expression of ETHE1 protein CTD PMID:25505154 NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998 		JBrowse link
G Etnk2 ethanolamine kinase 2 increases expression ISO resveratrol results in increased expression of ETNK2 mRNA CTD PMID:19371625 NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor multiple interactions ISO ETS1 protein promotes the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of MIR126 mRNA]]; resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of ETS1 protein] CTD PMID:24107596 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Etv2 ETS variant transcription factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of ETV2 mRNA CTD PMID:23557933 NCBI chr 1:95,017,980...95,021,582
Ensembl chr 1:95,017,687...95,021,457 		JBrowse link
G Etv4 ETS variant transcription factor 4 decreases activity
increases expression
multiple interactions 		ISO resveratrol results in decreased activity of ETV4 protein
resveratrol results in increased expression of ETV4 protein
[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ETV4 mRNA 		CTD PMID:22252971 PMID:25448084 PMID:26667767 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318 		JBrowse link
G Evpl envoplakin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EVPL mRNA CTD PMID:23557933 NCBI chr10:101,957,107...101,973,656
Ensembl chr10:101,941,064...101,973,656 		JBrowse link
G Evx1 even-skipped homeobox 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EVX1 mRNA CTD PMID:23557933 NCBI chr 4:82,747,192...82,751,569
Ensembl chr 4:82,746,993...82,751,569 		JBrowse link
G Ewsr1 EWS RNA-binding protein 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EWSR1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EWSR1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095 		JBrowse link
G Exd2 exonuclease 3'-5' domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EXD2 mRNA CTD PMID:23557933 NCBI chr 6:105,847,931...105,881,780
Ensembl chr 6:105,848,305...105,883,665 		JBrowse link
G Exo1 exonuclease 1 multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of EXO1 mRNA
Resveratrol results in decreased expression of EXO1 mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861 		JBrowse link
G Exoc1 exocyst complex component 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC1 mRNA CTD PMID:23557933 NCBI chr14:31,965,782...32,014,156
Ensembl chr14:31,965,782...32,014,127 		JBrowse link
G Exoc3l1 exocyst complex component 3-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EXOC3L mRNA CTD PMID:23557933 NCBI chr19:50,076,761...50,084,278
Ensembl chr19:50,076,266...50,082,422 		JBrowse link
G Exoc3l2 exocyst complex component 3-like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EXOC3L2 mRNA CTD PMID:23557933 NCBI chr 1:88,241,784...88,273,352
Ensembl chr 1:88,240,477...88,276,847 		JBrowse link
G Exoc5 exocyst complex component 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC5 mRNA CTD PMID:23557933 NCBI chr15:24,788,738...24,834,941
Ensembl chr15:24,790,337...24,834,970 		JBrowse link
G Exoc6 exocyst complex component 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC6 mRNA CTD PMID:23557933 NCBI chr 1:244,727,084...244,870,263
Ensembl chr 1:244,711,981...244,870,396 		JBrowse link
G Exog exo/endonuclease G multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOG mRNA CTD PMID:23557933 NCBI chr 8:128,062,688...128,082,529
Ensembl chr 8:128,059,126...128,083,460 		JBrowse link
G Exosc1 exosome component 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EXOSC1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of EXOSC1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:250,684,746...250,694,748
Ensembl chr 1:250,684,750...250,694,748 		JBrowse link
G Exosc10 exosome component 10 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of EXOSC10 protein
resveratrol promotes the reaction [KHSRP protein binds to EXOSC10 protein] 		CTD PMID:25352548 PMID:25505154 NCBI chr 5:164,278,414...164,302,067
Ensembl chr 5:164,278,440...164,302,067 		JBrowse link
G Exosc2 exosome component 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EXOSC2 mRNA CTD PMID:19167446 NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373 		JBrowse link
G Exosc5 exosome component 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EXOSC5 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOSC5 mRNA CTD PMID:23557933 NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046 		JBrowse link
G Exosc6 exosome component 6 decreases expression ISO resveratrol results in decreased expression of EXOSC6 protein CTD PMID:25505154 NCBI chr19:55,931,523...55,932,937
Ensembl chr19:55,931,523...55,932,937 		JBrowse link
G Exosc7 exosome component 7 decreases expression ISO resveratrol results in decreased expression of EXOSC7 protein CTD PMID:25505154 NCBI chr 8:131,650,988...131,676,399
Ensembl chr 8:131,651,050...131,696,825 		JBrowse link
G Eya1 EYA transcriptional coactivator and phosphatase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EYA1 mRNA CTD PMID:23557933 NCBI chr 5:9,646,599...9,884,609
Ensembl chr 5:9,646,591...9,884,614 		JBrowse link
G Eya2 EYA transcriptional coactivator and phosphatase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EYA2 mRNA CTD PMID:23557933 NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of EYA4 mRNA CTD PMID:23557933 NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:23,991,431...24,235,131 		JBrowse link
G Ezh1 enhancer of zeste 1 polycomb repressive complex 2 subunit increases expression ISO resveratrol results in increased expression of EZH1 mRNA CTD PMID:12002526 NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,626,308...86,652,620 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions
increases expression
increases response to substance
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA; EZH2 mRNA promotes the reaction [resveratrol results in decreased expression of ACTA2 mRNA]; EZH2 mRNA promotes the reaction [resveratrol results in decreased expression of ZEB1 mRNA]
Resveratrol results in increased expression of EZH2 mRNA; Resveratrol results in increased expression of EZH2 protein
EZH2 mRNA results in increased susceptibility to resveratrol
resveratrol results in decreased expression of EZH2 protein
MIR137 mRNA affects the reaction [resveratrol results in decreased expression of EZH2 protein] 		CTD PMID:19167446 PMID:25505154 PMID:26934322 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G F13a1 coagulation factor XIII A1 chain increases expression ISO resveratrol results in increased expression of F13A1 mRNA CTD PMID:25280562 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2 coagulation factor II, thrombin multiple interactions ISO resveratrol inhibits the reaction [F2 protein results in increased abundance of Adenosine Diphosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of Adenosine Triphosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate]; resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols]; resveratrol inhibits the reaction [F2 protein results in increased expression of SELP protein]; resveratrol inhibits the reaction [F2 protein results in increased phosphorylation of PLEK protein] CTD PMID:15342215 PMID:16051184 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246 		JBrowse link
G F2r coagulation factor II (thrombin) receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of F2R mRNA; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA] CTD PMID:23452621 PMID:23557933 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F2rl3 F2R like thrombin or trypsin receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of F2RL3 mRNA CTD PMID:23557933 NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,151,516...17,153,823 		JBrowse link
G F3 coagulation factor III, tissue factor decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of F3 mRNA
[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 mRNA]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of and results in increased expression of F3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of F3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of F3 mRNA]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of F3 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of F3 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased activity of F3 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of F3]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of F3 protein]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased activity of and results in increased expression of F3 protein]; Resveratrol inhibits the reaction [TNF protein results in increased activity of F3 protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of F3 mRNA] 		CTD PMID:9974427 PMID:11858183 PMID:12871381 PMID:20978007 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F8 coagulation factor VIII increases expression EXP resveratrol results in increased expression of F8 protein CTD PMID:16775512 NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683 		JBrowse link
G Fabp3 fatty acid binding protein 3 increases expression EXP resveratrol results in increased expression of FABP3 mRNA CTD PMID:25905778 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Fabp4 fatty acid binding protein 4 decreases expression
affects secretion
multiple interactions 		ISO resveratrol results in decreased expression of FABP4
resveratrol affects the secretion of FABP4 protein
Rosiglitazone inhibits the reaction [Resveratrol results in decreased expression of FABP4 mRNA]; splitomicin promotes the reaction [Resveratrol results in decreased expression of FABP4 mRNA]; splitomicin promotes the reaction [Resveratrol results in decreased expression of FABP4 protein]
Resveratrol results in decreased expression of FABP4 mRNA; Resveratrol results in decreased expression of FABP4 protein 		CTD PMID:16813520 PMID:18555852 PMID:21852083 PMID:23525482 PMID:24802182 More... NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fabp6 fatty acid binding protein 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FABP6 mRNA CTD PMID:23557933 NCBI chr10:28,565,054...28,569,727
Ensembl chr10:28,565,054...28,573,058 		JBrowse link
G Fabp7 fatty acid binding protein 7 increases expression
multiple interactions 		ISO resveratrol results in increased expression of FABP7 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of FABP7 mRNA 		CTD PMID:12002526 PMID:23557933 NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907 		JBrowse link
G Fadd Fas associated via death domain increases response to substance
increases localization
multiple interactions
increases expression
affects localization 		ISO FADD protein results in increased susceptibility to resveratrol
resveratrol results in increased localization of FADD protein
Nystatin inhibits the reaction [resveratrol affects the localization of FADD protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]; resveratrol promotes the reaction [FAS protein binds to FADD protein]
resveratrol results in increased expression of FADD protein 		CTD PMID:12902349 PMID:19561642 PMID:23452621 PMID:24299158 NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976 		JBrowse link
G Fads1 fatty acid desaturase 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of FADS1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of FADS1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615 		JBrowse link
G Fah fumarylacetoacetate hydrolase affects splicing ISO resveratrol affects the splicing of FAH mutant form CTD PMID:23895425 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046 		JBrowse link
G Faim Fas apoptotic inhibitory molecule increases expression ISO resveratrol results in increased expression of FAIM protein CTD PMID:25505154 NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151 		JBrowse link
G Faim2 Fas apoptotic inhibitory molecule 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAIM2 mRNA CTD PMID:23557933 NCBI chr 7:132,512,095...132,539,192
Ensembl chr 7:132,512,210...132,538,026 		JBrowse link
G Fam107a family with sequence similarity 107, member A decreases expression ISO resveratrol results in decreased expression of FAM107A mRNA CTD PMID:19371625 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam107b family with sequence similarity 107, member B multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM107B mRNA
resveratrol results in decreased expression of FAM107B mRNA 		CTD PMID:19167446 NCBI chr17:79,387,795...79,594,165
Ensembl chr17:79,387,795...79,594,288 		JBrowse link
G Fam110b family with sequence similarity 110, member B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM110B mRNA CTD PMID:19167446 NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:23,586,867...23,799,583 		JBrowse link
G Fam110c family with sequence similarity 110, member C multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of FAM110C mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM110C mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117 		JBrowse link
G Fam111a FAM111 trypsin like peptidase A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FAM111A mRNA CTD PMID:19167446 NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211 		JBrowse link
G Fam117a family with sequence similarity 117, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM117A mRNA CTD PMID:23557933 NCBI chr10:80,778,229...80,822,119
Ensembl chr10:80,755,883...80,822,119 		JBrowse link
G Fam131b family with sequence similarity 131, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM131B mRNA CTD PMID:23557933 NCBI chr 4:72,167,667...72,176,924
Ensembl chr 4:72,165,578...72,176,858 		JBrowse link
G Fam131c family with sequence similarity 131, member C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM131C mRNA CTD PMID:23557933 NCBI chr 5:158,957,444...158,973,773
Ensembl chr 5:158,957,451...158,974,019 		JBrowse link
G Fam133b family with sequence similarity 133, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM133B mRNA CTD PMID:23557933 NCBI chr 4:31,544,458...31,571,056
Ensembl chr 4:31,544,458...31,570,780 		JBrowse link
G Fam135a family with sequence similarity 135, member A multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FAM135A mRNA CTD PMID:26667767 NCBI chr 9:33,916,449...33,997,140
Ensembl chr 9:33,916,449...33,997,051 		JBrowse link
G Fam13a family with sequence similarity 13, member A multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of FAM13A mRNA] CTD PMID:31298478 NCBI chr 4:89,386,685...89,485,940
Ensembl chr 4:89,388,569...89,485,988 		JBrowse link
G Fam13b family with sequence similarity 13, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM13B mRNA CTD PMID:23557933 NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,314,440...26,380,732 		JBrowse link
G Fam149b1 family with sequence similarity 149, member B1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM149B1 mRNA CTD PMID:19167446 NCBI chr15:3,978,377...4,016,323
Ensembl chr15:3,978,377...4,016,317 		JBrowse link
G Fam161b FAM161 centrosomal protein B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM161B mRNA CTD PMID:19167446 NCBI chr 6:109,722,073...109,750,003
Ensembl chr 6:109,722,569...109,750,036 		JBrowse link
G Fam162a family with sequence similarity 162, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM162A mRNA CTD PMID:23557933 NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560 		JBrowse link
G Fam163b family with sequence similarity 163, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM163B mRNA CTD PMID:23557933 NCBI chr 3:30,834,145...30,865,802
Ensembl chr 3:30,834,146...30,864,530 		JBrowse link
G Fam167b family with sequence similarity 167, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM167B mRNA CTD PMID:23557933 NCBI chr 5:147,205,018...147,206,660
Ensembl chr 5:147,204,653...147,206,652 		JBrowse link
G Fam168a family with sequence similarity 168, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM168A mRNA CTD PMID:23557933 NCBI chr 1:164,469,447...164,615,542
Ensembl chr 1:164,469,471...164,615,506 		JBrowse link
G Fam170a family with sequence similarity 170, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM170A mRNA CTD PMID:23557933 NCBI chr18:45,707,817...45,712,548
Ensembl chr18:45,707,806...45,714,751 		JBrowse link
G Fam170b family with sequence similarity 170, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM170B mRNA CTD PMID:23557933 NCBI chr16:8,108,210...8,111,020
Ensembl chr16:8,108,210...8,111,020 		JBrowse link
G Fam171b family with sequence similarity 171, member B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA CTD PMID:19167446 NCBI chr 3:89,337,566...89,392,973
Ensembl chr 3:89,337,661...89,392,971 		JBrowse link
G Fam174c family with sequence similarity 174 member C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM174C mRNA CTD PMID:23557933 NCBI chr 7:10,182,653...10,184,363
Ensembl chr 7:10,182,653...10,184,363 		JBrowse link
G Fam178b family with sequence similarity 178, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM178B mRNA CTD PMID:23557933 NCBI chr 9:46,301,734...46,409,571
Ensembl chr 9:46,301,734...46,410,686 		JBrowse link
G Fam184b family with sequence similarity 184, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM184B mRNA CTD PMID:23557933 NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922 		JBrowse link
G Fam185a family with sequence similarity 185, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM185A mRNA CTD PMID:23557933 NCBI chr 4:14,469,165...14,555,167
Ensembl chr 4:14,499,869...14,555,167 		JBrowse link
G Fam199x family with sequence similarity 199, X-linked multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM199X mRNA CTD PMID:23557933 NCBI chr  X:105,176,504...105,212,207
Ensembl chr  X:105,176,504...105,212,207 		JBrowse link
G Fam210a family with sequence similarity 210, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM210A mRNA CTD PMID:23557933 NCBI chr18:64,116,274...64,155,971
Ensembl chr18:64,116,274...64,155,949 		JBrowse link
G Fam217b family with sequence similarity 217, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM217B mRNA CTD PMID:23557933 NCBI chr 3:185,883,277...185,892,976
Ensembl chr 3:185,883,367...185,892,974 		JBrowse link
G Fam219a family with sequence similarity 219, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM219A mRNA CTD PMID:23557933 NCBI chr 5:61,475,185...61,525,749
Ensembl chr 5:61,475,185...61,525,749 		JBrowse link
G Fam221a family with sequence similarity 221, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM221A mRNA CTD PMID:23557933 NCBI chr 4:79,668,130...79,689,768
Ensembl chr 4:79,667,284...79,689,761 		JBrowse link
G Fam222a family with sequence similarity 222, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM222A mRNA CTD PMID:23557933 NCBI chr12:47,647,221...47,693,703
Ensembl chr12:47,647,405...47,693,703 		JBrowse link
G Fam222b family with sequence similarity 222, member B multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM222B mRNA
resveratrol results in decreased expression of FAM222B mRNA 		CTD PMID:19167446 PMID:23557933 NCBI chr10:63,484,651...63,550,422
Ensembl chr10:63,484,652...63,550,288 		JBrowse link
G Fam241b family with sequence similarity 241 member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM241B mRNA CTD PMID:23557933 NCBI chr20:30,595,082...30,598,007
Ensembl chr20:30,595,084...30,597,844
Ensembl chr 6:30,595,084...30,597,844 		JBrowse link
G Fam32a family with sequence similarity 32, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM32A mRNA CTD PMID:23557933 NCBI chr16:17,637,078...17,641,448
Ensembl chr16:17,637,087...17,641,399 		JBrowse link
G Fam3a FAM3 metabolism regulating signaling molecule A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM3A mRNA CTD PMID:23557933 NCBI chr  X:157,317,993...157,326,640
Ensembl chr  X:157,317,990...157,326,612 		JBrowse link
G Fam3d FAM3 metabolism regulating signaling molecule D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM3D mRNA CTD PMID:23557933 NCBI chr15:18,969,737...19,003,276
Ensembl chr15:18,969,737...19,004,701 		JBrowse link
G Fam43a family with sequence similarity 43, member A multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA
resveratrol results in decreased expression of FAM43A mRNA 		CTD PMID:19167446 NCBI chr11:83,633,165...83,636,313
Ensembl chr11:83,633,154...83,695,297 		JBrowse link
G Fam47a family with sequence similarity 47, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM47A mRNA CTD PMID:23557933 NCBI chr  X:46,649,284...46,650,940
Ensembl chr  X:46,649,284...46,650,940 		JBrowse link
G Fam76a family with sequence similarity 76, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM76A mRNA CTD PMID:23557933 NCBI chr 5:150,391,460...150,419,526
Ensembl chr 5:150,391,463...150,419,807 		JBrowse link
G Fam78b family with sequence similarity 78, member B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM78B mRNA CTD PMID:23557933 NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784 		JBrowse link
G Fam83e family with sequence similarity 83, member E multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM83E mRNA CTD PMID:23557933 NCBI chr 1:105,328,297...105,337,641
Ensembl chr 1:105,328,247...105,337,638 		JBrowse link
G Fam91a1 family with sequence similarity 91, member A1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM91A1 mRNA CTD PMID:23557933 NCBI chr 7:91,857,261...91,897,019
Ensembl chr 7:91,859,062...91,898,195 		JBrowse link
G Fam98a family with sequence similarity 98, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM98A mRNA CTD PMID:23557933 NCBI chr 6:25,626,108...25,640,767
Ensembl chr 6:25,625,984...25,640,767 		JBrowse link
G Fan1 FANCD2 and FANCI associated nuclease 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FAN1 mRNA CTD PMID:23557933 NCBI chr 1:127,327,098...127,356,807
Ensembl chr 1:127,330,016...127,356,400 		JBrowse link
G Fanca FA complementation group A multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of FANCA mRNA
Resveratrol results in decreased expression of FANCA mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019 		JBrowse link
G Fancc FA complementation group C decreases expression EXP Resveratrol results in decreased expression of FANCC mRNA CTD PMID:33775663 NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096 		JBrowse link
G Fancd2 FA complementation group D2 decreases response to substance
multiple interactions
decreases expression 		ISO
EXP 		resveratrol results in decreased susceptibility to FANCD2 gene mutant form
[Coumestrol co-treated with Resveratrol] results in increased expression of FANCD2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCD2 mRNA
Resveratrol results in decreased expression of FANCD2 mRNA 		CTD PMID:19167446 PMID:22628295 PMID:23557933 PMID:33775663 NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035 		JBrowse link
G Fancf FA complementation group F multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCF mRNA CTD PMID:23557933 NCBI chr 1:110,585,054...110,587,870
Ensembl chr 1:110,576,389...110,587,863 		JBrowse link
G Fancg FA complementation group G multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FANCG mRNA CTD PMID:19167446 NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787 		JBrowse link
G Fanci FA complementation group I multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of FANCI mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCI mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999 		JBrowse link
G Fancl FA complementation group L multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FANCL mRNA CTD PMID:19167446 NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297 		JBrowse link
G Fancm FA complementation group M multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCM mRNA CTD PMID:23557933 NCBI chr 6:88,862,898...88,916,701
Ensembl chr 6:88,863,306...88,921,652 		JBrowse link
G Far1 fatty acyl CoA reductase 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of FAR1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of FAR1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:177,078,973...177,140,363
Ensembl chr 1:177,079,150...177,161,696 		JBrowse link
G Fas Fas cell surface death receptor increases expression
multiple interactions
affects localization
increases response to substance 		ISO
EXP 		resveratrol analog results in increased expression of FAS mRNA; resveratrol results in increased expression of FAS mRNA; resveratrol results in increased expression of FAS protein
resveratrol inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in decreased expression of FAS mRNA]; resveratrol inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in decreased expression of FAS protein]
resveratrol affects the localization of FAS protein
[allyl sulfide co-treated with resveratrol] results in increased expression of FAS protein; [IFNG protein results in increased expression of and results in increased localization of FAS protein] which results in increased susceptibility to resveratrol; Capsaicin promotes the reaction [resveratrol results in increased expression of FAS protein]; Nystatin inhibits the reaction [resveratrol affects the localization of FAS protein]; resveratrol promotes the reaction [FAS protein binds to CASP10 protein]; resveratrol promotes the reaction [FAS protein binds to CASP8 protein]; resveratrol promotes the reaction [FAS protein binds to FADD protein]
FAS protein results in increased susceptibility to resveratrol; resveratrol results in increased susceptibility to FAS protein 		CTD PMID:12902349 PMID:17261084 PMID:17872969 PMID:18512326 PMID:19561642 More... NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand increases cleavage
increases expression
multiple interactions 		ISO resveratrol results in increased cleavage of FASLG protein
resveratrol results in increased expression of FASL protein
resveratrol analog results in increased expression of FASLG mRNA; resveratrol results in increased expression of FASLG mRNA; resveratrol results in increased expression of FASLG protein
resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]; resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter]; SB 203580 promotes the reaction [resveratrol results in increased cleavage of FASLG protein] 		CTD PMID:9680369 PMID:15217905 PMID:17513867 PMID:17872969 PMID:20717957 More... NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase multiple interactions
decreases expression 		EXP
ISO 		[Fenofibrate co-treated with Resveratrol] inhibits the reaction [Fructose results in increased expression of FASN mRNA]; dorsomorphin inhibits the reaction [Resveratrol metabolite inhibits the reaction [T0901317 results in increased expression of FASN mRNA]]; Resveratrol inhibits the reaction [Fructose results in increased expression of FASN mRNA]; Resveratrol inhibits the reaction [High Fructose Corn Syrup results in increased expression of FASN mRNA]; Resveratrol inhibits the reaction [INS1 protein results in increased expression of FASN mRNA]; Resveratrol metabolite inhibits the reaction [T0901317 results in increased expression of FASN mRNA]
[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; Resveratrol inhibits the reaction [Hydrocortisone results in increased expression of FASN mRNA]; Resveratrol inhibits the reaction [T0901317 results in increased expression of FASN mRNA]
Resveratrol results in decreased expression of FASN mRNA; Resveratrol results in decreased expression of FASN protein
resveratrol results in decreased expression of FASN mRNA
[resveratrol results in decreased expression of SREBF1 mRNA] which results in decreased expression of FASN mRNA; resveratrol results in decreased expression of FASN mRNA
resveratrol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] 		CTD PMID:16626303 PMID:18482975 PMID:18755807 PMID:18930334 PMID:20878097 More... NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fastk Fas-activated serine/threonine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FASTK mRNA CTD PMID:23557933 NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867 		JBrowse link
G Fastkd1 FAST kinase domains 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FASTKD1 mRNA CTD PMID:23557933 NCBI chr 3:74,857,539...74,883,483
Ensembl chr 3:74,845,261...74,883,367 		JBrowse link
G Fastkd2 FAST kinase domains 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FASTKD2 mRNA CTD PMID:23557933 NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:72,661,764...72,721,338 		JBrowse link
G Fbh1 F-box DNA helicase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBH1 mRNA CTD PMID:23557933 NCBI chr17:71,659,351...71,697,431
Ensembl chr17:71,659,249...71,697,432 		JBrowse link
G Fblim1 filamin binding LIM protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBLIM1 mRNA CTD PMID:23557933 NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853 		JBrowse link
G Fbln2 fibulin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBLN2 mRNA CTD PMID:23557933 NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029 		JBrowse link
G Fbln5 fibulin 5 increases expression ISO resveratrol results in increased expression of FBLN5 mRNA CTD PMID:25888808 NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296 		JBrowse link
G Fbrs fibrosin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBRS mRNA CTD PMID:23557933 NCBI chr 1:191,520,148...191,534,510
Ensembl chr 1:191,522,036...191,534,500 		JBrowse link
G Fbrsl1 fibrosin-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBRSL1 mRNA CTD PMID:23557933 NCBI chr12:51,891,211...51,979,715
Ensembl chr12:51,960,790...51,979,361 		JBrowse link
G Fbxl16 F-box and leucine-rich repeat protein 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL16 mRNA CTD PMID:23557933 NCBI chr10:15,333,996...15,346,253
Ensembl chr10:15,334,014...15,346,232 		JBrowse link
G Fbxl18 F-box and leucine-rich repeat protein 18 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL18 mRNA CTD PMID:23557933 NCBI chr12:16,781,901...16,812,728
Ensembl chr12:16,789,665...16,814,240 		JBrowse link
G Fbxl20 F-box and leucine-rich repeat protein 20 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXL20 mRNA CTD PMID:23557933 NCBI chr10:83,577,038...83,640,022
Ensembl chr10:83,577,038...83,639,977 		JBrowse link
G Fbxl3 F-box and leucine-rich repeat protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXL3 mRNA CTD PMID:23557933 NCBI chr15:86,321,504...86,341,387
Ensembl chr15:86,321,504...86,341,387 		JBrowse link
G Fbxl6 F-box and leucine-rich repeat protein 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL6 mRNA CTD PMID:23557933 NCBI chr 7:110,140,243...110,143,176
Ensembl chr 7:110,140,244...110,143,141 		JBrowse link
G Fbxl7 F-box and leucine-rich repeat protein 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL7 mRNA CTD PMID:23557933 NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697 		JBrowse link
G Fbxo11 F-box protein 11 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of FBXO11 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO11 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 6:12,240,348...12,316,223
Ensembl chr 6:12,239,801...12,316,221 		JBrowse link
G Fbxo17 F-box protein 17 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXO17 mRNA CTD PMID:23557933 NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981 		JBrowse link
G Fbxo22 F-box protein 22 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO22 mRNA CTD PMID:23557933 NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062 		JBrowse link
G Fbxo3 F-box protein 3 decreases expression EXP resveratrol results in decreased expression of FBXO3 mRNA CTD PMID:25905778 NCBI chr 3:110,872,185...110,904,479
Ensembl chr 3:110,872,220...110,904,479 		JBrowse link
G Fbxo30 F-box protein 30 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO30 mRNA CTD PMID:23557933 NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199 		JBrowse link
G Fbxo32 F-box protein 32 increases expression
multiple interactions
decreases expression 		ISO
EXP 		resveratrol results in increased expression of FBXO32 mRNA
FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 mRNA]]; resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 mRNA]; resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 protein]
resveratrol results in decreased expression of FBXO32 mRNA
[resveratrol results in increased localization of and results in increased activity of FOXO1 protein] which results in increased expression of FBXO32 mRNA; resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] 		CTD PMID:18077353 PMID:22146233 PMID:24534773 PMID:25888808 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fbxo34 F-box protein 34 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO34 mRNA CTD PMID:23557933 NCBI chr15:23,199,103...23,266,929
Ensembl chr15:23,171,312...23,270,071 		JBrowse link
G Fbxo45 F-box protein 45 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO45 mRNA CTD PMID:23557933 NCBI chr11:82,056,457...82,072,080
Ensembl chr11:82,056,457...82,072,080 		JBrowse link
G Fbxo46 F-box protein 46 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXO46 mRNA CTD PMID:23557933 NCBI chr 1:87,898,029...87,914,615
Ensembl chr 1:87,897,888...87,926,021 		JBrowse link
G Fbxo48 F-box protein 48 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO48 mRNA CTD PMID:23557933 NCBI chr14:95,582,493...95,583,950
Ensembl chr14:95,581,279...95,587,616 		JBrowse link
G Fbxo5 F-box protein 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA CTD PMID:19167446 NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781 		JBrowse link
G Fbxo9 f-box protein 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO9 mRNA CTD PMID:23557933 NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504 		JBrowse link
G Fbxw2 F-box and WD repeat domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXW2 mRNA CTD PMID:23557933 NCBI chr 3:38,486,358...38,511,683
Ensembl chr 3:38,486,362...38,511,667 		JBrowse link
G Fcer1a Fc epsilon receptor Ia decreases expression ISO resveratrol results in decreased expression of FCER1A mRNA CTD PMID:25280562 NCBI chr13:88,218,427...88,224,723
Ensembl chr13:88,218,420...88,224,681 		JBrowse link
G Fcer1g Fc epsilon receptor Ig multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of FCER1G mRNA CTD PMID:25905778 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fchsd1 FCH and double SH3 domains 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FCHSD1 mRNA CTD PMID:23557933 NCBI chr18:30,043,466...30,056,326
Ensembl chr18:30,045,106...30,055,673 		JBrowse link
G Fchsd2 FCH and double SH3 domains 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FCHSD2 mRNA CTD PMID:23557933 NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391 		JBrowse link
G Fcmr Fc mu receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FCMR mRNA CTD PMID:23557933 NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314 		JBrowse link
G Fcna ficolin A increases expression
multiple interactions 		EXP Resveratrol results in increased expression of FCNA mRNA
[Resveratrol co-treated with Streptozocin] results in increased expression of FCNA mRNA 		CTD PMID:25905778 NCBI chr 3:28,844,036...28,847,441
Ensembl chr 3:28,844,039...28,847,237 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression
increases expression
multiple interactions 		ISO resveratrol results in decreased expression of FDFT1 mRNA
resveratrol results in increased expression of FDFT1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of FDFT1 mRNA; resveratrol inhibits the reaction [Simvastatin results in increased expression of FDFT1 mRNA] 		CTD PMID:18930334 PMID:19167446 PMID:22153697 PMID:23386644 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FDPS mRNA; resveratrol inhibits the reaction [Simvastatin results in increased expression of FDPS mRNA] CTD PMID:19167446 PMID:23386644 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fdx1 ferredoxin 1 decreases expression EXP resveratrol results in decreased expression of FDX1 mRNA CTD PMID:25905778 NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583 		JBrowse link
G Fdxr ferredoxin reductase increases expression ISO resveratrol results in increased expression of FDXR mRNA CTD PMID:25888808 NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542 		JBrowse link
G Fem1b fem-1 homolog B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FEM1B mRNA CTD PMID:23557933 NCBI chr 8:72,160,722...72,173,996
Ensembl chr 8:72,160,722...72,173,996 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in increased expression of FEN1 mRNA
Resveratrol results in decreased expression of FEN1 mRNA 		CTD PMID:19167446 PMID:33775663 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fer FER tyrosine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FER mRNA CTD PMID:23557933 NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315 		JBrowse link
G Fes FES proto-oncogene, tyrosine kinase increases expression EXP resveratrol results in increased expression of FES mRNA CTD PMID:25905778 NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:143,746,945...143,756,181 		JBrowse link
G Fez2 fasciculation and elongation protein zeta 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FEZ2 mRNA CTD PMID:23557933 NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:22,406,632...22,447,041 		JBrowse link
G Fezf1 Fez family zinc finger 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FEZF1 mRNA CTD PMID:23557933 NCBI chr 4:52,728,385...52,733,315
Ensembl chr 4:52,728,391...52,731,718 		JBrowse link
G Fezf2 Fez family zinc finger 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FEZF2 mRNA CTD PMID:23557933 NCBI chr15:15,199,045...15,207,982
Ensembl chr15:15,204,193...15,207,982 		JBrowse link
G Ffar1 free fatty acid receptor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FFAR1 mRNA CTD PMID:23557933 NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691 		JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FFAR3 mRNA CTD PMID:23557933 NCBI chr 1:95,232,804...95,234,144
Ensembl chr 1:95,232,336...95,234,354 		JBrowse link
G Fgd4 FYVE, RhoGEF and PH domain containing 4 increases expression ISO resveratrol results in increased expression of FGD4 protein CTD PMID:18089832 NCBI chr11:97,904,182...98,055,190
Ensembl chr11:97,904,182...98,055,190 		JBrowse link
G Fgd5 FYVE, RhoGEF and PH domain containing 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGD5 mRNA CTD PMID:23557933 NCBI chr 4:126,054,201...126,151,698
Ensembl chr 4:126,054,210...126,151,697 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression ISO resveratrol results in increased expression of FGF1 mRNA CTD PMID:20706672 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgf10 fibroblast growth factor 10 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of FGF10 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF10 mRNA 		CTD PMID:23525482 PMID:23557933 PMID:25338179 NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:52,533,939...52,610,980 		JBrowse link
G Fgf11 fibroblast growth factor 11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF11 mRNA CTD PMID:23557933 NCBI chr10:55,015,232...55,020,773
Ensembl chr10:55,016,411...55,020,454 		JBrowse link
G Fgf12 fibroblast growth factor 12 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF12 mRNA CTD PMID:23557933 NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543 		JBrowse link
G Fgf16 fibroblast growth factor 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF16 mRNA CTD PMID:23557933 NCBI chr  X:74,882,863...74,893,598
Ensembl chr  X:74,882,995...74,944,246 		JBrowse link
G Fgf2 fibroblast growth factor 2 decreases activity
decreases expression
multiple interactions 		ISO resveratrol results in decreased activity of FGF2 protein
resveratrol results in decreased expression of FGF2 mRNA
resveratrol inhibits the reaction [FGF2 protein results in increased expression of TNFRSF11B mRNA]; resveratrol inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein]; resveratrol inhibits the reaction [FGF2 protein results in increased secretion of TNFRSF11B protein]
resveratrol results in decreased expression of FGF2 mRNA; resveratrol results in decreased expression of FGF2 protein 		CTD PMID:16675471 PMID:17935668 PMID:20028382 PMID:25290095 PMID:25338179 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf21 fibroblast growth factor 21 multiple interactions
increases expression 		ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of FGF21 mRNA]
resveratrol results in increased expression of FGF21 mRNA; resveratrol results in increased expression of FGF21 protein 		CTD PMID:24184811 PMID:31298478 NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056 		JBrowse link
G Fgf23 fibroblast growth factor 23 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF23 mRNA CTD PMID:23557933 NCBI chr 4:161,600,439...161,609,991
Ensembl chr 4:161,600,383...161,609,991 		JBrowse link
G Fgf4 fibroblast growth factor 4 decreases expression ISO resveratrol results in decreased expression of FGF4 mRNA CTD PMID:21188121 NCBI chr 1:209,453,229...209,457,085
Ensembl chr 1:209,453,229...209,457,085 		JBrowse link
G Fgf6 fibroblast growth factor 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF6 mRNA CTD PMID:23557933 NCBI chr 4:161,541,089...161,549,624
Ensembl chr 4:161,541,089...161,553,521 		JBrowse link
G Fgf7 fibroblast growth factor 7 decreases expression ISO resveratrol results in decreased expression of FGF7 mRNA CTD PMID:23525482 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgf8 fibroblast growth factor 8 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FGF8 mRNA
Resveratrol results in decreased expression of FGF8 mRNA 		CTD PMID:23557933 PMID:29990529 NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:254,533,504...254,539,605 		JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 increases expression ISO resveratrol results in increased expression of FGFR1 mRNA CTD PMID:12002526 NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855 		JBrowse link
G Fgfr1op2 FGFR1 oncogene partner 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FGFR1OP2 mRNA CTD PMID:23557933 NCBI chr 4:181,222,298...181,243,318
Ensembl chr 4:181,222,323...181,243,322 		JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 decreases expression ISO resveratrol results in decreased expression of FGFR3 mRNA CTD PMID:23525482 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209 		JBrowse link
G Fgl1 fibrinogen-like 1 multiple interactions ISO resveratrol inhibits the reaction [Dietary Fats affects the expression of FGL1 mRNA] CTD PMID:17086191 NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429 		JBrowse link
G Fgr FGR proto-oncogene, Src family tyrosine kinase increases expression EXP resveratrol results in increased expression of FGR mRNA CTD PMID:25905778 NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169 		JBrowse link
G Fh fumarate hydratase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FH mRNA CTD PMID:23557933 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627 		JBrowse link
G Fhdc1 FH2 domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FHDC1 mRNA CTD PMID:23557933 NCBI chr 2:172,088,987...172,127,838
Ensembl chr 2:172,089,010...172,125,956 		JBrowse link
G Fhl2 four and a half LIM domains 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FHL2 mRNA CTD PMID:19167446 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fibcd1 fibrinogen C domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FIBCD1 mRNA CTD PMID:23557933 NCBI chr 3:35,490,459...35,524,142
Ensembl chr 3:35,490,459...35,524,142 		JBrowse link
G Ficd FIC domain protein adenylyltransferase multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of FICD mRNA] CTD PMID:31298478 NCBI chr12:48,549,737...48,554,626
Ensembl chr12:48,549,737...48,554,626 		JBrowse link
G Fig4 FIG4 phosphoinositide 5-phosphatase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FIG4 mRNA CTD PMID:23557933 NCBI chr20:46,183,225...46,306,686
Ensembl chr20:46,183,225...46,306,477 		JBrowse link
G Fignl1 fidgetin-like 1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of FIGNL1 mRNA
resveratrol results in increased expression of FIGNL1 mRNA 		CTD PMID:19167446 NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316 		JBrowse link
G Firrm FIGNL1 interacting regulator of recombination and mitosis multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of FIRRM mRNA CTD PMID:19167446 NCBI chr13:78,835,081...78,879,022
Ensembl chr13:78,834,216...78,879,213 		JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions
increases expression 		EXP
ISO 		resveratrol inhibits the reaction [Rotenone results in decreased expression of FIS1 mRNA]; resveratrol inhibits the reaction [Rotenone results in decreased expression of FIS1 protein]
resveratrol results in increased expression of FIS1 mRNA 		CTD PMID:21224254 PMID:26770656 NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335 		JBrowse link
G Fitm2 fat storage-inducing transmembrane protein 2 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of FITM2 mRNA CTD PMID:25905778 NCBI chr 3:172,560,781...172,567,291
Ensembl chr 3:172,560,781...172,567,291 		JBrowse link
G Fkbp10 FKBP prolyl isomerase 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FKBP10 mRNA CTD PMID:23557933 NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FKBP11 mRNA CTD PMID:19167446 NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Fkbp14 FKBP prolyl isomerase 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FKBP14 mRNA CTD PMID:23557933 NCBI chr 4:85,035,840...85,051,917
Ensembl chr 4:85,037,145...85,051,808 		JBrowse link
G Fkbp1b FKBP prolyl isomerase 1B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FKBP1B mRNA CTD PMID:23557933 NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129 		JBrowse link
G Fkbp3 FKBP prolyl isomerase 3 decreases expression ISO resveratrol results in decreased expression of FKBP3 protein CTD PMID:25505154 NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:88,843,879...88,863,447 		JBrowse link
G Fkbp4 FKBP prolyl isomerase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FKBP4 mRNA CTD PMID:19167446 NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA
resveratrol results in increased expression of FKBP5 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fkbp8 FKBP prolyl isomerase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FKBP8 mRNA CTD PMID:23557933 NCBI chr16:18,929,581...18,936,621
Ensembl chr16:18,929,582...18,936,543 		JBrowse link
G Fkbpl FKBP prolyl isomerase like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FKBPL mRNA CTD PMID:23557933 NCBI chr20:4,104,457...4,105,927
Ensembl chr20:4,104,019...4,105,615 		JBrowse link
G Flot1 flotillin 1 increases expression ISO resveratrol results in increased expression of FLOT1 mRNA CTD PMID:12002526 NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,922,655...2,932,771 		JBrowse link
G Flrt1 fibronectin leucine rich transmembrane protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FLRT1 mRNA CTD PMID:23557933 NCBI chr 1:213,704,983...213,782,958
Ensembl chr 1:213,704,038...213,782,981 		JBrowse link
G Flrt2 fibronectin leucine rich transmembrane protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FLRT2 mRNA CTD PMID:23557933 NCBI chr 6:120,507,998...120,603,133
Ensembl chr 6:120,507,689...120,609,004 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions
decreases secretion
decreases expression 		ISO resveratrol inhibits the reaction [2-furoyl-LIGRLO-amide results in increased expression of FLT1 mRNA]; resveratrol inhibits the reaction [2-furoyl-LIGRLO-amide results in increased secretion of FLT1 protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of FLT1 protein]
resveratrol results in decreased secretion of FLT1 protein
resveratrol results in decreased expression of FLT1 mRNA; resveratrol results in decreased expression of FLT1 protein 		CTD PMID:17992120 PMID:22197494 PMID:26933402 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Flt3lg Fms related receptor tyrosine kinase 3 ligand multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FLT3LG mRNA; Resveratrol results in increased activity of [KITL protein co-treated with THPO protein co-treated with FLT3LG protein co-treated with IL6 protein] CTD PMID:23557933 PMID:26160960 NCBI chr 1:104,751,518...104,756,925
Ensembl chr 1:104,749,983...104,757,038 		JBrowse link
G Flywch1 FLYWCH-type zinc finger 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FLYWCH1 mRNA CTD PMID:23557933 NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925 		JBrowse link
G Fmnl2 formin-like 2 decreases expression ISO resveratrol results in decreased expression of FMNL2 mRNA CTD PMID:19167446 NCBI chr 3:57,758,236...58,033,832
Ensembl chr 3:57,758,191...58,033,831 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions EXP resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1 mRNA]; resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1] CTD PMID:24894866 NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874 		JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FMO2 mRNA CTD PMID:23557933 NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534 		JBrowse link
G Fmo4 flavin containing dimethylaniline monoxygenase 4 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of FMO4 mRNA CTD PMID:25905778 NCBI chr13:77,687,909...77,706,100
Ensembl chr13:77,687,909...77,706,100 		JBrowse link
G Fmo5 flavin containing dimethylaniline monoxygenase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FMO5 mRNA CTD PMID:23557933 NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464 		JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of FMR1 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of FMR1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr  X:152,284,857...152,322,686
Ensembl chr  X:152,284,841...152,322,675 		JBrowse link
G Fn1 fibronectin 1 decreases expression
affects secretion
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of FN1 mRNA; resveratrol results in decreased expression of FN1 mRNA alternative form; resveratrol results in decreased expression of FN1 protein alternative form
resveratrol affects the secretion of FN1 protein
resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; resveratrol inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA alternative form]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA alternative form]]
Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of FN1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]
resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein] 		CTD PMID:19228061 PMID:19765649 PMID:20878097 PMID:21300041 PMID:22245600 More... NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fn3krp fructosamine-3-kinase-related protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FN3KRP mRNA CTD PMID:23557933 NCBI chr10:107,186,695...107,195,419 JBrowse link
G Fndc3a fibronectin type III domain containing 3a multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FNDC3A mRNA CTD PMID:23557933 NCBI chr15:54,099,510...54,276,963
Ensembl chr15:54,099,510...54,276,407 		JBrowse link
G Fndc3b fibronectin type III domain containing 3B multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FNDC3B mRNA CTD PMID:26667767 NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:112,243,202...112,546,306 		JBrowse link
G Fndc4 fibronectin type III domain containing 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FNDC4 mRNA CTD PMID:23557933 NCBI chr 6:30,797,102...30,800,782
Ensembl chr 6:30,796,871...30,800,769 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression
decreases activity
increases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of FOS
resveratrol results in decreased activity of FOS protein
Resveratrol metabolite results in increased expression of FOS mRNA; Resveratrol results in increased expression of FOS mRNA; Resveratrol results in increased expression of FOS protein
resveratrol results in decreased expression of FOS protein
[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of FOS protein]; resveratrol inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of FOS protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of FOS mRNA]; [Resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9; EGF protein inhibits the reaction [Resveratrol results in increased expression of FOS mRNA]; Resveratrol affects the localization of and results in increased activity of FOS protein; Resveratrol inhibits the reaction [Glucose results in increased expression of FOS protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased activity of FOS protein]; Resveratrol inhibits the reaction [JUN protein binds to FOS protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; Resveratrol results in increased expression of and results in increased activity of FOS protein 		CTD PMID:10381133 PMID:10843709 PMID:11889192 PMID:12663506 PMID:14623829 More... NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOSL1 mRNA CTD PMID:23557933 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Foxa1 forkhead box A1 multiple interactions
increases phosphorylation 		ISO FOXA1 protein promotes the reaction [resveratrol results in increased activity of ESR1 protein]; FOXA1 protein promotes the reaction [resveratrol results in increased expression of BMP2 protein]
resveratrol results in increased phosphorylation of FOXA1 protein 		CTD PMID:17513867 PMID:25311616 NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191 		JBrowse link
G Foxa2 forkhead box A2 decreases expression
increases expression 		ISO resveratrol results in decreased expression of FOXA2 mRNA
resveratrol results in increased expression of FOXA2 mRNA 		CTD PMID:20878097 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxa3 forkhead box A3 affects expression ISO resveratrol affects the expression of FOXA3 mRNA CTD PMID:18586690 NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:87,790,012...87,800,953 		JBrowse link
G Foxc2 forkhead box C2 multiple interactions ISO [Dietary Fats co-treated with Resveratrol] results in increased expression of FOXC2 mRNA CTD PMID:29197120 NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977 		JBrowse link
G Foxd1 forkhead box D1 increases expression ISO resveratrol results in increased expression of FOXD1 mRNA CTD PMID:19371625 NCBI chr 2:31,436,802...31,439,222
Ensembl chr 2:31,436,813...31,439,399 		JBrowse link
G Foxd2 forkhead box D2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXD2 mRNA CTD PMID:23557933 NCBI chr 5:133,664,760...133,667,483
Ensembl chr 5:133,664,760...133,667,483 		JBrowse link
G Foxe1 forkhead box E1 increases expression
decreases expression 		ISO
EXP 		resveratrol results in increased expression of FOXE1 mRNA
resveratrol results in decreased expression of FOXE1 mRNA 		CTD PMID:23594881 PMID:28668442 NCBI chr 5:65,425,630...65,428,438
Ensembl chr 5:65,425,630...65,428,438 		JBrowse link
G Foxf1 forkhead box F1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXF1 mRNA CTD PMID:23557933 NCBI chr19:66,062,635...66,066,427
Ensembl chr19:66,062,369...66,066,428 		JBrowse link
G Foxg1 forkhead box G1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXG1 mRNA CTD PMID:23557933 NCBI chr 6:72,401,582...72,404,392
Ensembl chr 6:72,394,239...72,427,392 		JBrowse link
G Foxi1 forkhead box I1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXI1 mRNA CTD PMID:23557933 NCBI chr10:19,310,466...19,314,405
Ensembl chr10:19,310,482...19,314,405 		JBrowse link
G Foxi2 forkhead box I2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXI2 mRNA CTD PMID:23557933 NCBI chr 1:199,652,703...199,656,503
Ensembl chr 1:199,652,703...199,656,498 		JBrowse link
G Foxj2 forkhead box J2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXJ2 mRNA CTD PMID:23557933 NCBI chr 4:157,718,990...157,745,468
Ensembl chr 4:157,718,992...157,745,450 		JBrowse link
G Foxl1 forkhead box L1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXL1 mRNA CTD PMID:23557933 NCBI chr19:66,105,953...66,109,366 JBrowse link
G Foxl2 forkhead box L2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXL2 mRNA CTD PMID:23557933 NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:108,382,872...108,396,835 		JBrowse link
G Foxm1 forkhead box M1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA
resveratrol results in increased expression of FOXM1 mRNA 		CTD PMID:19167446 NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172 		JBrowse link
G Foxn3 forkhead box N3 decreases expression ISO resveratrol results in decreased expression of FOXN3 mRNA CTD PMID:12569576 NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040 		JBrowse link
G Foxn4 forkhead box N4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXN4 mRNA CTD PMID:23557933 NCBI chr12:47,997,308...48,020,526
Ensembl chr12:48,000,257...48,020,526 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions
increases expression
increases response to substance
increases phosphorylation
increases activity
decreases expression
increases stability
decreases ubiquitination
affects localization
decreases response to substance
decreases acetylation
decreases phosphorylation 		ISO
EXP 		dorsomorphin inhibits the reaction [Resveratrol affects the localization of FOXO1 protein]; dorsomorphin inhibits the reaction [Resveratrol results in increased stability of FOXO1 protein]; FOXO1 protein affects the reaction [Resveratrol results in decreased expression of CCND1 protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of BCL2L11 protein alternative form]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of CDKN1B protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of NOS3 mRNA]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of NOS3 protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of TNFRSF10A protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of TNFRSF10B protein]; Resveratrol affects the localization of and results in decreased phosphorylation of FOXO1 protein; Resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein]; Resveratrol promotes the reaction [FOXO1 protein binds to NOS3 promoter]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of SOD2 mRNA]
resveratrol results in increased expression of FOXO1 protein
FOXO1 protein results in increased susceptibility to resveratrol
resveratrol results in increased phosphorylation of FOXO1 protein
resveratrol results in increased expression of FOXO1 mRNA
resveratrol results in increased activity of FOXO1 protein
resveratrol results in decreased expression of FOXO1 protein modified form
resveratrol results in increased stability of FOXO1 protein
resveratrol results in decreased ubiquitination of FOXO1 protein
resveratrol affects the localization of FOXO1 protein
[Resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein]] which results in decreased expression of GCK mRNA; [Resveratrol results in increased activity of SIRT1 protein] which results in increased acetylation of and results in decreased degradation of FOXO1 protein; [Resveratrol results in increased localization of and results in increased activity of FOXO1 protein] which results in increased expression of FBXO32 mRNA; bafilomycin A1 inhibits the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of G6PC1 mRNA]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of IGFBP1 mRNA]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [HNF4A protein binds to GCK promoter]]; FOXO1 protein promotes the reaction [Resveratrol results in decreased activity of GCK protein]; FOXO1 protein promotes the reaction [Resveratrol results in decreased expression of GCK mRNA]; Resveratrol inhibits the reaction [AGT protein promotes the reaction [SIRT1 protein binds to FOXO1 protein]]; Resveratrol inhibits the reaction [AGT protein results in increased acetylation of FOXO1 protein]; Resveratrol inhibits the reaction [CREBBP protein results in increased acetylation of FOXO1 protein]; Resveratrol inhibits the reaction [Diazinon results in increased expression of FOXO1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]; Resveratrol inhibits the reaction [Palmitic Acid results in increased localization of FOXO1 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of FOXO1 mRNA]; Resveratrol inhibits the reaction [Streptozocin results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; Resveratrol promotes the reaction [FOXO1 protein binds to GCK promoter]; Resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein]; Resveratrol promotes the reaction [FOXO1 protein binds to RAB7A promoter]; Resveratrol promotes the reaction [FOXO1 protein results in increased abundance of Glucose]; Resveratrol results in increased localization of and results in increased activity of FOXO1 protein; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]; SIRT1 protein promotes the reaction [Resveratrol promotes the reaction [FOXO1 protein binds to RAB7A promoter]]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]
FOXO1 protein results in decreased susceptibility to resveratrol
resveratrol results in decreased acetylation of FOXO1 protein
resveratrol results in decreased phosphorylation of FOXO1 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased acetylation of FOXO1 protein]]; [Antimycin A co-treated with Resveratrol] results in decreased acetylation of FOXO1 protein; [FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; [Resveratrol co-treated with Ethanol] results in increased expression of FOXO1 mRNA; [Resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of FOXO1 mRNA; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of ADIPOQ protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of GSTK1 protein]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of TRIM63 mRNA]]; Resveratrol inhibits the reaction [Doxorubicin results in increased acetylation of FOXO1 protein]; Resveratrol inhibits the reaction [stearic acid results in decreased expression of FOXO1 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased acetylation of FOXO1 protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of and results in decreased phosphorylation of FOXO1 protein]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of G6PC1 mRNA]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA]; Resveratrol results in decreased phosphorylation of and results in decreased acetylation of and results in increased localization of FOXO1 protein; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased acetylation of FOXO1 protein]] 		CTD PMID:15788402 PMID:16343977 PMID:16917544 PMID:17374693 PMID:18077353 More... NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxo3 forkhead box O3 decreases phosphorylation
increases expression
multiple interactions
increases activity
decreases expression
affects localization
decreases response to substance 		ISO
EXP 		resveratrol results in decreased phosphorylation of FOXO3 protein
Resveratrol results in increased expression of FOXO3 protein; Resveratrol results in increased expression of FOXO3A mRNA
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]]; [Resveratrol co-treated with Streptozocin] results in increased expression of FOXO3A mRNA; [Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in increased phosphorylation of FOXO3 protein; [Streptozocin co-treated with Resveratrol] results in increased phosphorylation of FOXO3 protein; Resveratrol inhibits the reaction [chromium hexavalent ion results in increased acetylation of FOXO3 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of FOXO3 protein]
resveratrol results in increased activity of FOXO3 protein
resveratrol results in decreased expression of FOXO3 protein
resveratrol affects the localization of FOXO3 protein
resveratrol results in increased expression of FOXO3 mRNA
resveratrol results in increased expression of FOXO3 mRNA; resveratrol results in increased expression of FOXO3 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein]; [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; [FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; [resveratrol results in increased activity of SIRT1 protein] which results in decreased localization of FOXO3 protein; [resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with resveratrol] affects the expression of SOD2 mRNA]; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with resveratrol] affects the expression of SOD2 protein]; resveratrol inhibits the reaction [Ethanol results in increased acetylation of FOXO3 protein]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of FOXO3 protein]; resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased acetylation of FOXO3 protein]
[resveratrol results in increased activity of SIRT1 protein] which results in increased expression of FOXO3 protein; FOXO3 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein]; FOXO3 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form]; FOXO3 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein]; FOXO3 protein affects the reaction [resveratrol results in increased expression of NOS3 mRNA]; FOXO3 protein affects the reaction [resveratrol results in increased expression of NOS3 protein]; FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein]; FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein]; MAT2B mutant form inhibits the reaction [resveratrol results in increased expression of FOXO3 protein]; Niacinamide inhibits the reaction [resveratrol results in increased expression of FOXO3 protein]; PARP1 protein affects the reaction [resveratrol results in increased expression of FOXO3 protein]; resveratrol affects the localization of and results in increased activity of FOXO3 protein; resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of FOXO3 protein]; resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of FOXO3 protein]; resveratrol promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in increased localization of FOXO3 protein]; resveratrol promotes the reaction [[[SIRT1 protein binds to FOXO3 protein] which binds to RUNX2 3' UTR] which results in increased expression of RUNX2 mRNA]; resveratrol promotes the reaction [[SIRT1 protein binds to FOXO3 protein] which binds to RUNX2 3' UTR]; resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter]; resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter]; resveratrol promotes the reaction [FOXO3 protein binds to NOS3 promoter]; resveratrol promotes the reaction [SIRT1 protein binds to FOXO3 protein]; resveratrol results in decreased phosphorylation of and results in increased localization of FOXO3 protein; resveratrol results in increased acetylation of and results in increased expression of FOXO3 protein; SIRT1 protein affects the reaction [resveratrol results in increased expression of FOXO3 protein]; STF-118804 inhibits the reaction [resveratrol results in increased expression of FOXO3 protein]
FOXO3 protein results in decreased susceptibility to resveratrol 		CTD PMID:17513867 PMID:18077353 PMID:18222423 PMID:19293636 PMID:20012470 More... NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Foxo4 forkhead box O4 multiple interactions
decreases phosphorylation
decreases response to substance
increases expression 		ISO
EXP 		FOXO4 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein]; FOXO4 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form]; FOXO4 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein]; FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein]; FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein]; resveratrol inhibits the reaction [INS protein results in increased phosphorylation of FOXO4 protein]
resveratrol results in decreased phosphorylation of FOXO4 protein
FOXO4 protein results in decreased susceptibility to resveratrol
resveratrol results in increased expression of FOXO4 protein
[FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with resveratrol] affects the expression of SOD2 mRNA]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with resveratrol] affects the expression of SOD2 protein] 		CTD PMID:17550345 PMID:20012470 PMID:21179458 PMID:24040102 PMID:24040416 NCBI chr  X:70,425,218...70,432,120
Ensembl chr  X:70,425,563...70,432,120 		JBrowse link
G Foxp3 forkhead box P3 multiple interactions ISO resveratrol inhibits the reaction [tetrandrine results in increased expression of FOXP3 mRNA] CTD PMID:26640276 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Foxp4 forkhead box P4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXP4 mRNA CTD PMID:23557933 NCBI chr 9:20,556,270...20,612,967
Ensembl chr 9:20,556,270...20,612,967 		JBrowse link
G Foxred2 FAD-dependent oxidoreductase domain containing 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FOXRED2 mRNA CTD PMID:19167446 NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:111,402,322...111,417,988 		JBrowse link
G Foxs1 forkhead box S1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXS1 mRNA CTD PMID:23557933 NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662 		JBrowse link
G Fra10ac1 FRA10A associated CGG repeat 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FRA10AC1 mRNA CTD PMID:23557933 NCBI chr 1:245,381,538...245,413,879
Ensembl chr 1:245,366,451...245,414,189 		JBrowse link
G Frmd1 FERM domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FRMD1 mRNA CTD PMID:23557933 NCBI chr 1:63,750,852...63,762,383 JBrowse link
G Frmd6 FERM domain containing 6 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA CTD PMID:19167446 NCBI chr 6:95,081,958...95,155,561
Ensembl chr 6:95,081,985...95,155,560 		JBrowse link
G Frmd8 FERM domain containing 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FRMD8 mRNA CTD PMID:23557933 NCBI chr 1:212,572,534...212,593,181
Ensembl chr 1:212,572,537...212,592,695 		JBrowse link
G Frrs1l ferric-chelate reductase 1-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FRRS1L mRNA CTD PMID:23557933 NCBI chr 5:76,451,101...76,485,319
Ensembl chr 5:76,451,101...76,485,316 		JBrowse link
G Frs2 fibroblast growth factor receptor substrate 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FRS2 mRNA CTD PMID:23557933 NCBI chr 7:54,597,182...54,678,656
Ensembl chr 7:54,597,182...54,678,774 		JBrowse link
G Fshb follicle stimulating hormone subunit beta decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of FSHB mRNA; resveratrol results in decreased expression of FSHB protein
Resveratrol inhibits the reaction [bisphenol A analog results in increased expression of FSHB protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of FSHB protein]; Resveratrol inhibits the reaction [Cisplatin results in increased expression of FSHB protein]
SRT1720 promotes the reaction [resveratrol results in decreased expression of FSHB mRNA] 		CTD PMID:21679764 PMID:24492640 PMID:33582552 PMID:33587916 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Fst follistatin increases expression ISO resveratrol results in increased expression of FST mRNA CTD PMID:17257620 PMID:25888808 NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491 		JBrowse link
G Fstl4 follistatin-like 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FSTL4 mRNA CTD PMID:23557933 NCBI chr10:37,412,288...37,845,405
Ensembl chr10:37,412,288...37,845,393 		JBrowse link
G Ftcd formimidoyltransferase cyclodeaminase increases expression ISO resveratrol results in increased expression of FTCD mRNA CTD PMID:25436977 NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
increases expression 		ISO Resveratrol inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of FTH1 mRNA]; GSK3B protein affects the reaction [resveratrol results in increased expression of FTH1 mRNA]; resveratrol promotes the reaction [NFE2L2 protein binds to FTH1 enhancer]
resveratrol results in increased expression of FTH1 protein 		CTD PMID:23829535 PMID:25505154 PMID:34044072 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Fthl17a ferritin, heavy polypeptide-like 17, member A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FTHL17 mRNA CTD PMID:23557933 NCBI chr  X:53,547,274...53,548,251
Ensembl chr  X:53,547,274...53,548,251 		JBrowse link
G Ftmt ferritin mitochondrial multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FTMT mRNA CTD PMID:23557933 NCBI chr18:47,957,235...47,958,484
Ensembl chr18:47,957,228...47,958,768 		JBrowse link
G Ftsj3 FtsJ RNA 2'-O-methyltransferase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FTSJ3 mRNA CTD PMID:23557933 NCBI chr10:91,680,735...91,687,475
Ensembl chr10:91,680,753...91,687,179 		JBrowse link
G Fubp1 far upstream element binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FUBP1 mRNA CTD PMID:23557933 NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428 		JBrowse link
G Fuca1 alpha-L-fucosidase 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FUCA1 mRNA CTD PMID:19167446 NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511 		JBrowse link
G Fuca2 alpha-L-fucosidase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FUCA2 mRNA CTD PMID:23557933 NCBI chr 1:9,706,121...9,720,910
Ensembl chr 1:9,706,094...9,721,706 		JBrowse link
G Fxn frataxin increases expression ISO resveratrol results in increased expression of FXN mRNA; resveratrol results in increased expression of FXN protein CTD PMID:23418481 NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989 		JBrowse link
G Fxr1 FMR1 autosomal homolog 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of FXR1 mRNA CTD PMID:23557933 NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027 		JBrowse link
G Fxyd2 FXYD domain-containing ion transport regulator 2 multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of FXYD2 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of FXYD2 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 8:54,609,658...54,616,788
Ensembl chr 8:54,609,658...54,616,957 		JBrowse link
G Fxyd7 FXYD domain-containing ion transport regulator 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FXYD7 mRNA CTD PMID:23557933 NCBI chr 1:95,405,071...95,414,407
Ensembl chr 1:95,405,225...95,414,345 		JBrowse link
G Fyb2 FYN binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FYB2 mRNA CTD PMID:19167446 NCBI chr 5:124,906,005...125,029,867
Ensembl chr 5:124,905,982...125,029,865 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase affects localization
multiple interactions 		ISO resveratrol affects the localization of FYN protein
resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of FYN protein] 		CTD PMID:21467134 NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479 		JBrowse link
G Fyttd1 forty-two-three domain containing 1 decreases expression EXP resveratrol results in decreased expression of FYTTD1 mRNA CTD PMID:25905778 NCBI chr11:81,383,040...81,412,604
Ensembl chr11:81,383,040...81,412,599 		JBrowse link
G Fzd2 frizzled class receptor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FZD2 mRNA CTD PMID:19167446 NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396 		JBrowse link
G Fzd4 frizzled class receptor 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FZD4 mRNA CTD PMID:23557933 NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:152,692,507...152,701,372 		JBrowse link
G Fzd7 frizzled class receptor 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of FZD7 mRNA CTD PMID:23557933 NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585 		JBrowse link
G G0s2 G0/G1switch 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of G0S2 mRNA
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of G0S2 mRNA] 		CTD PMID:17257620 PMID:31298478 NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293 		JBrowse link
G G2 G2 protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of KIAA1549L mRNA CTD PMID:23557933 NCBI chr 3:110,961,478...111,237,308
Ensembl chr 3:110,961,478...111,237,223 		JBrowse link
G G2e3 G2/M-phase specific E3 ubiquitin protein ligase increases expression ISO resveratrol results in increased expression of G2E3 mRNA CTD PMID:19167446 NCBI chr 6:74,498,801...74,530,703
Ensembl chr 6:74,503,109...74,528,198 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO
EXP 		[T0901317 co-treated with Resveratrol] results in decreased expression of G6PC1 mRNA; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of G6PC1 mRNA]; Resveratrol promotes the reaction [FOXO1 protein results in increased expression of G6PC1 mRNA]
FOXO1 protein affects the reaction [Resveratrol results in increased expression of G6PC1 mRNA]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of G6PC1 protein] 		CTD PMID:15788402 PMID:16917544 PMID:23591747 PMID:37570835 PMID:37759824 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G G6pc3 glucose 6 phosphatase catalytic subunit 3 increases expression ISO resveratrol results in increased expression of G6PC3 protein CTD PMID:25505154 NCBI chr10:87,647,149...87,651,385
Ensembl chr10:87,647,062...87,653,453 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions
decreases activity 		EXP resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of G6PD protein]
resveratrol results in decreased activity of G6PD protein 		CTD PMID:19059388 PMID:24012391 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144 		JBrowse link
G Gab1 GRB2-associated binding protein 1 multiple interactions EXP resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased localization of GAB1 protein]; resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased localization of GAB1 protein] CTD PMID:15849355 NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617 		JBrowse link
G Gabarap GABA type A receptor-associated protein increases expression ISO resveratrol results in increased expression of GABARAP mRNA CTD PMID:23750556 NCBI chr10:55,213,465...55,216,787
Ensembl chr10:55,212,075...55,216,154 		JBrowse link
G Gabpa GA binding protein transcription factor subunit alpha multiple interactions
increases expression
decreases expression 		ISO
EXP 		SIRT1 protein affects the reaction [Resveratrol results in increased expression of GABPA mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of GABPA mRNA]
[Plant Extracts co-treated with Resveratrol] results in increased expression of GABPA mRNA
resveratrol results in decreased expression of GABPA mRNA 		CTD PMID:23557933 PMID:25905778 PMID:34216621 NCBI chr11:37,375,040...37,404,060
Ensembl chr11:37,375,084...37,404,059 		JBrowse link
G Gabpb1 GA binding protein transcription factor subunit beta 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GABPB1 mRNA CTD PMID:23557933 NCBI chr 3:134,333,339...134,380,239
Ensembl chr 3:134,333,339...134,361,344 		JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GABRA4 mRNA CTD PMID:23557933 NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648 		JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GABRB2 mRNA CTD PMID:23557933 NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of GADD45A mRNA
Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of GADD45A mRNA]; Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]; SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]] 		CTD PMID:15280659 PMID:16081268 PMID:16624241 PMID:17261084 PMID:20797428 More... NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of GADD45B mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of GADD45B mRNA 		CTD PMID:20797428 PMID:23525482 PMID:25905778 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma multiple interactions
decreases expression
increases expression 		ISO
EXP 		panobinostat promotes the reaction [resveratrol inhibits the reaction [STAT3 protein binds to GADD45G promoter]]; panobinostat promotes the reaction [resveratrol results in increased expression of GADD45G mRNA]; resveratrol inhibits the reaction [STAT3 protein binds to GADD45G promoter]; resveratrol promotes the reaction [panobinostat results in increased expression of GADD45G mRNA]
Resveratrol results in decreased expression of GADD45G mRNA
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of GADD45G mRNA] 		CTD PMID:23681230 PMID:31298478 PMID:33775663 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369 		JBrowse link
G Gal galanin and GMAP prepropeptide multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GAL mRNA CTD PMID:23557933 NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229 		JBrowse link
G Gal3st4 galactose-3-O-sulfotransferase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GAL3ST4 mRNA CTD PMID:23557933 NCBI chr12:22,381,576...22,390,566
Ensembl chr12:22,381,576...22,390,824 		JBrowse link
G Galk2 galactokinase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GALK2 mRNA CTD PMID:23557933 NCBI chr 3:133,563,524...133,696,423
Ensembl chr 3:133,563,538...133,696,528 		JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT10 mRNA CTD PMID:19167446 NCBI chr10:42,321,691...42,468,087
Ensembl chr10:42,322,161...42,468,087 		JBrowse link
G Galnt14 polypeptide N-acetylgalactosaminyltransferase 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT14 mRNA CTD PMID:23557933 NCBI chr 6:27,507,878...27,724,033
Ensembl chr 6:27,507,627...27,724,031 		JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT15 mRNA CTD PMID:23557933 NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT16 mRNA CTD PMID:23557933 NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350 		JBrowse link
G Galnt17 polypeptide N-acetylgalactosaminyltransferase 17 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT17 mRNA CTD PMID:23557933 NCBI chr12:30,959,460...31,418,150
Ensembl chr12:30,959,447...31,418,149 		JBrowse link
G Galnt4 polypeptide N-acetylgalactosaminyltransferase 4 increases expression
multiple interactions 		ISO resveratrol results in increased expression of GALNT4 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of GALNT4 mRNA 		CTD PMID:19371625 PMID:23557933 NCBI chr 7:35,811,904...35,814,445 JBrowse link
G Galnt5 polypeptide N-acetylgalactosaminyltransferase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT5 mRNA CTD PMID:23557933 NCBI chr 3:62,982,465...63,028,724
Ensembl chr 3:62,982,465...63,028,724 		JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of GALNT7 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of GALNT7 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr16:37,589,368...37,713,911
Ensembl chr16:37,589,425...37,713,909 		JBrowse link
G Galr1 galanin receptor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALR1 mRNA CTD PMID:23557933 NCBI chr18:78,046,803...78,062,359
Ensembl chr18:78,046,805...78,062,359 		JBrowse link
G Galr3 galanin receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALR3 mRNA CTD PMID:23557933 NCBI chr 7:112,483,183...112,496,359
Ensembl chr 7:112,485,672...112,488,136 		JBrowse link
G Gap43 growth associated protein 43 decreases expression ISO resveratrol results in decreased expression of GAP43 mRNA CTD PMID:12002526 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase affects expression EXP resveratrol affects the expression of GAPDH mRNA CTD PMID:15748624 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Gapvd1 GTPase activating protein and VPS9 domains 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of GAPVD1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of GAPVD1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:38,365,854...38,439,403
Ensembl chr 3:38,365,854...38,439,390 		JBrowse link
G Garin1b golgi associated RAB2 interactor 1B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GARIN1B mRNA CTD PMID:23557933 NCBI chr 4:58,880,537...58,903,966
Ensembl chr 4:58,880,594...58,903,961 		JBrowse link
G Garin3 golgi associated RAB2 interactor family member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GARIN3 mRNA CTD PMID:23557933 NCBI chr10:31,331,196...31,334,434
Ensembl chr10:31,331,177...31,334,430 		JBrowse link
G Garin4 golgi associated RAB2 interactor family member 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GARIN4 mRNA CTD PMID:23557933 NCBI chr13:105,274,107...105,276,287
Ensembl chr13:105,274,106...105,276,286 		JBrowse link
G Garin5b golgi associated RAB2 interactor family member 5B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GARIN5B mRNA CTD PMID:23557933 NCBI chr 1:78,105,042...78,122,663
Ensembl chr 1:78,105,964...78,122,660 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GARS1 mRNA CTD PMID:23557933 NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876 		JBrowse link
G Gart phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GART mRNA CTD PMID:23557933 NCBI chr11:44,351,841...44,377,086
Ensembl chr11:44,351,851...44,377,086 		JBrowse link
G Gas2l1 growth arrest-specific 2 like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GAS2L1 mRNA CTD PMID:23557933 NCBI chr14:84,169,398...84,175,514
Ensembl chr14:84,169,398...84,175,514 		JBrowse link
G Gas2l3 growth arrest-specific 2 like 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GAS2L3 mRNA CTD PMID:19167446 NCBI chr 7:25,690,929...25,726,806
Ensembl chr 7:25,693,660...25,716,942 		JBrowse link
G Gas6 growth arrest specific 6 increases expression EXP resveratrol results in increased expression of GAS6 mRNA CTD PMID:25905778 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gask1a golgi associated kinase 1A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GASK1A mRNA CTD PMID:23557933 NCBI chr 8:130,488,279...130,521,242
Ensembl chr 8:130,488,354...130,521,242 		JBrowse link
G Gast gastrin decreases expression ISO resveratrol results in decreased expression of GAST mRNA CTD PMID:23224687 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880 		JBrowse link
G Gata3 GATA binding protein 3 decreases expression ISO resveratrol results in decreased expression of GATA3 mRNA CTD PMID:22962611 NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670 		JBrowse link
G Gata5 GATA binding protein 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GATA5 mRNA CTD PMID:23557933 NCBI chr 3:187,796,140...187,804,327
Ensembl chr 3:187,796,142...187,804,327 		JBrowse link
G Gatd3a glutamine amidotransferase class 1 domain containing 3A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GATD3 mRNA CTD PMID:23557933 NCBI chr20:10,514,459...10,522,556
Ensembl chr20:10,514,443...10,522,555 		JBrowse link
G Gatm glycine amidinotransferase decreases expression EXP resveratrol results in decreased expression of GATM mRNA CTD PMID:25905778 NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355 		JBrowse link
G Gba1 glucosylceramidase beta 1 multiple interactions ISO Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of ACAT1 protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of CS protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of PDHX protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased expression of AIFM1 protein]; Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased expression of BAX protein] CTD PMID:26027833 NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985 		JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GBE1 mRNA CTD PMID:23557933 NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GBP2 mRNA CTD PMID:23557933 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gbx2 gastrulation brain homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GBX2 mRNA CTD PMID:23557933 NCBI chr 9:97,957,304...97,959,883
Ensembl chr 9:97,957,304...97,959,883 		JBrowse link
G Gcat glycine C-acetyltransferase multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GCAT mRNA
resveratrol results in increased expression of GCAT mRNA 		CTD PMID:22610192 PMID:23557933 NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664 		JBrowse link
G Gcc1 GRIP and coiled-coil domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GCC1 mRNA CTD PMID:23557933 NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,996,267...58,002,185 		JBrowse link
G Gcfc2 GC-rich sequence DNA-binding factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GCFC2 mRNA CTD PMID:23557933 NCBI chr 4:116,039,432...116,076,330
Ensembl chr 4:116,039,433...116,077,152 		JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of GCH1 protein
[resveratrol results in increased expression of GCH1 mRNA] which results in increased abundance of sapropterin
fulvestrant inhibits the reaction [resveratrol results in increased expression of GCH1 protein] 		CTD PMID:17666920 PMID:20610621 NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412 		JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GCHFR mRNA CTD PMID:19167446 NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926 		JBrowse link
G Gck glucokinase multiple interactions
decreases expression
decreases activity
increases expression 		ISO
EXP 		6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]]; SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]
Resveratrol results in decreased expression of GCK mRNA; Resveratrol results in decreased expression of GCK protein
resveratrol results in decreased activity of GCK protein
Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GCK mRNA]
[Resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein]] which results in decreased expression of GCK mRNA; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [HNF4A protein binds to GCK promoter]]; FOXO1 protein promotes the reaction [Resveratrol results in decreased activity of GCK protein]; FOXO1 protein promotes the reaction [Resveratrol results in decreased expression of GCK mRNA]; Resveratrol affects the reaction [HNF4A protein binds to GCK promoter]; Resveratrol inhibits the reaction [bisphenol A results in decreased expression of GCK mRNA]; Resveratrol inhibits the reaction [INS1 protein results in increased expression of GCK mRNA]; Resveratrol promotes the reaction [FOXO1 protein binds to GCK promoter] 		CTD PMID:16626303 PMID:19740748 PMID:21163946 PMID:37570835 PMID:37759824 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions
increases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of GCLC mRNA]; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of GCLC mRNA; [Resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA; NFE2L2 protein affects the reaction [Resveratrol results in increased expression of GCLC mRNA]; Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GCLC protein]; Resveratrol promotes the reaction [hydroquinone results in increased expression of GCLC mRNA]
resveratrol results in increased expression of GCLC mRNA
resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC protein]
Resveratrol results in increased expression of GCLC mRNA; Resveratrol results in increased expression of GCLC protein
NFE2L2 protein affects the reaction [Resveratrol results in increased expression of GCLC protein] 		CTD PMID:11909699 PMID:15882976 PMID:20060927 PMID:20418481 PMID:21439372 More... NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression
multiple interactions 		ISO resveratrol results in increased expression of GCLM mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA; resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] 		CTD PMID:19167446 PMID:25808216 PMID:27818126 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gcm2 glial cells missing transcription factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GCM2 mRNA CTD PMID:23557933 NCBI chr17:23,858,379...23,867,495
Ensembl chr17:23,858,379...23,867,495 		JBrowse link
G Gcnt2 glucosaminyl (N-acetyl) transferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GCNT2 mRNA CTD PMID:23557933 NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989 		JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GCNT3 mRNA CTD PMID:23557933 NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595 		JBrowse link
G Gda guanine deaminase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GDA mRNA CTD PMID:23557933 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348 		JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GDAP1L1 mRNA CTD PMID:23557933 NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125 		JBrowse link
G Gdap2 ganglioside-induced differentiation-associated-protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GDAP2 mRNA CTD PMID:23557933 NCBI chr 2:190,217,158...190,276,128
Ensembl chr 2:190,217,164...190,276,126 		JBrowse link
G Gdf1 growth differentiation factor 1 decreases expression ISO resveratrol results in decreased expression of GDF1 mRNA CTD PMID:12002526 NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480 		JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GDF10 mRNA CTD PMID:23557933 NCBI chr16:9,243,434...9,256,788
Ensembl chr16:9,243,317...9,256,794 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression
multiple interactions 		ISO [Resveratrol results in increased expression of TP53 protein] which results in increased expression of GDF15 protein; Resveratrol metabolite results in increased expression of GDF15 protein; Resveratrol results in increased expression of GDF15 mRNA; Resveratrol results in increased expression of GDF15 protein
[indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15; [resveratrol results in increased expression of TP53] promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15]; Dactinomycin inhibits the reaction [resveratrol results in increased expression of GDF15 mRNA]; resveratrol promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15 mRNA] 		CTD PMID:11895857 PMID:15670751 PMID:17257620 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdf2 growth differentiation factor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GDF2 mRNA CTD PMID:23557933 NCBI chr16:9,261,679...9,267,678
Ensembl chr16:9,261,662...9,267,677 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Ethanol co-treated with Resveratrol] results in increased expression of GDNF mRNA; Resveratrol promotes the reaction [Ethanol results in increased expression of GDNF protein] CTD PMID:23770283 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Gdpd3 glycerophosphodiester phosphodiesterase domain containing 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GDPD3 mRNA CTD PMID:19167446 NCBI chr 1:190,804,053...190,813,609
Ensembl chr 1:190,803,993...190,813,606 		JBrowse link
G Gdpd5 glycerophosphodiester phosphodiesterase domain containing 5 increases expression ISO resveratrol results in increased expression of GDPD5 mRNA CTD PMID:19371625 NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:163,091,833...163,173,559 		JBrowse link
G Gdpgp1 GDP-D-glucose phosphorylase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GDPGP1 mRNA CTD PMID:23557933 NCBI chr 1:143,593,379...143,602,542
Ensembl chr 1:143,592,802...143,611,480 		JBrowse link
G Gemin2 gem (nuclear organelle) associated protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GEMIN2 mRNA CTD PMID:23557933 NCBI chr 6:82,442,419...82,456,050
Ensembl chr 6:82,442,350...82,456,048 		JBrowse link
G Gemin7 gem (nuclear organelle) associated protein 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GEMIN7 mRNA CTD PMID:23557933 NCBI chr 1:88,343,032...88,352,473
Ensembl chr 1:88,342,361...88,354,571 		JBrowse link
G Gen1 GEN1 Holliday junction 5' flap endonuclease multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GEN1 mRNA CTD PMID:23557933 NCBI chr 6:39,666,675...39,697,480
Ensembl chr 6:39,667,286...39,697,480 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
decreases expression
increases expression 		EXP
ISO 		Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of GFAP protein]; Resveratrol inhibits the reaction [Ethanol results in increased expression of GFAP protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of GFAP protein]
resveratrol results in decreased expression of GFAP protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of GFAP mRNA; Resveratrol promotes the reaction [Temozolomide results in increased expression of GFAP protein]; Temozolomide promotes the reaction [Resveratrol results in increased expression of GFAP protein]
resveratrol results in increased expression of GFAP protein
Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of GFAP protein]; Resveratrol inhibits the reaction [CDK5R1 protein results in increased expression of GFAP protein]; Resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of GFAP protein] 		CTD PMID:17581637 PMID:17888892 PMID:21224254 PMID:22530672 PMID:23557933 More... NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Gfm2 GTP dependent ribosome recycling factor mitochondrial 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GFM2 mRNA CTD PMID:23557933 NCBI chr 2:30,184,063...30,222,811
Ensembl chr 2:30,184,115...30,222,806 		JBrowse link
G Gfod1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GFOD1 mRNA CTD PMID:23557933 NCBI chr17:21,606,090...21,710,922
Ensembl chr17:21,605,415...21,710,920 		JBrowse link
G Gfra1 GDNF family receptor alpha 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GFRA1 mRNA CTD PMID:19167446 NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501 		JBrowse link
G Gfra2 GDNF family receptor alpha 2 decreases expression ISO resveratrol results in decreased expression of GFRA2 mRNA CTD PMID:15280659 NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782 		JBrowse link
G Gfra4 GDNF family receptor alpha 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GFRA4 mRNA CTD PMID:23557933 NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561 		JBrowse link
G Gga2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GGA2 mRNA CTD PMID:23557933 NCBI chr 1:185,983,302...186,016,582
Ensembl chr 1:185,983,223...186,057,074 		JBrowse link
G Ggh gamma-glutamyl hydrolase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GGH mRNA CTD PMID:19167446 NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647 		JBrowse link
G Ggn gametogenetin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GGN mRNA CTD PMID:23557933 NCBI chr 1:93,598,076...93,601,598
Ensembl chr 1:93,597,538...93,608,471 		JBrowse link
G Ggnbp2 gametogenetin binding protein 2 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of GGNBP2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of GGNBP2 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr10:70,208,950...70,240,554
Ensembl chr10:70,208,950...70,246,260 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of GGT1 mRNA CTD PMID:25905778 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Gh1 growth hormone 1 multiple interactions
decreases expression
decreases secretion 		EXP resveratrol inhibits the reaction [GHRH protein results in increased secretion of GH1 protein]; SIRT1 mutant form affects the reaction [resveratrol results in decreased expression of GH1 mRNA]; SIRT1 mutant form inhibits the reaction [resveratrol results in decreased secretion of GH1 protein]; sirtinol inhibits the reaction [resveratrol results in decreased secretion of GH1 protein] CTD PMID:23292070 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Ghitm growth hormone inducible transmembrane protein decreases expression ISO resveratrol results in decreased expression of GHITM protein CTD PMID:25505154 NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123 		JBrowse link
G Ghr growth hormone receptor multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GHR mRNA
[resveratrol co-treated with Streptozocin] results in decreased expression of GHR mRNA
resveratrol results in decreased expression of GHR mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331 		JBrowse link
G Ghrh growth hormone releasing hormone multiple interactions EXP
ISO 		resveratrol inhibits the reaction [GHRH protein results in increased secretion of GH1 protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of GHRH mRNA 		CTD PMID:23292070 PMID:23557933 NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:166,412,764...166,431,880 		JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GHRL mRNA CTD PMID:23557933 NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969 		JBrowse link
G Gigyf2 GRB10 interacting GYF protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GIGYF2 mRNA CTD PMID:23557933 NCBI chr 9:95,449,143...95,574,927
Ensembl chr 9:95,449,167...95,574,927 		JBrowse link
G Gins1 GINS complex subunit 1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of GINS1 mRNA
resveratrol results in increased expression of GINS1 mRNA 		CTD PMID:19167446 NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332 		JBrowse link
G Gins2 GINS complex subunit 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GINS2 mRNA CTD PMID:19167446 NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052 		JBrowse link
G Gins3 GINS complex subunit 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GINS3 mRNA CTD PMID:19167446 NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679 		JBrowse link
G Gipc1 GIPC PDZ domain containing family, member 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GIPC1 mRNA CTD PMID:23557933 NCBI chr19:41,380,125...41,392,078
Ensembl chr19:41,380,125...41,391,725 		JBrowse link
G Git2 GIT ArfGAP 2 decreases expression ISO resveratrol results in decreased expression of GIT2 protein CTD PMID:18089832 NCBI chr12:47,490,350...47,531,232
Ensembl chr12:47,490,369...47,533,250 		JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GJA1 mRNA; Resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Resveratrol affects the phosphorylation of and affects the localization of GJA1 protein; Resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of GJA1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of GJA1 protein]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of GJA1 protein]; Resveratrol promotes the reaction [CHRM3 protein binds to GJA1 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of GJA1 protein]; pyrazolanthrone inhibits the reaction [Resveratrol results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GJA1 mRNA]; SB 203580 inhibits the reaction [Resveratrol results in increased expression of GJA1 protein]
Resveratrol results in increased expression of GJA1 mRNA; Resveratrol results in increased expression of GJA1 protein
resveratrol results in decreased expression of GJA1 mRNA 		CTD PMID:10973802 PMID:17520802 PMID:19720069 PMID:20578705 PMID:22610192 More... NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja10 gap junction protein, alpha 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GJA10 mRNA CTD PMID:23557933 NCBI chr 5:51,787,407...51,799,827
Ensembl chr 5:51,786,277...51,803,613 		JBrowse link
G Gja3 gap junction protein, alpha 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GJA3 mRNA CTD PMID:23557933 NCBI chr15:35,296,946...35,322,405
Ensembl chr15:35,295,523...35,322,809 		JBrowse link
G Gja4 gap junction protein, alpha 4 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of GJA4 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of GJA4 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216 		JBrowse link
G Gjb2 gap junction protein, beta 2 increases expression ISO resveratrol results in increased expression of GJB2 mRNA CTD PMID:25888808 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gjd2 gap junction protein, delta 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GJD2 mRNA CTD PMID:23557933 NCBI chr 3:121,226,372...121,229,367
Ensembl chr 3:121,226,368...121,230,603 		JBrowse link
G Gjd3 gap junction protein, delta 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GJD3 mRNA CTD PMID:23557933 NCBI chr10:84,429,923...84,432,011
Ensembl chr10:84,429,036...84,433,870 		JBrowse link
G Gjd4 gap junction protein, delta 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GJD4 mRNA CTD PMID:23557933 NCBI chr17:62,043,770...62,047,527
Ensembl chr17:62,043,770...62,047,527 		JBrowse link
G Gk glycerol kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GK mRNA CTD PMID:23557933 NCBI chr  X:54,106,708...54,189,940
Ensembl chr  X:54,112,214...54,196,701 		JBrowse link
G Gk5 glycerol kinase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GK5 mRNA CTD PMID:23557933 NCBI chr 8:105,562,018...105,630,975
Ensembl chr 8:105,562,050...105,631,978 		JBrowse link
G Gla galactosidase, alpha multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GLA mRNA CTD PMID:19167446 NCBI chr  X:102,062,497...102,073,915
Ensembl chr  X:102,056,718...102,073,915 		JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions EXP
ISO 		resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]; resveratrol inhibits the reaction [sodium arsenite results in increased activity of GLB1 protein]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]
[resveratrol co-treated with Nicotinamide Mononucleotide] inhibits the reaction [RETN protein results in increased activity of GLB1 protein] 		CTD PMID:22561310 PMID:23104429 PMID:23827175 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Glce glucuronic acid epimerase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GLCE mRNA CTD PMID:23557933 NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587 		JBrowse link
G Gli1 GLI family zinc finger 1 decreases expression
multiple interactions
decreases activity 		ISO
EXP 		resveratrol results in decreased expression of GLI1
cyclopamine inhibits the reaction [resveratrol results in increased expression of GLI1 protein]; resveratrol results in increased expression of and affects the localization of GLI1 protein
[Plant Extracts co-treated with Resveratrol] results in decreased expression of GLI1 mRNA; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of GLI1 protein]
resveratrol results in decreased activity of GLI1 protein
resveratrol results in decreased expression of GLI1 mRNA; resveratrol results in decreased expression of GLI1 protein 		CTD PMID:20395211 PMID:22301921 PMID:22397755 PMID:23557933 PMID:24464877 More... NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli4 GLI family zinc finger 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLI4 mRNA CTD PMID:23557933 NCBI chr 7:109,205,812...109,211,650
Ensembl chr 7:109,205,953...109,211,648 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GLIPR1 mRNA CTD PMID:23557933 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glipr2 GLI pathogenesis-related 2 decreases expression ISO resveratrol results in decreased expression of GLIPR2 protein CTD PMID:25505154 NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716 		JBrowse link
G Glis1 GLIS family zinc finger 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLIS1 mRNA CTD PMID:23557933 NCBI chr 5:127,450,934...127,640,929
Ensembl chr 5:127,451,293...127,640,928 		JBrowse link
G Glis2 GLIS family zinc finger 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLIS2 mRNA CTD PMID:23557933 NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995 		JBrowse link
G Glmn glomulin, FKBP associated protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GLMN mRNA CTD PMID:23557933 NCBI chr14:2,332,052...2,375,366
Ensembl chr14:2,332,497...2,375,695 		JBrowse link
G Glmp glycosylated lysosomal membrane protein multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GLMP mRNA CTD PMID:19167446 NCBI chr 2:176,092,098...176,095,688
Ensembl chr 2:176,091,839...176,097,208 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions
increases expression
increases activity 		ISO
EXP 		NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein]]; resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein]
resveratrol results in increased expression of GLO1 protein
resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein]
resveratrol results in increased activity of GLO1 protein 		CTD PMID:21439372 PMID:22917016 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Glrx2 glutaredoxin 2 increases expression ISO resveratrol results in increased expression of GLRX2 mRNA CTD PMID:19371625 NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150 		JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO resveratrol results in increased expression of GLRX5 protein CTD PMID:25505154 NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278 		JBrowse link
G Gls2 glutaminase 2 multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of GLS2 mRNA CTD PMID:26667767 NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013 		JBrowse link
G Glt1d1 glycosyltransferase 1 domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GLT1D1 mRNA CTD PMID:23557933 NCBI chr12:34,611,942...34,685,591
Ensembl chr12:34,612,643...34,685,468 		JBrowse link
G Glt6d1 glycosyltransferase 6 domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLT6D1 mRNA CTD PMID:23557933 NCBI chr 3:29,026,023...29,037,010
Ensembl chr 3:29,026,025...29,036,699 		JBrowse link
G Gltpd2 glycolipid transfer protein domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLTPD2 mRNA CTD PMID:23557933 NCBI chr10:55,732,199...55,734,974
Ensembl chr10:55,732,208...55,734,735 		JBrowse link
G Glud1 glutamate dehydrogenase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GLUD1 mRNA CTD PMID:23557933 NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210 		JBrowse link
G Glul glutamate-ammonia ligase multiple interactions
increases expression
increases activity 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of GLUL mRNA; resveratrol inhibits the reaction [Ammonia results in decreased activity of GLUL protein]; resveratrol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of GLUL protein]; resveratrol inhibits the reaction [Glucose results in decreased expression of GLUL mRNA]; resveratrol inhibits the reaction [Streptozocin results in decreased expression of GLUL mRNA]; resveratrol inhibits the reaction [Streptozocin results in decreased expression of GLUL protein]; zinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Ammonia results in decreased activity of GLUL protein]]; zinc protoporphyrin inhibits the reaction [resveratrol results in increased activity of GLUL protein]
resveratrol results in increased expression of GLUL protein 		CTD PMID:16904623 PMID:17554623 PMID:25905778 PMID:26318273 PMID:26677078 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gmfb glia maturation factor, beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GMFB mRNA CTD PMID:23557933 NCBI chr15:22,549,705...22,560,125
Ensembl chr15:22,547,034...22,560,308 		JBrowse link
G Gmip Gem-interacting protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GMIP mRNA CTD PMID:23557933 NCBI chr16:19,634,630...19,648,916
Ensembl chr16:19,634,630...19,647,933 		JBrowse link
G Gmnn geminin, DNA replication inhibitor multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of GMNN mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of GMNN mRNA CTD PMID:19167446 PMID:23557933 NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068 		JBrowse link
G Gmppb GDP-mannose pyrophosphorylase B increases expression EXP resveratrol results in increased expression of GMPPB mRNA CTD PMID:25905778 NCBI chr 8:117,616,029...117,622,866 JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GNAI2 mRNA CTD PMID:23557933 NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622 		JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNAI3 mRNA CTD PMID:23557933 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnas GNAS complex locus decreases expression ISO resveratrol results in decreased expression of GNAS mRNA CTD PMID:22610192 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536 		JBrowse link
G Gnb1 G protein subunit beta 1 decreases expression ISO resveratrol results in decreased expression of GNB1 mRNA
resveratrol results in decreased expression of GNB1 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488 		JBrowse link
G Gnb4 G protein subunit beta 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNB4 mRNA CTD PMID:23557933 NCBI chr 2:117,289,112...117,329,050
Ensembl chr 2:117,293,284...117,328,945 		JBrowse link
G Gng4 G protein subunit gamma 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GNG4 mRNA CTD PMID:23557933 NCBI chr17:93,432,791...93,481,709
Ensembl chr17:93,433,195...93,481,709 		JBrowse link
G Gngt2 G protein subunit gamma transducin 2 increases expression EXP resveratrol results in increased expression of GNGT2 mRNA CTD PMID:25905778 NCBI chr10:81,271,916...81,280,980
Ensembl chr10:81,277,423...81,280,970 		JBrowse link
G Gnl2 G protein nucleolar 2 decreases expression ISO resveratrol results in decreased expression of GNL2 protein CTD PMID:25505154 NCBI chr 5:142,577,798...142,603,185
Ensembl chr 5:142,577,731...142,603,178 		JBrowse link
G Gnl3l G protein nucleolar 3 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNL3L mRNA CTD PMID:23557933 NCBI chr  X:23,404,324...23,437,501
Ensembl chr  X:23,404,324...23,439,315 		JBrowse link
G Gnpda1 glucosamine-6-phosphate deaminase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNPDA1 mRNA CTD PMID:23557933 NCBI chr18:30,416,599...30,428,630
Ensembl chr18:30,416,607...30,428,630 		JBrowse link
G Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 increases expression ISO resveratrol results in increased expression of GNPNAT1 protein CTD PMID:25505154 NCBI chr15:21,076,129...21,088,526
Ensembl chr15:21,076,130...21,088,423 		JBrowse link
G Gnptab N-acetylglucosamine-1-phosphate transferase subunits alpha and beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNPTAB mRNA CTD PMID:23557933 NCBI chr 7:24,687,923...24,754,821
Ensembl chr 7:24,687,969...24,754,821 		JBrowse link
G Gns glucosamine (N-acetyl)-6-sulfatase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GNS mRNA CTD PMID:23557933 NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:58,774,625...58,808,650 		JBrowse link
G Golga4 golgin A4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOLGA4 mRNA CTD PMID:23557933 NCBI chr 8:127,085,830...127,163,227
Ensembl chr 8:127,085,848...127,163,603 		JBrowse link
G Golgb1 golgin B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOLGB1 mRNA CTD PMID:23557933 NCBI chr11:77,348,573...77,406,165
Ensembl chr11:77,348,961...77,406,006 		JBrowse link
G Golim4 golgi integral membrane protein 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOLIM4 mRNA CTD PMID:23557933 NCBI chr 2:162,939,429...163,031,901
Ensembl chr 2:162,939,429...163,031,901 		JBrowse link
G Golt1b golgi transport 1B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOLT1B mRNA CTD PMID:23557933 NCBI chr 4:177,064,071...177,077,165
Ensembl chr 4:177,064,073...177,077,164 		JBrowse link
G Gopc golgi associated PDZ and coiled-coil motif containing multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOPC mRNA CTD PMID:23557933 NCBI chr20:32,270,314...32,319,635
Ensembl chr20:32,270,314...32,319,611 		JBrowse link
G Gorab golgin, RAB6-interacting multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GORAB mRNA CTD PMID:23557933 NCBI chr13:78,278,868...78,295,490
Ensembl chr13:78,278,871...78,295,488 		JBrowse link
G Gosr2 golgi SNAP receptor complex member 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GOSR2 mRNA CTD PMID:23557933 NCBI chr10:89,085,323...89,105,665
Ensembl chr10:89,086,331...89,105,637 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of GOT1 mRNA CTD PMID:25905778 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA CTD PMID:19167446 NCBI chr 7:109,932,556...109,936,139
Ensembl chr 7:109,932,544...109,936,138 		JBrowse link
G Gpalpp1 GPALPP motifs containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPALPP1 mRNA CTD PMID:23557933 NCBI chr15:57,818,490...57,838,723
Ensembl chr15:57,821,205...57,838,723 		JBrowse link
G Gpam glycerol-3-phosphate acyltransferase, mitochondrial multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [Ethanol results in increased expression of GPAM mRNA]
resveratrol results in decreased expression of GPAM mRNA 		CTD PMID:18755807 NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911 		JBrowse link
G Gpat3 glycerol-3-phosphate acyltransferase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPAT3 mRNA CTD PMID:23557933 NCBI chr14:9,018,762...9,072,552 JBrowse link
G Gpat4 glycerol-3-phosphate acyltransferase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GPAT4 mRNA CTD PMID:19167446 NCBI chr16:75,515,935...75,555,431
Ensembl chr16:75,521,640...75,557,847 		JBrowse link
G Gpatch1 G patch domain containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPATCH1 mRNA CTD PMID:23557933 NCBI chr 1:97,062,539...97,111,487
Ensembl chr 1:97,062,551...97,111,465 		JBrowse link
G Gpatch2 G patch domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPATCH2 mRNA CTD PMID:23557933 NCBI chr13:101,316,413...101,457,109
Ensembl chr13:101,316,413...101,457,109 		JBrowse link
G Gpatch4 G patch domain containing 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPATCH4 mRNA CTD PMID:23557933 NCBI chr 2:175,797,503...175,816,547
Ensembl chr 2:175,807,682...175,817,358 		JBrowse link
G Gpc1 glypican 1 decreases expression ISO resveratrol results in decreased expression of GPC1 protein CTD PMID:25505154 NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933 		JBrowse link
G Gpc6 glypican 6 decreases expression ISO resveratrol results in decreased expression of GPC6 mRNA CTD PMID:25888808 NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPD1 mRNA
[resveratrol co-treated with Streptozocin] results in decreased expression of GPD1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gpd1l glycerol-3-phosphate dehydrogenase 1 like increases expression ISO resveratrol results in increased expression of GPD1L protein CTD PMID:25505154 NCBI chr 8:123,469,282...123,498,948
Ensembl chr 8:123,466,667...123,498,908 		JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPD2 mRNA CTD PMID:23557933 NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593 		JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GPER1 mRNA CTD PMID:19167446 NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144 		JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPIHBP1 mRNA CTD PMID:23557933 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448 		JBrowse link
G Gpld1 glycosylphosphatidylinositol specific phospholipase D1 decreases expression ISO resveratrol results in decreased expression of GPLD1 mRNA CTD PMID:12002526 NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975 		JBrowse link
G Gpn1 GPN-loop GTPase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPN1 mRNA CTD PMID:23557933 NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011 		JBrowse link
G Gpn3 GPN-loop GTPase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPN3 mRNA CTD PMID:23557933 NCBI chr12:39,850,070...39,859,032
Ensembl chr12:39,850,070...39,859,032 		JBrowse link
G Gpr137 G protein-coupled receptor 137 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR137 mRNA CTD PMID:23557933 NCBI chr 1:213,558,846...213,562,422
Ensembl chr 1:213,558,846...213,563,966 		JBrowse link
G Gpr139 G protein-coupled receptor 139 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR139 mRNA CTD PMID:23557933 NCBI chr 1:182,909,476...182,953,942
Ensembl chr 1:182,909,476...182,953,942 		JBrowse link
G Gpr142 G protein-coupled receptor 142 increases expression ISO resveratrol results in increased expression of GPR142 mRNA CTD PMID:19371625 NCBI chr10:100,339,112...100,342,453
Ensembl chr10:100,339,112...100,342,453 		JBrowse link
G Gpr143 G protein-coupled receptor 143 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR143 mRNA CTD PMID:23557933 NCBI chr  X:25,498,601...25,523,408
Ensembl chr  X:25,498,601...25,523,400 		JBrowse link
G Gpr150 G protein-coupled receptor 150 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR150 mRNA CTD PMID:23557933 NCBI chr 2:7,278,166...7,283,216
Ensembl chr 2:7,279,255...7,283,550 		JBrowse link
G Gpr152 G protein-coupled receptor 152 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR152 mRNA CTD PMID:23557933 NCBI chr 1:210,865,338...210,867,833
Ensembl chr 1:210,865,338...210,867,833 		JBrowse link
G Gpr155 G protein-coupled receptor 155 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GPR155 mRNA CTD PMID:23557933 NCBI chr 3:78,623,931...78,677,803
Ensembl chr 3:78,607,976...78,677,803 		JBrowse link
G Gpr161 G protein-coupled receptor 161 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR161 mRNA CTD PMID:23557933 NCBI chr13:80,111,271...80,156,517
Ensembl chr13:80,117,114...80,152,861 		JBrowse link
G Gpr17 G protein-coupled receptor 17 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR17 mRNA CTD PMID:23557933 NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702 		JBrowse link
G Gpr173 G-protein coupled receptor 173 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR173 mRNA CTD PMID:23557933 NCBI chr  X:24,925,634...24,950,485
Ensembl chr  X:24,922,704...24,950,887 		JBrowse link
G Gpr27 G protein-coupled receptor 27 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR27 mRNA CTD PMID:23557933 NCBI chr 4:133,884,894...133,886,027
Ensembl chr 4:133,883,234...133,904,093 		JBrowse link
G Gpr3 G protein-coupled receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR3 mRNA CTD PMID:23557933 NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:150,695,251...150,706,529 		JBrowse link
G Gpr31 G protein-coupled receptor 31 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR31 mRNA CTD PMID:23557933 NCBI chr 1:55,474,484...55,475,443
Ensembl chr 1:55,474,484...55,475,443 		JBrowse link
G Gpr37l1 G protein-coupled receptor 37-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR37L1 mRNA CTD PMID:23557933 NCBI chr13:49,150,355...49,157,204
Ensembl chr13:49,150,359...49,157,204 		JBrowse link
G Gpr83 G protein-coupled receptor 83 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR83 mRNA CTD PMID:23557933 NCBI chr 8:19,974,995...19,985,483
Ensembl chr 8:19,974,993...19,985,490 		JBrowse link
G Gpr88 G-protein coupled receptor 88 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR88 mRNA CTD PMID:23557933 NCBI chr 2:206,876,373...206,885,034
Ensembl chr 2:206,868,585...206,884,945 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of GPRC5A mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPRC5A mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625 		JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of GPRIN1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPRIN1 mRNA 		CTD PMID:23557933 PMID:25436977 NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,868,571...9,894,560 		JBrowse link
G Gpsm1 G-protein signaling modulator 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPSM1 mRNA CTD PMID:23557933 NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:29,526,802...29,565,920 		JBrowse link
G Gpsm2 G-protein signaling modulator 2 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of GPSM2 mRNA
resveratrol results in increased expression of GPSM2 mRNA 		CTD PMID:19167446 NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:199,015,250...199,063,056 		JBrowse link
G Gpsm3 G-protein signaling modulator 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPSM3 mRNA CTD PMID:23557933 NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,161,730...4,189,072 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPT mRNA
resveratrol results in increased expression of GPT protein
[raspberry ketone co-treated with Resveratrol] inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; [Resveratrol co-treated with Niacinamide] inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of GPT protein]; Resveratrol analog inhibits the reaction [bisphenol A results in increased activity of GPT protein]; Resveratrol inhibits the reaction [[2-cyano-N-((ethylamino)carbonyl)-2-(methoxyimino)acetamide co-treated with mancozeb] results in increased expression of GPT protein]; Resveratrol inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of GPT protein]; Resveratrol inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; Resveratrol inhibits the reaction [chromium hexavalent ion results in increased activity of GPT protein]; Resveratrol inhibits the reaction [Diazinon results in increased expression of GPT protein]; Resveratrol inhibits the reaction [Methotrexate results in increased expression of GPT protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of GPT protein]
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased activity of GPT protein]]; Resveratrol affects the reaction [Cisplatin results in increased activity of GPT protein]; Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased activity of GPT protein]; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPT protein] 		CTD PMID:15748624 PMID:23424212 PMID:23557933 PMID:26071184 PMID:26498332 More... NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 increases activity
increases expression
multiple interactions
increases expression 		ISO
EXP 		resveratrol results in increased activity of GPX1 protein
resveratrol results in increased expression of GPX1 mRNA; resveratrol results in increased expression of GPX1 protein
[Resveratrol analog co-treated with bisphenol A] results in increased expression of GPX1 mRNA; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of GPX1 mRNA]
resveratrol results in increased expression of GPX1; resveratrol results in increased expression of GPX1 mRNA; resveratrol results in increased expression of GPX1 protein
resveratrol inhibits the reaction [Calcium Chloride results in increased expression of GPX1 mRNA]; resveratrol inhibits the reaction [stearic acid results in decreased expression of GPX1 mRNA]
Resveratrol increases expression of GPX1 mRNA in non-small-cell lung cancer cells 		CTD
RGD		 PMID:17261084 PMID:17374693 PMID:20083859 PMID:20610621 PMID:21530968 More... RGD:152998893 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPX2 mRNA
resveratrol results in increased expression of GPX2 mRNA
[Resveratrol co-treated with Streptozocin] results in increased expression of GPX2 mRNA; Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of GPX2 mRNA] 		CTD PMID:17210444 PMID:23557933 PMID:25905778 PMID:34067838 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gpx3 glutathione peroxidase 3 multiple interactions ISO resveratrol inhibits the reaction [Calcium Chloride results in increased expression of GPX3 mRNA] CTD PMID:21530968 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions
increases expression 		ISO Resveratrol inhibits the reaction [Acrolein results in decreased expression of GPX4 protein]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of GPX4 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Streptozocin results in decreased expression of GPX4 protein]]
Resveratrol results in increased expression of GPX4 mRNA
Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GPX4 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]]
resveratrol results in increased expression of GPX4 mRNA; resveratrol results in increased expression of GPX4 protein 		CTD PMID:22610192 PMID:25505154 PMID:34391968 PMID:34813903 PMID:37419272 More... NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Gpx8 glutathione peroxidase 8 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GPX8 mRNA CTD PMID:19167446 NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:46,409,139...46,413,406 		JBrowse link
G Gramd1a GRAM domain containing 1A multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of GRAMD1A mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRAMD1A mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 1:95,494,378...95,520,730
Ensembl chr 1:95,494,378...95,520,716 		JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression ISO resveratrol results in increased expression of GRB10 mRNA CTD PMID:18586690 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387 		JBrowse link
G Grb2 growth factor receptor bound protein 2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of GRB2 mRNA
resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of GRB2 protein] 		CTD PMID:12002526 PMID:21467134 NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
increases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of GREB1 mRNA; fulvestrant inhibits the reaction [resveratrol results in increased expression of GREB1 mRNA]; resveratrol promotes the reaction [ESR1 protein binds to GREB1 enhancer]; resveratrol promotes the reaction [NCOA3 protein binds to GREB1 enhancer] CTD PMID:19167446 PMID:20846786 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grhl3 grainyhead-like transcription factor 3 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of GRHL3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRHL3 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 5:153,057,760...153,089,890
Ensembl chr 5:153,057,760...153,089,890 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions ISO resveratrol promotes the reaction [Cocaine results in increased phosphorylation of GRIA1 protein] CTD PMID:23499958 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions
decreases expression 		EXP
ISO 		resveratrol inhibits the reaction [Morphine results in increased expression of [GRIN1 protein binds to GRIN2B protein binds to DLG4 protein]]; resveratrol inhibits the reaction [Morphine results in increased expression of GRIN1 protein]
[2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate co-treated with resveratrol] affects the phosphorylation of GRIN1 protein
resveratrol results in decreased expression of GRIN1 protein modified form 		CTD PMID:22713680 PMID:24885036 PMID:27093858 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of GRIN2B mRNA
Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of GRIN2B protein]
resveratrol inhibits the reaction [Morphine results in increased expression of [GRIN1 protein binds to GRIN2B protein binds to DLG4 protein]]; resveratrol inhibits the reaction [Morphine results in increased expression of GRIN2B protein] 		CTD PMID:22713680 PMID:23557933 PMID:34050381 NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570 		JBrowse link
G Grin2c glutamate ionotropic receptor NMDA type subunit 2C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRIN2C mRNA CTD PMID:23557933 NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,987,513...101,005,409 		JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRIN2D mRNA CTD PMID:23557933 NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:105,444,813...105,481,236 		JBrowse link
G Grina glutamate ionotropic receptor NMDA type subunit associated protein 1 increases expression ISO resveratrol results in increased expression of GRINA mRNA CTD PMID:17257620 NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042 		JBrowse link
G Gripap1 GRIP1 associated protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GRIPAP1 mRNA CTD PMID:23557933 NCBI chr  X:17,350,817...17,380,626
Ensembl chr  X:17,350,819...17,380,588 		JBrowse link
G Grk1 G protein-coupled receptor kinase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRK1 mRNA CTD PMID:23557933 NCBI chr16:82,821,184...82,837,971
Ensembl chr16:82,826,022...82,837,971 		JBrowse link
G Grk3 G protein-coupled receptor kinase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GRK3 mRNA CTD PMID:23557933 NCBI chr12:49,285,228...49,395,803
Ensembl chr12:49,285,263...49,395,802 		JBrowse link
G Grk5 G protein-coupled receptor kinase 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GRK5 mRNA CTD PMID:23557933 NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:270,014,282...270,204,928 		JBrowse link
G Grm3 glutamate metabotropic receptor 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRM3 mRNA CTD PMID:23557933 NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764 		JBrowse link
G Grm4 glutamate metabotropic receptor 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRM4 mRNA CTD PMID:23557933 NCBI chr20:5,486,024...5,574,668
Ensembl chr20:5,482,977...5,574,668 		JBrowse link
G Grm7 glutamate metabotropic receptor 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRM7 mRNA CTD PMID:23557933 NCBI chr 4:145,286,714...146,169,099
Ensembl chr 4:145,286,924...146,169,201 		JBrowse link
G Grm8 glutamate metabotropic receptor 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRM8 mRNA CTD PMID:23557933 NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639 		JBrowse link
G Grn granulin precursor increases expression
multiple interactions 		ISO resveratrol results in increased expression of GRN mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of GRN mRNA 		CTD PMID:19167446 PMID:20706672 NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936 		JBrowse link
G Grp gastrin releasing peptide multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GRP mRNA CTD PMID:23557933 NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037 		JBrowse link
G Grpel2 GrpE-like 2, mitochondrial increases expression ISO resveratrol results in increased expression of GRPEL2 protein CTD PMID:25505154 NCBI chr18:57,438,168...57,450,408
Ensembl chr18:57,438,168...57,450,717 		JBrowse link
G Gsap gamma-secretase activating protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GSAP mRNA CTD PMID:23557933 NCBI chr 4:14,705,237...14,800,057
Ensembl chr 4:14,705,237...14,800,005 		JBrowse link
G Gsc goosecoid homeobox multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GSC mRNA CTD PMID:23557933 NCBI chr 6:129,152,836...129,154,875
Ensembl chr 6:129,152,836...129,154,875 		JBrowse link
G Gsc2 goosecoid homeobox 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GSC2 mRNA CTD PMID:23557933 NCBI chr11:96,576,424...96,578,412
Ensembl chr11:96,575,600...96,578,412 		JBrowse link
G Gsdmd gasdermin D multiple interactions ISO Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD mRNA]; Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD protein] CTD PMID:34614429 NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722 		JBrowse link
G Gsg1 germ cell associated 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GSG1 mRNA CTD PMID:23557933 NCBI chr 4:169,822,111...169,838,379
Ensembl chr 4:169,822,114...169,838,379 		JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha multiple interactions
increases phosphorylation
decreases phosphorylation 		ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3A protein]; resveratrol results in decreased phosphorylation of and results in increased activity of GSK3A protein
resveratrol results in decreased phosphorylation of GSK3A protein 		CTD PMID:14750165 PMID:17486135 NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases phosphorylation
increases activity
increases phosphorylation
affects phosphorylation
multiple interactions
increases expression
decreases activity
decreases expression
affects expression 		ISO
EXP 		resveratrol results in decreased phosphorylation of GSK3B protein
resveratrol results in increased activity of GSK3B protein
Resveratrol results in increased phosphorylation of GSK3B protein
resveratrol affects the phosphorylation of GSK3B protein
resveratrol results in increased phosphorylation of GSK3B protein
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]; [resveratrol results in increased activity of GSK3B protein] which results in increased phosphorylation of VASP protein; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of GSK3B protein modified form]; resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein]; resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein; resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of GSK3B protein
resveratrol results in increased expression of GSK3B protein modified form
resveratrol results in decreased activity of GSK3B protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein]; [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein; [Resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA; [Resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein; [Resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA; [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein; ARRB2 protein affects the reaction [Resveratrol results in decreased expression of GSK3B protein modified form]; dorsomorphin inhibits the reaction [Resveratrol results in decreased activity of GSK3B protein]; dorsomorphin inhibits the reaction [Resveratrol results in increased phosphorylation of GSK3B protein]; GSK3B protein affects the reaction [Resveratrol results in increased expression of FTH1 mRNA]; Okadaic Acid inhibits the reaction [Resveratrol results in decreased phosphorylation of GSK3B protein]; Resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein]; Resveratrol inhibits the reaction [GSK3B protein binds to SIRT1 protein]; Resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form]; Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein; Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein
resveratrol results in decreased expression of GSK3B protein modified form
resveratrol affects the expression of GSK3B protein modified form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein]; [Resveratrol co-treated with Excitatory Amino Acid Agents] results in increased phosphorylation of and results in decreased activity of GSK3B protein; [Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose; dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA]; Resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein 		CTD PMID:14750165 PMID:16860989 PMID:17868649 PMID:19135050 PMID:19620254 More... NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsn gelsolin multiple interactions ISO [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein CTD PMID:19423619 NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gspt1 G1 to S phase transition 1 decreases expression ISO resveratrol results in decreased expression of GSPT1 mRNA CTD PMID:12002526 NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,869,465...4,908,040 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression
multiple interactions
increases activity 		ISO
EXP 		resveratrol results in increased expression of GSR protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of GSR mRNA
[Niacinamide co-treated with Resveratrol] inhibits the reaction [[Ethanol co-treated with Aflatoxin B1] results in decreased expression of GSR protein]; Resveratrol inhibits the reaction [1,2-Dimethylhydrazine results in decreased activity of GSR protein]; Resveratrol inhibits the reaction [[Ethanol co-treated with Aflatoxin B1] results in decreased expression of GSR protein]; Resveratrol inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in decreased activity of GSR protein]; Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GSR protein]; Resveratrol inhibits the reaction [APP protein modified form results in decreased activity of GSR protein]; Resveratrol inhibits the reaction [Fenitrothion results in decreased expression of GSR protein]
[Curcumin co-treated with Resveratrol] inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]; NFE2L2 protein promotes the reaction [Resveratrol promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GSR protein]; Resveratrol inhibits the reaction [Ethanol results in decreased activity of GSR protein]; Resveratrol inhibits the reaction [Pyrogallol results in decreased activity of GSR protein]; Resveratrol promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]
resveratrol analog results in increased activity of GSR protein; resveratrol results in increased activity of GSR protein
resveratrol results in increased expression of GSR mRNA 		CTD PMID:12002526 PMID:12569576 PMID:12797471 PMID:16169743 PMID:18789925 More... NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gss glutathione synthetase multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GSS mRNA; Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GSS protein]; Resveratrol promotes the reaction [deoxynivalenol results in increased expression of GSS protein]
Resveratrol results in increased expression of GSS mRNA 		CTD PMID:23557933 PMID:37419272 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of GSTA1 mRNA
Resveratrol inhibits the reaction [lead nitrate results in decreased expression of GSTA1 mRNA] 		CTD PMID:16169743 PMID:31682781 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions ISO Resveratrol inhibits the reaction [Dietary Fats affects the expression of GSTA1 mRNA]; Resveratrol inhibits the reaction [Pyrogallol results in decreased expression of GSTA1 mRNA] CTD PMID:17086191 PMID:18789925 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 increases expression ISO resveratrol results in increased expression of GSTA4 mRNA CTD PMID:12002526 NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488 		JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in increased expression of GSTA5 mRNA CTD PMID:25905778 NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 multiple interactions
increases expression
affects response to substance 		ISO dorsomorphin inhibits the reaction [Resveratrol results in increased expression of GSTK1 protein]; FOXO1 protein affects the reaction [Resveratrol results in increased expression of GSTK1 protein]; GSTK1 protein affects the reaction [Resveratrol promotes the reaction [ADIPOQ protein binds to ADIPOQ protein]]; GSTK1 protein affects the reaction [Resveratrol results in increased expression of ADIPOQ protein]; Resveratrol promotes the reaction [PDPK1 gene mutant form results in increased expression of GSTK1 protein]
resveratrol results in increased expression of GSTK1 mRNA; resveratrol results in increased expression of GSTK1 protein
GSTK1 protein affects the susceptibility to resveratrol 		CTD PMID:20980258 NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP resveratrol results in increased expression of GSTM1 mRNA CTD PMID:19228061 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions EXP resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] CTD PMID:21439372 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 increases expression ISO resveratrol results in increased expression of GSTO1 mRNA; resveratrol results in increased expression of GSTO1 protein CTD PMID:22610192 PMID:25505154 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions
increases expression 		ISO
EXP 		[Resveratrol co-treated with Plant Extracts] results in increased expression of GSTP1 mRNA; [Resveratrol co-treated with Polyphenols] results in increased expression of GSTP1 mRNA; [Resveratrol co-treated with xanthohumol] results in increased expression of GSTP1 mRNA
[Niacinamide co-treated with Resveratrol] inhibits the reaction [[Ethanol co-treated with Aflatoxin B1] results in increased expression of GSTP1 protein]; Resveratrol inhibits the reaction [[Ethanol co-treated with Aflatoxin B1] results in increased expression of GSTP1 protein]
resveratrol results in increased expression of GSTP1 protein
resveratrol results in increased expression of GSTP1 mRNA 		CTD PMID:12002526 PMID:21289251 PMID:23750556 PMID:25505154 PMID:32070777 More... NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gstp3 glutathione S-transferase pi 3 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of GSTP3 mRNA] CTD PMID:31298478 NCBI chr 1:210,785,151...210,787,705
Ensembl chr 1:210,785,151...210,787,684 		JBrowse link
G Gstz1 glutathione S-transferase zeta 1 increases expression ISO resveratrol results in increased expression of GSTZ1 mRNA CTD PMID:22610192 NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233 		JBrowse link
G Gsx1 GS homeobox 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GSX1 mRNA CTD PMID:23557933 NCBI chr12:12,994,588...12,996,874
Ensembl chr12:12,994,588...12,996,874 		JBrowse link
G Gtf2a1 general transcription factor 2A subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GTF2A1 mRNA CTD PMID:23557933 NCBI chr 6:116,219,614...116,252,220
Ensembl chr 6:116,219,614...116,252,220 		JBrowse link
G Gtf2b general transcription factor IIB increases expression
decreases expression 		ISO resveratrol results in increased expression of GTF2B mRNA
resveratrol results in increased expression of GTF2B protein
resveratrol results in decreased expression of GTF2B mRNA 		CTD PMID:12002526 PMID:25505154 NCBI chr 2:234,427,734...234,446,043
Ensembl chr 2:234,427,637...234,446,049 		JBrowse link
G Gtf2e2 general transcription factor IIE subunit 2 increases expression
multiple interactions 		ISO resveratrol results in increased expression of GTF2E2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of GTF2E2 mRNA 		CTD PMID:12002526 PMID:12569576 PMID:23557933 NCBI chr16:65,102,386...65,152,563
Ensembl chr16:65,102,390...65,161,394 		JBrowse link
G Gtf2h4 general transcription factor 2H subunit 4 increases expression ISO resveratrol results in increased expression of GTF2H4 mRNA CTD PMID:12002526 NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760 		JBrowse link
G Gtf2ird2 GTF2I repeat domain containing 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GTF2IRD2 mRNA CTD PMID:23557933 NCBI chr12:28,134,199...28,179,089
Ensembl chr12:28,133,792...28,172,876 		JBrowse link
G Gtf3a general transcription factor III A decreases expression ISO resveratrol results in decreased expression of GTF3A mRNA CTD PMID:12002526 NCBI chr12:13,250,643...13,258,587
Ensembl chr12:13,250,644...13,258,587 		JBrowse link
G Gtf3c3 general transcription factor IIIC subunit 3 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of GTF3C3 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of GTF3C3 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 9:63,375,860...63,437,475
Ensembl chr 9:63,375,874...63,437,413 		JBrowse link
G Gtpbp4 GTP binding protein 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GTPBP4 mRNA CTD PMID:23557933 NCBI chr17:65,997,472...66,019,530
Ensembl chr17:66,276,566...66,289,637 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of GTSE1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of GTSE1 mRNA 		CTD PMID:19167446 PMID:23137833 NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661 		JBrowse link
G Guca2a guanylate cyclase activator 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GUCA2A mRNA CTD PMID:23557933 NCBI chr 5:138,522,446...138,524,288
Ensembl chr 5:138,522,446...138,524,287 		JBrowse link
G Gucy1a2 guanylate cyclase 1 soluble subunit alpha 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of GUCY1A2 mRNA CTD PMID:23557933 NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:8,785,121...9,174,272 		JBrowse link
G Guf1 GTP binding elongation factor GUF1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GUF1 mRNA CTD PMID:23557933 NCBI chr14:38,891,905...38,911,283
Ensembl chr14:38,891,905...38,911,283 		JBrowse link
G Gusb glucuronidase, beta multiple interactions ISO resveratrol inhibits the reaction [triptolide results in decreased activity of GUSB protein] CTD PMID:29723566 NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024 		JBrowse link
G Gxylt1 glucoside xylosyltransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of GXYLT1 mRNA CTD PMID:23557933 NCBI chr 7:126,280,349...126,320,803
Ensembl chr 7:126,280,349...126,314,237 		JBrowse link
G Gypa glycophorin A increases expression ISO Resveratrol results in increased expression of GYPA mRNA; Resveratrol results in increased expression of GYPA protein CTD PMID:24526417 NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291 		JBrowse link
G Gys1 glycogen synthase 1 multiple interactions ISO 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [resveratrol results in increased phosphorylation of GYS1 protein]; TSC2 mutant form inhibits the reaction [resveratrol results in increased phosphorylation of GYS1 protein] CTD PMID:23292070 NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419 		JBrowse link
G Gys2 glycogen synthase 2 multiple interactions EXP resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of GYS2 protein] CTD PMID:19059388 NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:177,096,063...177,137,236 		JBrowse link
G Gzmb granzyme B decreases expression ISO resveratrol results in decreased expression of GZMB mRNA CTD PMID:25280562 NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469 		JBrowse link
G H19 H19 imprinted maternally expressed transcript increases expression
multiple interactions 		ISO
EXP 		Resveratrol results in increased expression of H19 mRNA
[Resveratrol co-treated with Streptozocin] results in increased expression of H19 mRNA 		CTD PMID:25888808 PMID:25905778 NCBI chr 1:207,160,175...207,162,851 JBrowse link
G H1f10 H1.10 linker histone multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of H1-10 mRNA CTD PMID:23557933 NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:121,997,831...121,998,966 		JBrowse link
G H1f8 H1.8 linker histone multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of H1-8 mRNA CTD PMID:23557933 NCBI chr 4:150,665,727...150,670,846
Ensembl chr 4:150,665,727...150,670,993 		JBrowse link
G H2ac6 H2A clustered histone 6 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of H2AC6 mRNA CTD PMID:19167446 NCBI chr17:47,403,701...47,404,167 JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases phosphorylation
increases expression
increases response to substance
decreases expression 		ISO 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Resveratrol results in increased phosphorylation of H2AX protein]; [Coumestrol co-treated with Resveratrol] results in increased expression of H2AX mRNA; [Resveratrol co-treated with pterostilbene] results in decreased expression of H2AX protein modified form; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AX protein; [Temozolomide co-treated with Resveratrol] results in increased phosphorylation of H2AX protein; Caffeine inhibits the reaction [Resveratrol results in increased phosphorylation of H2AX protein]; Erlotinib Hydrochloride promotes the reaction [Resveratrol results in increased expression of H2AX protein modified form]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Resveratrol promotes the reaction [Panobinostat results in increased expression of H2AX protein]]; pyrazolanthrone inhibits the reaction [Resveratrol results in increased phosphorylation of H2AX protein]; Resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased expression of H2AX protein modified form]; Resveratrol promotes the reaction [Panobinostat results in increased expression of H2AX protein]; Resveratrol promotes the reaction [Vorinostat results in increased expression of H2AX protein]
Resveratrol results in increased expression of H2AX protein; Resveratrol results in increased expression of H2AX protein modified form
H2AX protein results in increased susceptibility to Resveratrol
Resveratrol results in decreased expression of H2AX protein; Resveratrol results in decreased expression of H2AX protein modified form
Resveratrol inhibits the reaction [bisphenol A promotes the reaction [Cholesterol results in increased phosphorylation of H2AX protein]] 		CTD PMID:15975956 PMID:19167446 PMID:19559722 PMID:20697895 PMID:22923501 More... NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2az1 H2A.Z variant histone 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of H2AZ1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of H2AZ1 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411 		JBrowse link
G H2bc14 H2B clustered histone 14 decreases expression
multiple interactions 		ISO Resveratrol results in decreased expression of H2BC5 mRNA
[Coumestrol co-treated with Resveratrol] results in decreased expression of H2BC5 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of H2BC5 mRNA 		CTD PMID:19167446 PMID:19371625 PMID:23557933 NCBI chr17:47,488,627...47,489,008 JBrowse link
G H2bc6 H2B clustered histone 6 increases expression ISO Resveratrol results in increased expression of H2BC6 mRNA CTD PMID:17257620 NCBI chr17:41,948,813...41,949,276
Ensembl chr17:47,392,229...47,449,312 		JBrowse link
G H2bc8 H2B clustered histone 8 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of H2BC8 mRNA CTD PMID:19167446 NCBI chr17:47,404,405...47,405,155 JBrowse link
G H3c13 H3 clustered histone 13 decreases expression ISO Resveratrol results in decreased expression of H3C13 mRNA CTD PMID:23137833 NCBI chr17:41,959,540...41,960,009
Ensembl chr17:41,958,965...41,960,099 		JBrowse link
G H3f3b H3.3 histone B multiple interactions
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of H3-3B mRNA
resveratrol results in decreased expression of H3F3B mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636 		JBrowse link
G H4c3 H4 clustered histone 3 increases expression ISO Resveratrol results in increased expression of H4C6 mRNA CTD PMID:17257620 NCBI chr17:41,796,600...41,860,389 JBrowse link
G Hacd2 3-hydroxyacyl-CoA dehydratase 2 increases expression ISO resveratrol results in increased expression of HACD2 protein CTD PMID:25505154 NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126 		JBrowse link
G Hacd3 3-hydroxyacyl-CoA dehydratase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HACD3 mRNA CTD PMID:23557933 NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700 		JBrowse link
G Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HACE1 mRNA CTD PMID:23557933 NCBI chr20:50,618,004...50,733,460
Ensembl chr20:50,618,004...50,733,466 		JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HACL1 mRNA CTD PMID:23557933 NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HADH mRNA CTD PMID:19167446 NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446 		JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta increases expression ISO resveratrol results in increased expression of HADHB protein CTD PMID:25505154 NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835 		JBrowse link
G Haghl hydroxyacylglutathione hydrolase-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HAGHL mRNA CTD PMID:23557933 NCBI chr10:15,309,469...15,313,910
Ensembl chr10:15,308,668...15,312,181 		JBrowse link
G Hao2 hydroxyacid oxidase 2 multiple interactions EXP [resveratrol co-treated with Streptozocin] results in decreased expression of HAO2 mRNA CTD PMID:25905778 NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:188,889,212...188,913,133 		JBrowse link
G Hapln2 hyaluronan and proteoglycan link protein 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HAPLN2 mRNA CTD PMID:23557933 NCBI chr 2:175,786,767...175,794,515
Ensembl chr 2:175,789,009...175,794,438 		JBrowse link
G Hapln4 hyaluronan and proteoglycan link protein 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HAPLN4 mRNA CTD PMID:23557933 NCBI chr16:19,367,041...19,375,173
Ensembl chr16:19,367,041...19,375,442 		JBrowse link
G Hars2 histidyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HARS2 mRNA CTD PMID:23557933 NCBI chr18:28,672,810...28,682,367
Ensembl chr18:28,672,824...28,682,359 		JBrowse link
G Has1 hyaluronan synthase 1 decreases expression ISO resveratrol results in decreased expression of HAS1 mRNA CTD PMID:20706672 NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444 		JBrowse link
G Haspin histone H3 associated protein kinase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HASPIN mRNA CTD PMID:19167446 NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249 		JBrowse link
G Haus1 HAUS augmin-like complex, subunit 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HAUS1 mRNA CTD PMID:19167446 NCBI chr18:73,550,549...73,561,757
Ensembl chr18:73,548,669...73,565,761 		JBrowse link
G Haus2 HAUS augmin like complex subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HAUS2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of HAUS2 mRNA CTD PMID:23557933 NCBI chr 3:128,006,894...128,019,730
Ensembl chr 3:128,006,932...128,019,729 		JBrowse link
G Haus6 HAUS augmin like complex subunit 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HAUS6 mRNA CTD PMID:23557933 NCBI chr 5:106,162,526...106,201,503
Ensembl chr 5:106,162,526...106,199,072 		JBrowse link
G Haus8 HAUS augmin-like complex, subunit 8 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of HAUS8 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of HAUS8 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Cisplatin results in increased expression of HAVCR1 protein]]; resveratrol inhibits the reaction [Cisplatin results in increased expression of HAVCR1 protein] CTD PMID:21593185 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 multiple interactions ISO [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA CTD PMID:16806235 NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872 		JBrowse link
G Hax1 HCLS1 associated protein X-1 increases expression ISO resveratrol results in increased expression of HAX1 mRNA CTD PMID:22610192 NCBI chr 2:177,731,918...177,735,670
Ensembl chr 2:177,731,921...177,735,390 		JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 multiple interactions ISO resveratrol inhibits the reaction [Dietary Fats affects the expression of HBA-A1 mRNA] CTD PMID:17086191 NCBI chr10:15,841,724...15,842,580
Ensembl chr10:15,841,763...15,842,603 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases expression ISO resveratrol results in increased expression of HBA1 mRNA CTD PMID:24526417 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hbb hemoglobin subunit beta increases expression ISO resveratrol results in increased expression of HBB mRNA CTD PMID:24526417 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbq1b hemoglobin subunit theta 1B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HBQ1 mRNA CTD PMID:23557933 NCBI chr10:15,838,752...15,840,074
Ensembl chr10:15,825,223...15,825,858 		JBrowse link
G Hbs1l HBS1-like translational GTPase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HBS1L mRNA CTD PMID:23557933 NCBI chr 1:17,912,139...17,989,651
Ensembl chr 1:17,912,070...17,989,646 		JBrowse link
G Hccs holocytochrome c synthase increases expression
multiple interactions 		ISO resveratrol results in increased expression of HCCS protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HCCS mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr  X:28,505,370...28,514,812
Ensembl chr  X:28,505,417...28,514,812 		JBrowse link
G Hcfc1r1 host cell factor C1 regulator 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HCFC1R1 mRNA CTD PMID:23557933 NCBI chr10:13,209,757...13,211,445
Ensembl chr10:13,209,558...13,211,443 		JBrowse link
G Hcfc2 host cell factor C2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HCFC2 mRNA CTD PMID:23557933 NCBI chr 7:22,875,440...22,907,391
Ensembl chr 7:22,864,278...22,907,322 		JBrowse link
G Hck HCK proto-oncogene, Src family tyrosine kinase decreases expression
increases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of HCK mRNA
resveratrol results in increased expression of HCK mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of HCK mRNA 		CTD PMID:15280659 PMID:25905778 NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935 		JBrowse link
G Hcls1 hematopoietic cell specific Lyn substrate 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HCLS1 mRNA CTD PMID:23557933 NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387 		JBrowse link
G Hcrtr1 hypocretin receptor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HCRTR1 mRNA CTD PMID:23557933 NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions
decreases expression
increases expression 		ISO [[resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein]] which results in increased acetylation of and results in increased activity of TP53 protein; [resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein]; HDAC1 protein promotes the reaction [resveratrol results in decreased expression of ZBTB7A mRNA]; resveratrol inhibits the reaction [SP1 protein binds to HDAC1 protein]; resveratrol promotes the reaction [HDAC1 protein binds to SP1 protein]; resveratrol promotes the reaction [HDAC1 protein binds to ZBTB7A promoter]
resveratrol results in decreased expression of HDAC1 protein
resveratrol results in increased expression of HDAC1 mRNA 		CTD PMID:19810103 PMID:22610192 PMID:23593078 PMID:25875864 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hdac2 histone deacetylase 2 multiple interactions
increases metabolic processing
decreases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in increased expression of HDAC2 mRNA
resveratrol results in increased metabolism of HDAC2 protein
resveratrol results in decreased expression of HDAC2 mRNA 		CTD PMID:23463510 PMID:23557933 PMID:25905778 NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311 		JBrowse link
G Hdac3 histone deacetylase 3 increases expression ISO resveratrol results in increased expression of HDAC3 mRNA CTD PMID:15767336 NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025 		JBrowse link
G Hdac5 histone deacetylase 5 multiple interactions
increases phosphorylation 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HDAC5 mRNA; Resveratrol inhibits the reaction [HDAC5 protein binds to SOD2 promoter]
resveratrol results in increased phosphorylation of HDAC5 protein 		CTD PMID:23557933 PMID:26443543 NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244 		JBrowse link
G Hdac7 histone deacetylase 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HDAC7 mRNA CTD PMID:23557933 NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017 		JBrowse link
G Hdac8 histone deacetylase 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HDAC8 mRNA CTD PMID:23557933 NCBI chr  X:71,425,240...71,632,865
Ensembl chr  X:71,394,928...71,632,865 		JBrowse link
G Hdac9 histone deacetylase 9 increases expression ISO Resveratrol results in increased expression of HDAC9 mRNA CTD PMID:30481203 NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:56,490,988...57,351,835 		JBrowse link
G Hdgf heparin binding growth factor decreases expression
increases expression 		ISO resveratrol results in decreased expression of HDGF mRNA
resveratrol results in increased expression of HDGF mRNA 		CTD PMID:12002526 PMID:12154049 NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225 		JBrowse link
G Hdgfl2 HDGF like 2 decreases expression ISO resveratrol results in decreased expression of HDGFL2 protein CTD PMID:25505154 NCBI chr 9:996,687...1,016,352
Ensembl chr 9:996,758...1,016,735 		JBrowse link
G Heatr1 HEAT repeat containing 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HEATR1 mRNA CTD PMID:23557933 NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186 		JBrowse link
G Heatr3 HEAT repeat containing 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HEATR3 mRNA CTD PMID:23557933 NCBI chr19:35,065,915...35,103,779
Ensembl chr19:35,067,060...35,103,978 		JBrowse link
G Heatr4 HEAT repeat containing 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HEATR4 mRNA CTD PMID:23557933 NCBI chr 6:109,305,459...109,338,331
Ensembl chr 6:109,304,557...109,342,693 		JBrowse link
G Heatr5a HEAT repeat containing 5A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HEATR5A mRNA CTD PMID:23557933 NCBI chr 6:75,057,226...75,155,207
Ensembl chr 6:75,057,226...75,155,120 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HECTD1 mRNA CTD PMID:23557933 NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408 		JBrowse link
G Hectd4 HECT domain E3 ubiquitin protein ligase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HECTD4 mRNA CTD PMID:23557933 NCBI chr12:40,800,232...40,991,584
Ensembl chr12:40,843,770...40,991,798 		JBrowse link
G Hecw1 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HECW1 mRNA CTD PMID:23557933 NCBI chr17:55,366,904...55,780,028
Ensembl chr17:55,366,657...55,776,212 		JBrowse link
G Hells helicase, lymphoid specific decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of HELLS mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of HELLS mRNA 		CTD PMID:15767336 PMID:19167446 PMID:25905778 NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228 		JBrowse link
G Helq helicase, POLQ-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HELQ mRNA CTD PMID:23557933 NCBI chr14:9,122,978...9,167,310
Ensembl chr14:9,122,978...9,167,310 		JBrowse link
G Helt helt bHLH transcription factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HELT mRNA CTD PMID:23557933 NCBI chr16:52,723,828...52,725,610
Ensembl chr16:52,723,739...52,726,162 		JBrowse link
G Herc3 HECT and RLD domain containing E3 ubiquitin protein ligase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HERC3 mRNA CTD PMID:23557933 NCBI chr 4:89,282,374...89,372,656
Ensembl chr 4:89,282,445...89,372,652 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HERPUD1 mRNA] CTD PMID:31298478 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 decreases expression ISO resveratrol results in decreased expression of HES1 mRNA; resveratrol results in decreased expression of HES1 protein CTD PMID:17868649 PMID:25061499 PMID:25896424 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HES5 mRNA CTD PMID:23557933 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021 		JBrowse link
G Hexa hexosaminidase subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HEXA mRNA CTD PMID:23557933 NCBI chr 8:68,832,524...68,857,462
Ensembl chr 8:68,809,615...68,859,560 		JBrowse link
G Hexb hexosaminidase subunit beta decreases secretion ISO resveratrol analog results in decreased secretion of HEXB protein; resveratrol results in decreased secretion of HEXB protein CTD PMID:24832111 NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771 		JBrowse link
G Hgf hepatocyte growth factor multiple interactions
increases expression
decreases expression 		EXP
ISO 		resveratrol inhibits the reaction [Reactive Oxygen Species results in increased expression of HGF mRNA]
resveratrol results in increased expression of HGF mRNA; resveratrol results in increased expression of HGF protein
resveratrol results in decreased expression of HGF mRNA 		CTD PMID:15280659 PMID:15672869 PMID:22086758 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hhip Hedgehog-interacting protein decreases expression
increases expression 		ISO resveratrol results in decreased expression of HHIP mRNA
resveratrol results in increased expression of HHIP mRNA 		CTD PMID:20878097 PMID:25888808 NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795 		JBrowse link
G Hhipl1 HHIP-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HHIPL1 mRNA CTD PMID:23557933 NCBI chr 6:132,984,028...133,008,248
Ensembl chr 6:132,984,032...133,006,947 		JBrowse link
G Hibadh 3-hydroxyisobutyrate dehydrogenase increases expression ISO resveratrol results in increased expression of HIBADH protein CTD PMID:25505154 NCBI chr 4:82,979,759...83,077,819
Ensembl chr 4:82,979,765...83,111,242 		JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HIBCH mRNA CTD PMID:23557933 NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886 		JBrowse link
G Hid1 HID1 domain containing multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HID1 mRNA CTD PMID:23557933 NCBI chr10:101,088,526...101,109,011
Ensembl chr10:101,088,526...101,109,011 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha affects expression
multiple interactions
decreases expression
increases degradation
increases expression 		ISO
EXP 		resveratrol affects the expression of HIF1A protein
[resveratrol co-treated with plastochromanol 8] results in decreased expression of HIF1A protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein]; resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]]
resveratrol results in decreased expression of HIF1A protein
resveratrol results in increased degradation of HIF1A protein
[Resveratrol results in increased activity of SIRT1 protein] which results in increased expression of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Resveratrol inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Dinoprostone results in increased expression of and results in increased acetylation of HIF1A protein]; Resveratrol inhibits the reaction [HIF1A protein results in increased activity of AR protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [INS protein results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Oxygen deficiency affects the localization of HIF1A protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Resveratrol results in decreased expression of and affects the localization of HIF1A protein; Resveratrol results in increased ubiquitination of and results in increased degradation of HIF1A protein; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]]
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of HIF1A protein]; resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of HIF1A protein]; resveratrol inhibits the reaction [Nicotine results in decreased expression of HIF1A mRNA]
resveratrol results in increased expression of HIF1A protein
resveratrol results in decreased expression of HIF1A; resveratrol results in decreased expression of HIF1A mRNA; resveratrol results in decreased expression of HIF1A protein 		CTD PMID:12002526 PMID:15297429 PMID:16227395 PMID:17473185 PMID:17919812 More... NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hif3a hypoxia inducible factor 3 subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HIF3A mRNA CTD PMID:23557933 NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:86,850,554...86,877,838 		JBrowse link
G Higd1a HIG1 hypoxia inducible domain family, member 1A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HIGD1A mRNA CTD PMID:23557933 NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888 		JBrowse link
G Hikeshi heat shock protein nuclear import factor hikeshi multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HIKESHI mRNA CTD PMID:23557933 NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:153,237,948...153,261,911 		JBrowse link
G Hils1 histone linker H1 domain, spermatid-specific 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of H1-9P mRNA CTD PMID:23557933 NCBI chr10:80,410,361...80,411,157
Ensembl chr10:80,399,812...80,411,157 		JBrowse link
G Hint2 histidine triad nucleotide binding protein 2 increases expression ISO resveratrol results in increased expression of HINT2 protein CTD PMID:25505154 NCBI chr 5:62,700,383...62,702,638
Ensembl chr 5:62,700,384...62,702,915 		JBrowse link
G Hint3 histidine triad nucleotide binding protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HINT3 mRNA CTD PMID:23557933 NCBI chr 1:28,854,860...28,864,723
Ensembl chr 1:28,854,844...28,867,125 		JBrowse link
G Hipk1 homeodomain interacting protein kinase 1 decreases expression EXP resveratrol results in decreased expression of HIPK1 mRNA CTD PMID:25905778 NCBI chr 2:193,937,261...193,988,247
Ensembl chr 2:193,937,261...193,975,164 		JBrowse link
G Hipk2 homeodomain interacting protein kinase 2 decreases expression ISO resveratrol results in decreased expression of HIPK2 mRNA CTD PMID:23525482 NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108 		JBrowse link
G Hirip3 HIRA interacting protein 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HIRIP3 mRNA CTD PMID:19167446 NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:190,902,593...190,905,607 		JBrowse link
G Hivep1 HIVEP zinc finger 1 multiple interactions
decreases expression 		ISO
EXP 		[Coumestrol co-treated with resveratrol] results in decreased expression of HIVEP1 mRNA
resveratrol results in decreased expression of HIVEP1 mRNA 		CTD PMID:19167446 PMID:25905778 NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,790,855...22,917,196 		JBrowse link
G Hjurp Holliday junction recognition protein multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HJURP mRNA
Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of HJURP mRNA] 		CTD PMID:19167446 PMID:31298478 NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657 		JBrowse link
G Hjv hemojuvelin BMP co-receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HJV mRNA CTD PMID:23557933 NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:186,754,811...186,758,867 		JBrowse link
G Hk1 hexokinase 1 increases expression ISO resveratrol results in increased expression of HK1 mRNA CTD PMID:22610192 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814 		JBrowse link
G Hk2 hexokinase 2 decreases expression ISO resveratrol results in decreased expression of HK2 mRNA CTD PMID:16979140 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275 		JBrowse link
G Hlcs holocarboxylase synthetase decreases activity ISO resveratrol results in decreased activity of HLCS protein CTD PMID:26303405 NCBI chr11:46,925,491...47,123,111
Ensembl chr11:46,925,491...47,105,082 		JBrowse link
G Hltf helicase-like transcription factor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HLTF mRNA CTD PMID:23557933 NCBI chr 2:104,478,725...104,538,531
Ensembl chr 2:104,478,772...104,538,818 		JBrowse link
G Hm13 histocompatibility minor 13 increases expression ISO resveratrol results in increased expression of H13 protein CTD PMID:25505154 NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:161,606,052...161,644,805 		JBrowse link
G Hmbs hydroxymethylbilane synthase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HMBS mRNA CTD PMID:23557933 NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802 		JBrowse link
G Hmcn2 hemicentin 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HMCN2 mRNA CTD PMID:23557933 NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:34,986,263...35,136,106 		JBrowse link
G Hmga1 high mobility group AT-hook 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HMGA1 mRNA CTD PMID:23557933 NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593 		JBrowse link
G Hmga2 high mobility group AT-hook 2 decreases expression ISO resveratrol results in decreased expression of HMGA2 protein CTD PMID:25505154 NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of HMGB1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of HMGB1 mRNA; Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]]
[Resveratrol co-treated with HMGB1 protein] affects the localization of NFE2L2 protein; [Resveratrol co-treated with HMGB1 protein] results in increased expression of ABCC5 mRNA; [Resveratrol co-treated with HMGB1 protein] results in increased expression of AKR1B10 mRNA; [Resveratrol co-treated with HMGB1 protein] results in increased expression of HMOX1 mRNA; [Resveratrol co-treated with HMGB1 protein] results in increased expression of NQO1 mRNA; NFE2L2 protein affects the reaction [Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of CDH5 protein]]; Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMGB1 mRNA]; Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of CDH5 protein]; Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of NFE2L2 mRNA]; Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of NFE2L2 protein]; Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of TJP1 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of HMGB1 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMGB1 protein]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of and results in increased acetylation of HMGB1 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Streptozocin results in increased expression of and results in increased acetylation of HMGB1 protein]] 		CTD PMID:19167446 PMID:23557933 PMID:24802390 PMID:25651848 PMID:25979658 More... NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgb1-ps33 high-mobility group box 1, pseudogene 33 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HMGB1P1 mRNA CTD PMID:23557933 NCBI chr19:71,943,091...71,944,367
Ensembl chr19:71,943,082...71,944,278 		JBrowse link
G Hmgb2 high mobility group box 2 multiple interactions
decreases expression 		ISO [Coumestrol co-treated with Resveratrol] results in increased expression of HMGB2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of HMGB2 mRNA
resveratrol results in decreased expression of HMGB2 mRNA 		CTD PMID:15767336 PMID:19167446 PMID:23557933 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions
decreases activity
decreases expression
increases expression 		EXP
ISO 		Resveratrol inhibits the reaction [bisphenol A results in increased expression of HMGCR protein]; Resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR mRNA]; Resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR protein]; Resveratrol promotes the reaction [Simvastatin results in decreased activity of HMGCR protein]; Resveratrol results in decreased expression of and results in decreased activity of HMGCR protein
resveratrol results in decreased activity of HMGCR protein
resveratrol results in decreased expression of HMGCR mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of HMGCR mRNA; Resveratrol inhibits the reaction [Caffeine results in increased expression of HMGCR mRNA]; Resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR mRNA]; Resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR protein]; Resveratrol promotes the reaction [Simvastatin results in decreased activity of HMGCR protein]
resveratrol results in increased expression of HMGCR mRNA 		CTD PMID:18611391 PMID:21907337 PMID:22153697 PMID:23386644 PMID:23557933 More... NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression
multiple interactions 		ISO resveratrol results in increased expression of HMGCS1 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of HMGCS1 mRNA; Resveratrol inhibits the reaction [Caffeine results in increased expression of HMGCS1 mRNA] 		CTD PMID:22153697 PMID:23557933 PMID:30825513 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 increases expression ISO resveratrol results in increased expression of HMGCS2 mRNA CTD PMID:22610192 NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242 		JBrowse link
G Hmgn1 high mobility group nucleosome binding domain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HMGN1 mRNA CTD PMID:23557933 NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771 		JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 decreases expression ISO resveratrol results in decreased expression of HMGN2 mRNA CTD PMID:19371625 NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HMMR mRNA CTD PMID:19167446 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hmox1 heme oxygenase 1 affects expression
increases expression
multiple interactions
decreases activity
decreases response to substance
decreases expression 		EXP
ISO 		resveratrol affects the expression of HMOX1 mRNA
resveratrol results in increased expression of HMOX1 mRNA; resveratrol results in increased expression of HMOX1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; [Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of HMOX1 protein]; [Resveratrol analog co-treated with bisphenol A] results in increased expression of HMOX1 protein; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [Resveratrol results in increased abundance of Glutathione]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] which results in decreased susceptibility to Resveratrol; Cycloheximide inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Fulvestrant inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; HMOX1 protein promotes the reaction [Resveratrol results in decreased activity of MPO protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [chromium hexavalent ion results in decreased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [chromium hexavalent ion results in decreased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Dibutyl Phthalate results in decreased expression of HMOX1 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of HMOX1 protein]]; Resveratrol inhibits the reaction [Paraquat results in decreased expression of HMOX1 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 mRNA]; Resveratrol results in increased expression of and results in increased activity of HMOX1 protein; SB 203580 inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; U 0126 inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; Wortmannin inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of HMOX1 mRNA; [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of HMOX1 protein; [Resveratrol co-treated with hydroquinone] results in increased expression of HMOX1 protein; [Resveratrol results in decreased phosphorylation of NFKBIA protein] which results in decreased expression of HMOX1; [Resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA; [Resveratrol results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased expression of HMOX1; Ascorbic Acid inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Ascorbic Acid inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; Cycloheximide inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Cycloheximide inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of NDUFB8 protein]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of PPARGC1A mRNA]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of UQCRC1 protein]; Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]]; NFE2L2 protein affects the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; PIK 75 inhibits the reaction [[Lipopolysaccharides co-treated with Resveratrol] results in increased expression of HMOX1 protein]; Resveratrol affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]; Resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP2 protein]; Resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein]; Resveratrol inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of HMOX1 protein]; Resveratrol promotes the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Resveratrol promotes the reaction [Paraquat results in increased expression of HMOX1 mRNA]; tin protoporphyrin IX promotes the reaction [Resveratrol results in increased expression of HMOX1 protein]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Resveratrol results in increased expression of HMOX1 protein]
resveratrol results in decreased activity of HMOX1 protein
HMOX1 promoter mutant form results in decreased susceptibility to resveratrol
resveratrol results in decreased expression of HMOX1 mRNA
[Resveratrol co-treated with HMGB1 protein] results in increased expression of HMOX1 mRNA; HMOX1 protein promotes the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; NFE2L2 protein affects the reaction [Resveratrol results in increased expression of HMOX1 protein]; NFE2L2 protein promotes the reaction [Resveratrol promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; NFE2L2 protein promotes the reaction [Resveratrol results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Arginine results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Dibutyl Phthalate results in decreased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of and results in decreased activity of HMOX1 protein]; Resveratrol inhibits the reaction [IRS2 gene mutant form results in decreased expression of HMOX1 mRNA]; Resveratrol promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]; Resveratrol promotes the reaction [Azoxymethane results in increased expression of HMOX1 protein]; Resveratrol promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]; Resveratrol promotes the reaction [Paraquat results in increased activity of HMOX1 protein]; Resveratrol promotes the reaction [Smoke analog results in increased expression of and results in increased activity of HMOX1 protein]; Resveratrol promotes the reaction [Smoke analog results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of and results in decreased activity of HMOX1 protein]]
resveratrol results in decreased expression of HMOX1 protein
Resveratrol results in increased expression of HMOX1 mRNA; Resveratrol results in increased expression of HMOX1 protein 		CTD PMID:10942521 PMID:15345140 PMID:15588712 PMID:15748624 PMID:15882976 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hmx3 H6 family homeobox 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HMX3 mRNA CTD PMID:23557933 NCBI chr 1:195,743,411...195,745,375
Ensembl chr 1:195,743,271...195,746,444 		JBrowse link
G Hnf1a HNF1 homeobox A increases expression ISO resveratrol results in increased expression of HNF1A mRNA CTD PMID:21163946 NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755 		JBrowse link
G Hnf1b HNF1 homeobox B decreases expression ISO resveratrol results in decreased expression of HNF1B mRNA CTD PMID:15280659 NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions EXP [resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein]] which results in decreased expression of GCK mRNA; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [HNF4A protein binds to GCK promoter]]; resveratrol affects the reaction [HNF4A protein binds to GCK promoter]; resveratrol promotes the reaction [FOXO1 protein binds to HNF4A protein] CTD PMID:19740748 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758 		JBrowse link
G Hnmt histamine N-methyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNMT mRNA CTD PMID:23557933 NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482 		JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of HNRNPA1 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPA1 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of HNRNPA2B1 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPA2B1 mRNA
resveratrol results in decreased expression of HNRNPA2B1 protein 		CTD PMID:23557933 PMID:25505154 PMID:25905778 NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572 		JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of HNRNPA3 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPA3 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043 		JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPAB mRNA
resveratrol results in decreased expression of HNRNPAB protein 		CTD PMID:23557933 PMID:25505154 NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307 		JBrowse link
G Hnrnpc heterogeneous nuclear ribonucleoprotein C multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HNRNPC mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPC mRNA CTD PMID:23557933 NCBI chr15:27,253,098...27,282,779
Ensembl chr15:27,253,098...27,282,715 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D decreases expression ISO resveratrol results in decreased expression of HNRNPD protein CTD PMID:25505154 NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066 		JBrowse link
G Hnrnpdl heterogeneous nuclear ribonucleoprotein D-like decreases expression ISO resveratrol results in decreased expression of HNRNPDL protein CTD PMID:25505154 NCBI chr14:9,861,716...9,867,945
Ensembl chr14:9,861,716...9,867,945 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPH1 mRNA CTD PMID:23557933 NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906 		JBrowse link
G Hnrnph2 heterogeneous nuclear ribonucleoprotein H2 decreases expression
multiple interactions 		EXP
ISO 		resveratrol results in decreased expression of HNRNPH2 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPH2 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr  X:102,074,175...102,080,115
Ensembl chr  X:102,074,179...102,081,025 		JBrowse link
G Hnrnph3 heterogeneous nuclear ribonucleoprotein H3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPH3 mRNA CTD PMID:23557933 NCBI chr20:25,619,540...25,624,397
Ensembl chr20:25,615,577...25,625,162 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression ISO resveratrol results in decreased expression of HNRNPK protein CTD PMID:25505154 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565 		JBrowse link
G Hnrnpll heterogeneous nuclear ribonucleoprotein L-like decreases expression EXP resveratrol results in decreased expression of HNRNPLL mRNA CTD PMID:25905778 NCBI chr 6:20,720,013...20,752,803
Ensembl chr 6:20,722,184...20,752,802 		JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPM mRNA CTD PMID:23557933 NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871 		JBrowse link
G Hnrnpr heterogeneous nuclear ribonucleoprotein R decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of HNRNPR protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPR mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344 		JBrowse link
G Hnrnpu heterogeneous nuclear ribonucleoprotein U multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPU mRNA CTD PMID:23557933 NCBI chr13:92,609,791...92,618,580
Ensembl chr13:92,605,216...92,618,612 		JBrowse link
G Hnrnpul2 heterogeneous nuclear ribonucleoprotein U-like 2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of HNRNPUL2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPUL2 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 1:215,142,750...215,154,668
Ensembl chr 1:215,142,644...215,155,161 		JBrowse link
G Homer2 homer scaffold protein 2 decreases expression ISO resveratrol results in decreased expression of HOMER2 mRNA CTD PMID:18586690 NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:144,976,436...145,068,997 		JBrowse link
G Hook1 hook microtubule-tethering protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HOOK1 mRNA CTD PMID:23557933 NCBI chr 5:115,940,199...116,003,482
Ensembl chr 5:115,940,080...116,003,482 		JBrowse link
G Hook3 hook microtubule-tethering protein 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HOOK3 mRNA CTD PMID:23557933 NCBI chr16:72,656,929...72,751,696
Ensembl chr16:72,657,019...72,764,071 		JBrowse link
G Hopx HOP homeobox multiple interactions
increases expression 		EXP [resveratrol co-treated with Streptozocin] results in increased expression of HOPX mRNA
resveratrol results in increased expression of HOPX mRNA 		CTD PMID:25905778 NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,410,221...31,437,188 		JBrowse link
G Hoxa1 homeobox A1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of HOXA1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXA1 mRNA 		CTD PMID:20878097 PMID:23557933 NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209 		JBrowse link
G Hoxa13 homeo box A13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXA13 mRNA CTD PMID:23557933 NCBI chr 4:82,689,566...82,691,701
Ensembl chr 4:82,689,566...82,691,701 		JBrowse link
G Hoxa3 homeobox A3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXA3 mRNA CTD PMID:23557933 NCBI chr 4:82,599,860...82,643,831
Ensembl chr 4:82,599,860...82,643,831 		JBrowse link
G Hoxb1 homeo box B1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXB1 mRNA CTD PMID:23557933 NCBI chr10:81,827,915...81,830,404
Ensembl chr10:81,827,915...81,830,404 		JBrowse link
G Hoxb5 homeo box B5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXB5 mRNA CTD PMID:23557933 NCBI chr10:81,765,911...81,768,119 JBrowse link
G Hoxb6 homeo box B6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXB6 mRNA CTD PMID:23557933 NCBI chr10:81,755,263...81,763,999 JBrowse link
G Hoxb9 homeo box B9 multiple interactions
decreases expression 		ISO [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of HOXB9 mRNA
Resveratrol results in decreased expression of HOXB9 mRNA 		CTD PMID:26667767 PMID:29990529 NCBI chr10:81,733,857...81,737,363
Ensembl chr10:81,733,658...81,738,872 		JBrowse link
G Hoxc6 homeo box C6 multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of HOXC6 mRNA
Resveratrol results in decreased expression of HOXC6 mRNA 		CTD PMID:19167446 PMID:29990529 NCBI chr 7:136,013,679...136,051,601
Ensembl chr 7:136,024,961...136,027,365 		JBrowse link
G Hoxc8 homeobox C8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXC8 mRNA CTD PMID:23557933 NCBI chr 7:136,006,407...136,008,973
Ensembl chr 7:136,006,162...136,009,849 		JBrowse link
G Hoxd1 homeo box D1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXD1 mRNA CTD PMID:23557933 NCBI chr 3:80,073,041...80,075,180
Ensembl chr 3:80,073,041...80,075,180 		JBrowse link
G Hoxd11 homeobox D11 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXD11 mRNA CTD PMID:23557933 NCBI chr 3:79,992,394...79,994,688
Ensembl chr 3:79,992,394...79,994,688 		JBrowse link
G Hoxd12 homeo box D12 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXD12 mRNA CTD PMID:23557933 NCBI chr 3:79,985,106...79,986,227
Ensembl chr 3:79,985,106...79,986,227 		JBrowse link
G Hoxd13 homeo box D13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXD13 mRNA CTD PMID:23557933 NCBI chr 3:79,978,077...79,981,393
Ensembl chr 3:79,978,076...79,981,393 		JBrowse link
G Hpca hippocalcin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HPCA mRNA CTD PMID:23557933 NCBI chr 5:146,739,978...146,750,961
Ensembl chr 5:146,739,978...146,749,983 		JBrowse link
G Hpcal1 hippocalcin-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HPCAL1 mRNA CTD PMID:23557933 NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353 		JBrowse link
G Hpd 4-hydroxyphenylpyruvate dioxygenase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HPD mRNA CTD PMID:23557933 NCBI chr12:39,042,246...39,053,596
Ensembl chr12:39,042,238...39,053,612 		JBrowse link
G Hpf1 histone PARylation factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HPF1 mRNA CTD PMID:23557933 NCBI chr16:34,211,971...34,230,551
Ensembl chr16:34,193,421...34,253,210 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HPGD mRNA] CTD PMID:31298478 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hpn hepsin multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HPN mRNA CTD PMID:23557933 NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of HPRT1 mRNA
resveratrol results in decreased expression of HPRT1 protein 		CTD PMID:19167446 PMID:23724044 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hps3 HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HPS3 mRNA CTD PMID:23557933 NCBI chr 2:104,413,618...104,455,091
Ensembl chr 2:104,413,417...104,455,091 		JBrowse link
G Hpse heparanase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HPSE mRNA CTD PMID:23557933 NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754 		JBrowse link
G Hpse2 heparanase 2 (inactive) multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HPSE2 mRNA CTD PMID:23557933 NCBI chr 1:251,532,149...252,231,316
Ensembl chr 1:251,532,149...252,195,255 		JBrowse link
G Hpx hemopexin multiple interactions ISO Resveratrol promotes the reaction [titanium dioxide results in increased expression of HPX mRNA] CTD PMID:31298478 NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156 		JBrowse link
G Hr HR, lysine demethylase and nuclear receptor corepressor increases expression
multiple interactions 		ISO resveratrol results in increased expression of HR mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of HR mRNA 		CTD PMID:23557933 PMID:25888808 NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015 		JBrowse link
G Hras HRas proto-oncogene, GTPase affects expression
multiple interactions 		ISO resveratrol affects the expression of HRAS mRNA mutant form; resveratrol affects the expression of HRAS protein mutant form
[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]
HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein]; HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK3 protein]; HRAS protein promotes the reaction [resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein]; HRAS protein promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA]; HRAS protein promotes the reaction [resveratrol results in increased expression of TP53 mRNA]; HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein]; HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein]; HRAS protein promotes the reaction [TP53 protein results in increased susceptibility to resveratrol] 		CTD PMID:11889192 PMID:16369916 PMID:20103723 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrg histidine-rich glycoprotein multiple interactions ISO resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of HRG mRNA] CTD PMID:26667767 NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982 		JBrowse link
G Hrh1 histamine receptor H 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HRH1 mRNA CTD PMID:23557933 NCBI chr 4:149,120,511...149,204,267
Ensembl chr 4:149,120,039...149,208,248 		JBrowse link
G Hs1bp3 HCLS1 binding protein 3 increases expression ISO resveratrol results in increased expression of HS1BP3 protein CTD PMID:25505154 NCBI chr 6:36,911,864...36,942,126
Ensembl chr 6:36,911,864...36,942,126 		JBrowse link
G Hs3st1 heparan sulfate-glucosamine 3-sulfotransferase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST1 mRNA CTD PMID:23557933 NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848 		JBrowse link
G Hs3st2 heparan sulfate-glucosamine 3-sulfotransferase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST2 mRNA CTD PMID:23557933 NCBI chr 1:185,387,445...185,508,700
Ensembl chr 1:185,386,761...185,508,700 		JBrowse link
G Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST4 mRNA CTD PMID:23557933 NCBI chr 1:187,970,127...188,375,869
Ensembl chr 1:187,969,943...188,375,465 		JBrowse link
G Hs3st6 heparan sulfate-glucosamine 3-sulfotransferase 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST6 mRNA CTD PMID:23557933 NCBI chr10:14,286,555...14,292,660
Ensembl chr10:14,286,507...14,292,660 		JBrowse link
G Hsbp1 heat shock factor binding protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSBP1 mRNA CTD PMID:23557933 NCBI chr19:64,309,703...64,314,035
Ensembl chr19:64,309,703...64,314,035 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases activity
multiple interactions 		ISO
EXP 		resveratrol results in decreased activity of HSD11B1 protein
Resveratrol inhibits the reaction [HSD11B1 protein results in increased chemical synthesis of Corticosterone]; Resveratrol inhibits the reaction [HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone] 		CTD PMID:23814014 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSD11B2 mRNA CTD PMID:23557933 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSD17B1 mRNA CTD PMID:23557933 NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210 		JBrowse link
G Hsd17b12 hydroxysteroid (17-beta) dehydrogenase 12 increases expression
multiple interactions 		ISO resveratrol results in increased expression of HSD17B12 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HSD17B12 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 3:100,445,393...100,568,898
Ensembl chr 3:100,445,400...100,568,938 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 increases expression
multiple interactions 		EXP resveratrol results in increased expression of HSD17B2 mRNA
[resveratrol co-treated with Streptozocin] results in decreased expression of HSD17B2 mRNA 		CTD PMID:19228061 PMID:25905778 NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Hsd17b4 hydroxysteroid (17-beta) dehydrogenase 4 increases expression
multiple interactions 		ISO resveratrol results in increased expression of HSD17B4 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HSD17B4 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467 		JBrowse link
G Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 increases expression ISO resveratrol results in increased expression of HSD17B7 protein CTD PMID:25505154 NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions
decreases expression 		EXP [Simvastatin co-treated with resveratrol] results in decreased expression of HSD3B1 mRNA
resveratrol results in decreased expression of HSD3B1 mRNA 		CTD PMID:24524197 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hsd3b7 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSD3B7 mRNA CTD PMID:23557933 NCBI chr 1:191,842,688...191,845,919
Ensembl chr 1:191,842,636...191,845,921 		JBrowse link
G Hsdl2 hydroxysteroid dehydrogenase like 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSDL2 mRNA CTD PMID:23557933 NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798 		JBrowse link
G Hsf1 heat shock transcription factor 1 multiple interactions
increases activity 		ISO [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA; [resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA; resveratrol inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of HSF1 protein]; resveratrol inhibits the reaction [sodium arsenite results in decreased phosphorylation of HSF1 protein]; resveratrol results in decreased localization of and results in decreased activity of HSF1 protein
Resveratrol results in increased activity of HSF1 protein 		CTD PMID:18429957 PMID:20090934 PMID:24412756 PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions EXP resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA] CTD PMID:26361869 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HSP90B1 mRNA CTD PMID:19167446 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa12a heat shock protein family A (Hsp70) member 12A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPA12A mRNA CTD PMID:23557933 NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794 		JBrowse link
G Hspa14 heat shock protein family A (Hsp70) member 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA14 mRNA CTD PMID:23557933 NCBI chr17:79,638,106...79,658,888
Ensembl chr17:79,638,058...79,658,885 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of HSPA1A mRNA; resveratrol results in decreased expression of HSPA1A protein
Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HSPA1A mRNA]
resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSPA1A mRNA]
[resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein 		CTD PMID:18089832 PMID:20090934 PMID:26361869 PMID:31298478 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions
increases expression 		ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HSPA1B mRNA]
resveratrol results in increased expression of HSPA1B mRNA 		CTD PMID:17956190 PMID:31298478 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa4 heat shock protein family A (Hsp70) member 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA4 mRNA CTD PMID:23557933 NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression ISO resveratrol results in increased expression of HSPA4L protein CTD PMID:25505154 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Resveratrol results in increased expression of HSPA5 protein
[Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Resveratrol inhibits the reaction [Acrolein results in increased expression of HSPA5 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of HSPA5 protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of HSPA5 mRNA]
resveratrol results in increased expression of HSPA5 protein
resveratrol results in decreased expression of HSPA5 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA5 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of HSPA5 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of HSPA5 mRNA]; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of HSPA5 protein]; Resveratrol inhibits the reaction [Ethanol results in increased expression of HSPA5 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]
Resveratrol results in decreased expression of HSPA5 mRNA; Resveratrol results in decreased expression of HSPA5 protein 		CTD PMID:17914584 PMID:18089832 PMID:20198347 PMID:20717957 PMID:21321189 More... NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 multiple interactions
increases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA9 mRNA; Resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein]
resveratrol results in increased expression of HSPA9 protein 		CTD PMID:23557933 PMID:24218232 PMID:25505154 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		resveratrol results in increased expression of HSPB1 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPB1 mRNA; [Resveratrol results in decreased expression of HSPB1 protein] which results in increased susceptibility to Doxorubicin; Resveratrol results in increased expression of and results in increased phosphorylation of HSPB1 protein
resveratrol results in decreased expression of HSPB1 mRNA; resveratrol results in decreased expression of HSPB1 protein
resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein] 		CTD PMID:19228061 PMID:20706672 PMID:20878097 PMID:22349766 PMID:23421680 More... NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspb6 heat shock protein family B (small) member 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPB6 mRNA CTD PMID:23557933 NCBI chr 1:94,934,372...94,936,516
Ensembl chr 1:94,933,543...94,936,512 		JBrowse link
G Hspb7 heat shock protein family B (small) member 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPB7 mRNA CTD PMID:23557933 NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:159,010,629...159,014,243 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression ISO resveratrol results in increased expression of HSPB8 protein CTD PMID:25505154 NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937 		JBrowse link
G Hspb9 heat shock protein family B (small) member 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPB9 mRNA CTD PMID:23557933 NCBI chr10:86,141,603...86,142,248
Ensembl chr10:86,141,269...86,147,839 		JBrowse link
G Hspbap1 HSPB1 associated protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPBAP1 mRNA CTD PMID:23557933 NCBI chr11:78,445,376...78,500,034
Ensembl chr11:78,445,376...78,500,034 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 multiple interactions
increases expression
affects expression
decreases expression 		EXP
ISO 		resveratrol inhibits the reaction [Adenosine Triphosphate results in increased expression of HSPD1 protein]; resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSPD1 mRNA]
resveratrol results in increased expression of HSPD1 mRNA
resveratrol affects the expression of HSPD1 protein
resveratrol results in decreased expression of HSPD1 protein 		CTD PMID:16178011 PMID:22234583 PMID:22610192 PMID:23255428 PMID:24170104 More... NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 increases expression ISO resveratrol results in increased expression of HSPE1 mRNA CTD PMID:22610192 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPG2 mRNA CTD PMID:23557933 NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPH1 mRNA CTD PMID:23557933 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Htatsf1 HIV-1 Tat specific factor 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of HTATSF1 mRNA CTD PMID:23557933 NCBI chr  X:139,972,742...139,986,923
Ensembl chr  X:139,972,742...139,986,923 		JBrowse link
G Htr1b 5-hydroxytryptamine receptor 1B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HTR1B mRNA CTD PMID:23557933 NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583 		JBrowse link
G Htr1d 5-hydroxytryptamine receptor 1D multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HTR1D mRNA CTD PMID:23557933 NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012 		JBrowse link
G Htr6 5-hydroxytryptamine receptor 6 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HTR6 mRNA CTD PMID:23557933 NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147 		JBrowse link
G Htra2 HtrA serine peptidase 2 increases expression ISO resveratrol results in increased expression of HTRA2 mRNA CTD PMID:22610192 NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793 		JBrowse link
G Hus1 HUS1 checkpoint clamp component decreases expression EXP Resveratrol results in decreased expression of HUS1 mRNA CTD PMID:33775663 NCBI chr14:87,902,458...87,917,221
Ensembl chr14:87,902,458...87,917,134 		JBrowse link
G Hyal1 hyaluronidase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HYAL1 mRNA CTD PMID:23557933 NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:117,129,277...117,133,146 		JBrowse link
G Hyal3 hyaluronidase 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HYAL3 mRNA CTD PMID:23557933 NCBI chr 8:117,133,028...117,138,663
Ensembl chr 8:117,132,649...117,139,289 		JBrowse link
G Hydin Hydin, axonemal central pair apparatus protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of HYDIN mRNA CTD PMID:23557933 NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660 		JBrowse link
G Hykk hydroxylysine kinase multiple interactions ISO [Lipopolysaccharides co-treated with resveratrol] results in increased expression of HYKK mRNA CTD PMID:26667767 NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:64,212,071...64,235,818 		JBrowse link
G Hyls1 HYLS1, centriolar and ciliogenesis associated multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HYLS1 mRNA CTD PMID:19167446 NCBI chr 8:42,170,505...42,179,573
Ensembl chr 8:42,168,546...42,179,725 		JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO resveratrol results in increased expression of HYOU1 protein CTD PMID:25505154 NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997 		JBrowse link
G Iars1 isoleucyl-tRNA synthetase 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IARS1 mRNA CTD PMID:23557933 NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652 		JBrowse link
G Iars2 isoleucyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IARS2 mRNA CTD PMID:23557933 NCBI chr13:99,363,035...99,397,068
Ensembl chr13:99,362,696...99,397,068 		JBrowse link
G Ibtk inhibitor of Bruton tyrosine kinase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IBTK mRNA CTD PMID:23557933 NCBI chr 8:95,505,630...95,579,435
Ensembl chr 8:95,505,630...95,578,301 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		3-methyladenine inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; ATG5 protein affects the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; BECN1 protein affects the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; Chloroquine inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; garcinol inhibits the reaction [resveratrol promotes the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; parthenolide inhibits the reaction [resveratrol promotes the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; parthenolide inhibits the reaction [resveratrol results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; resveratrol promotes the reaction [TNF protein results in increased expression of ICAM1 mRNA]; resveratrol promotes the reaction [TNF protein results in increased expression of ICAM1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]
resveratrol results in increased expression of ICAM1 mRNA; resveratrol results in increased expression of ICAM1 protein
resveratrol analog results in decreased expression of ICAM1; resveratrol results in decreased expression of ICAM1 protein
resveratrol inhibits the reaction [Calcium Chloride results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of ICAM1 protein]; resveratrol inhibits the reaction [Streptozocin results in increased expression of ICAM1 protein]
chromium mesoporphyrin inhibits the reaction [resveratrol results in decreased activity of ICAM1 protein]; chromium mesoporphyrin inhibits the reaction [resveratrol results in decreased expression of ICAM1 protein]; fulvestrant inhibits the reaction [resveratrol results in decreased expression of ICAM1 protein]; resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of ICAM1 protein]; resveratrol inhibits the reaction [Fructose results in increased expression of ICAM1 protein modified form]; resveratrol inhibits the reaction [Streptozocin results in increased expression of ICAM1 protein]; resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ICAM1 mRNA]; resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; resveratrol promotes the reaction [TNF protein results in increased expression of ICAM1 mRNA]; SB 203580 inhibits the reaction [resveratrol results in decreased expression of ICAM1 protein]; wortmannin inhibits the reaction [resveratrol results in decreased activity of ICAM1 protein]
resveratrol results in decreased expression of ICAM1 mRNA
resveratrol results in decreased expression of ICAM1 mRNA; resveratrol results in decreased expression of ICAM1 protein 		CTD PMID:9846848 PMID:12615669 PMID:15637762 PMID:15652768 PMID:16178859 More... NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icam2 intercellular adhesion molecule 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ICAM2 mRNA CTD PMID:23557933 NCBI chr10:91,808,449...91,819,319
Ensembl chr10:91,808,316...91,815,072 		JBrowse link
G Ice1 interactor of little elongation complex ELL subunit 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ICE1 mRNA CTD PMID:23557933 NCBI chr 1:34,468,839...34,508,346
Ensembl chr 1:34,468,659...34,508,346 		JBrowse link
G Ice2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ICE2 mRNA CTD PMID:23557933 NCBI chr 8:78,921,962...78,965,983
Ensembl chr 8:78,924,421...78,966,200 		JBrowse link
G Icmt isoprenylcysteine carboxyl methyltransferase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ICMT mRNA CTD PMID:23557933 NCBI chr 5:168,084,487...168,097,519
Ensembl chr 5:168,086,057...168,093,094 		JBrowse link
G Id1 inhibitor of DNA binding 1 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ID1 mRNA; resveratrol results in decreased expression of ID1 protein
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of ID1 mRNA] 		CTD PMID:21554132 PMID:26667767 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id3 inhibitor of DNA binding 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ID3 mRNA CTD PMID:19167446 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Id4 inhibitor of DNA binding 4 decreases expression EXP resveratrol results in decreased expression of ID4 mRNA CTD PMID:25905778 NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492 		JBrowse link
G Ide insulin degrading enzyme multiple interactions EXP resveratrol inhibits the reaction [APP protein modified form results in decreased expression of IDE protein] CTD PMID:25654502 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526 		JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IDH1 mRNA CTD PMID:23557933 NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions
increases expression 		ISO
EXP 		resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
resveratrol results in increased expression of IDH2 mRNA
resveratrol results in increased expression of IDH2 protein 		CTD PMID:25505154 PMID:25522270 PMID:25905778 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha increases expression ISO resveratrol results in increased expression of IDH3A protein CTD PMID:25505154 NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223 		JBrowse link
G Idh3b isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta increases expression ISO resveratrol results in increased expression of IDH3B mRNA; resveratrol results in increased expression of IDH3B protein CTD PMID:22610192 PMID:25505154 NCBI chr 3:137,934,971...137,940,275
Ensembl chr 3:137,934,697...137,940,107 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 multiple interactions ISO resveratrol inhibits the reaction [Dietary Fats affects the expression of IDI1 mRNA] CTD PMID:17086191 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 affects activity ISO resveratrol affects the activity of IDO1 protein CTD PMID:16154495 NCBI chr16:74,133,259...74,145,328
Ensembl chr16:74,133,259...74,145,328 		JBrowse link
G Ids iduronate 2-sulfatase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of IDS mRNA CTD PMID:19167446 NCBI chr  X:154,070,781...154,093,681
Ensembl chr  X:154,070,781...154,091,444 		JBrowse link
G Ier2 immediate early response 2 increases expression ISO resveratrol results in increased expression of IER2 mRNA CTD PMID:12002526 NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708 		JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of IER3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of IER3 mRNA CTD PMID:23557933 PMID:26667767 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ier3ip1-ps1 immediate early response 3 interacting protein 1, pseudogene 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IER3IP1 mRNA CTD PMID:23557933 NCBI chr 4:133,898,662...133,899,156
Ensembl chr 4:133,887,903...133,898,847 		JBrowse link
G Ier5l immediate early response 5-like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IER5L mRNA CTD PMID:23557933 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452 		JBrowse link
G Ifi30 IFI30, lysosomal thiol reductase increases expression ISO resveratrol results in increased expression of IFI30 mRNA CTD PMID:25888808 NCBI chr16:18,709,570...18,713,635
Ensembl chr16:18,709,563...18,715,711 		JBrowse link
G Ifi35 interferon-induced protein 35 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IFI35 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of IFI35 mRNA CTD PMID:23557933 NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750 		JBrowse link
G Ifi44 interferon-induced protein 44 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFI44 mRNA CTD PMID:23557933 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifih1 interferon induced with helicase C domain 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFIH1 mRNA CTD PMID:23557933 NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions ISO resveratrol inhibits the reaction [Dietary Fats affects the expression of IFIT3 mRNA] CTD PMID:17086191 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifitm1 interferon induced transmembrane protein 1 multiple interactions
increases expression 		ISO
EXP 		[Plant Extracts co-treated with Resveratrol] results in decreased expression of IFITM1 mRNA
Resveratrol results in increased expression of IFITM1 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776 		JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 decreases expression
multiple interactions 		EXP resveratrol results in decreased expression of IFITM3 mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of IFITM3 mRNA 		CTD PMID:19228061 PMID:25905778 NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920 		JBrowse link
G Ifitm5 interferon induced transmembrane protein 5 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IFITM5 mRNA CTD PMID:23557933 NCBI chr 1:205,475,465...205,478,191
Ensembl chr 1:205,475,330...205,476,896 		JBrowse link
G Ifna1 interferon, alpha 1 multiple interactions ISO Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA] CTD PMID:23452621 NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809 		JBrowse link
G Ifnar2 interferon alpha and beta receptor subunit 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFNAR2 mRNA CTD PMID:23557933 NCBI chr11:44,099,574...44,131,941
Ensembl chr11:44,099,753...44,131,937 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IFNB1 mRNA
resveratrol results in decreased expression of IFNB1 mRNA
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; resveratrol inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA]; resveratrol inhibits the reaction [TICAM1 protein results in increased expression of IFNB1 mRNA] 		CTD PMID:16116226 PMID:23224687 PMID:23557933 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Ifng interferon gamma multiple interactions
increases expression
decreases expression
affects expression 		EXP
ISO 		Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [sulfoxaflor results in increased expression of IFNG protein]; Resveratrol promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein]
Resveratrol results in increased expression of IFNG mRNA
[Benzo(a)pyrene co-treated with Resveratrol] results in decreased expression of IFNG protein; [IFNG protein results in increased expression of and results in increased localization of FAS protein] which results in increased susceptibility to Resveratrol; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased activity of NFE2L2 protein; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of GCLC mRNA; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of HMOX1 mRNA; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL8 mRNA]]; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of TNF mRNA]]; Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Resveratrol] results in increased expression of HMOX1 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL8 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL8 mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL8 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]; Resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA]; Resveratrol promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein]
resveratrol results in decreased expression of IFNG mRNA; resveratrol results in decreased expression of IFNG protein
[Resveratrol co-treated with Tetracyclines] inhibits the reaction [Paraquat results in increased expression of IFNG protein]; KHSRP gene mutant form inhibits the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of CXCL1 mRNA]]; KHSRP gene mutant form inhibits the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]]; KHSRP gene mutant form inhibits the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of TNF mRNA]]; Resveratrol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein]; Resveratrol inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of CXCL1 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Resveratrol inhibits the reaction [Ethanol results in increased activity of IFNG protein]; Resveratrol inhibits the reaction [IFNG protein results in increased abundance of Dinoprostone]; Resveratrol inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]
resveratrol affects the expression of IFNG protein 		CTD PMID:11020457 PMID:15779068 PMID:16154495 PMID:16256029 PMID:16366677 More... NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifnl3 interferon, lambda 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IFNL3 mRNA CTD PMID:23557933 NCBI chr 1:92,941,988...92,943,628 JBrowse link
G Ifrd1 interferon-related developmental regulator 1 decreases expression ISO resveratrol results in decreased expression of IFRD1 mRNA CTD PMID:12002526 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Ifrd2 interferon-related developmental regulator 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of IFRD2 mRNA CTD PMID:19167446 NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836 		JBrowse link
G Ift122 intraflagellar transport 122 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of IFT122 mRNA CTD PMID:19167446 NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:150,539,786...150,648,052 		JBrowse link
G Ift22 intraflagellar transport 22 increases expression ISO resveratrol results in increased expression of IFT22 protein CTD PMID:25505154 NCBI chr12:25,397,092...25,405,522
Ensembl chr12:25,387,347...25,405,510 		JBrowse link
G Ift25 intraflagellar transport 25 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFT25 mRNA CTD PMID:23557933 NCBI chr 5:127,264,450...127,291,225
Ensembl chr 5:127,264,498...127,291,225 		JBrowse link
G Ift27 intraflagellar transport 27 increases expression ISO resveratrol results in increased expression of IFT27 protein CTD PMID:25505154 NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:111,619,077...111,634,936 		JBrowse link
G Ift43 intraflagellar transport 43 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of IFT43 mRNA CTD PMID:19167446 NCBI chr 6:111,460,689...111,537,224
Ensembl chr 6:111,456,476...111,537,224 		JBrowse link
G Ift46 intraflagellar transport 46 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFT46 mRNA CTD PMID:23557933 NCBI chr 8:53,975,085...54,000,837
Ensembl chr 8:53,984,242...54,000,836 		JBrowse link
G Ift57 intraflagellar transport 57 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFT57 mRNA CTD PMID:23557933 NCBI chr11:64,528,349...64,593,545
Ensembl chr11:64,528,349...64,593,545 		JBrowse link
G Ift80 intraflagellar transport 80 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFT80 mRNA CTD PMID:23557933 NCBI chr 2:155,455,773...155,550,082
Ensembl chr 2:155,455,774...155,550,275 		JBrowse link
G Ift88 intraflagellar transport 88 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IFT88 mRNA CTD PMID:23557933 NCBI chr15:35,685,678...35,786,875
Ensembl chr15:35,688,927...35,781,634 		JBrowse link
G Igdcc3 immunoglobulin superfamily, DCC subclass, member 3 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGDCC3 mRNA CTD PMID:23557933 NCBI chr 8:74,556,348...74,603,136
Ensembl chr 8:74,556,348...74,603,136 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
decreases response to substance
increases expression
decreases expression 		EXP
ISO 		resveratrol inhibits the reaction [Dihydrotestosterone results in increased secretion of IGF1 protein]; resveratrol inhibits the reaction [IGF1 protein results in increased expression of RPS6KB1 protein modified form]; resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK3 protein]
resveratrol results in decreased susceptibility to IGF1 protein
resveratrol inhibits the reaction [IGF1 protein binds to and results in increased phosphorylation of and results in increased activity of IGF1R protein]; resveratrol inhibits the reaction [IGF1 protein results in increased expression of COL1A2 mRNA]
resveratrol results in increased expression of IGF1 mRNA
resveratrol results in decreased expression of IGF1 mRNA; resveratrol results in decreased expression of IGF1 protein
Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 protein]; Resveratrol inhibits the reaction [IGF1 protein binds to and results in increased phosphorylation of and results in increased activity of IGF1R protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased expression of VEGFA mRNA]; Resveratrol inhibits the reaction [IGF1 protein results in increased expression of VEGFA protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4E protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of FOXO3 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6KB1 protein] 		CTD PMID:12002526 PMID:15297429 PMID:16626303 PMID:17086191 PMID:17513867 More... NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor multiple interactions
decreases phosphorylation
increases expression
decreases expression 		ISO
EXP 		resveratrol inhibits the reaction [bisphenol A results in increased expression of IGF1R mRNA]; resveratrol inhibits the reaction [Estradiol results in increased expression of IGF1R mRNA]; resveratrol inhibits the reaction [IGF1 protein binds to and results in increased phosphorylation of and results in increased activity of IGF1R protein]; resveratrol inhibits the reaction [Metribolone results in increased expression of IGF1R mRNA]
resveratrol results in decreased phosphorylation of IGF1R protein
resveratrol results in increased expression of IGF1R mRNA
resveratrol results in increased expression of IGF1R mRNA; resveratrol results in increased expression of IGF1R protein
resveratrol results in decreased expression of IGF1R mRNA; resveratrol results in decreased expression of IGF1R protein
Resveratrol inhibits the reaction [bisphenol A results in decreased expression of IGF1R mRNA] 		CTD PMID:17675339 PMID:18586690 PMID:20504360 PMID:23525482 PMID:23810794 More... NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions
decreases secretion
increases expression
affects expression 		ISO [resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein; Estradiol promotes the reaction [resveratrol results in decreased secretion of IGF2 protein]; resveratrol inhibits the reaction [Estradiol results in increased secretion of IGF2 protein]; resveratrol results in increased expression of and results in increased secretion of IGF2 protein; Tamoxifen inhibits the reaction [resveratrol results in increased secretion of IGF2 protein]
resveratrol affects the expression of IGF2 mRNA 		CTD PMID:16037384 PMID:16393696 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 increases expression ISO resveratrol results in increased expression of IGF2BP2 protein CTD PMID:25505154 NCBI chr11:92,378,908...92,478,893
Ensembl chr11:92,378,908...92,478,867 		JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of IGF2BP3 protein
[resveratrol co-treated with Streptozocin] results in decreased expression of IGF2BP3 mRNA 		CTD PMID:25505154 PMID:25905778 NCBI chr 4:79,391,367...79,525,923
Ensembl chr 4:79,393,067...79,525,730 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor increases expression ISO resveratrol results in increased expression of IGF2R mRNA CTD PMID:12002526 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFALS mRNA CTD PMID:23557933 NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions
increases expression 		EXP
ISO 		FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA]; resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA]
resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP1 mRNA 		CTD PMID:12154049 PMID:15788402 PMID:16236254 PMID:16626303 PMID:16917544 More... NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 increases expression
multiple interactions 		ISO
EXP 		resveratrol results in increased expression of IGFBP2 mRNA
[resveratrol co-treated with Streptozocin] results in increased expression of IGFBP2 mRNA 		CTD PMID:12002526 PMID:12569576 PMID:25905778 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 increases expression ISO resveratrol results in increased expression of IGFBP3 mRNA CTD PMID:12154049 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP4 mRNA; Resveratrol inhibits the reaction [IL1B protein results in increased degradation of IGFBP4 protein]; Resveratrol inhibits the reaction [TNF protein results in increased degradation of IGFBP4 protein]
resveratrol results in decreased expression of IGFBP4 mRNA 		CTD PMID:16338976 PMID:23224687 PMID:23557933 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of IGFBP5 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of IGFBP5 mRNA 		CTD PMID:15280659 PMID:19167446 PMID:19228061 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbpl1 insulin-like growth factor binding protein-like 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBPL1 mRNA CTD PMID:23557933 NCBI chr 5:64,872,056...64,887,461
Ensembl chr 5:64,872,057...64,887,461 		JBrowse link
G Igip IgA-inducing protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IGIP mRNA CTD PMID:23557933 NCBI chr18:28,178,048...28,179,539 JBrowse link
G Igsf6 immunoglobulin superfamily, member 6 multiple interactions EXP
ISO 		[resveratrol co-treated with Streptozocin] results in increased expression of IGSF6 mRNA
[Plant Extracts co-treated with Resveratrol] results in increased expression of IGSF6 mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:185,041,462...185,051,956
Ensembl chr 1:185,041,462...185,052,245 		JBrowse link
G Igsf9 immunoglobulin superfamily, member 9 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGSF9 mRNA CTD PMID:23557933 NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974 		JBrowse link
G Ihh Indian hedgehog signaling molecule decreases expression ISO resveratrol results in decreased expression of IHH mRNA; resveratrol results in decreased expression of IHH protein CTD PMID:25190613 NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:83,952,986...83,959,203 		JBrowse link
G Ik IK cytokine decreases expression ISO resveratrol results in decreased expression of IK protein CTD PMID:25505154 NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions
decreases phosphorylation
decreases expression
affects expression 		ISO
EXP 		resveratrol inhibits the reaction [Dextran Sulfate results in increased activity of IKBKB protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein]
resveratrol results in decreased phosphorylation of IKBKB protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of IKBKB mRNA; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]
resveratrol results in decreased expression of IKBKB mRNA
resveratrol affects the expression of IKBKB protein 		CTD PMID:16474181 PMID:17112897 PMID:19819963 PMID:20155626 PMID:23452621 More... NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma decreases expression
decreases phosphorylation
multiple interactions 		ISO resveratrol results in decreased expression of IKBKG mRNA
resveratrol results in decreased phosphorylation of IKBKG protein
resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IKBKG mRNA] 		CTD PMID:21188121 PMID:23452621 PMID:25692777 NCBI chr  X:157,358,279...157,397,563
Ensembl chr  X:157,367,639...157,392,757 		JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IKZF4 mRNA CTD PMID:23557933 NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094 		JBrowse link
G Il10 interleukin 10 multiple interactions
increases secretion
increases expression
decreases secretion
decreases expression
affects expression 		ISO
EXP 		[Resveratrol co-treated with Tetracyclines] affects the reaction [Paraquat affects the expression of IL10 protein]; IL10 protein affects the reaction [[Resveratrol co-treated with Lipopolysaccharides] results in increased expression of SOCS3 protein]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; IL10 protein affects the reaction [Resveratrol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]]; IL10 protein affects the reaction [Resveratrol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]]; Resveratrol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL10 protein]; Resveratrol inhibits the reaction [[tetrandrine co-treated with COL2A1 protein] results in increased expression of IL10 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL10 protein]; Resveratrol inhibits the reaction [Ethanol results in increased activity of IL10 protein]; Resveratrol inhibits the reaction [tetrandrine results in increased expression of IL10 mRNA]; Resveratrol promotes the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
resveratrol results in increased secretion of IL10 protein
Resveratrol results in increased expression of IL10 mRNA; Resveratrol results in increased expression of IL10 protein
resveratrol results in increased expression of IL10; resveratrol results in increased expression of IL10 protein
resveratrol results in decreased secretion of IL10 protein
[resveratrol co-treated with [Lipopolysaccharides binds to and results in increased activity of TLR4 protein]] results in decreased secretion of IL10 protein; [resveratrol co-treated with TLR2 protein] results in decreased secretion of IL10 protein; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; resveratrol promotes the reaction [7-ketocholesterol results in increased expression of IL10 protein]
[Resveratrol co-treated with Ceruletide] results in increased expression of IL10 protein; [Resveratrol co-treated with raspberry ketone] inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL10 mRNA]; Resveratrol inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL10 mRNA]; Resveratrol inhibits the reaction [sulfoxaflor results in increased expression of IL10 protein]
resveratrol results in decreased expression of IL10 protein
resveratrol affects the expression of IL10 protein 		CTD PMID:15135313 PMID:20132809 PMID:20730501 PMID:21086752 PMID:21111721 More... NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]; resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12B protein co-treated with IL12A protein]]
Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of IL12A mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL12A protein] 		CTD PMID:14996416 PMID:15135313 PMID:23452621 PMID:30165701 NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]; resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12B protein co-treated with IL12A protein]]; resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]
resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein] 		CTD PMID:14996416 PMID:15135313 PMID:23452621 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il13 interleukin 13 multiple interactions
decreases secretion
decreases expression
decreases response to substance 		EXP
ISO 		Resveratrol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL13 protein]; Resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased secretion of IL13 protein]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL13 mRNA; Resveratrol inhibits the reaction [IL13 protein results in increased expression of CCL11 mRNA]; Resveratrol inhibits the reaction [IL13 protein results in increased secretion of CCL11 protein]
resveratrol results in decreased secretion of IL13 protein
resveratrol results in decreased expression of IL13 mRNA
resveratrol results in decreased expression of IL13 protein
resveratrol results in decreased susceptibility to IL13 protein 		CTD PMID:22254182 PMID:22962611 PMID:22986054 PMID:23224687 PMID:23251493 More... NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il17a interleukin 17A multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; resveratrol inhibits the reaction [Glucose results in increased expression of IL17A mRNA]; resveratrol inhibits the reaction [Glucose results in increased secretion of IL17A protein]; resveratrol inhibits the reaction [imiquimod results in increased expression of IL17A mRNA]; resveratrol inhibits the reaction [tetrandrine inhibits the reaction [COL2A1 protein results in increased expression of IL17A protein]]
resveratrol results in decreased expression of IL17A mRNA
resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL17A mRNA] 		CTD PMID:18310510 PMID:23199342 PMID:23224687 PMID:24548422 PMID:25965695 More... NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17c interleukin 17C decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of IL17C mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL17C mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr19:67,393,435...67,394,714
Ensembl chr19:67,393,435...67,394,714 		JBrowse link
G Il17f interleukin 17F multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL17F mRNA CTD PMID:23557933 NCBI chr 9:30,686,532...30,697,918
Ensembl chr 9:30,686,538...30,697,918 		JBrowse link
G Il17rb interleukin 17 receptor B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of IL17RB mRNA CTD PMID:19167446 NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694 		JBrowse link
G Il18 interleukin 18 multiple interactions ISO
EXP 		resveratrol inhibits the reaction [BSG protein results in increased expression of and results in increased secretion of IL18 protein]; resveratrol inhibits the reaction [BSG protein results in increased expression of IL18 mRNA]; resveratrol inhibits the reaction [IL18 protein results in increased abundance of Reactive Oxygen Species]; resveratrol inhibits the reaction [IL18 protein results in increased expression of BSG mRNA]; resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL18 mRNA]; resveratrol promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL18 protein]
resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 protein]
Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of IL18 protein] 		CTD PMID:19561311 PMID:24149798 PMID:26464617 PMID:34614429 PMID:35156769 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il18bp interleukin 18 binding protein increases expression
multiple interactions 		EXP
ISO 		resveratrol results in increased expression of IL18BP mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL18BP mRNA 		CTD PMID:23557933 PMID:25905778 NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955 		JBrowse link
G Il19 interleukin 19 multiple interactions ISO resveratrol inhibits the reaction [imiquimod results in increased expression of IL19 mRNA] CTD PMID:25965695 NCBI chr13:44,949,989...44,958,714
Ensembl chr13:44,949,989...44,958,714 		JBrowse link
G Il1a interleukin 1 alpha decreases expression
multiple interactions 		ISO resveratrol analog results in decreased expression of IL1A mRNA
resveratrol results in decreased expression of IL1A mRNA
[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased activity of NFE2L2 protein; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased expression of GCLC mRNA; [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased expression of HMOX1 mRNA; Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased expression of HMOX1 mRNA]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein]; resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA]
[Resveratrol co-treated with Tetracyclines] inhibits the reaction [Paraquat results in increased expression of IL1A protein] 		CTD PMID:15652768 PMID:17929310 PMID:20706672 PMID:22933405 PMID:24707119 More... NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta decreases response to substance
decreases expression
decreases activity
increases secretion
multiple interactions
increases expression 		ISO
EXP 		IL1B protein results in decreased susceptibility to resveratrol; resveratrol results in decreased susceptibility to IL1B protein
resveratrol results in decreased expression of IL1B mRNA; resveratrol results in decreased expression of IL1B protein
resveratrol results in decreased activity of IL1B protein
resveratrol analog results in increased secretion of IL1B protein; resveratrol results in increased secretion of IL1B protein
[Fish Oils co-treated with Resveratrol] inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; [Resveratrol co-treated with raspberry ketone] inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA]; [Resveratrol co-treated with Streptozocin] results in increased expression of IL1B mRNA; Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of and results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK1 protein modified form]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK3 protein modified form]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK8 protein modified form]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK9 protein modified form]; Resveratrol inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Ammonia results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [chromium hexavalent ion results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Cisplatin results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Dimethylnitrosamine results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Ethanol results in increased expression of IL1B]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Ifosfamide results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Methotrexate results in increased expression of IL1B]; Resveratrol inhibits the reaction [Morphine results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Pilocarpine results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Pilocarpine results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [sulfoxaflor results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL1B mRNA]; Resveratrol promotes the reaction [Acetic Acid results in increased expression of IL1B protein]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]]; [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL1B mRNA; [Resveratrol co-treated with nano-diamino-tetrac] results in decreased expression of IL1B mRNA; [Resveratrol co-treated with nano-diamino-tetrac] results in decreased expression of IL1B protein; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of IL1B mRNA]; [Resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of IL1B mRNA]; [Resveratrol co-treated with TLR5 protein] results in increased secretion of IL1B protein; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP3 protein]; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL8 mRNA]]; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; KHSRP protein promotes the reaction [Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of TNF mRNA]]; Pertussis Toxin inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]; Pertussis Toxin inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]]; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL8 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol inhibits the reaction [[IL1B protein co-treated with Oligomycins] affects the localization of RELA protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased abundance of Dinoprostone]; Resveratrol inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of CXCL8 protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [[IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Resveratrol inhibits the reaction [ALB protein modified form results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ACAN mRNA]]; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]]; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SOX9 mRNA]]; Resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [IL1B protein results in decreased expression of COL2A1 protein]; Resveratrol inhibits the reaction [IL1B protein results in decreased expression of ITGB1 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased abundance of 8-epi-prostaglandin F2alpha]; Resveratrol inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Resveratrol inhibits the reaction [IL1B protein results in increased abundance of Leukotriene B4]; Resveratrol inhibits the reaction [IL1B protein results in increased abundance of Prostaglandin D2]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of and results in increased expression of F3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of F3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased activity of PAPPA protein]; Resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased degradation of IGFBP4 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of PTGS2 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of F3 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA protein]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of SERPINE1 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of TP53 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP1 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP13 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP3 protein]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of Reactive Oxygen Species]; Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Particulate Matter results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B protein]; Resveratrol promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; Resveratrol promotes the reaction [IL1B protein results in increased secretion of CXCL8 protein]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]; Tamoxifen promotes the reaction [Resveratrol inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]]
[Hyaluronic Acid co-treated with Resveratrol] results in decreased expression of IL1B mRNA; [Resveratrol co-treated with beta-1,3-glucan] results in increased secretion of IL1B protein; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Morphine results in increased expression of IL1B protein]]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK1 protein modified form]; Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK3 protein modified form]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Aluminum Chloride results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Arginine results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [bisphenol A promotes the reaction [Cholesterol results in increased secretion of IL1B protein]]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Ceruletide results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Morphine results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL1B protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Streptozocin results in increased expression of IL1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL1B protein]]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; tin protoporphyrin IX inhibits the reaction [Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]
resveratrol analog results in increased expression of IL1B mRNA
Resveratrol results in decreased expression of IL1B mRNA; Resveratrol results in decreased expression of IL1B protein 		CTD PMID:9974427 PMID:10496962 PMID:11376495 PMID:12689943 PMID:12871381 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression
multiple interactions
increases expression 		EXP
ISO 		resveratrol results in decreased expression of IL1RN mRNA
[resveratrol co-treated with 7-ketocholesterol] results in increased expression of IL1RN protein; resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1RN protein]
resveratrol results in increased expression of IL1RN mRNA 		CTD PMID:19228061 PMID:24707119 PMID:24895526 PMID:25905778 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 multiple interactions
decreases expression
affects expression
increases expression 		ISO resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]
resveratrol results in decreased expression of IL2 mRNA; resveratrol results in decreased expression of IL2 protein
resveratrol affects the expression of IL2 protein
resveratrol results in increased expression of IL2 protein 		CTD PMID:14996416 PMID:16154495 PMID:16256029 PMID:17872969 PMID:20730501 More... NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il20 interleukin 20 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of IL20 mRNA CTD PMID:19167446 NCBI chr13:44,933,249...44,936,893
Ensembl chr13:44,933,249...44,936,893 		JBrowse link
G Il20ra interleukin 20 receptor subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL20RA mRNA CTD PMID:23557933 NCBI chr 1:16,243,683...16,313,229
Ensembl chr 1:16,243,801...16,313,221 		JBrowse link
G Il23a interleukin 23 subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL23A mRNA CTD PMID:23557933 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il24 interleukin 24 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of IL24 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL24 mRNA 		CTD PMID:23224687 PMID:23557933 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760 		JBrowse link
G Il27 interleukin 27 multiple interactions ISO resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL27 protein] CTD PMID:22118570 NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258 		JBrowse link
G Il27ra interleukin 27 receptor subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IL27RA mRNA CTD PMID:23557933 NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha multiple interactions
decreases expression 		ISO resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL2RA protein]
resveratrol results in decreased expression of IL2RA protein 		CTD PMID:20715097 PMID:22962611 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il2rg interleukin 2 receptor subunit gamma multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL2RG mRNA CTD PMID:23557933 NCBI chr  X:70,435,340...70,439,052
Ensembl chr  X:70,435,343...70,439,161 		JBrowse link
G Il3 interleukin 3 decreases expression
multiple interactions 		ISO
EXP 		resveratrol results in decreased expression of IL3 mRNA
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL3 mRNA
resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased secretion of IL3 protein] 		CTD PMID:23224687 PMID:23557933 PMID:26621445 NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810 		JBrowse link
G Il31 interleukin 31 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL31 mRNA CTD PMID:23557933 NCBI chr12:38,756,231...38,765,917
Ensembl chr12:38,762,870...38,765,921 		JBrowse link
G Il34 interleukin 34 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL34 mRNA CTD PMID:23557933 NCBI chr19:55,624,368...55,690,576
Ensembl chr19:55,624,369...55,673,376 		JBrowse link
G Il36b interleukin 36, beta multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL36B mRNA CTD PMID:23557933 NCBI chr 3:27,422,980...27,521,344
Ensembl chr 3:27,423,171...27,428,678 		JBrowse link
G Il36g interleukin 36, gamma multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL36G mRNA CTD PMID:23557933 NCBI chr 3:27,346,675...27,352,839
Ensembl chr 3:27,346,670...27,352,834 		JBrowse link
G Il36rn interleukin 36 receptor antagonist multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL36RN mRNA CTD PMID:23557933 NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:27,442,709...27,449,306 		JBrowse link
G Il4 interleukin 4 affects expression
multiple interactions
decreases expression 		ISO
EXP 		resveratrol affects the expression of IL4 protein
Resveratrol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL4 protein]; Resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased secretion of IL4 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of IL4]
Resveratrol results in decreased expression of IL4 mRNA; Resveratrol results in decreased expression of IL4 protein
Resveratrol analog results in decreased expression of IL4 mRNA; Resveratrol analog results in decreased expression of IL4 protein
[Resveratrol co-treated with Tetracyclines] inhibits the reaction [Paraquat results in increased expression of IL4 protein] 		CTD PMID:20730501 PMID:22962611 PMID:22986054 PMID:23751068 PMID:24073240 More... NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 multiple interactions
decreases expression 		ISO resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein]
Resveratrol results in decreased expression of IL5 mRNA; Resveratrol results in decreased expression of IL5 protein 		CTD PMID:18776917 PMID:22986054 PMID:23751068 PMID:24073240 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 increases expression
decreases secretion
affects expression
decreases expression
multiple interactions
increases secretion
decreases expression 		ISO
EXP 		resveratrol analog results in increased expression of IL6 mRNA; resveratrol results in increased expression of IL6 mRNA
resveratrol results in decreased secretion of IL6 protein
resveratrol affects the expression of IL6 protein
resveratrol results in decreased expression of IL6; resveratrol results in decreased expression of IL6 mRNA; resveratrol results in decreased expression of IL6 protein
[Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Resveratrol co-treated with beta-1,3-glucan] results in increased secretion of IL6 protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Morphine results in increased expression of IL6 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; Fulvestrant inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; PNPLA2 protein promotes the reaction [Resveratrol results in decreased expression of IL6 mRNA]; Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]; Resveratrol analog inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Resveratrol analog inhibits the reaction [di-n-butyltin results in increased expression of IL6 mRNA]; Resveratrol analog inhibits the reaction [di-n-butyltin results in increased expression of IL6 protein]; Resveratrol analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [APP protein results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Arginine results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of IL6]; Resveratrol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Morphine results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Rotenone results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Smoke analog results in increased expression of and results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [stearic acid results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Streptozocin results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [TNF protein results in increased secretion of IL6 protein]; Resveratrol promotes the reaction [Acetaminophen results in increased expression of IL6 mRNA]; Resveratrol results in decreased expression of and results in decreased secretion of IL6 protein; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Streptozocin results in increased expression of IL6 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 protein]]; tin protoporphyrin IX inhibits the reaction [Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of IL6 protein; [Resveratrol co-treated with TLR2 protein] results in increased secretion of IL6 protein; [Resveratrol co-treated with TLR5 protein] results in increased secretion of IL6 protein; [TNF protein co-treated with Resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]; CREBBP mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; ESR1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [CREBBP protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [NCOA2 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [NCOA3 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [NCOR2 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [NMNAT1 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [RELA protein modified form binds to IL6 promoter]]; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [SIRT1 protein binds to IL6 promoter]]; Fulvestrant inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; Fulvestrant inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased secretion of IL6 protein]]; garcinol inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; NCOA2 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; NCOA3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; NMNAT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; parthenolide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; parthenolide inhibits the reaction [Resveratrol results in decreased expression of IL6 mRNA]; RCOR1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; Resveratrol affects the reaction [TNF protein promotes the reaction [KAT2B protein binds to IL6 promoter]]; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein]; Resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Paraquat results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [TNF protein inhibits the reaction [NCOA3 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein inhibits the reaction [RCOR1 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein promotes the reaction [EP300 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein promotes the reaction [RELA protein modified form binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein promotes the reaction [SIRT1 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein promotes the reaction [SIRT2 protein binds to IL6 promoter]]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [TNF protein results in increased secretion of IL6 protein]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Resveratrol promotes the reaction [TNF protein promotes the reaction [CREBBP protein binds to IL6 promoter]]; Resveratrol promotes the reaction [TNF protein promotes the reaction [NCOA2 protein binds to IL6 promoter]]; Resveratrol promotes the reaction [TNF protein promotes the reaction [NMNAT1 protein binds to IL6 promoter]]; Resveratrol results in decreased expression of and results in decreased secretion of IL6 protein; Resveratrol results in increased activity of [KITL protein co-treated with THPO protein co-treated with FLT3LG protein co-treated with IL6 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]]; SIRT1 protein promotes the reaction [Resveratrol results in decreased expression of and results in decreased secretion of IL6 protein]
[Resveratrol co-treated with Phenylephrine] results in increased expression of IL6 mRNA; [Resveratrol co-treated with raspberry ketone] inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; chromium mesoporphyrin inhibits the reaction [Resveratrol results in decreased activity of IL6 protein]; chromium mesoporphyrin inhibits the reaction [Resveratrol results in decreased expression of IL6 protein]; Fulvestrant inhibits the reaction [Resveratrol results in decreased expression of IL6 protein]; Leuprolide inhibits the reaction [Resveratrol results in decreased expression of IL6 protein]; Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Resveratrol affects the reaction [sulfoxaflor results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; Resveratrol inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Adenosine Triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; Resveratrol inhibits the reaction [Ammonia results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [bisphenol A results in decreased expression of IL6 protein]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Cisplatin results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Fenitrothion results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Fructose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Ifosfamide results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [Leuprolide results in decreased expression of IL6 protein]; Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Morphine results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [Resveratrol results in decreased expression of IL6 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]]; Wortmannin inhibits the reaction [Resveratrol results in decreased activity of IL6 protein]
resveratrol results in increased secretion of IL6 protein
resveratrol decreases expression of Tnfa and IL6 protein in striatum of heroin treated rats 		CTD
RGD		 PMID:11108930 PMID:15135313 PMID:15652768 PMID:15734790 PMID:15971681 More... RGD:598130076 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Il6st interleukin 6 cytokine family signal transducer multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of IL6ST mRNA CTD PMID:19167446 NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182 		JBrowse link
G Il7r interleukin 7 receptor increases expression ISO resveratrol results in increased expression of IL7R mRNA CTD PMID:12154049 NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027 		JBrowse link
G Il9 interleukin 9 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of IL9 mRNA
resveratrol results in decreased expression of IL9 protein 		CTD PMID:17872969 PMID:23557933 NCBI chr17:8,117,028...8,120,151
Ensembl chr17:8,117,028...8,120,151 		JBrowse link
G Ildr2 immunoglobulin-like domain containing receptor 2 multiple interactions ISO Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ILDR2 mRNA]
[Plant Extracts co-treated with Resveratrol] results in decreased expression of ILDR2 mRNA 		CTD PMID:23557933 PMID:31298478 NCBI chr13:81,051,723...81,113,590
Ensembl chr13:81,051,647...81,109,861 		JBrowse link
G Ilf2 interleukin enhancer binding factor 2 decreases expression ISO resveratrol results in decreased expression of ILF2 protein CTD PMID:25505154 NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:178,248,585...178,268,920 		JBrowse link
G Ilf3 interleukin enhancer binding factor 3 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of ILF3 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of ILF3 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612 		JBrowse link
G Ilkap ILK associated serine/threonine phosphatase multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of ILKAP mRNA CTD PMID:23557933 NCBI chr 9:99,413,981...99,436,262
Ensembl chr 9:99,413,978...99,436,418 		JBrowse link
G Ilvbl ilvB acetolactate synthase like multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of HACL2 mRNA CTD PMID:19167446 NCBI chr 7:11,690,445...11,700,498
Ensembl chr 7:11,690,445...11,700,498 		JBrowse link
G Immp1l inner mitochondrial membrane peptidase subunit 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of IMMP1L mRNA CTD PMID:19167446 NCBI chr 3:112,840,015...112,904,297
Ensembl chr 3:112,840,113...112,904,296 		JBrowse link
G Impact impact RWD domain protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IMPACT mRNA CTD PMID:23557933 NCBI chr18:4,383,546...4,422,280
Ensembl chr18:4,383,575...4,422,278 		JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 increases expression ISO resveratrol results in increased expression of IMPDH2 mRNA CTD PMID:19371625 NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873 		JBrowse link
G Ina internexin neuronal intermediate filament protein, alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INA mRNA CTD PMID:23557933 NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:255,838,129...255,849,680 		JBrowse link
G Inca1 inhibitor of CDK, cyclin A1 interacting protein 1 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INCA1 mRNA CTD PMID:23557933 NCBI chr10:55,900,610...55,912,975
Ensembl chr10:55,900,610...55,912,698 		JBrowse link
G Incenp inner centromere protein multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of INCENP mRNA
resveratrol results in decreased expression of INCENP protein 		CTD PMID:19167446 PMID:25505154 NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084 		JBrowse link
G Inha inhibin subunit alpha multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INHA mRNA CTD PMID:23557933 NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009 		JBrowse link
G Inhba inhibin subunit beta A increases expression ISO resveratrol results in increased expression of INHBA mRNA CTD PMID:11588890 NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508 		JBrowse link
G Inhbb inhibin subunit beta B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INHBB mRNA CTD PMID:23557933 NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609 		JBrowse link
G Inip INTS3 and NABP interacting protein multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INIP mRNA CTD PMID:23557933 NCBI chr 5:79,443,317...79,457,552
Ensembl chr 5:79,443,317...79,457,552 		JBrowse link
G Inpp4a inositol polyphosphate-4-phosphatase type I A increases expression ISO resveratrol results in increased expression of INPP4A protein CTD PMID:22986054 NCBI chr 9:47,024,064...47,142,391
Ensembl chr 9:47,087,471...47,135,968 		JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase type II B decreases expression ISO resveratrol results in decreased expression of INPP4B mRNA CTD PMID:18586690 PMID:19167446 NCBI chr19:42,824,710...43,575,039
Ensembl chr19:42,829,871...43,185,091 		JBrowse link
G Inpp5a inositol polyphosphate-5-phosphatase A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INPP5A mRNA CTD PMID:23557933 NCBI chr 1:203,619,676...203,810,035
Ensembl chr 1:203,619,637...203,810,028 		JBrowse link
G Inpp5b inositol polyphosphate-5-phosphatase B multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INPP5B mRNA CTD PMID:23557933 NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:142,281,418...142,345,991 		JBrowse link
G Inpp5e inositol polyphosphate-5-phosphatase E multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INPP5E mRNA CTD PMID:23557933 NCBI chr 3:29,614,868...29,627,542
Ensembl chr 3:29,614,868...29,627,542 		JBrowse link
G Ins1 insulin 1 multiple interactions
increases expression
decreases secretion
increases secretion 		EXP
ISO 		Resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of INS1 protein]; Resveratrol inhibits the reaction [bisphenol A results in increased expression of INS1 protein]; Resveratrol inhibits the reaction [Diazinon results in increased expression of INS1 protein]; Resveratrol inhibits the reaction [Dietary Fats inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Dietary Fats results in increased secretion of INS1 protein]; Resveratrol inhibits the reaction [Fructose results in increased expression of INS1 protein]; Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Resveratrol inhibits the reaction [INS1 protein promotes the reaction [IRS1 protein binds to PIK3R1 protein]]; Resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA]; Resveratrol inhibits the reaction [INS1 protein results in decreased expression of PCK1 mRNA]; Resveratrol inhibits the reaction [INS1 protein results in increased expression of FASN mRNA]; Resveratrol inhibits the reaction [INS1 protein results in increased expression of GCK mRNA]; Resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
Resveratrol results in increased expression of INS1 protein
Resveratrol results in decreased secretion of INS1 protein
Resveratrol inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein]
Resveratrol results in increased secretion of INS1 protein 		CTD PMID:16626303 PMID:17069794 PMID:17346750 PMID:17550345 PMID:17578889 More... NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Ins2 insulin 2 multiple interactions
increases response to substance
decreases expression
increases expression
decreases response to substance 		ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]]; resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]; resveratrol inhibits the reaction [INS protein results in increased expression of HIF1A protein]; resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; resveratrol inhibits the reaction [INS protein results in increased phosphorylation of FOXO4 protein]; resveratrol inhibits the reaction [IRS2 gene mutant form inhibits the reaction [INS protein results in increased expression of IRS2 protein]]; resveratrol inhibits the reaction [IRS2 gene mutant form inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; resveratrol inhibits the reaction [IRS2 gene mutant form inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; resveratrol inhibits the reaction [Streptozocin inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]
resveratrol results in increased susceptibility to INS protein
resveratrol results in decreased expression of INS protein
resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [INS protein results in increased uptake of Glucose]]; resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in decreased susceptibility to INS protein]
resveratrol results in increased expression of INS protein
INS protein results in decreased susceptibility to resveratrol; resveratrol results in decreased susceptibility to INS protein 		CTD PMID:15297429 PMID:16626303 PMID:17550345 PMID:20015842 PMID:20960276 More... NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Insig1 insulin induced gene 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA CTD PMID:19167446 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Insm1 INSM transcriptional repressor 1 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INSM1 mRNA
resveratrol results in decreased expression of INSM1 mRNA 		CTD PMID:12569576 PMID:23557933 NCBI chr 3:154,093,310...154,096,243
Ensembl chr 3:154,092,734...154,096,047 		JBrowse link
G Insm2 INSM transcriptional repressor 2 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INSM2 mRNA CTD PMID:23557933 NCBI chr 6:78,708,983...78,711,575
Ensembl chr 6:78,705,641...78,717,027 		JBrowse link
G Insr insulin receptor multiple interactions
increases phosphorylation 		ISO
EXP 		resveratrol inhibits the reaction [IRS2 gene mutant form inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; resveratrol inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of INSR protein]; resveratrol inhibits the reaction [Streptozocin inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]
resveratrol binds to and results in decreased phosphorylation of and results in decreased activity of INSR protein
resveratrol results in increased phosphorylation of INSR protein
ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of INSR protein]; fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of INSR protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of INSR protein] 		CTD PMID:18426865 PMID:22917016 PMID:22935344 PMID:25352008 PMID:25808216 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803 		JBrowse link
G Insrr insulin receptor-related receptor multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INSRR mRNA CTD PMID:23557933 NCBI chr 2:175,553,244...175,572,676
Ensembl chr 2:175,553,293...175,572,676 		JBrowse link
G Insyn2a inhibitory synaptic factor 2A multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INSYN2A mRNA CTD PMID:23557933 NCBI chr 1:199,127,735...199,183,077
Ensembl chr 1:198,962,151...199,182,799 		JBrowse link
G Ints10 integrator complex subunit 10 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INTS10 mRNA CTD PMID:23557933 NCBI chr16:25,682,818...25,735,840
Ensembl chr16:25,682,050...25,734,528 		JBrowse link
G Ints13 integrator complex subunit 13 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INTS13 mRNA CTD PMID:23557933 NCBI chr 4:181,190,438...181,222,235
Ensembl chr 4:181,189,765...181,222,235 		JBrowse link
G Ints14 integrator complex subunit 14 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INTS14 mRNA CTD PMID:23557933 NCBI chr 8:74,370,687...74,398,153
Ensembl chr 8:74,371,015...74,396,209 		JBrowse link
G Ints2 integrator complex subunit 2 decreases expression
multiple interactions 		ISO resveratrol results in decreased expression of INTS2 protein
[Plant Extracts co-treated with Resveratrol] results in increased expression of INTS2 mRNA 		CTD PMID:23557933 PMID:25505154 NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206 		JBrowse link
G Ints3 integrator complex subunit 3 multiple interactions
decreases expression 		ISO [Plant Extracts co-treated with Resveratrol] results in decreased expression of INTS3 mRNA
resveratrol results in decreased expression of INTS3 protein 		CTD PMID:23557933 PMID:25505154 NCBI chr 2:178,157,015...178,209,263
Ensembl chr 2:178,157,015...178,209,137 		JBrowse link
G Ints4 integrator complex subunit 4 decreases expression ISO resveratrol results in decreased expression of INTS4 protein CTD PMID:25505154 NCBI chr 1:161,201,284...161,265,042
Ensembl chr 1:161,197,708...161,269,124 		JBrowse link
G Ints5 integrator complex subunit 5 decreases expression ISO resveratrol results in decreased expression of INTS5 protein CTD PMID:25505154 NCBI chr 1:215,218,012...215,222,790
Ensembl chr 1:215,218,017...215,223,240 		JBrowse link
G Ints6 integrator complex subunit 6 decreases expression ISO resveratrol results in decreased expression of INTS6 protein CTD PMID:25505154 NCBI chr15:41,080,584...41,224,350
Ensembl chr15:41,109,125...41,197,519 		JBrowse link
G Ints6l integrator complex subunit 6 like multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of INTS6L mRNA CTD PMID:23557933 NCBI chr  X:139,295,490...139,363,090
Ensembl chr  X:139,295,512...139,359,161 		JBrowse link
G Ints7 integrator complex subunit 7 multiple interactions
decreases expression 		ISO [Coumestrol co-treated with resveratrol] results in increased expression of INTS7 mRNA
resveratrol results in decreased expression of INTS7 protein 		CTD PMID:19167446 PMID:25505154 NCBI chr13:105,686,208...105,739,609
Ensembl chr13:105,686,128...105,739,608 		JBrowse link
G Ints8 integrator complex subunit 8 decreases expression ISO resveratrol results in decreased expression of INTS8 protein CTD PMID:25505154 NCBI chr 5:29,094,475...29,141,874
Ensembl chr 5:29,094,475...29,142,099 		JBrowse link
G Ipo13 importin 13 increases expression ISO resveratrol results in increased expression of IPO13 mRNA CTD PMID:19371625 NCBI chr 5:136,719,204...136,740,118
Ensembl chr 5:136,719,204...136,741,847 		JBrowse link
G Ipo7 importin 7 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IPO7 mRNA CTD PMID:23557933 NCBI chr 1:173,497,472...173,537,707
Ensembl chr 1:173,497,503...173,536,778 		JBrowse link
G Ipo8 importin 8 multiple interactions ISO [Plant Extracts co-treated with Resveratrol] results in increased expression of IPO8 mRNA CTD PMID:23557933 NCBI chr 4:183,460,583...183,529,259
Ensembl chr 4:183,460,583...183,524,519 		JBrowse link
G Ipo9 importin 9 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in increased expression of IPO9 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of IPO9 mRNA CTD PMID:19167446 PMID:23557933 NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477 		JBrowse link
G Ipp intracisternal A particle-promoted polypeptide multiple interactions